_unit_id,_created_at,_id,_started_at,_tainted,_channel,_trust,_worker_id,_country,_region,_city,_ip,relations,step_1_select_the_valid_relations,step_2a_copy__paste_only_the_words_from_the_sentence_that_express_the_relation_you_selected_in_step1,step_2b_if_you_selected_none_in_step_1_explain_why,b1,b2,baselinedec,e1,e2,rel-type,sent_id,sentence,term1,term2
720315663,5/11/2015 23:13:05,1634425928,5/11/2015 23:12:54,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],caused,N/A,13,43,1,23,62,TWrex-cause,811415-FS1,Treatment of BRUCELLOSIS   +    caused by  BRUCELLA MELITENSIS.,BRUCELLOSIS,BRUCELLA MELITENSIS
720315663,5/11/2015 23:22:43,1634430401,5/11/2015 23:22:28,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],caused,N/A,13,43,1,23,62,TWrex-cause,811415-FS1,Treatment of BRUCELLOSIS   +    caused by  BRUCELLA MELITENSIS.,BRUCELLOSIS,BRUCELLA MELITENSIS
720315663,5/11/2015 23:38:39,1634439257,5/11/2015 23:38:24,false,instagc,1,27914150,USA,TX,Dallas,72.190.59.224,[CAUSES],[CAUSES],caused,n/s,13,43,1,23,62,TWrex-cause,811415-FS1,Treatment of BRUCELLOSIS   +    caused by  BRUCELLA MELITENSIS.,BRUCELLOSIS,BRUCELLA MELITENSIS
720315663,5/11/2015 23:45:10,1634442310,5/11/2015 23:44:35,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES] [TREATS],"[TREATS]
[CAUSES]",Treatment caused,n/a,13,43,1,23,62,TWrex-cause,811415-FS1,Treatment of BRUCELLOSIS   +    caused by  BRUCELLA MELITENSIS.,BRUCELLOSIS,BRUCELLA MELITENSIS
720315663,5/11/2015 23:52:35,1634445092,5/11/2015 23:52:21,false,neodev,1,32103286,USA,CA,San Jose,23.27.248.48,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,13,43,1,23,62,TWrex-cause,811415-FS1,Treatment of BRUCELLOSIS   +    caused by  BRUCELLA MELITENSIS.,BRUCELLOSIS,BRUCELLA MELITENSIS
720315663,5/11/2015 23:56:18,1634446510,5/11/2015 23:56:08,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],Treatment,n/a,13,43,1,23,62,TWrex-cause,811415-FS1,Treatment of BRUCELLOSIS   +    caused by  BRUCELLA MELITENSIS.,BRUCELLOSIS,BRUCELLA MELITENSIS
720315663,5/12/2015 00:26:56,1634457943,5/12/2015 00:25:29,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],caused by,causes,13,43,1,23,62,TWrex-cause,811415-FS1,Treatment of BRUCELLOSIS   +    caused by  BRUCELLA MELITENSIS.,BRUCELLOSIS,BRUCELLA MELITENSIS
720315663,5/12/2015 00:42:43,1634464122,5/12/2015 00:42:13,false,instagc,1,29411108,USA,OH,Fairfield,71.79.16.89,[TREATS] [CAUSES],"[TREATS]
[CAUSES]",Treatment caused,None,13,43,1,23,62,TWrex-cause,811415-FS1,Treatment of BRUCELLOSIS   +    caused by  BRUCELLA MELITENSIS.,BRUCELLOSIS,BRUCELLA MELITENSIS
720315663,5/12/2015 00:44:50,1634465295,5/12/2015 00:44:28,false,clixsense,1,22947672,GBR,"","",88.144.126.61,[CAUSES],[CAUSES],BRUCELLOSIS + caused by BRUCELLA MELITENSIS.,n/a,13,43,1,23,62,TWrex-cause,811415-FS1,Treatment of BRUCELLOSIS   +    caused by  BRUCELLA MELITENSIS.,BRUCELLOSIS,BRUCELLA MELITENSIS
720315663,5/12/2015 01:04:27,1634473760,5/12/2015 01:04:04,false,elite,1,31848723,USA,"","",155.94.185.207,[CONTRAINDICATES] [ASSOCIATED_WITH],"[CONTRAINDICATES]
[ASSOCIATED_WITH]",BRUCELLOSIS BRUCELLA MELITENSIS.,N/A,13,43,1,23,62,TWrex-cause,811415-FS1,Treatment of BRUCELLOSIS   +    caused by  BRUCELLA MELITENSIS.,BRUCELLOSIS,BRUCELLA MELITENSIS
720315663,5/12/2015 01:11:41,1634477488,5/12/2015 01:11:18,false,elite,1,32306791,NLD,"","",31.3.156.41,[PREVENTS],[PREVENTS],Treatment BRUCELLOSIS,yhtr,13,43,1,23,62,TWrex-cause,811415-FS1,Treatment of BRUCELLOSIS   +    caused by  BRUCELLA MELITENSIS.,BRUCELLOSIS,BRUCELLA MELITENSIS
720315663,5/12/2015 01:21:50,1634483207,5/12/2015 01:21:17,false,instagc,1,32556346,USA,PA,Warren,207.255.244.59,[CAUSES],[CAUSES],caused,N/A,13,43,1,23,62,TWrex-cause,811415-FS1,Treatment of BRUCELLOSIS   +    caused by  BRUCELLA MELITENSIS.,BRUCELLOSIS,BRUCELLA MELITENSIS
720315663,5/12/2015 01:27:50,1634486294,5/12/2015 01:27:29,false,instagc,1,30326470,USA,CA,San Diego,170.213.2.111,[TREATS] [CAUSES],"[TREATS]
[CAUSES]",Treatment caused,N/A,13,43,1,23,62,TWrex-cause,811415-FS1,Treatment of BRUCELLOSIS   +    caused by  BRUCELLA MELITENSIS.,BRUCELLOSIS,BRUCELLA MELITENSIS
720315663,5/12/2015 02:47:29,1634528087,5/12/2015 02:47:16,false,neodev,1,30749660,USA,NC,Durham,24.211.188.217,[DIAGNOSE_BY_TEST_OR_DRUG] [PREVENTS],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]",Treatment of BRUCELLOSIS,n/a,13,43,1,23,62,TWrex-cause,811415-FS1,Treatment of BRUCELLOSIS   +    caused by  BRUCELLA MELITENSIS.,BRUCELLOSIS,BRUCELLA MELITENSIS
720315663,5/12/2015 02:51:27,1634530104,5/12/2015 02:51:14,false,superrewards,1,24796792,USA,NY,New York,72.80.63.240,[CAUSES],[CAUSES],caused,n/a,13,43,1,23,62,TWrex-cause,811415-FS1,Treatment of BRUCELLOSIS   +    caused by  BRUCELLA MELITENSIS.,BRUCELLOSIS,BRUCELLA MELITENSIS
720315664,5/11/2015 22:20:25,1634402655,5/11/2015 22:20:03,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],HYPERTENSION,N/A,86,200,1,104,216,TWrex-cause,812868-FS1,"HYPERTENSION  Although mild or moderate hypertension does not usually cause headache, SEVERE HYPERTENSION from the following conditions can cause headache: acute pressor response to exogenous agents, PHEOCHROMOCYTOMA malignant hypertension, and preeclampsia and eclampsia.",SEVERE HYPERTENSION,PHEOCHROMOCYTOMA
720315664,5/11/2015 22:22:27,1634403637,5/11/2015 22:22:05,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],can cause,n/a,86,200,1,104,216,TWrex-cause,812868-FS1,"HYPERTENSION  Although mild or moderate hypertension does not usually cause headache, SEVERE HYPERTENSION from the following conditions can cause headache: acute pressor response to exogenous agents, PHEOCHROMOCYTOMA malignant hypertension, and preeclampsia and eclampsia.",SEVERE HYPERTENSION,PHEOCHROMOCYTOMA
720315664,5/11/2015 22:24:48,1634404706,5/11/2015 22:23:59,false,instagc,1,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],"SEVERE HYPERTENSION cause PHEOCHROMOCYTOMA malignant hypertension,",n/a,86,200,1,104,216,TWrex-cause,812868-FS1,"HYPERTENSION  Although mild or moderate hypertension does not usually cause headache, SEVERE HYPERTENSION from the following conditions can cause headache: acute pressor response to exogenous agents, PHEOCHROMOCYTOMA malignant hypertension, and preeclampsia and eclampsia.",SEVERE HYPERTENSION,PHEOCHROMOCYTOMA
720315664,5/11/2015 22:33:32,1634408239,5/11/2015 22:33:01,false,elite,1,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],from the following conditions,n/a,86,200,1,104,216,TWrex-cause,812868-FS1,"HYPERTENSION  Although mild or moderate hypertension does not usually cause headache, SEVERE HYPERTENSION from the following conditions can cause headache: acute pressor response to exogenous agents, PHEOCHROMOCYTOMA malignant hypertension, and preeclampsia and eclampsia.",SEVERE HYPERTENSION,PHEOCHROMOCYTOMA
720315664,5/11/2015 22:34:04,1634408620,5/11/2015 22:32:55,false,neodev,1,11460728,CAN,BC,Burnaby,70.79.16.165,[IS_A],[IS_A],SEVERE HYPERTENSION from the following conditions can cause headache: PHEOCHROMOCYTOMA,N/A,86,200,1,104,216,TWrex-cause,812868-FS1,"HYPERTENSION  Although mild or moderate hypertension does not usually cause headache, SEVERE HYPERTENSION from the following conditions can cause headache: acute pressor response to exogenous agents, PHEOCHROMOCYTOMA malignant hypertension, and preeclampsia and eclampsia.",SEVERE HYPERTENSION,PHEOCHROMOCYTOMA
720315664,5/11/2015 22:39:40,1634411378,5/11/2015 22:38:46,false,neodev,1,24564999,GBR,H9,London,86.145.227.9,[CAUSES],[CAUSES],SEVERE HYPERTENSION from PHEOCHROMOCYTOMA,n/a,86,200,1,104,216,TWrex-cause,812868-FS1,"HYPERTENSION  Although mild or moderate hypertension does not usually cause headache, SEVERE HYPERTENSION from the following conditions can cause headache: acute pressor response to exogenous agents, PHEOCHROMOCYTOMA malignant hypertension, and preeclampsia and eclampsia.",SEVERE HYPERTENSION,PHEOCHROMOCYTOMA
720315664,5/11/2015 22:43:03,1634412790,5/11/2015 22:42:08,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],cause,n/a,86,200,1,104,216,TWrex-cause,812868-FS1,"HYPERTENSION  Although mild or moderate hypertension does not usually cause headache, SEVERE HYPERTENSION from the following conditions can cause headache: acute pressor response to exogenous agents, PHEOCHROMOCYTOMA malignant hypertension, and preeclampsia and eclampsia.",SEVERE HYPERTENSION,PHEOCHROMOCYTOMA
720315664,5/11/2015 22:46:03,1634414172,5/11/2015 22:45:15,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],SEVERE HYPERTENSION response to PHEOCHROMOCYTOMA,n/a,86,200,1,104,216,TWrex-cause,812868-FS1,"HYPERTENSION  Although mild or moderate hypertension does not usually cause headache, SEVERE HYPERTENSION from the following conditions can cause headache: acute pressor response to exogenous agents, PHEOCHROMOCYTOMA malignant hypertension, and preeclampsia and eclampsia.",SEVERE HYPERTENSION,PHEOCHROMOCYTOMA
720315664,5/11/2015 22:48:11,1634415328,5/11/2015 22:47:12,false,instagc,1,28519532,USA,IA,Neola,38.121.112.217,[CAUSES],[CAUSES],cause,na,86,200,1,104,216,TWrex-cause,812868-FS1,"HYPERTENSION  Although mild or moderate hypertension does not usually cause headache, SEVERE HYPERTENSION from the following conditions can cause headache: acute pressor response to exogenous agents, PHEOCHROMOCYTOMA malignant hypertension, and preeclampsia and eclampsia.",SEVERE HYPERTENSION,PHEOCHROMOCYTOMA
720315664,5/11/2015 22:52:54,1634417201,5/11/2015 22:51:35,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],"HYPERTENSION Although mild or moderate hypertension does not usually cause headache, SEVERE HYPERTENSION from the following conditions can cause headache: acute pressor response to exogenous agents, PHEOCHROMOCYTOMA malignant hypertension, and preeclampsia and eclampsia.",N/A,86,200,1,104,216,TWrex-cause,812868-FS1,"HYPERTENSION  Although mild or moderate hypertension does not usually cause headache, SEVERE HYPERTENSION from the following conditions can cause headache: acute pressor response to exogenous agents, PHEOCHROMOCYTOMA malignant hypertension, and preeclampsia and eclampsia.",SEVERE HYPERTENSION,PHEOCHROMOCYTOMA
720315664,5/11/2015 22:57:56,1634418922,5/11/2015 22:57:18,false,bitcoinget,1,21743413,USA,WA,Lynnwood,75.147.181.53,[CAUSES],[CAUSES],can cause,N/A,86,200,1,104,216,TWrex-cause,812868-FS1,"HYPERTENSION  Although mild or moderate hypertension does not usually cause headache, SEVERE HYPERTENSION from the following conditions can cause headache: acute pressor response to exogenous agents, PHEOCHROMOCYTOMA malignant hypertension, and preeclampsia and eclampsia.",SEVERE HYPERTENSION,PHEOCHROMOCYTOMA
720315664,5/11/2015 23:01:08,1634419881,5/11/2015 22:59:54,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,[PART_OF] [SYMPTOM],"[SYMPTOM]
[PART_OF]",from the following,N/A,86,200,1,104,216,TWrex-cause,812868-FS1,"HYPERTENSION  Although mild or moderate hypertension does not usually cause headache, SEVERE HYPERTENSION from the following conditions can cause headache: acute pressor response to exogenous agents, PHEOCHROMOCYTOMA malignant hypertension, and preeclampsia and eclampsia.",SEVERE HYPERTENSION,PHEOCHROMOCYTOMA
720315664,5/11/2015 23:01:26,1634419992,5/11/2015 23:00:05,false,clixsense,1,6330007,AUS,06,Hobart,101.178.23.54,[MANIFESTATION],[MANIFESTATION],from following conditions,n/a,86,200,1,104,216,TWrex-cause,812868-FS1,"HYPERTENSION  Although mild or moderate hypertension does not usually cause headache, SEVERE HYPERTENSION from the following conditions can cause headache: acute pressor response to exogenous agents, PHEOCHROMOCYTOMA malignant hypertension, and preeclampsia and eclampsia.",SEVERE HYPERTENSION,PHEOCHROMOCYTOMA
720315664,5/11/2015 23:01:50,1634420143,5/11/2015 23:00:03,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],cause,N/A,86,200,1,104,216,TWrex-cause,812868-FS1,"HYPERTENSION  Although mild or moderate hypertension does not usually cause headache, SEVERE HYPERTENSION from the following conditions can cause headache: acute pressor response to exogenous agents, PHEOCHROMOCYTOMA malignant hypertension, and preeclampsia and eclampsia.",SEVERE HYPERTENSION,PHEOCHROMOCYTOMA
720315664,5/11/2015 23:03:43,1634420741,5/11/2015 23:03:10,false,clixsense,1,19294877,USA,MA,Brookline,71.174.185.107,[ASSOCIATED_WITH] [SIDE_EFFECT],"[ASSOCIATED_WITH]
[SIDE_EFFECT]","SEVERE HYPERTENSION from the following conditions can cause headache: PHEOCHROMOCYTOMA malignant hypertension,",n/a,86,200,1,104,216,TWrex-cause,812868-FS1,"HYPERTENSION  Although mild or moderate hypertension does not usually cause headache, SEVERE HYPERTENSION from the following conditions can cause headache: acute pressor response to exogenous agents, PHEOCHROMOCYTOMA malignant hypertension, and preeclampsia and eclampsia.",SEVERE HYPERTENSION,PHEOCHROMOCYTOMA
720315665,5/11/2015 23:14:23,1634426646,5/11/2015 23:14:04,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],positive effects,N/A,301,154,-1,314,165,TWrex-cause,800802-FS1,INDICATIONS  Introduction  • There are consensus recommendations supporting the use of vitamin therapy for the following conditions: ◊ Hyperlipidemia and VITAMIN B 3  (niacin): Niacin treatment of hyperlipidemia has been studied over the past 2 decades and continues to show broad positive effects on HYPERLIPIDEMIA management.,HYPERLIPIDEMIA,VITAMIN B 3
720315665,5/11/2015 23:24:59,1634431357,5/11/2015 23:24:26,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],positive effects,N/A,301,154,-1,314,165,TWrex-cause,800802-FS1,INDICATIONS  Introduction  • There are consensus recommendations supporting the use of vitamin therapy for the following conditions: ◊ Hyperlipidemia and VITAMIN B 3  (niacin): Niacin treatment of hyperlipidemia has been studied over the past 2 decades and continues to show broad positive effects on HYPERLIPIDEMIA management.,HYPERLIPIDEMIA,VITAMIN B 3
720315665,5/11/2015 23:40:31,1634440159,5/11/2015 23:40:12,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treatment,n/a,301,154,-1,314,165,TWrex-cause,800802-FS1,INDICATIONS  Introduction  • There are consensus recommendations supporting the use of vitamin therapy for the following conditions: ◊ Hyperlipidemia and VITAMIN B 3  (niacin): Niacin treatment of hyperlipidemia has been studied over the past 2 decades and continues to show broad positive effects on HYPERLIPIDEMIA management.,HYPERLIPIDEMIA,VITAMIN B 3
720315665,5/11/2015 23:53:32,1634445439,5/11/2015 23:53:19,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.48,[LOCATION] [CAUSES] [SYMPTOM] [NONE],"[CAUSES]
[LOCATION]
[SYMPTOM]
[NONE]",no,no,301,154,-1,314,165,TWrex-cause,800802-FS1,INDICATIONS  Introduction  • There are consensus recommendations supporting the use of vitamin therapy for the following conditions: ◊ Hyperlipidemia and VITAMIN B 3  (niacin): Niacin treatment of hyperlipidemia has been studied over the past 2 decades and continues to show broad positive effects on HYPERLIPIDEMIA management.,HYPERLIPIDEMIA,VITAMIN B 3
720315665,5/12/2015 00:33:18,1634460335,5/12/2015 00:32:03,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],use of treatment,treats,301,154,-1,314,165,TWrex-cause,800802-FS1,INDICATIONS  Introduction  • There are consensus recommendations supporting the use of vitamin therapy for the following conditions: ◊ Hyperlipidemia and VITAMIN B 3  (niacin): Niacin treatment of hyperlipidemia has been studied over the past 2 decades and continues to show broad positive effects on HYPERLIPIDEMIA management.,HYPERLIPIDEMIA,VITAMIN B 3
720315665,5/12/2015 00:47:09,1634466219,5/12/2015 00:45:39,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[TREATS],[TREATS],vitamin therapy for following conditions:,N/A,301,154,-1,314,165,TWrex-cause,800802-FS1,INDICATIONS  Introduction  • There are consensus recommendations supporting the use of vitamin therapy for the following conditions: ◊ Hyperlipidemia and VITAMIN B 3  (niacin): Niacin treatment of hyperlipidemia has been studied over the past 2 decades and continues to show broad positive effects on HYPERLIPIDEMIA management.,HYPERLIPIDEMIA,VITAMIN B 3
720315665,5/12/2015 00:48:04,1634466568,5/12/2015 00:47:20,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[TREATS],[TREATS],VITAMIN B 3 (niacin): treatment of HYPERLIPIDEMIA,n/a,301,154,-1,314,165,TWrex-cause,800802-FS1,INDICATIONS  Introduction  • There are consensus recommendations supporting the use of vitamin therapy for the following conditions: ◊ Hyperlipidemia and VITAMIN B 3  (niacin): Niacin treatment of hyperlipidemia has been studied over the past 2 decades and continues to show broad positive effects on HYPERLIPIDEMIA management.,HYPERLIPIDEMIA,VITAMIN B 3
720315665,5/12/2015 01:06:31,1634474756,5/12/2015 01:06:04,false,elite,1.0,31848723,USA,"","",155.94.185.207,[TREATS],[TREATS],INDICATIONS VITAMIN HYPERLIPIDEMIA,N/A,301,154,-1,314,165,TWrex-cause,800802-FS1,INDICATIONS  Introduction  • There are consensus recommendations supporting the use of vitamin therapy for the following conditions: ◊ Hyperlipidemia and VITAMIN B 3  (niacin): Niacin treatment of hyperlipidemia has been studied over the past 2 decades and continues to show broad positive effects on HYPERLIPIDEMIA management.,HYPERLIPIDEMIA,VITAMIN B 3
720315665,5/12/2015 01:13:05,1634478144,5/12/2015 01:12:45,false,elite,1.0,32306791,NLD,"","",31.3.156.41,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],consensus treatment,Asas,301,154,-1,314,165,TWrex-cause,800802-FS1,INDICATIONS  Introduction  • There are consensus recommendations supporting the use of vitamin therapy for the following conditions: ◊ Hyperlipidemia and VITAMIN B 3  (niacin): Niacin treatment of hyperlipidemia has been studied over the past 2 decades and continues to show broad positive effects on HYPERLIPIDEMIA management.,HYPERLIPIDEMIA,VITAMIN B 3
720315665,5/12/2015 01:24:33,1634484599,5/12/2015 01:24:02,false,instagc,1.0,32556346,USA,PA,Warren,207.255.244.59,[TREATS],[TREATS],therapy,N/A,301,154,-1,314,165,TWrex-cause,800802-FS1,INDICATIONS  Introduction  • There are consensus recommendations supporting the use of vitamin therapy for the following conditions: ◊ Hyperlipidemia and VITAMIN B 3  (niacin): Niacin treatment of hyperlipidemia has been studied over the past 2 decades and continues to show broad positive effects on HYPERLIPIDEMIA management.,HYPERLIPIDEMIA,VITAMIN B 3
720315665,5/12/2015 01:31:44,1634488272,5/12/2015 01:30:36,false,instagc,1.0,30326470,USA,CA,San Diego,170.213.2.111,[TREATS],[TREATS],treatment,N/A,301,154,-1,314,165,TWrex-cause,800802-FS1,INDICATIONS  Introduction  • There are consensus recommendations supporting the use of vitamin therapy for the following conditions: ◊ Hyperlipidemia and VITAMIN B 3  (niacin): Niacin treatment of hyperlipidemia has been studied over the past 2 decades and continues to show broad positive effects on HYPERLIPIDEMIA management.,HYPERLIPIDEMIA,VITAMIN B 3
720315665,5/12/2015 02:48:41,1634528743,5/12/2015 02:48:32,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",There are consensus recommendations,n/a,301,154,-1,314,165,TWrex-cause,800802-FS1,INDICATIONS  Introduction  • There are consensus recommendations supporting the use of vitamin therapy for the following conditions: ◊ Hyperlipidemia and VITAMIN B 3  (niacin): Niacin treatment of hyperlipidemia has been studied over the past 2 decades and continues to show broad positive effects on HYPERLIPIDEMIA management.,HYPERLIPIDEMIA,VITAMIN B 3
720315665,5/12/2015 03:21:43,1634545433,5/12/2015 03:21:24,false,bitcoinget,1,31256687,USA,NY,Brooklyn,24.146.181.193,[OTHER],[OTHER],and,n/a,301,154,-1,314,165,TWrex-cause,800802-FS1,INDICATIONS  Introduction  • There are consensus recommendations supporting the use of vitamin therapy for the following conditions: ◊ Hyperlipidemia and VITAMIN B 3  (niacin): Niacin treatment of hyperlipidemia has been studied over the past 2 decades and continues to show broad positive effects on HYPERLIPIDEMIA management.,HYPERLIPIDEMIA,VITAMIN B 3
720315665,5/12/2015 03:34:33,1634552646,5/12/2015 03:33:47,false,neodev,1,32087449,USA,TX,Dallas,64.31.33.227,[MANIFESTATION],[MANIFESTATION],VITAMIN B 3 HYPERLIPIDEMIA,N/A,301,154,-1,314,165,TWrex-cause,800802-FS1,INDICATIONS  Introduction  • There are consensus recommendations supporting the use of vitamin therapy for the following conditions: ◊ Hyperlipidemia and VITAMIN B 3  (niacin): Niacin treatment of hyperlipidemia has been studied over the past 2 decades and continues to show broad positive effects on HYPERLIPIDEMIA management.,HYPERLIPIDEMIA,VITAMIN B 3
720315665,5/12/2015 04:09:26,1634569358,5/12/2015 04:08:44,false,bitcoinget,1,31947120,USA,CA,Arcadia,104.33.83.169,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",the use of,N/A,301,154,-1,314,165,TWrex-cause,800802-FS1,INDICATIONS  Introduction  • There are consensus recommendations supporting the use of vitamin therapy for the following conditions: ◊ Hyperlipidemia and VITAMIN B 3  (niacin): Niacin treatment of hyperlipidemia has been studied over the past 2 decades and continues to show broad positive effects on HYPERLIPIDEMIA management.,HYPERLIPIDEMIA,VITAMIN B 3
720315666,5/11/2015 22:24:50,1634404705,5/11/2015 22:24:20,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[MANIFESTATION],[MANIFESTATION],OPTIC DISK,N/A,89,0,-1,120,21,TWrex-cause,802829-FS1,"SEPTO OPTIC DYSPLASIA    A rare developmental disorder of the brain and eye in which the OPTIC DISK AND SEPTUM PELLUCIDUM do not develop normally, resulting in blindness, hormonal deficiencies, learning disabilities, decreased muscular tone, and, occasionally, seizures.",OPTIC DISK AND SEPTUM PELLUCIDUM,SEPTO OPTIC DYSPLASIA
720315666,5/11/2015 22:26:07,1634405237,5/11/2015 22:25:48,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],developmental disorder,n/a,89,0,-1,120,21,TWrex-cause,802829-FS1,"SEPTO OPTIC DYSPLASIA    A rare developmental disorder of the brain and eye in which the OPTIC DISK AND SEPTUM PELLUCIDUM do not develop normally, resulting in blindness, hormonal deficiencies, learning disabilities, decreased muscular tone, and, occasionally, seizures.",OPTIC DISK AND SEPTUM PELLUCIDUM,SEPTO OPTIC DYSPLASIA
720315666,5/11/2015 22:34:02,1634408608,5/11/2015 22:33:13,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],"SEPTO OPTIC DYSPLASIA in which the OPTIC DISK AND SEPTUM PELLUCIDUM do not develop normally,",n/a,89,0,-1,120,21,TWrex-cause,802829-FS1,"SEPTO OPTIC DYSPLASIA    A rare developmental disorder of the brain and eye in which the OPTIC DISK AND SEPTUM PELLUCIDUM do not develop normally, resulting in blindness, hormonal deficiencies, learning disabilities, decreased muscular tone, and, occasionally, seizures.",OPTIC DISK AND SEPTUM PELLUCIDUM,SEPTO OPTIC DYSPLASIA
720315666,5/11/2015 22:43:49,1634413140,5/11/2015 22:42:11,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[LOCATION],[LOCATION],disorder of the brain and eye,n/a,89,0,-1,120,21,TWrex-cause,802829-FS1,"SEPTO OPTIC DYSPLASIA    A rare developmental disorder of the brain and eye in which the OPTIC DISK AND SEPTUM PELLUCIDUM do not develop normally, resulting in blindness, hormonal deficiencies, learning disabilities, decreased muscular tone, and, occasionally, seizures.",OPTIC DISK AND SEPTUM PELLUCIDUM,SEPTO OPTIC DYSPLASIA
720315666,5/11/2015 22:45:58,1634414134,5/11/2015 22:44:43,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[LOCATION] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[LOCATION]",SEPTO OPTIC DYSPLASIA A rare developmental disorder OPTIC DISK AND SEPTUM PELLUCIDUM,N/A,89,0,-1,120,21,TWrex-cause,802829-FS1,"SEPTO OPTIC DYSPLASIA    A rare developmental disorder of the brain and eye in which the OPTIC DISK AND SEPTUM PELLUCIDUM do not develop normally, resulting in blindness, hormonal deficiencies, learning disabilities, decreased muscular tone, and, occasionally, seizures.",OPTIC DISK AND SEPTUM PELLUCIDUM,SEPTO OPTIC DYSPLASIA
720315666,5/11/2015 22:48:24,1634415440,5/11/2015 22:47:52,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[CAUSES],[CAUSES],"SEPTO OPTIC DYSPLASIA in which the OPTIC DISK AND SEPTUM PELLUCIDUM do not develop normally,",n/a,89,0,-1,120,21,TWrex-cause,802829-FS1,"SEPTO OPTIC DYSPLASIA    A rare developmental disorder of the brain and eye in which the OPTIC DISK AND SEPTUM PELLUCIDUM do not develop normally, resulting in blindness, hormonal deficiencies, learning disabilities, decreased muscular tone, and, occasionally, seizures.",OPTIC DISK AND SEPTUM PELLUCIDUM,SEPTO OPTIC DYSPLASIA
720315666,5/11/2015 22:58:25,1634419080,5/11/2015 22:57:44,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],SEPTO OPTIC DYSPLASIA in which the OPTIC DISK AND SEPTUM PELLUCIDUM,n/a,89,0,-1,120,21,TWrex-cause,802829-FS1,"SEPTO OPTIC DYSPLASIA    A rare developmental disorder of the brain and eye in which the OPTIC DISK AND SEPTUM PELLUCIDUM do not develop normally, resulting in blindness, hormonal deficiencies, learning disabilities, decreased muscular tone, and, occasionally, seizures.",OPTIC DISK AND SEPTUM PELLUCIDUM,SEPTO OPTIC DYSPLASIA
720315666,5/11/2015 23:03:39,1634420702,5/11/2015 23:03:10,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,75.147.181.53,[MANIFESTATION],[MANIFESTATION],in which the,N/A,89,0,-1,120,21,TWrex-cause,802829-FS1,"SEPTO OPTIC DYSPLASIA    A rare developmental disorder of the brain and eye in which the OPTIC DISK AND SEPTUM PELLUCIDUM do not develop normally, resulting in blindness, hormonal deficiencies, learning disabilities, decreased muscular tone, and, occasionally, seizures.",OPTIC DISK AND SEPTUM PELLUCIDUM,SEPTO OPTIC DYSPLASIA
720315666,5/11/2015 23:08:20,1634422586,5/11/2015 23:07:57,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],in which the,N/A,89,0,-1,120,21,TWrex-cause,802829-FS1,"SEPTO OPTIC DYSPLASIA    A rare developmental disorder of the brain and eye in which the OPTIC DISK AND SEPTUM PELLUCIDUM do not develop normally, resulting in blindness, hormonal deficiencies, learning disabilities, decreased muscular tone, and, occasionally, seizures.",OPTIC DISK AND SEPTUM PELLUCIDUM,SEPTO OPTIC DYSPLASIA
720315666,5/11/2015 23:09:41,1634423554,5/11/2015 23:07:53,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[LOCATION],[LOCATION],"SEPTO OPTIC DYSPLASIA A rare developmental disorder of the brain and eye in which the OPTIC DISK AND SEPTUM PELLUCIDUM do not develop normally, resulting in blindness, hormonal deficiencies, learning disabilities, decreased muscular tone, and, occasionally, seizures.",N/A,89,0,-1,120,21,TWrex-cause,802829-FS1,"SEPTO OPTIC DYSPLASIA    A rare developmental disorder of the brain and eye in which the OPTIC DISK AND SEPTUM PELLUCIDUM do not develop normally, resulting in blindness, hormonal deficiencies, learning disabilities, decreased muscular tone, and, occasionally, seizures.",OPTIC DISK AND SEPTUM PELLUCIDUM,SEPTO OPTIC DYSPLASIA
720315666,5/11/2015 23:12:17,1634425427,5/11/2015 23:11:37,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,[ASSOCIATED_WITH],[ASSOCIATED_WITH],AND,both do not develop normally,89,0,-1,120,21,TWrex-cause,802829-FS1,"SEPTO OPTIC DYSPLASIA    A rare developmental disorder of the brain and eye in which the OPTIC DISK AND SEPTUM PELLUCIDUM do not develop normally, resulting in blindness, hormonal deficiencies, learning disabilities, decreased muscular tone, and, occasionally, seizures.",OPTIC DISK AND SEPTUM PELLUCIDUM,SEPTO OPTIC DYSPLASIA
720315666,5/11/2015 23:13:00,1634425877,5/11/2015 23:11:39,false,elite,1,30957357,CAN,BC,Kelowna,24.71.41.51,[OTHER],[OTHER],"do not develop normally,",n/a,89,0,-1,120,21,TWrex-cause,802829-FS1,"SEPTO OPTIC DYSPLASIA    A rare developmental disorder of the brain and eye in which the OPTIC DISK AND SEPTUM PELLUCIDUM do not develop normally, resulting in blindness, hormonal deficiencies, learning disabilities, decreased muscular tone, and, occasionally, seizures.",OPTIC DISK AND SEPTUM PELLUCIDUM,SEPTO OPTIC DYSPLASIA
720315666,5/11/2015 23:15:00,1634427008,5/11/2015 23:13:28,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],developmental disorder brain,N/A,89,0,-1,120,21,TWrex-cause,802829-FS1,"SEPTO OPTIC DYSPLASIA    A rare developmental disorder of the brain and eye in which the OPTIC DISK AND SEPTUM PELLUCIDUM do not develop normally, resulting in blindness, hormonal deficiencies, learning disabilities, decreased muscular tone, and, occasionally, seizures.",OPTIC DISK AND SEPTUM PELLUCIDUM,SEPTO OPTIC DYSPLASIA
720315666,5/11/2015 23:15:16,1634427101,5/11/2015 23:13:04,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,[MANIFESTATION],[MANIFESTATION],disorder in which,n/a,89,0,-1,120,21,TWrex-cause,802829-FS1,"SEPTO OPTIC DYSPLASIA    A rare developmental disorder of the brain and eye in which the OPTIC DISK AND SEPTUM PELLUCIDUM do not develop normally, resulting in blindness, hormonal deficiencies, learning disabilities, decreased muscular tone, and, occasionally, seizures.",OPTIC DISK AND SEPTUM PELLUCIDUM,SEPTO OPTIC DYSPLASIA
720315666,5/11/2015 23:19:04,1634428693,5/11/2015 23:16:34,false,clixsense,1,28457001,CAN,ON,North Bay,24.204.202.220,[SYMPTOM],[SYMPTOM],in which,n/a,89,0,-1,120,21,TWrex-cause,802829-FS1,"SEPTO OPTIC DYSPLASIA    A rare developmental disorder of the brain and eye in which the OPTIC DISK AND SEPTUM PELLUCIDUM do not develop normally, resulting in blindness, hormonal deficiencies, learning disabilities, decreased muscular tone, and, occasionally, seizures.",OPTIC DISK AND SEPTUM PELLUCIDUM,SEPTO OPTIC DYSPLASIA
720315667,5/11/2015 23:27:23,1634432277,5/11/2015 23:27:05,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,N/A,90,60,-1,99,68,TWrex-cause,803919-FS1,"Chirurgi VA, Edelstein H, Oster SE et al. Ceftibuten versus CEFACLOR for the treatment of BRONCHITIS",BRONCHITIS,CEFACLOR
720315667,5/11/2015 23:42:45,1634441147,5/11/2015 23:42:34,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treatment,n/a,90,60,-1,99,68,TWrex-cause,803919-FS1,"Chirurgi VA, Edelstein H, Oster SE et al. Ceftibuten versus CEFACLOR for the treatment of BRONCHITIS",BRONCHITIS,CEFACLOR
720315667,5/11/2015 23:54:52,1634446056,5/11/2015 23:54:40,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.48,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,90,60,-1,99,68,TWrex-cause,803919-FS1,"Chirurgi VA, Edelstein H, Oster SE et al. Ceftibuten versus CEFACLOR for the treatment of BRONCHITIS",BRONCHITIS,CEFACLOR
720315667,5/12/2015 00:40:20,1634463090,5/12/2015 00:38:23,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],for the treatment,N/A,90,60,-1,99,68,TWrex-cause,803919-FS1,"Chirurgi VA, Edelstein H, Oster SE et al. Ceftibuten versus CEFACLOR for the treatment of BRONCHITIS",BRONCHITIS,CEFACLOR
720315667,5/12/2015 00:50:33,1634467473,5/12/2015 00:50:05,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[TREATS],[TREATS],treatment of,N/A,90,60,-1,99,68,TWrex-cause,803919-FS1,"Chirurgi VA, Edelstein H, Oster SE et al. Ceftibuten versus CEFACLOR for the treatment of BRONCHITIS",BRONCHITIS,CEFACLOR
720315667,5/12/2015 00:52:28,1634468248,5/12/2015 00:51:53,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[TREATS],[TREATS],CEFACLOR treatment of BRONCHITIS,n/a,90,60,-1,99,68,TWrex-cause,803919-FS1,"Chirurgi VA, Edelstein H, Oster SE et al. Ceftibuten versus CEFACLOR for the treatment of BRONCHITIS",BRONCHITIS,CEFACLOR
720315667,5/12/2015 01:09:01,1634476047,5/12/2015 01:08:38,false,elite,1.0,31848723,USA,"","",155.94.185.207,[SYMPTOM],[SYMPTOM],CEFACLOR BRONCHITIS,N/A,90,60,-1,99,68,TWrex-cause,803919-FS1,"Chirurgi VA, Edelstein H, Oster SE et al. Ceftibuten versus CEFACLOR for the treatment of BRONCHITIS",BRONCHITIS,CEFACLOR
720315667,5/12/2015 01:15:51,1634479774,5/12/2015 01:15:37,false,elite,1.0,32306791,NLD,"","",31.3.156.41,[PREVENTS],[PREVENTS],Edelstein Ceftibuten,gdf,90,60,-1,99,68,TWrex-cause,803919-FS1,"Chirurgi VA, Edelstein H, Oster SE et al. Ceftibuten versus CEFACLOR for the treatment of BRONCHITIS",BRONCHITIS,CEFACLOR
720315667,5/12/2015 01:26:32,1634485606,5/12/2015 01:26:15,false,instagc,1.0,32556346,USA,PA,Warren,207.255.244.59,[TREATS],[TREATS],treatment,N/A,90,60,-1,99,68,TWrex-cause,803919-FS1,"Chirurgi VA, Edelstein H, Oster SE et al. Ceftibuten versus CEFACLOR for the treatment of BRONCHITIS",BRONCHITIS,CEFACLOR
720315667,5/12/2015 01:36:19,1634490665,5/12/2015 01:35:30,false,instagc,1.0,30326470,USA,CA,San Diego,170.213.2.111,[TREATS],[TREATS],for the treatment of,N/A,90,60,-1,99,68,TWrex-cause,803919-FS1,"Chirurgi VA, Edelstein H, Oster SE et al. Ceftibuten versus CEFACLOR for the treatment of BRONCHITIS",BRONCHITIS,CEFACLOR
720315667,5/12/2015 03:23:31,1634546599,5/12/2015 03:23:16,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[TREATS],[TREATS],treatment,n/a,90,60,-1,99,68,TWrex-cause,803919-FS1,"Chirurgi VA, Edelstein H, Oster SE et al. Ceftibuten versus CEFACLOR for the treatment of BRONCHITIS",BRONCHITIS,CEFACLOR
720315667,5/12/2015 03:37:44,1634554108,5/12/2015 03:37:22,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.227,[LOCATION],[LOCATION],CEFACLOR BRONCHITIS,N/A,90,60,-1,99,68,TWrex-cause,803919-FS1,"Chirurgi VA, Edelstein H, Oster SE et al. Ceftibuten versus CEFACLOR for the treatment of BRONCHITIS",BRONCHITIS,CEFACLOR
720315667,5/12/2015 04:11:30,1634570461,5/12/2015 04:11:16,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[TREATS],[TREATS],treatment,N/A,90,60,-1,99,68,TWrex-cause,803919-FS1,"Chirurgi VA, Edelstein H, Oster SE et al. Ceftibuten versus CEFACLOR for the treatment of BRONCHITIS",BRONCHITIS,CEFACLOR
720315667,5/12/2015 04:45:10,1634586425,5/12/2015 04:44:39,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treatment,none,90,60,-1,99,68,TWrex-cause,803919-FS1,"Chirurgi VA, Edelstein H, Oster SE et al. Ceftibuten versus CEFACLOR for the treatment of BRONCHITIS",BRONCHITIS,CEFACLOR
720315667,5/12/2015 05:00:48,1634594130,5/12/2015 05:00:32,false,neodev,1,31910622,USA,CA,Los Angeles,108.185.211.151,[TREATS],[TREATS],the treatment of,I didn´t select none.,90,60,-1,99,68,TWrex-cause,803919-FS1,"Chirurgi VA, Edelstein H, Oster SE et al. Ceftibuten versus CEFACLOR for the treatment of BRONCHITIS",BRONCHITIS,CEFACLOR
720315668,5/11/2015 23:56:13,1634446467,5/11/2015 23:56:00,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.48,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,96,166,1,143,194,TWrex-cause,814092-FS1,"Kay GN, Pressley JC, Packer DL, et al: Value of the 12 lead electrocardiogram in discriminating ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA from circus movement ATRIOVENTRICULAR TACHYCARDIA utilizing a retrograde accessory pathway.",ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA,ATRIOVENTRICULAR TACHYCARDIA
720315668,5/12/2015 00:50:48,1634467579,5/12/2015 00:48:11,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],from,N/A,96,166,1,143,194,TWrex-cause,814092-FS1,"Kay GN, Pressley JC, Packer DL, et al: Value of the 12 lead electrocardiogram in discriminating ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA from circus movement ATRIOVENTRICULAR TACHYCARDIA utilizing a retrograde accessory pathway.",ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA,ATRIOVENTRICULAR TACHYCARDIA
720315668,5/12/2015 00:55:41,1634469577,5/12/2015 00:54:42,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[ASSOCIATED_WITH] [OTHER],"[ASSOCIATED_WITH]
[OTHER]",ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA from ATRIOVENTRICULAR TACHYCARDIA,n/a,96,166,1,143,194,TWrex-cause,814092-FS1,"Kay GN, Pressley JC, Packer DL, et al: Value of the 12 lead electrocardiogram in discriminating ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA from circus movement ATRIOVENTRICULAR TACHYCARDIA utilizing a retrograde accessory pathway.",ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA,ATRIOVENTRICULAR TACHYCARDIA
720315668,5/12/2015 00:55:50,1634469685,5/12/2015 00:55:05,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[NONE],[NONE],N/A,N/A,96,166,1,143,194,TWrex-cause,814092-FS1,"Kay GN, Pressley JC, Packer DL, et al: Value of the 12 lead electrocardiogram in discriminating ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA from circus movement ATRIOVENTRICULAR TACHYCARDIA utilizing a retrograde accessory pathway.",ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA,ATRIOVENTRICULAR TACHYCARDIA
720315668,5/12/2015 01:11:57,1634477637,5/12/2015 01:11:27,false,elite,1.0,31848723,USA,"","",155.94.185.207,[ASSOCIATED_WITH],[ASSOCIATED_WITH],ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA ATRIOVENTRICULAR TACHYCARDIA,N/A,96,166,1,143,194,TWrex-cause,814092-FS1,"Kay GN, Pressley JC, Packer DL, et al: Value of the 12 lead electrocardiogram in discriminating ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA from circus movement ATRIOVENTRICULAR TACHYCARDIA utilizing a retrograde accessory pathway.",ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA,ATRIOVENTRICULAR TACHYCARDIA
720315668,5/12/2015 01:27:41,1634486208,5/12/2015 01:27:19,false,elite,1.0,32306791,USA,TX,Dallas,69.162.75.37,[PREVENTS],[PREVENTS],ATRIOVENTRICULAR TACHYCARDIA,N/a,96,166,1,143,194,TWrex-cause,814092-FS1,"Kay GN, Pressley JC, Packer DL, et al: Value of the 12 lead electrocardiogram in discriminating ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA from circus movement ATRIOVENTRICULAR TACHYCARDIA utilizing a retrograde accessory pathway.",ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA,ATRIOVENTRICULAR TACHYCARDIA
720315668,5/12/2015 01:28:31,1634486582,5/12/2015 01:27:54,false,instagc,1.0,32556346,USA,PA,Warren,207.255.244.59,[PART_OF],[PART_OF],accessory,N/A,96,166,1,143,194,TWrex-cause,814092-FS1,"Kay GN, Pressley JC, Packer DL, et al: Value of the 12 lead electrocardiogram in discriminating ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA from circus movement ATRIOVENTRICULAR TACHYCARDIA utilizing a retrograde accessory pathway.",ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA,ATRIOVENTRICULAR TACHYCARDIA
720315668,5/12/2015 01:39:55,1634492845,5/12/2015 01:38:28,false,instagc,1.0,30326470,USA,CA,San Diego,170.213.2.111,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],electrocardiogram in discriminating,N/A,96,166,1,143,194,TWrex-cause,814092-FS1,"Kay GN, Pressley JC, Packer DL, et al: Value of the 12 lead electrocardiogram in discriminating ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA from circus movement ATRIOVENTRICULAR TACHYCARDIA utilizing a retrograde accessory pathway.",ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA,ATRIOVENTRICULAR TACHYCARDIA
720315668,5/12/2015 03:25:04,1634547494,5/12/2015 03:24:44,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[LOCATION],[LOCATION],movement,n/a,96,166,1,143,194,TWrex-cause,814092-FS1,"Kay GN, Pressley JC, Packer DL, et al: Value of the 12 lead electrocardiogram in discriminating ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA from circus movement ATRIOVENTRICULAR TACHYCARDIA utilizing a retrograde accessory pathway.",ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA,ATRIOVENTRICULAR TACHYCARDIA
720315668,5/12/2015 03:41:13,1634555734,5/12/2015 03:40:45,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.227,[TREATS],[TREATS],ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA ATRIOVENTRICULAR TACHYCARDIA,N/A,96,166,1,143,194,TWrex-cause,814092-FS1,"Kay GN, Pressley JC, Packer DL, et al: Value of the 12 lead electrocardiogram in discriminating ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA from circus movement ATRIOVENTRICULAR TACHYCARDIA utilizing a retrograde accessory pathway.",ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA,ATRIOVENTRICULAR TACHYCARDIA
720315668,5/12/2015 04:14:43,1634571976,5/12/2015 04:13:12,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[NONE],[NONE],N/A,using 12 lead electrocardiogram can help differentiate atrioventricular nodal reciprocating tachycardia from movement of atrioventricular tachycardia.,96,166,1,143,194,TWrex-cause,814092-FS1,"Kay GN, Pressley JC, Packer DL, et al: Value of the 12 lead electrocardiogram in discriminating ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA from circus movement ATRIOVENTRICULAR TACHYCARDIA utilizing a retrograde accessory pathway.",ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA,ATRIOVENTRICULAR TACHYCARDIA
720315668,5/12/2015 04:49:27,1634588414,5/12/2015 04:47:41,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA and   ATRIOVENTRICULAR TACHYCARDIA are two different conditions diagnosed with an EKG,96,166,1,143,194,TWrex-cause,814092-FS1,"Kay GN, Pressley JC, Packer DL, et al: Value of the 12 lead electrocardiogram in discriminating ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA from circus movement ATRIOVENTRICULAR TACHYCARDIA utilizing a retrograde accessory pathway.",ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA,ATRIOVENTRICULAR TACHYCARDIA
720315668,5/12/2015 05:04:26,1634596290,5/12/2015 05:03:19,false,neodev,1.0,31910622,USA,CA,Los Angeles,108.185.211.151,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],utilizing a retrograde accessory pathway.,I didn´t select none.,96,166,1,143,194,TWrex-cause,814092-FS1,"Kay GN, Pressley JC, Packer DL, et al: Value of the 12 lead electrocardiogram in discriminating ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA from circus movement ATRIOVENTRICULAR TACHYCARDIA utilizing a retrograde accessory pathway.",ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA,ATRIOVENTRICULAR TACHYCARDIA
720315668,5/12/2015 05:51:48,1634626390,5/12/2015 05:50:28,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,[IS_A],[IS_A],discriminating,N/A,96,166,1,143,194,TWrex-cause,814092-FS1,"Kay GN, Pressley JC, Packer DL, et al: Value of the 12 lead electrocardiogram in discriminating ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA from circus movement ATRIOVENTRICULAR TACHYCARDIA utilizing a retrograde accessory pathway.",ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA,ATRIOVENTRICULAR TACHYCARDIA
720315668,5/12/2015 06:16:43,1634638412,5/12/2015 06:15:27,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.56,[OTHER],[OTHER],TACHYCARDIA,N/A,96,166,1,143,194,TWrex-cause,814092-FS1,"Kay GN, Pressley JC, Packer DL, et al: Value of the 12 lead electrocardiogram in discriminating ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA from circus movement ATRIOVENTRICULAR TACHYCARDIA utilizing a retrograde accessory pathway.",ATRIOVENTRICULAR NODAL RECIPROCATING TACHYCARDIA,ATRIOVENTRICULAR TACHYCARDIA
720315669,5/11/2015 23:29:24,1634433285,5/11/2015 23:29:04,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treated,N/A,65,99,-1,77,113,TWrex-cause,804051-FS1,"Some autonomic symptoms can be treated effectively; for example, GASTROPARESIS can be treated with METOCLOPRAMIDE and orthostatism can be treated with support hose, volume expansion, and vasopressors such as midodrine.",GASTROPARESIS,METOCLOPRAMIDE
720315669,5/11/2015 23:43:30,1634441566,5/11/2015 23:43:21,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treated,n/a,65,99,-1,77,113,TWrex-cause,804051-FS1,"Some autonomic symptoms can be treated effectively; for example, GASTROPARESIS can be treated with METOCLOPRAMIDE and orthostatism can be treated with support hose, volume expansion, and vasopressors such as midodrine.",GASTROPARESIS,METOCLOPRAMIDE
720315669,5/11/2015 23:55:41,1634446357,5/11/2015 23:55:27,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.48,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,65,99,-1,77,113,TWrex-cause,804051-FS1,"Some autonomic symptoms can be treated effectively; for example, GASTROPARESIS can be treated with METOCLOPRAMIDE and orthostatism can be treated with support hose, volume expansion, and vasopressors such as midodrine.",GASTROPARESIS,METOCLOPRAMIDE
720315669,5/12/2015 00:47:02,1634466182,5/12/2015 00:45:47,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treated with,N/A,65,99,-1,77,113,TWrex-cause,804051-FS1,"Some autonomic symptoms can be treated effectively; for example, GASTROPARESIS can be treated with METOCLOPRAMIDE and orthostatism can be treated with support hose, volume expansion, and vasopressors such as midodrine.",GASTROPARESIS,METOCLOPRAMIDE
720315669,5/12/2015 00:53:07,1634468481,5/12/2015 00:52:11,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[TREATS],[TREATS],treated METOCLOPRAMIDE orthostatism treated,None,65,99,-1,77,113,TWrex-cause,804051-FS1,"Some autonomic symptoms can be treated effectively; for example, GASTROPARESIS can be treated with METOCLOPRAMIDE and orthostatism can be treated with support hose, volume expansion, and vasopressors such as midodrine.",GASTROPARESIS,METOCLOPRAMIDE
720315669,5/12/2015 00:54:11,1634468909,5/12/2015 00:53:49,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[TREATS],[TREATS],GASTROPARESIS can be treated with METOCLOPRAMIDE,n/a,65,99,-1,77,113,TWrex-cause,804051-FS1,"Some autonomic symptoms can be treated effectively; for example, GASTROPARESIS can be treated with METOCLOPRAMIDE and orthostatism can be treated with support hose, volume expansion, and vasopressors such as midodrine.",GASTROPARESIS,METOCLOPRAMIDE
720315669,5/12/2015 01:10:49,1634477072,5/12/2015 01:10:07,false,elite,1.0,31848723,USA,"","",155.94.185.207,[ASSOCIATED_WITH],[ASSOCIATED_WITH],GASTROPARESIS METOCLOPRAMIDE,N/A,65,99,-1,77,113,TWrex-cause,804051-FS1,"Some autonomic symptoms can be treated effectively; for example, GASTROPARESIS can be treated with METOCLOPRAMIDE and orthostatism can be treated with support hose, volume expansion, and vasopressors such as midodrine.",GASTROPARESIS,METOCLOPRAMIDE
720315669,5/12/2015 01:26:55,1634485772,5/12/2015 01:26:23,false,elite,1.0,32306791,USA,TX,Dallas,69.162.75.37,[MANIFESTATION],[MANIFESTATION],"expansion, and",wre,65,99,-1,77,113,TWrex-cause,804051-FS1,"Some autonomic symptoms can be treated effectively; for example, GASTROPARESIS can be treated with METOCLOPRAMIDE and orthostatism can be treated with support hose, volume expansion, and vasopressors such as midodrine.",GASTROPARESIS,METOCLOPRAMIDE
720315669,5/12/2015 01:27:38,1634486189,5/12/2015 01:27:20,false,instagc,1.0,32556346,USA,PA,Warren,207.255.244.59,[TREATS],[TREATS],treated,N/A,65,99,-1,77,113,TWrex-cause,804051-FS1,"Some autonomic symptoms can be treated effectively; for example, GASTROPARESIS can be treated with METOCLOPRAMIDE and orthostatism can be treated with support hose, volume expansion, and vasopressors such as midodrine.",GASTROPARESIS,METOCLOPRAMIDE
720315669,5/12/2015 01:37:51,1634491536,5/12/2015 01:37:30,false,instagc,1.0,30326470,USA,CA,San Diego,170.213.2.111,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",be treated,N/A,65,99,-1,77,113,TWrex-cause,804051-FS1,"Some autonomic symptoms can be treated effectively; for example, GASTROPARESIS can be treated with METOCLOPRAMIDE and orthostatism can be treated with support hose, volume expansion, and vasopressors such as midodrine.",GASTROPARESIS,METOCLOPRAMIDE
720315669,5/12/2015 03:24:21,1634547104,5/12/2015 03:24:07,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[TREATS],[TREATS],treated,n/a,65,99,-1,77,113,TWrex-cause,804051-FS1,"Some autonomic symptoms can be treated effectively; for example, GASTROPARESIS can be treated with METOCLOPRAMIDE and orthostatism can be treated with support hose, volume expansion, and vasopressors such as midodrine.",GASTROPARESIS,METOCLOPRAMIDE
720315669,5/12/2015 03:40:03,1634555277,5/12/2015 03:39:14,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.227,[DIAGNOSE_BY_TEST_OR_DRUG] [SYMPTOM],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SYMPTOM]",GASTROPARESIS METOCLOPRAMIDE,N/A,65,99,-1,77,113,TWrex-cause,804051-FS1,"Some autonomic symptoms can be treated effectively; for example, GASTROPARESIS can be treated with METOCLOPRAMIDE and orthostatism can be treated with support hose, volume expansion, and vasopressors such as midodrine.",GASTROPARESIS,METOCLOPRAMIDE
720315669,5/12/2015 04:12:57,1634571219,5/12/2015 04:12:44,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[TREATS],[TREATS],treated,N/A,65,99,-1,77,113,TWrex-cause,804051-FS1,"Some autonomic symptoms can be treated effectively; for example, GASTROPARESIS can be treated with METOCLOPRAMIDE and orthostatism can be treated with support hose, volume expansion, and vasopressors such as midodrine.",GASTROPARESIS,METOCLOPRAMIDE
720315669,5/12/2015 04:47:05,1634587304,5/12/2015 04:46:39,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treated,none,65,99,-1,77,113,TWrex-cause,804051-FS1,"Some autonomic symptoms can be treated effectively; for example, GASTROPARESIS can be treated with METOCLOPRAMIDE and orthostatism can be treated with support hose, volume expansion, and vasopressors such as midodrine.",GASTROPARESIS,METOCLOPRAMIDE
720315669,5/12/2015 05:02:58,1634595355,5/12/2015 05:01:49,false,neodev,1.0,31910622,USA,CA,Los Angeles,108.185.211.151,[TREATS],[TREATS],treated with,I didn´t select none.,65,99,-1,77,113,TWrex-cause,804051-FS1,"Some autonomic symptoms can be treated effectively; for example, GASTROPARESIS can be treated with METOCLOPRAMIDE and orthostatism can be treated with support hose, volume expansion, and vasopressors such as midodrine.",GASTROPARESIS,METOCLOPRAMIDE
720315670,5/12/2015 06:52:08,1634654378,5/12/2015 06:51:49,false,elite,1,31856422,GBR,C9,Workington,92.18.169.149,[ASSOCIATED_WITH] [MANIFESTATION],"[MANIFESTATION]
[ASSOCIATED_WITH]",Treatment of in children with,N/A,60,100,-1,81,124,TWrex-cause,800093-FS1,"di Martino L, Davidson RN, Giacchinno R et al. Treatment of VISCERAL LEISHMANIASIS in children with LIPOSOMAL AMPHOTERICIN B.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B
720315670,5/12/2015 06:55:31,1634655889,5/12/2015 06:54:59,false,prodege,1,16878855,CAN,BC,Fort Saint John,216.232.163.142,[TREATS],[TREATS],Treatment,NA,60,100,-1,81,124,TWrex-cause,800093-FS1,"di Martino L, Davidson RN, Giacchinno R et al. Treatment of VISCERAL LEISHMANIASIS in children with LIPOSOMAL AMPHOTERICIN B.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B
720315670,5/12/2015 07:08:08,1634661341,5/12/2015 07:07:47,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],Treatment,n/a,60,100,-1,81,124,TWrex-cause,800093-FS1,"di Martino L, Davidson RN, Giacchinno R et al. Treatment of VISCERAL LEISHMANIASIS in children with LIPOSOMAL AMPHOTERICIN B.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B
720315670,5/12/2015 08:04:15,1634695323,5/12/2015 08:03:42,false,elite,1,32732290,GBR,A7,Birmingham,86.147.79.250,[MANIFESTATION] [ASSOCIATED_WITH],"[MANIFESTATION]
[ASSOCIATED_WITH]",in children with,N/A,60,100,-1,81,124,TWrex-cause,800093-FS1,"di Martino L, Davidson RN, Giacchinno R et al. Treatment of VISCERAL LEISHMANIASIS in children with LIPOSOMAL AMPHOTERICIN B.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B
720315670,5/12/2015 08:19:17,1634702791,5/12/2015 08:18:47,false,prodege,1,16101132,GBR,F9,Hayes,2.223.214.149,[TREATS],[TREATS],Treatment,Treated with,60,100,-1,81,124,TWrex-cause,800093-FS1,"di Martino L, Davidson RN, Giacchinno R et al. Treatment of VISCERAL LEISHMANIASIS in children with LIPOSOMAL AMPHOTERICIN B.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B
720315670,5/12/2015 08:56:45,1634723256,5/12/2015 08:56:17,false,prodege,1,14528761,GBR,V2,Glasgow,2.222.244.231,[CAUSES],[CAUSES],Treatment with,N/A,60,100,-1,81,124,TWrex-cause,800093-FS1,"di Martino L, Davidson RN, Giacchinno R et al. Treatment of VISCERAL LEISHMANIASIS in children with LIPOSOMAL AMPHOTERICIN B.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B
720315670,5/12/2015 09:03:23,1634726557,5/12/2015 09:02:56,false,inboxpounds,1,29059658,GBR,H9,London,79.77.3.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],in children with,N/A,60,100,-1,81,124,TWrex-cause,800093-FS1,"di Martino L, Davidson RN, Giacchinno R et al. Treatment of VISCERAL LEISHMANIASIS in children with LIPOSOMAL AMPHOTERICIN B.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B
720315670,5/12/2015 11:04:25,1634827257,5/12/2015 11:03:57,false,clixsense,1,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],Treatment of,n.a,60,100,-1,81,124,TWrex-cause,800093-FS1,"di Martino L, Davidson RN, Giacchinno R et al. Treatment of VISCERAL LEISHMANIASIS in children with LIPOSOMAL AMPHOTERICIN B.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B
720315670,5/12/2015 11:57:43,1634860554,5/12/2015 11:57:06,false,prodege,1,14848125,GBR,L6,Shrewsbury,86.138.223.142,[MANIFESTATION],[MANIFESTATION],in children with,N/A,60,100,-1,81,124,TWrex-cause,800093-FS1,"di Martino L, Davidson RN, Giacchinno R et al. Treatment of VISCERAL LEISHMANIASIS in children with LIPOSOMAL AMPHOTERICIN B.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B
720315670,5/12/2015 11:58:25,1634860861,5/12/2015 11:57:55,false,clixsense,1,29594612,NLD,11,Rotterdam,82.156.132.195,[PART_OF],[PART_OF],in children with,N/A,60,100,-1,81,124,TWrex-cause,800093-FS1,"di Martino L, Davidson RN, Giacchinno R et al. Treatment of VISCERAL LEISHMANIASIS in children with LIPOSOMAL AMPHOTERICIN B.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B
720315670,5/12/2015 12:42:20,1634880592,5/12/2015 12:41:48,false,clixsense,1,27969116,NLD,"","",212.78.195.38,[TREATS],[TREATS],Treatment of,it  treats the decise.,60,100,-1,81,124,TWrex-cause,800093-FS1,"di Martino L, Davidson RN, Giacchinno R et al. Treatment of VISCERAL LEISHMANIASIS in children with LIPOSOMAL AMPHOTERICIN B.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B
720315670,5/12/2015 13:05:20,1634889403,5/12/2015 13:04:49,false,bitcoinget,1,24960279,USA,NY,Bronx,24.184.60.73,[TREATS],[TREATS],Treatment,n/a,60,100,-1,81,124,TWrex-cause,800093-FS1,"di Martino L, Davidson RN, Giacchinno R et al. Treatment of VISCERAL LEISHMANIASIS in children with LIPOSOMAL AMPHOTERICIN B.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B
720315670,5/12/2015 14:31:18,1634929033,5/12/2015 14:31:00,false,neodev,1,31726043,USA,DE,"",108.59.8.208,[CAUSES],[CAUSES],LEISHMANIASIS,vvv,60,100,-1,81,124,TWrex-cause,800093-FS1,"di Martino L, Davidson RN, Giacchinno R et al. Treatment of VISCERAL LEISHMANIASIS in children with LIPOSOMAL AMPHOTERICIN B.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B
720315670,5/12/2015 14:40:07,1634933281,5/12/2015 14:38:04,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],Treatment of VISCERAL LEISHMANIASIS with LIPOSOMAL AMPHOTERICIN B.,N/A,60,100,-1,81,124,TWrex-cause,800093-FS1,"di Martino L, Davidson RN, Giacchinno R et al. Treatment of VISCERAL LEISHMANIASIS in children with LIPOSOMAL AMPHOTERICIN B.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B
720315670,5/12/2015 15:28:37,1634977376,5/12/2015 15:27:08,false,prodege,1,13300986,CAN,AB,Edmonton,68.150.40.134,[ASSOCIATED_WITH],[ASSOCIATED_WITH],in children with,n/a,60,100,-1,81,124,TWrex-cause,800093-FS1,"di Martino L, Davidson RN, Giacchinno R et al. Treatment of VISCERAL LEISHMANIASIS in children with LIPOSOMAL AMPHOTERICIN B.",VISCERAL LEISHMANIASIS,LIPOSOMAL AMPHOTERICIN B
720315671,5/11/2015 22:21:00,1634403003,5/11/2015 22:20:26,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],ASTHMAtic,N/A,109,0,-1,114,11,TWrex-cause,805143-FS1,MONTELUKAST moderately decreased asthma symptoms in children with persistent asthma  Keywords: Acetates Anti ASTHMAtic agents Asthma Leukotriene antagonists  ACP Journal Club.,ASTHMA,MONTELUKAST
720315671,5/11/2015 22:22:46,1634403811,5/11/2015 22:22:28,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],decreased symptoms,n/a,109,0,-1,114,11,TWrex-cause,805143-FS1,MONTELUKAST moderately decreased asthma symptoms in children with persistent asthma  Keywords: Acetates Anti ASTHMAtic agents Asthma Leukotriene antagonists  ACP Journal Club.,ASTHMA,MONTELUKAST
720315671,5/11/2015 22:25:09,1634404817,5/11/2015 22:24:49,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],MONTELUKAST decreased asthma symptoms ASTHMAtic,n/a,109,0,-1,114,11,TWrex-cause,805143-FS1,MONTELUKAST moderately decreased asthma symptoms in children with persistent asthma  Keywords: Acetates Anti ASTHMAtic agents Asthma Leukotriene antagonists  ACP Journal Club.,ASTHMA,MONTELUKAST
720315671,5/11/2015 22:34:41,1634408943,5/11/2015 22:34:05,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],MONTELUKAST moderately decreased asthma symptoms ASTHMAtic,N/A,109,0,-1,114,11,TWrex-cause,805143-FS1,MONTELUKAST moderately decreased asthma symptoms in children with persistent asthma  Keywords: Acetates Anti ASTHMAtic agents Asthma Leukotriene antagonists  ACP Journal Club.,ASTHMA,MONTELUKAST
720315671,5/11/2015 22:35:31,1634409326,5/11/2015 22:33:34,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],moderately decreased symptoms,n/a,109,0,-1,114,11,TWrex-cause,805143-FS1,MONTELUKAST moderately decreased asthma symptoms in children with persistent asthma  Keywords: Acetates Anti ASTHMAtic agents Asthma Leukotriene antagonists  ACP Journal Club.,ASTHMA,MONTELUKAST
720315671,5/11/2015 22:40:41,1634411737,5/11/2015 22:39:42,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],MONTELUKAST Anti ASTHMAtic,n/a,109,0,-1,114,11,TWrex-cause,805143-FS1,MONTELUKAST moderately decreased asthma symptoms in children with persistent asthma  Keywords: Acetates Anti ASTHMAtic agents Asthma Leukotriene antagonists  ACP Journal Club.,ASTHMA,MONTELUKAST
720315671,5/11/2015 22:43:31,1634413033,5/11/2015 22:43:04,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[PREVENTS],[PREVENTS],decreased,n/a,109,0,-1,114,11,TWrex-cause,805143-FS1,MONTELUKAST moderately decreased asthma symptoms in children with persistent asthma  Keywords: Acetates Anti ASTHMAtic agents Asthma Leukotriene antagonists  ACP Journal Club.,ASTHMA,MONTELUKAST
720315671,5/11/2015 22:47:06,1634414686,5/11/2015 22:46:11,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],MONTELUKAST moderately decreased asthma symptoms,n/a,109,0,-1,114,11,TWrex-cause,805143-FS1,MONTELUKAST moderately decreased asthma symptoms in children with persistent asthma  Keywords: Acetates Anti ASTHMAtic agents Asthma Leukotriene antagonists  ACP Journal Club.,ASTHMA,MONTELUKAST
720315671,5/11/2015 22:54:02,1634417628,5/11/2015 22:52:55,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SYMPTOM] [PREVENTS],"[PREVENTS]
[SYMPTOM]",MONTELUKAST moderately decreased asthma symptoms in children with persistent asthma Keywords: Acetates Anti ASTHMAtic agents Asthma Leukotriene antagonists ACP,N/A,109,0,-1,114,11,TWrex-cause,805143-FS1,MONTELUKAST moderately decreased asthma symptoms in children with persistent asthma  Keywords: Acetates Anti ASTHMAtic agents Asthma Leukotriene antagonists  ACP Journal Club.,ASTHMA,MONTELUKAST
720315671,5/11/2015 22:58:28,1634419083,5/11/2015 22:57:58,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,75.147.181.53,[TREATS],[TREATS],moderately decreased asthma symptoms,N/A,109,0,-1,114,11,TWrex-cause,805143-FS1,MONTELUKAST moderately decreased asthma symptoms in children with persistent asthma  Keywords: Acetates Anti ASTHMAtic agents Asthma Leukotriene antagonists  ACP Journal Club.,ASTHMA,MONTELUKAST
720315671,5/11/2015 23:00:49,1634419725,5/11/2015 23:00:17,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[TREATS],[TREATS],moderately decreased symptoms,n/a,109,0,-1,114,11,TWrex-cause,805143-FS1,MONTELUKAST moderately decreased asthma symptoms in children with persistent asthma  Keywords: Acetates Anti ASTHMAtic agents Asthma Leukotriene antagonists  ACP Journal Club.,ASTHMA,MONTELUKAST
720315671,5/11/2015 23:01:07,1634419880,5/11/2015 23:00:30,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],decreased,the drug minimises the asthma,109,0,-1,114,11,TWrex-cause,805143-FS1,MONTELUKAST moderately decreased asthma symptoms in children with persistent asthma  Keywords: Acetates Anti ASTHMAtic agents Asthma Leukotriene antagonists  ACP Journal Club.,ASTHMA,MONTELUKAST
720315671,5/11/2015 23:02:01,1634420224,5/11/2015 23:01:32,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],moderately decreased symptoms,n/a,109,0,-1,114,11,TWrex-cause,805143-FS1,MONTELUKAST moderately decreased asthma symptoms in children with persistent asthma  Keywords: Acetates Anti ASTHMAtic agents Asthma Leukotriene antagonists  ACP Journal Club.,ASTHMA,MONTELUKAST
720315671,5/11/2015 23:02:26,1634420328,5/11/2015 23:01:14,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],moderately decreased,N/A,109,0,-1,114,11,TWrex-cause,805143-FS1,MONTELUKAST moderately decreased asthma symptoms in children with persistent asthma  Keywords: Acetates Anti ASTHMAtic agents Asthma Leukotriene antagonists  ACP Journal Club.,ASTHMA,MONTELUKAST
720315671,5/11/2015 23:03:07,1634420572,5/11/2015 23:01:28,false,clixsense,1.0,6330007,AUS,06,Hobart,101.178.23.54,[TREATS],[TREATS],moderately decreased,n/a,109,0,-1,114,11,TWrex-cause,805143-FS1,MONTELUKAST moderately decreased asthma symptoms in children with persistent asthma  Keywords: Acetates Anti ASTHMAtic agents Asthma Leukotriene antagonists  ACP Journal Club.,ASTHMA,MONTELUKAST
720315672,5/11/2015 22:18:48,1634401835,5/11/2015 22:18:14,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],MEMBRANOUS NEPHROPATHY,N/A,65,6,1,86,19,TWrex-cause,815102-FS1,"Gold, PENICILLAMINE NSAIDs, and mercury have been shown to cause MEMBRANOUS NEPHROPATHY",MEMBRANOUS NEPHROPATHY,PENICILLAMINE
720315672,5/11/2015 22:20:42,1634402819,5/11/2015 22:20:28,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],shown to cause,n/a,65,6,1,86,19,TWrex-cause,815102-FS1,"Gold, PENICILLAMINE NSAIDs, and mercury have been shown to cause MEMBRANOUS NEPHROPATHY",MEMBRANOUS NEPHROPATHY,PENICILLAMINE
720315672,5/11/2015 22:20:49,1634402914,5/11/2015 22:20:05,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],"PENICILLAMINE NSAIDs, shown to cause MEMBRANOUS NEPHROPATHY",n/a,65,6,1,86,19,TWrex-cause,815102-FS1,"Gold, PENICILLAMINE NSAIDs, and mercury have been shown to cause MEMBRANOUS NEPHROPATHY",MEMBRANOUS NEPHROPATHY,PENICILLAMINE
720315672,5/11/2015 22:27:22,1634405810,5/11/2015 22:26:31,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],PENICILLAMINE shown to cause MEMBRANOUS NEPHROPATHY,N/A,65,6,1,86,19,TWrex-cause,815102-FS1,"Gold, PENICILLAMINE NSAIDs, and mercury have been shown to cause MEMBRANOUS NEPHROPATHY",MEMBRANOUS NEPHROPATHY,PENICILLAMINE
720315672,5/11/2015 22:29:22,1634406535,5/11/2015 22:28:40,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],shown to cause,n/a,65,6,1,86,19,TWrex-cause,815102-FS1,"Gold, PENICILLAMINE NSAIDs, and mercury have been shown to cause MEMBRANOUS NEPHROPATHY",MEMBRANOUS NEPHROPATHY,PENICILLAMINE
720315672,5/11/2015 22:36:32,1634409687,5/11/2015 22:36:13,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[CAUSES],[CAUSES],cause,n/a,65,6,1,86,19,TWrex-cause,815102-FS1,"Gold, PENICILLAMINE NSAIDs, and mercury have been shown to cause MEMBRANOUS NEPHROPATHY",MEMBRANOUS NEPHROPATHY,PENICILLAMINE
720315672,5/11/2015 22:36:33,1634409697,5/11/2015 22:35:52,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],cause,n/a,65,6,1,86,19,TWrex-cause,815102-FS1,"Gold, PENICILLAMINE NSAIDs, and mercury have been shown to cause MEMBRANOUS NEPHROPATHY",MEMBRANOUS NEPHROPATHY,PENICILLAMINE
720315672,5/11/2015 22:42:15,1634412354,5/11/2015 22:41:18,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],PENICILLAMINE cause MEMBRANOUS NEPHROPATHY,n/a,65,6,1,86,19,TWrex-cause,815102-FS1,"Gold, PENICILLAMINE NSAIDs, and mercury have been shown to cause MEMBRANOUS NEPHROPATHY",MEMBRANOUS NEPHROPATHY,PENICILLAMINE
720315672,5/11/2015 22:44:53,1634413657,5/11/2015 22:44:36,false,instagc,1.0,28519532,USA,IA,Neola,38.121.112.217,[CAUSES],[CAUSES],cause,na,65,6,1,86,19,TWrex-cause,815102-FS1,"Gold, PENICILLAMINE NSAIDs, and mercury have been shown to cause MEMBRANOUS NEPHROPATHY",MEMBRANOUS NEPHROPATHY,PENICILLAMINE
720315672,5/11/2015 22:46:43,1634414493,5/11/2015 22:45:48,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],"Gold, PENICILLAMINE NSAIDs, and mercury have been shown to cause MEMBRANOUS NEPHROPATHY",N/A,65,6,1,86,19,TWrex-cause,815102-FS1,"Gold, PENICILLAMINE NSAIDs, and mercury have been shown to cause MEMBRANOUS NEPHROPATHY",MEMBRANOUS NEPHROPATHY,PENICILLAMINE
720315672,5/11/2015 22:54:31,1634417800,5/11/2015 22:54:11,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,75.147.181.53,[CAUSES],[CAUSES],shown to cause,N/A,65,6,1,86,19,TWrex-cause,815102-FS1,"Gold, PENICILLAMINE NSAIDs, and mercury have been shown to cause MEMBRANOUS NEPHROPATHY",MEMBRANOUS NEPHROPATHY,PENICILLAMINE
720315672,5/11/2015 22:56:27,1634418410,5/11/2015 22:55:41,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],cause,N/A,65,6,1,86,19,TWrex-cause,815102-FS1,"Gold, PENICILLAMINE NSAIDs, and mercury have been shown to cause MEMBRANOUS NEPHROPATHY",MEMBRANOUS NEPHROPATHY,PENICILLAMINE
720315672,5/11/2015 22:56:29,1634418427,5/11/2015 22:56:12,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],to cause,N/A,65,6,1,86,19,TWrex-cause,815102-FS1,"Gold, PENICILLAMINE NSAIDs, and mercury have been shown to cause MEMBRANOUS NEPHROPATHY",MEMBRANOUS NEPHROPATHY,PENICILLAMINE
720315672,5/11/2015 22:56:47,1634418562,5/11/2015 22:56:05,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[CAUSES],[CAUSES],"PENICILLAMINE NSAIDs, and mercury have been shown to cause MEMBRANOUS NEPHROPATHY",n/a,65,6,1,86,19,TWrex-cause,815102-FS1,"Gold, PENICILLAMINE NSAIDs, and mercury have been shown to cause MEMBRANOUS NEPHROPATHY",MEMBRANOUS NEPHROPATHY,PENICILLAMINE
720315672,5/11/2015 23:00:02,1634419504,5/11/2015 22:59:13,false,clixsense,1.0,6330007,AUS,06,Hobart,101.178.23.54,[MANIFESTATION],[MANIFESTATION],shown to cause,n/a,65,6,1,86,19,TWrex-cause,815102-FS1,"Gold, PENICILLAMINE NSAIDs, and mercury have been shown to cause MEMBRANOUS NEPHROPATHY",MEMBRANOUS NEPHROPATHY,PENICILLAMINE
720315673,5/12/2015 01:34:32,1634489648,5/12/2015 01:34:19,false,instagc,1.0,32556346,USA,PA,Warren,207.255.244.59,[IS_A],[IS_A],is,N/A,0,56,1,8,77,TWrex-cause,812595-FS1,AMEBIASIS  (Entamebiasis)  AMEBIASIS is infection with  ENTAMOEBA HISTOLYTICA.,AMEBIASIS,ENTAMOEBA HISTOLYTICA
720315673,5/12/2015 01:46:21,1634496151,5/12/2015 01:46:03,false,instagc,1.0,30326470,USA,CA,San Diego,170.213.2.111,[MANIFESTATION],[MANIFESTATION],is infection,N/A,0,56,1,8,77,TWrex-cause,812595-FS1,AMEBIASIS  (Entamebiasis)  AMEBIASIS is infection with  ENTAMOEBA HISTOLYTICA.,AMEBIASIS,ENTAMOEBA HISTOLYTICA
720315673,5/12/2015 03:29:05,1634549702,5/12/2015 03:28:35,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[OTHER],[OTHER],with,n/a,0,56,1,8,77,TWrex-cause,812595-FS1,AMEBIASIS  (Entamebiasis)  AMEBIASIS is infection with  ENTAMOEBA HISTOLYTICA.,AMEBIASIS,ENTAMOEBA HISTOLYTICA
720315673,5/12/2015 03:47:56,1634558628,5/12/2015 03:47:36,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.227,[SIDE_EFFECT],[SIDE_EFFECT],AMEBIASIS ENTAMOEBA HISTOLYTICA.,N/A,0,56,1,8,77,TWrex-cause,812595-FS1,AMEBIASIS  (Entamebiasis)  AMEBIASIS is infection with  ENTAMOEBA HISTOLYTICA.,AMEBIASIS,ENTAMOEBA HISTOLYTICA
720315673,5/12/2015 04:22:13,1634575332,5/12/2015 04:22:00,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[IS_A],[IS_A],is infection,N/A,0,56,1,8,77,TWrex-cause,812595-FS1,AMEBIASIS  (Entamebiasis)  AMEBIASIS is infection with  ENTAMOEBA HISTOLYTICA.,AMEBIASIS,ENTAMOEBA HISTOLYTICA
720315673,5/12/2015 05:01:25,1634594602,5/12/2015 05:01:04,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],with,none,0,56,1,8,77,TWrex-cause,812595-FS1,AMEBIASIS  (Entamebiasis)  AMEBIASIS is infection with  ENTAMOEBA HISTOLYTICA.,AMEBIASIS,ENTAMOEBA HISTOLYTICA
720315673,5/12/2015 05:11:24,1634600272,5/12/2015 05:11:04,false,neodev,1.0,31910622,USA,CA,San Francisco,108.169.6.201,[ASSOCIATED_WITH],[ASSOCIATED_WITH],is infection with,I didn´t select none.,0,56,1,8,77,TWrex-cause,812595-FS1,AMEBIASIS  (Entamebiasis)  AMEBIASIS is infection with  ENTAMOEBA HISTOLYTICA.,AMEBIASIS,ENTAMOEBA HISTOLYTICA
720315673,5/12/2015 06:12:42,1634636517,5/12/2015 06:10:41,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CAUSES],[CAUSES],infection with,N/A,0,56,1,8,77,TWrex-cause,812595-FS1,AMEBIASIS  (Entamebiasis)  AMEBIASIS is infection with  ENTAMOEBA HISTOLYTICA.,AMEBIASIS,ENTAMOEBA HISTOLYTICA
720315673,5/12/2015 06:24:51,1634642233,5/12/2015 06:24:31,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[CAUSES],[CAUSES],infection with,N/A,0,56,1,8,77,TWrex-cause,812595-FS1,AMEBIASIS  (Entamebiasis)  AMEBIASIS is infection with  ENTAMOEBA HISTOLYTICA.,AMEBIASIS,ENTAMOEBA HISTOLYTICA
720315673,5/12/2015 06:41:28,1634649732,5/12/2015 06:40:50,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[SYMPTOM],[SYMPTOM],infection,NA,0,56,1,8,77,TWrex-cause,812595-FS1,AMEBIASIS  (Entamebiasis)  AMEBIASIS is infection with  ENTAMOEBA HISTOLYTICA.,AMEBIASIS,ENTAMOEBA HISTOLYTICA
720315673,5/12/2015 06:42:16,1634650086,5/12/2015 06:41:44,false,prodege,1,18793920,USA,CA,Salinas,73.162.0.87,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH] [PART_OF],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]
[PART_OF]",AMEBIASIS is infection with ENTAMOEBA HISTOLYTICA.,n/a,0,56,1,8,77,TWrex-cause,812595-FS1,AMEBIASIS  (Entamebiasis)  AMEBIASIS is infection with  ENTAMOEBA HISTOLYTICA.,AMEBIASIS,ENTAMOEBA HISTOLYTICA
720315673,5/12/2015 06:42:46,1634650310,5/12/2015 06:42:03,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[CAUSES],[CAUSES],is infection with,n/a,0,56,1,8,77,TWrex-cause,812595-FS1,AMEBIASIS  (Entamebiasis)  AMEBIASIS is infection with  ENTAMOEBA HISTOLYTICA.,AMEBIASIS,ENTAMOEBA HISTOLYTICA
720315673,5/12/2015 06:45:49,1634651715,5/12/2015 06:45:15,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[ASSOCIATED_WITH] [SYMPTOM],"[SYMPTOM]
[ASSOCIATED_WITH]",infection with,N/A,0,56,1,8,77,TWrex-cause,812595-FS1,AMEBIASIS  (Entamebiasis)  AMEBIASIS is infection with  ENTAMOEBA HISTOLYTICA.,AMEBIASIS,ENTAMOEBA HISTOLYTICA
720315673,5/12/2015 07:01:18,1634658350,5/12/2015 06:59:44,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[IS_A],[IS_A],is infection with,N/a,0,56,1,8,77,TWrex-cause,812595-FS1,AMEBIASIS  (Entamebiasis)  AMEBIASIS is infection with  ENTAMOEBA HISTOLYTICA.,AMEBIASIS,ENTAMOEBA HISTOLYTICA
720315673,5/12/2015 07:51:42,1634689160,5/12/2015 07:51:09,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[IS_A],[IS_A],is,N/A,0,56,1,8,77,TWrex-cause,812595-FS1,AMEBIASIS  (Entamebiasis)  AMEBIASIS is infection with  ENTAMOEBA HISTOLYTICA.,AMEBIASIS,ENTAMOEBA HISTOLYTICA
720315674,5/12/2015 06:23:49,1634641720,5/12/2015 06:23:09,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],"randomized, controlled, multicenter trial.",N/A,83,37,-1,111,48,TWrex-cause,800650-FS1,"Riddle MA, Reeve EA, Yaryura JA et alFLUVOXAMINE for children and adolescents with OBSESSIVE COMPULSIVE DISORDER: a randomized, controlled, multicenter trial.",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
720315674,5/12/2015 06:29:22,1634644569,5/12/2015 06:29:02,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[TREATS],[TREATS],trial.,N/A,83,37,-1,111,48,TWrex-cause,800650-FS1,"Riddle MA, Reeve EA, Yaryura JA et alFLUVOXAMINE for children and adolescents with OBSESSIVE COMPULSIVE DISORDER: a randomized, controlled, multicenter trial.",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
720315674,5/12/2015 06:48:58,1634653018,5/12/2015 06:48:09,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],trial.,NA,83,37,-1,111,48,TWrex-cause,800650-FS1,"Riddle MA, Reeve EA, Yaryura JA et alFLUVOXAMINE for children and adolescents with OBSESSIVE COMPULSIVE DISORDER: a randomized, controlled, multicenter trial.",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
720315674,5/12/2015 06:48:59,1634653029,5/12/2015 06:48:43,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[TREATS],[TREATS],for children and adolescents with,N/A,83,37,-1,111,48,TWrex-cause,800650-FS1,"Riddle MA, Reeve EA, Yaryura JA et alFLUVOXAMINE for children and adolescents with OBSESSIVE COMPULSIVE DISORDER: a randomized, controlled, multicenter trial.",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
720315674,5/12/2015 06:59:17,1634657526,5/12/2015 06:58:45,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[OTHER],[OTHER],"randomized, controlled, multicenter trial.",n/a,83,37,-1,111,48,TWrex-cause,800650-FS1,"Riddle MA, Reeve EA, Yaryura JA et alFLUVOXAMINE for children and adolescents with OBSESSIVE COMPULSIVE DISORDER: a randomized, controlled, multicenter trial.",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
720315674,5/12/2015 07:58:40,1634692537,5/12/2015 07:58:20,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],for children and adolescents with,N/A,83,37,-1,111,48,TWrex-cause,800650-FS1,"Riddle MA, Reeve EA, Yaryura JA et alFLUVOXAMINE for children and adolescents with OBSESSIVE COMPULSIVE DISORDER: a randomized, controlled, multicenter trial.",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
720315674,5/12/2015 08:12:42,1634699660,5/12/2015 08:12:05,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[OTHER],[OTHER],trial.,Trial,83,37,-1,111,48,TWrex-cause,800650-FS1,"Riddle MA, Reeve EA, Yaryura JA et alFLUVOXAMINE for children and adolescents with OBSESSIVE COMPULSIVE DISORDER: a randomized, controlled, multicenter trial.",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
720315674,5/12/2015 08:52:00,1634720889,5/12/2015 08:51:30,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[TREATS],[TREATS],trial.,N/A,83,37,-1,111,48,TWrex-cause,800650-FS1,"Riddle MA, Reeve EA, Yaryura JA et alFLUVOXAMINE for children and adolescents with OBSESSIVE COMPULSIVE DISORDER: a randomized, controlled, multicenter trial.",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
720315674,5/12/2015 08:57:39,1634723680,5/12/2015 08:57:09,false,inboxpounds,1.0,29059658,GBR,H9,London,79.77.3.89,[TREATS],[TREATS],for children and adolescents with,N/A,83,37,-1,111,48,TWrex-cause,800650-FS1,"Riddle MA, Reeve EA, Yaryura JA et alFLUVOXAMINE for children and adolescents with OBSESSIVE COMPULSIVE DISORDER: a randomized, controlled, multicenter trial.",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
720315674,5/12/2015 10:42:22,1634803510,5/12/2015 10:40:53,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],alFLUVOXAMINE OBSESSIVE COMPULSIVE DISORDER: trial.,N/A,83,37,-1,111,48,TWrex-cause,800650-FS1,"Riddle MA, Reeve EA, Yaryura JA et alFLUVOXAMINE for children and adolescents with OBSESSIVE COMPULSIVE DISORDER: a randomized, controlled, multicenter trial.",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
720315674,5/12/2015 10:57:25,1634817554,5/12/2015 10:57:06,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],alFLUVOXAMINE OBSESSIVE COMPULSIVE DISORDER:,n/a,83,37,-1,111,48,TWrex-cause,800650-FS1,"Riddle MA, Reeve EA, Yaryura JA et alFLUVOXAMINE for children and adolescents with OBSESSIVE COMPULSIVE DISORDER: a randomized, controlled, multicenter trial.",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
720315674,5/12/2015 11:51:16,1634857549,5/12/2015 11:50:51,false,instagc,1,29444531,USA,GA,Conyers,184.37.251.52,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,NA,83,37,-1,111,48,TWrex-cause,800650-FS1,"Riddle MA, Reeve EA, Yaryura JA et alFLUVOXAMINE for children and adolescents with OBSESSIVE COMPULSIVE DISORDER: a randomized, controlled, multicenter trial.",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
720315674,5/12/2015 11:52:03,1634857999,5/12/2015 11:51:27,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[TREATS],[TREATS],for children and adolescents,N/A,83,37,-1,111,48,TWrex-cause,800650-FS1,"Riddle MA, Reeve EA, Yaryura JA et alFLUVOXAMINE for children and adolescents with OBSESSIVE COMPULSIVE DISORDER: a randomized, controlled, multicenter trial.",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
720315674,5/12/2015 11:53:17,1634858564,5/12/2015 11:52:00,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[OTHER],[OTHER],trial.,It is a trial of the drug for treatment or prevention of the disease.,83,37,-1,111,48,TWrex-cause,800650-FS1,"Riddle MA, Reeve EA, Yaryura JA et alFLUVOXAMINE for children and adolescents with OBSESSIVE COMPULSIVE DISORDER: a randomized, controlled, multicenter trial.",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
720315674,5/12/2015 12:05:17,1634863937,5/12/2015 12:04:27,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],trial.,N/A,83,37,-1,111,48,TWrex-cause,800650-FS1,"Riddle MA, Reeve EA, Yaryura JA et alFLUVOXAMINE for children and adolescents with OBSESSIVE COMPULSIVE DISORDER: a randomized, controlled, multicenter trial.",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
720315675,5/12/2015 06:26:38,1634643169,5/12/2015 06:26:16,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treatment,N/A,105,74,-1,124,84,TWrex-cause,800530-FS1,"1]  Mismetti P, Quenet S, Levine M, Merli G, Decousus H, Derobert E, et alENOXAPARIN in the treatment of DEEP VEIN THROMBOSIS with or without pulmonary embolism: an individual patient data meta analysis.",DEEP VEIN THROMBOSIS,ENOXAPARIN
720315675,5/12/2015 06:32:19,1634645823,5/12/2015 06:32:00,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[TREATS],[TREATS],treatment,N/A,105,74,-1,124,84,TWrex-cause,800530-FS1,"1]  Mismetti P, Quenet S, Levine M, Merli G, Decousus H, Derobert E, et alENOXAPARIN in the treatment of DEEP VEIN THROMBOSIS with or without pulmonary embolism: an individual patient data meta analysis.",DEEP VEIN THROMBOSIS,ENOXAPARIN
720315675,5/12/2015 06:50:09,1634653508,5/12/2015 06:49:56,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[TREATS],[TREATS],in the treatment,N/A,105,74,-1,124,84,TWrex-cause,800530-FS1,"1]  Mismetti P, Quenet S, Levine M, Merli G, Decousus H, Derobert E, et alENOXAPARIN in the treatment of DEEP VEIN THROMBOSIS with or without pulmonary embolism: an individual patient data meta analysis.",DEEP VEIN THROMBOSIS,ENOXAPARIN
720315675,5/12/2015 06:51:45,1634654238,5/12/2015 06:51:16,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[TREATS],[TREATS],treatment,NA,105,74,-1,124,84,TWrex-cause,800530-FS1,"1]  Mismetti P, Quenet S, Levine M, Merli G, Decousus H, Derobert E, et alENOXAPARIN in the treatment of DEEP VEIN THROMBOSIS with or without pulmonary embolism: an individual patient data meta analysis.",DEEP VEIN THROMBOSIS,ENOXAPARIN
720315675,5/12/2015 07:04:18,1634659579,5/12/2015 07:03:40,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],treatment,n/a,105,74,-1,124,84,TWrex-cause,800530-FS1,"1]  Mismetti P, Quenet S, Levine M, Merli G, Decousus H, Derobert E, et alENOXAPARIN in the treatment of DEEP VEIN THROMBOSIS with or without pulmonary embolism: an individual patient data meta analysis.",DEEP VEIN THROMBOSIS,ENOXAPARIN
720315675,5/12/2015 08:00:31,1634693422,5/12/2015 08:00:17,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],in the treatment of,N/A,105,74,-1,124,84,TWrex-cause,800530-FS1,"1]  Mismetti P, Quenet S, Levine M, Merli G, Decousus H, Derobert E, et alENOXAPARIN in the treatment of DEEP VEIN THROMBOSIS with or without pulmonary embolism: an individual patient data meta analysis.",DEEP VEIN THROMBOSIS,ENOXAPARIN
720315675,5/12/2015 08:15:35,1634701099,5/12/2015 08:15:13,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[TREATS],[TREATS],treatment,Treated with,105,74,-1,124,84,TWrex-cause,800530-FS1,"1]  Mismetti P, Quenet S, Levine M, Merli G, Decousus H, Derobert E, et alENOXAPARIN in the treatment of DEEP VEIN THROMBOSIS with or without pulmonary embolism: an individual patient data meta analysis.",DEEP VEIN THROMBOSIS,ENOXAPARIN
720315675,5/12/2015 08:53:58,1634722010,5/12/2015 08:53:33,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[TREATS],[TREATS],treatment,N/A,105,74,-1,124,84,TWrex-cause,800530-FS1,"1]  Mismetti P, Quenet S, Levine M, Merli G, Decousus H, Derobert E, et alENOXAPARIN in the treatment of DEEP VEIN THROMBOSIS with or without pulmonary embolism: an individual patient data meta analysis.",DEEP VEIN THROMBOSIS,ENOXAPARIN
720315675,5/12/2015 09:00:11,1634724988,5/12/2015 08:59:52,false,inboxpounds,1.0,29059658,GBR,H9,London,79.77.3.89,[TREATS],[TREATS],in the treatment,N/A,105,74,-1,124,84,TWrex-cause,800530-FS1,"1]  Mismetti P, Quenet S, Levine M, Merli G, Decousus H, Derobert E, et alENOXAPARIN in the treatment of DEEP VEIN THROMBOSIS with or without pulmonary embolism: an individual patient data meta analysis.",DEEP VEIN THROMBOSIS,ENOXAPARIN
720315675,5/12/2015 11:01:02,1634822233,5/12/2015 11:00:41,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],treatment,n/a,105,74,-1,124,84,TWrex-cause,800530-FS1,"1]  Mismetti P, Quenet S, Levine M, Merli G, Decousus H, Derobert E, et alENOXAPARIN in the treatment of DEEP VEIN THROMBOSIS with or without pulmonary embolism: an individual patient data meta analysis.",DEEP VEIN THROMBOSIS,ENOXAPARIN
720315675,5/12/2015 11:37:17,1634849601,5/12/2015 11:35:24,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",alENOXAPARIN in treatment of DEEP VEIN THROMBOSIS an individual patient data meta analysis.,N/A,105,74,-1,124,84,TWrex-cause,800530-FS1,"1]  Mismetti P, Quenet S, Levine M, Merli G, Decousus H, Derobert E, et alENOXAPARIN in the treatment of DEEP VEIN THROMBOSIS with or without pulmonary embolism: an individual patient data meta analysis.",DEEP VEIN THROMBOSIS,ENOXAPARIN
720315675,5/12/2015 11:54:15,1634859032,5/12/2015 11:53:44,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[TREATS],[TREATS],in the treatment of,N/A,105,74,-1,124,84,TWrex-cause,800530-FS1,"1]  Mismetti P, Quenet S, Levine M, Merli G, Decousus H, Derobert E, et alENOXAPARIN in the treatment of DEEP VEIN THROMBOSIS with or without pulmonary embolism: an individual patient data meta analysis.",DEEP VEIN THROMBOSIS,ENOXAPARIN
720315675,5/12/2015 11:55:21,1634859489,5/12/2015 11:55:03,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[TREATS],[TREATS],in the treatment of,N/A,105,74,-1,124,84,TWrex-cause,800530-FS1,"1]  Mismetti P, Quenet S, Levine M, Merli G, Decousus H, Derobert E, et alENOXAPARIN in the treatment of DEEP VEIN THROMBOSIS with or without pulmonary embolism: an individual patient data meta analysis.",DEEP VEIN THROMBOSIS,ENOXAPARIN
720315675,5/12/2015 12:10:26,1634866241,5/12/2015 12:10:00,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],treatment,N/A,105,74,-1,124,84,TWrex-cause,800530-FS1,"1]  Mismetti P, Quenet S, Levine M, Merli G, Decousus H, Derobert E, et alENOXAPARIN in the treatment of DEEP VEIN THROMBOSIS with or without pulmonary embolism: an individual patient data meta analysis.",DEEP VEIN THROMBOSIS,ENOXAPARIN
720315675,5/12/2015 12:37:47,1634878338,5/12/2015 12:37:11,false,clixsense,1.0,27969116,NLD,"","",212.78.195.38,[TREATS],[TREATS],in the treatment of,N/A,105,74,-1,124,84,TWrex-cause,800530-FS1,"1]  Mismetti P, Quenet S, Levine M, Merli G, Decousus H, Derobert E, et alENOXAPARIN in the treatment of DEEP VEIN THROMBOSIS with or without pulmonary embolism: an individual patient data meta analysis.",DEEP VEIN THROMBOSIS,ENOXAPARIN
720315676,5/11/2015 22:22:15,1634403546,5/11/2015 22:21:57,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],SPOROTRICHOSIS:,N/A,50,5,-1,73,32,TWrex-cause,803643-FS1,"429  CONVENTIONAL AMPHOTERICIN B in patients with MENINGEAL SPOROTRICHOSIS: 0.7 1 mg/kg daily can be used for initial therapy, but a lipid formulation is preferred.",MENINGEAL SPOROTRICHOSIS,CONVENTIONAL AMPHOTERICIN B
720315676,5/11/2015 22:23:55,1634404300,5/11/2015 22:23:38,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],in patients with,n/a,50,5,-1,73,32,TWrex-cause,803643-FS1,"429  CONVENTIONAL AMPHOTERICIN B in patients with MENINGEAL SPOROTRICHOSIS: 0.7 1 mg/kg daily can be used for initial therapy, but a lipid formulation is preferred.",MENINGEAL SPOROTRICHOSIS,CONVENTIONAL AMPHOTERICIN B
720315676,5/11/2015 22:28:39,1634406279,5/11/2015 22:27:45,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],CONVENTIONAL AMPHOTERICIN B in patients with MENINGEAL SPOROTRICHOSIS:,na,50,5,-1,73,32,TWrex-cause,803643-FS1,"429  CONVENTIONAL AMPHOTERICIN B in patients with MENINGEAL SPOROTRICHOSIS: 0.7 1 mg/kg daily can be used for initial therapy, but a lipid formulation is preferred.",MENINGEAL SPOROTRICHOSIS,CONVENTIONAL AMPHOTERICIN B
720315676,5/11/2015 22:37:37,1634410252,5/11/2015 22:37:14,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],"initial therapy,",n/a,50,5,-1,73,32,TWrex-cause,803643-FS1,"429  CONVENTIONAL AMPHOTERICIN B in patients with MENINGEAL SPOROTRICHOSIS: 0.7 1 mg/kg daily can be used for initial therapy, but a lipid formulation is preferred.",MENINGEAL SPOROTRICHOSIS,CONVENTIONAL AMPHOTERICIN B
720315676,5/11/2015 22:38:43,1634410918,5/11/2015 22:38:04,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],"CONVENTIONAL AMPHOTERICIN B MENINGEAL SPOROTRICHOSIS: used for initial therapy,",N/A,50,5,-1,73,32,TWrex-cause,803643-FS1,"429  CONVENTIONAL AMPHOTERICIN B in patients with MENINGEAL SPOROTRICHOSIS: 0.7 1 mg/kg daily can be used for initial therapy, but a lipid formulation is preferred.",MENINGEAL SPOROTRICHOSIS,CONVENTIONAL AMPHOTERICIN B
720315676,5/11/2015 22:42:30,1634412534,5/11/2015 22:42:07,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],"can be used for initial therapy,",n/a,50,5,-1,73,32,TWrex-cause,803643-FS1,"429  CONVENTIONAL AMPHOTERICIN B in patients with MENINGEAL SPOROTRICHOSIS: 0.7 1 mg/kg daily can be used for initial therapy, but a lipid formulation is preferred.",MENINGEAL SPOROTRICHOSIS,CONVENTIONAL AMPHOTERICIN B
720315676,5/11/2015 22:50:04,1634416118,5/11/2015 22:49:18,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],CONVENTIONAL AMPHOTERICIN B in patients with MENINGEAL SPOROTRICHOSIS:,n/a,50,5,-1,73,32,TWrex-cause,803643-FS1,"429  CONVENTIONAL AMPHOTERICIN B in patients with MENINGEAL SPOROTRICHOSIS: 0.7 1 mg/kg daily can be used for initial therapy, but a lipid formulation is preferred.",MENINGEAL SPOROTRICHOSIS,CONVENTIONAL AMPHOTERICIN B
720315676,5/11/2015 22:58:51,1634419165,5/11/2015 22:57:46,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"CONVENTIONAL AMPHOTERICIN B in patients with MENINGEAL SPOROTRICHOSIS: 0.7 1 mg/kg daily can be used for initial therapy, but a lipid formulation is preferred.",N/A,50,5,-1,73,32,TWrex-cause,803643-FS1,"429  CONVENTIONAL AMPHOTERICIN B in patients with MENINGEAL SPOROTRICHOSIS: 0.7 1 mg/kg daily can be used for initial therapy, but a lipid formulation is preferred.",MENINGEAL SPOROTRICHOSIS,CONVENTIONAL AMPHOTERICIN B
720315676,5/11/2015 23:00:25,1634419600,5/11/2015 22:59:55,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,75.147.181.53,[TREATS],[TREATS],"for initial therapy,",N/A,50,5,-1,73,32,TWrex-cause,803643-FS1,"429  CONVENTIONAL AMPHOTERICIN B in patients with MENINGEAL SPOROTRICHOSIS: 0.7 1 mg/kg daily can be used for initial therapy, but a lipid formulation is preferred.",MENINGEAL SPOROTRICHOSIS,CONVENTIONAL AMPHOTERICIN B
720315676,5/11/2015 23:04:50,1634421094,5/11/2015 23:04:03,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[TREATS],[TREATS],"initial therapy,",n/a,50,5,-1,73,32,TWrex-cause,803643-FS1,"429  CONVENTIONAL AMPHOTERICIN B in patients with MENINGEAL SPOROTRICHOSIS: 0.7 1 mg/kg daily can be used for initial therapy, but a lipid formulation is preferred.",MENINGEAL SPOROTRICHOSIS,CONVENTIONAL AMPHOTERICIN B
720315676,5/11/2015 23:05:41,1634421402,5/11/2015 23:04:52,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],"therapy,",the drug treats the condition,50,5,-1,73,32,TWrex-cause,803643-FS1,"429  CONVENTIONAL AMPHOTERICIN B in patients with MENINGEAL SPOROTRICHOSIS: 0.7 1 mg/kg daily can be used for initial therapy, but a lipid formulation is preferred.",MENINGEAL SPOROTRICHOSIS,CONVENTIONAL AMPHOTERICIN B
720315676,5/11/2015 23:06:06,1634421522,5/11/2015 23:05:24,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],patients,N/A,50,5,-1,73,32,TWrex-cause,803643-FS1,"429  CONVENTIONAL AMPHOTERICIN B in patients with MENINGEAL SPOROTRICHOSIS: 0.7 1 mg/kg daily can be used for initial therapy, but a lipid formulation is preferred.",MENINGEAL SPOROTRICHOSIS,CONVENTIONAL AMPHOTERICIN B
720315676,5/11/2015 23:06:33,1634421823,5/11/2015 23:05:25,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],"used for initial therapy,",N/A,50,5,-1,73,32,TWrex-cause,803643-FS1,"429  CONVENTIONAL AMPHOTERICIN B in patients with MENINGEAL SPOROTRICHOSIS: 0.7 1 mg/kg daily can be used for initial therapy, but a lipid formulation is preferred.",MENINGEAL SPOROTRICHOSIS,CONVENTIONAL AMPHOTERICIN B
720315676,5/11/2015 23:07:08,1634422053,5/11/2015 23:05:24,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],"be used for initial therapy,",N/A,50,5,-1,73,32,TWrex-cause,803643-FS1,"429  CONVENTIONAL AMPHOTERICIN B in patients with MENINGEAL SPOROTRICHOSIS: 0.7 1 mg/kg daily can be used for initial therapy, but a lipid formulation is preferred.",MENINGEAL SPOROTRICHOSIS,CONVENTIONAL AMPHOTERICIN B
720315676,5/11/2015 23:07:38,1634422295,5/11/2015 23:04:51,false,clixsense,1.0,6330007,AUS,06,Hobart,101.178.23.54,[CONTRAINDICATES] [TREATS],"[TREATS]
[CONTRAINDICATES]","initial therapy,",n/a,50,5,-1,73,32,TWrex-cause,803643-FS1,"429  CONVENTIONAL AMPHOTERICIN B in patients with MENINGEAL SPOROTRICHOSIS: 0.7 1 mg/kg daily can be used for initial therapy, but a lipid formulation is preferred.",MENINGEAL SPOROTRICHOSIS,CONVENTIONAL AMPHOTERICIN B
720315677,5/12/2015 01:03:20,1634473293,5/12/2015 01:02:44,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[ASSOCIATED_WITH] [OTHER],"[ASSOCIATED_WITH]
[OTHER]",POSTPRANDIAL BLOOD GLUCOSE CONTROL and HYPOGLYCEMIA,n/a,103,46,-1,114,80,TWrex-cause,800256-FS1,"Roach P, Trautmann M, Arora V et al. Improved POSTPRANDIAL BLOOD GLUCOSE CONTROL and reduced nocturnal HYPOGLYCEMIA during treatment with two novel insulin lispro protamine formulations, insulin lispro mix25 and insulin lispro mix50.",HYPOGLYCEMIA,POSTPRANDIAL BLOOD GLUCOSE CONTROL
720315677,5/12/2015 01:06:23,1634474723,5/12/2015 01:05:48,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],reduced nocturnal,N/A,103,46,-1,114,80,TWrex-cause,800256-FS1,"Roach P, Trautmann M, Arora V et al. Improved POSTPRANDIAL BLOOD GLUCOSE CONTROL and reduced nocturnal HYPOGLYCEMIA during treatment with two novel insulin lispro protamine formulations, insulin lispro mix25 and insulin lispro mix50.",HYPOGLYCEMIA,POSTPRANDIAL BLOOD GLUCOSE CONTROL
720315677,5/12/2015 01:16:21,1634480067,5/12/2015 01:15:45,false,elite,1.0,31848723,USA,"","",155.94.185.207,[TREATS],[TREATS],POSTPRANDIAL GLUCOSE CONTROL,N/A,103,46,-1,114,80,TWrex-cause,800256-FS1,"Roach P, Trautmann M, Arora V et al. Improved POSTPRANDIAL BLOOD GLUCOSE CONTROL and reduced nocturnal HYPOGLYCEMIA during treatment with two novel insulin lispro protamine formulations, insulin lispro mix25 and insulin lispro mix50.",HYPOGLYCEMIA,POSTPRANDIAL BLOOD GLUCOSE CONTROL
720315677,5/12/2015 01:31:24,1634488060,5/12/2015 01:31:09,false,elite,1.0,32306791,USA,TX,Dallas,69.162.75.37,[TREATS],[TREATS],BLOOD insulin,N/A,103,46,-1,114,80,TWrex-cause,800256-FS1,"Roach P, Trautmann M, Arora V et al. Improved POSTPRANDIAL BLOOD GLUCOSE CONTROL and reduced nocturnal HYPOGLYCEMIA during treatment with two novel insulin lispro protamine formulations, insulin lispro mix25 and insulin lispro mix50.",HYPOGLYCEMIA,POSTPRANDIAL BLOOD GLUCOSE CONTROL
720315677,5/12/2015 01:33:35,1634489094,5/12/2015 01:33:06,false,instagc,1.0,32556346,USA,PA,Warren,207.255.244.59,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,103,46,-1,114,80,TWrex-cause,800256-FS1,"Roach P, Trautmann M, Arora V et al. Improved POSTPRANDIAL BLOOD GLUCOSE CONTROL and reduced nocturnal HYPOGLYCEMIA during treatment with two novel insulin lispro protamine formulations, insulin lispro mix25 and insulin lispro mix50.",HYPOGLYCEMIA,POSTPRANDIAL BLOOD GLUCOSE CONTROL
720315677,5/12/2015 01:45:02,1634495495,5/12/2015 01:44:40,false,instagc,1.0,30326470,USA,CA,San Diego,170.213.2.111,[TREATS],[TREATS],treatment,N/A,103,46,-1,114,80,TWrex-cause,800256-FS1,"Roach P, Trautmann M, Arora V et al. Improved POSTPRANDIAL BLOOD GLUCOSE CONTROL and reduced nocturnal HYPOGLYCEMIA during treatment with two novel insulin lispro protamine formulations, insulin lispro mix25 and insulin lispro mix50.",HYPOGLYCEMIA,POSTPRANDIAL BLOOD GLUCOSE CONTROL
720315677,5/12/2015 03:27:39,1634548817,5/12/2015 03:27:25,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[PREVENTS],[PREVENTS],reduced,n/a,103,46,-1,114,80,TWrex-cause,800256-FS1,"Roach P, Trautmann M, Arora V et al. Improved POSTPRANDIAL BLOOD GLUCOSE CONTROL and reduced nocturnal HYPOGLYCEMIA during treatment with two novel insulin lispro protamine formulations, insulin lispro mix25 and insulin lispro mix50.",HYPOGLYCEMIA,POSTPRANDIAL BLOOD GLUCOSE CONTROL
720315677,5/12/2015 03:46:07,1634557803,5/12/2015 03:45:42,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.227,[TREATS],[TREATS],POSTPRANDIAL BLOOD GLUCOSE CONTROL HYPOGLYCEMIA,N/A,103,46,-1,114,80,TWrex-cause,800256-FS1,"Roach P, Trautmann M, Arora V et al. Improved POSTPRANDIAL BLOOD GLUCOSE CONTROL and reduced nocturnal HYPOGLYCEMIA during treatment with two novel insulin lispro protamine formulations, insulin lispro mix25 and insulin lispro mix50.",HYPOGLYCEMIA,POSTPRANDIAL BLOOD GLUCOSE CONTROL
720315677,5/12/2015 04:21:02,1634574643,5/12/2015 04:19:58,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[NONE],[NONE],N/A,Treatment with two novel  insulin improves blood glucose control and reduces nocturnal hypoglycemia,103,46,-1,114,80,TWrex-cause,800256-FS1,"Roach P, Trautmann M, Arora V et al. Improved POSTPRANDIAL BLOOD GLUCOSE CONTROL and reduced nocturnal HYPOGLYCEMIA during treatment with two novel insulin lispro protamine formulations, insulin lispro mix25 and insulin lispro mix50.",HYPOGLYCEMIA,POSTPRANDIAL BLOOD GLUCOSE CONTROL
720315677,5/12/2015 05:00:16,1634593870,5/12/2015 04:58:29,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[NONE],[NONE],none,HYPOGLYCEMIA and   POSTPRANDIAL BLOOD GLUCOSE CONTROL were established by the drug,103,46,-1,114,80,TWrex-cause,800256-FS1,"Roach P, Trautmann M, Arora V et al. Improved POSTPRANDIAL BLOOD GLUCOSE CONTROL and reduced nocturnal HYPOGLYCEMIA during treatment with two novel insulin lispro protamine formulations, insulin lispro mix25 and insulin lispro mix50.",HYPOGLYCEMIA,POSTPRANDIAL BLOOD GLUCOSE CONTROL
720315677,5/12/2015 05:09:59,1634599524,5/12/2015 05:09:41,false,neodev,1.0,31910622,USA,CA,San Francisco,108.169.6.201,[MANIFESTATION],[MANIFESTATION],reduced nocturnal during treatment,I didn´t select none.,103,46,-1,114,80,TWrex-cause,800256-FS1,"Roach P, Trautmann M, Arora V et al. Improved POSTPRANDIAL BLOOD GLUCOSE CONTROL and reduced nocturnal HYPOGLYCEMIA during treatment with two novel insulin lispro protamine formulations, insulin lispro mix25 and insulin lispro mix50.",HYPOGLYCEMIA,POSTPRANDIAL BLOOD GLUCOSE CONTROL
720315677,5/12/2015 06:09:11,1634634884,5/12/2015 06:06:53,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[OTHER],[OTHER],and,N/A,103,46,-1,114,80,TWrex-cause,800256-FS1,"Roach P, Trautmann M, Arora V et al. Improved POSTPRANDIAL BLOOD GLUCOSE CONTROL and reduced nocturnal HYPOGLYCEMIA during treatment with two novel insulin lispro protamine formulations, insulin lispro mix25 and insulin lispro mix50.",HYPOGLYCEMIA,POSTPRANDIAL BLOOD GLUCOSE CONTROL
720315677,5/12/2015 06:23:47,1634641700,5/12/2015 06:22:05,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[OTHER],[OTHER],Improved reduced during treatment,N/A,103,46,-1,114,80,TWrex-cause,800256-FS1,"Roach P, Trautmann M, Arora V et al. Improved POSTPRANDIAL BLOOD GLUCOSE CONTROL and reduced nocturnal HYPOGLYCEMIA during treatment with two novel insulin lispro protamine formulations, insulin lispro mix25 and insulin lispro mix50.",HYPOGLYCEMIA,POSTPRANDIAL BLOOD GLUCOSE CONTROL
720315677,5/12/2015 06:32:02,1634645586,5/12/2015 06:29:55,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Improved POSTPRANDIAL BLOOD GLUCOSE CONTROL and reduced nocturnal HYPOGLYCEMIA,n/a,103,46,-1,114,80,TWrex-cause,800256-FS1,"Roach P, Trautmann M, Arora V et al. Improved POSTPRANDIAL BLOOD GLUCOSE CONTROL and reduced nocturnal HYPOGLYCEMIA during treatment with two novel insulin lispro protamine formulations, insulin lispro mix25 and insulin lispro mix50.",HYPOGLYCEMIA,POSTPRANDIAL BLOOD GLUCOSE CONTROL
720315677,5/12/2015 06:40:50,1634649502,5/12/2015 06:39:33,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[PREVENTS],[PREVENTS],reduced,n/a,103,46,-1,114,80,TWrex-cause,800256-FS1,"Roach P, Trautmann M, Arora V et al. Improved POSTPRANDIAL BLOOD GLUCOSE CONTROL and reduced nocturnal HYPOGLYCEMIA during treatment with two novel insulin lispro protamine formulations, insulin lispro mix25 and insulin lispro mix50.",HYPOGLYCEMIA,POSTPRANDIAL BLOOD GLUCOSE CONTROL
720315678,5/12/2015 00:55:08,1634469297,5/12/2015 00:53:44,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],characterized by,N/A,108,0,1,115,24,TWrex-cause,812632-FS1,"EPIDERMAL NEVUS SYNDROME  The EPIDERMAL NEVUS SYNDROME is characterized by systemic manifestations, such as SEIZURES mental retardation, blindness, and skeletal abnormalities in association with large epidermal nevi.",SEIZURES,EPIDERMAL NEVUS SYNDROME
720315678,5/12/2015 00:59:21,1634471501,5/12/2015 00:58:40,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[MANIFESTATION],[MANIFESTATION],"EPIDERMAL NEVUS SYNDROME is characterized by manifestations, such as SEIZURES",n/a,108,0,1,115,24,TWrex-cause,812632-FS1,"EPIDERMAL NEVUS SYNDROME  The EPIDERMAL NEVUS SYNDROME is characterized by systemic manifestations, such as SEIZURES mental retardation, blindness, and skeletal abnormalities in association with large epidermal nevi.",SEIZURES,EPIDERMAL NEVUS SYNDROME
720315678,5/12/2015 00:59:44,1634471633,5/12/2015 00:57:59,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[MANIFESTATION],[MANIFESTATION],"characterized by manifestations,",N/A,108,0,1,115,24,TWrex-cause,812632-FS1,"EPIDERMAL NEVUS SYNDROME  The EPIDERMAL NEVUS SYNDROME is characterized by systemic manifestations, such as SEIZURES mental retardation, blindness, and skeletal abnormalities in association with large epidermal nevi.",SEIZURES,EPIDERMAL NEVUS SYNDROME
720315678,5/12/2015 01:13:20,1634478298,5/12/2015 01:13:00,false,elite,1.0,31848723,USA,"","",155.94.185.207,[SYMPTOM],[SYMPTOM],SYNDROME SEIZURES,N/A,108,0,1,115,24,TWrex-cause,812632-FS1,"EPIDERMAL NEVUS SYNDROME  The EPIDERMAL NEVUS SYNDROME is characterized by systemic manifestations, such as SEIZURES mental retardation, blindness, and skeletal abnormalities in association with large epidermal nevi.",SEIZURES,EPIDERMAL NEVUS SYNDROME
720315678,5/12/2015 01:29:30,1634487040,5/12/2015 01:28:38,false,elite,1.0,32306791,USA,TX,Dallas,69.162.75.37,[TREATS],[TREATS],NEVUS association,N/A,108,0,1,115,24,TWrex-cause,812632-FS1,"EPIDERMAL NEVUS SYNDROME  The EPIDERMAL NEVUS SYNDROME is characterized by systemic manifestations, such as SEIZURES mental retardation, blindness, and skeletal abnormalities in association with large epidermal nevi.",SEIZURES,EPIDERMAL NEVUS SYNDROME
720315678,5/12/2015 01:29:36,1634487087,5/12/2015 01:29:08,false,instagc,1.0,32556346,USA,PA,Warren,207.255.244.59,[ASSOCIATED_WITH],[ASSOCIATED_WITH],characterized,N/A,108,0,1,115,24,TWrex-cause,812632-FS1,"EPIDERMAL NEVUS SYNDROME  The EPIDERMAL NEVUS SYNDROME is characterized by systemic manifestations, such as SEIZURES mental retardation, blindness, and skeletal abnormalities in association with large epidermal nevi.",SEIZURES,EPIDERMAL NEVUS SYNDROME
720315678,5/12/2015 01:41:38,1634493714,5/12/2015 01:41:10,false,instagc,1.0,30326470,USA,CA,San Diego,170.213.2.111,[SYMPTOM],[SYMPTOM],is characterized,N/A,108,0,1,115,24,TWrex-cause,812632-FS1,"EPIDERMAL NEVUS SYNDROME  The EPIDERMAL NEVUS SYNDROME is characterized by systemic manifestations, such as SEIZURES mental retardation, blindness, and skeletal abnormalities in association with large epidermal nevi.",SEIZURES,EPIDERMAL NEVUS SYNDROME
720315678,5/12/2015 03:25:57,1634547930,5/12/2015 03:25:39,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[MANIFESTATION],[MANIFESTATION],"manifestations,",n/a,108,0,1,115,24,TWrex-cause,812632-FS1,"EPIDERMAL NEVUS SYNDROME  The EPIDERMAL NEVUS SYNDROME is characterized by systemic manifestations, such as SEIZURES mental retardation, blindness, and skeletal abnormalities in association with large epidermal nevi.",SEIZURES,EPIDERMAL NEVUS SYNDROME
720315678,5/12/2015 03:43:12,1634556685,5/12/2015 03:42:35,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.227,[TREATS],[TREATS],EPIDERMAL NEVUS SYNDROME SEIZURES,N/A,108,0,1,115,24,TWrex-cause,812632-FS1,"EPIDERMAL NEVUS SYNDROME  The EPIDERMAL NEVUS SYNDROME is characterized by systemic manifestations, such as SEIZURES mental retardation, blindness, and skeletal abnormalities in association with large epidermal nevi.",SEIZURES,EPIDERMAL NEVUS SYNDROME
720315678,5/12/2015 04:16:08,1634572585,5/12/2015 04:15:39,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[PART_OF] [SYMPTOM],"[SYMPTOM]
[PART_OF]",characterized by,N/A,108,0,1,115,24,TWrex-cause,812632-FS1,"EPIDERMAL NEVUS SYNDROME  The EPIDERMAL NEVUS SYNDROME is characterized by systemic manifestations, such as SEIZURES mental retardation, blindness, and skeletal abnormalities in association with large epidermal nevi.",SEIZURES,EPIDERMAL NEVUS SYNDROME
720315678,5/12/2015 04:51:46,1634589301,5/12/2015 04:50:39,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],"manifestations,",none,108,0,1,115,24,TWrex-cause,812632-FS1,"EPIDERMAL NEVUS SYNDROME  The EPIDERMAL NEVUS SYNDROME is characterized by systemic manifestations, such as SEIZURES mental retardation, blindness, and skeletal abnormalities in association with large epidermal nevi.",SEIZURES,EPIDERMAL NEVUS SYNDROME
720315678,5/12/2015 05:05:28,1634596843,5/12/2015 05:05:11,false,neodev,1.0,31910622,USA,CA,Los Angeles,108.185.211.151,[MANIFESTATION],[MANIFESTATION],"by systemic manifestations, such as",I didn´t select none.,108,0,1,115,24,TWrex-cause,812632-FS1,"EPIDERMAL NEVUS SYNDROME  The EPIDERMAL NEVUS SYNDROME is characterized by systemic manifestations, such as SEIZURES mental retardation, blindness, and skeletal abnormalities in association with large epidermal nevi.",SEIZURES,EPIDERMAL NEVUS SYNDROME
720315678,5/12/2015 05:54:56,1634628064,5/12/2015 05:54:12,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[MANIFESTATION],[MANIFESTATION],"manifestations,",N/A,108,0,1,115,24,TWrex-cause,812632-FS1,"EPIDERMAL NEVUS SYNDROME  The EPIDERMAL NEVUS SYNDROME is characterized by systemic manifestations, such as SEIZURES mental retardation, blindness, and skeletal abnormalities in association with large epidermal nevi.",SEIZURES,EPIDERMAL NEVUS SYNDROME
720315678,5/12/2015 06:18:33,1634639387,5/12/2015 06:18:09,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[MANIFESTATION],[MANIFESTATION],"manifestations,",N/A,108,0,1,115,24,TWrex-cause,812632-FS1,"EPIDERMAL NEVUS SYNDROME  The EPIDERMAL NEVUS SYNDROME is characterized by systemic manifestations, such as SEIZURES mental retardation, blindness, and skeletal abnormalities in association with large epidermal nevi.",SEIZURES,EPIDERMAL NEVUS SYNDROME
720315678,5/12/2015 06:22:06,1634640842,5/12/2015 06:20:18,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]","EPIDERMAL NEVUS SYNDROME is characterized by systemic manifestations, such as SEIZURES",n/a,108,0,1,115,24,TWrex-cause,812632-FS1,"EPIDERMAL NEVUS SYNDROME  The EPIDERMAL NEVUS SYNDROME is characterized by systemic manifestations, such as SEIZURES mental retardation, blindness, and skeletal abnormalities in association with large epidermal nevi.",SEIZURES,EPIDERMAL NEVUS SYNDROME
720315679,5/12/2015 03:31:13,1634550792,5/12/2015 03:30:54,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosed,n/a,173,122,-1,187,131,TWrex-cause,804339-FS1,"United Kingdom Prospective Diabetes Study 24: a 6 year, randomized, controlled trial comparing sulfonylurea, insulin, and METFORMIN therapy in patients with newly diagnosed TYPE 2 DIABETES that could not be controlled with diet therapy.",TYPE 2 DIABETES,METFORMIN
720315679,5/12/2015 03:49:44,1634559407,5/12/2015 03:49:08,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.227,[SYMPTOM],[SYMPTOM],METFORMIN TYPE 2 DIABETES,N/A,173,122,-1,187,131,TWrex-cause,804339-FS1,"United Kingdom Prospective Diabetes Study 24: a 6 year, randomized, controlled trial comparing sulfonylurea, insulin, and METFORMIN therapy in patients with newly diagnosed TYPE 2 DIABETES that could not be controlled with diet therapy.",TYPE 2 DIABETES,METFORMIN
720315679,5/12/2015 04:23:39,1634576045,5/12/2015 04:23:23,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[TREATS],[TREATS],therapy in,N/A,173,122,-1,187,131,TWrex-cause,804339-FS1,"United Kingdom Prospective Diabetes Study 24: a 6 year, randomized, controlled trial comparing sulfonylurea, insulin, and METFORMIN therapy in patients with newly diagnosed TYPE 2 DIABETES that could not be controlled with diet therapy.",TYPE 2 DIABETES,METFORMIN
720315679,5/12/2015 05:05:28,1634596852,5/12/2015 05:04:35,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],controlled,none,173,122,-1,187,131,TWrex-cause,804339-FS1,"United Kingdom Prospective Diabetes Study 24: a 6 year, randomized, controlled trial comparing sulfonylurea, insulin, and METFORMIN therapy in patients with newly diagnosed TYPE 2 DIABETES that could not be controlled with diet therapy.",TYPE 2 DIABETES,METFORMIN
720315679,5/12/2015 05:12:33,1634601085,5/12/2015 05:12:16,false,neodev,1.0,31910622,USA,CA,San Francisco,108.169.6.201,[TREATS],[TREATS],therapy in patients,I didn´t select none.,173,122,-1,187,131,TWrex-cause,804339-FS1,"United Kingdom Prospective Diabetes Study 24: a 6 year, randomized, controlled trial comparing sulfonylurea, insulin, and METFORMIN therapy in patients with newly diagnosed TYPE 2 DIABETES that could not be controlled with diet therapy.",TYPE 2 DIABETES,METFORMIN
720315679,5/12/2015 06:15:27,1634637882,5/12/2015 06:14:24,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],therapy,N/A,173,122,-1,187,131,TWrex-cause,804339-FS1,"United Kingdom Prospective Diabetes Study 24: a 6 year, randomized, controlled trial comparing sulfonylurea, insulin, and METFORMIN therapy in patients with newly diagnosed TYPE 2 DIABETES that could not be controlled with diet therapy.",TYPE 2 DIABETES,METFORMIN
720315679,5/12/2015 06:26:06,1634642930,5/12/2015 06:25:46,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[TREATS],[TREATS],therapy,N/A,173,122,-1,187,131,TWrex-cause,804339-FS1,"United Kingdom Prospective Diabetes Study 24: a 6 year, randomized, controlled trial comparing sulfonylurea, insulin, and METFORMIN therapy in patients with newly diagnosed TYPE 2 DIABETES that could not be controlled with diet therapy.",TYPE 2 DIABETES,METFORMIN
720315679,5/12/2015 06:43:45,1634650754,5/12/2015 06:43:22,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],trial,NA,173,122,-1,187,131,TWrex-cause,804339-FS1,"United Kingdom Prospective Diabetes Study 24: a 6 year, randomized, controlled trial comparing sulfonylurea, insulin, and METFORMIN therapy in patients with newly diagnosed TYPE 2 DIABETES that could not be controlled with diet therapy.",TYPE 2 DIABETES,METFORMIN
720315679,5/12/2015 06:44:09,1634650948,5/12/2015 06:43:50,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[TREATS],[TREATS],METFORMIN therapy newly diagnosed TYPE 2 DIABETES,n/a,173,122,-1,187,131,TWrex-cause,804339-FS1,"United Kingdom Prospective Diabetes Study 24: a 6 year, randomized, controlled trial comparing sulfonylurea, insulin, and METFORMIN therapy in patients with newly diagnosed TYPE 2 DIABETES that could not be controlled with diet therapy.",TYPE 2 DIABETES,METFORMIN
720315679,5/12/2015 06:46:54,1634652152,5/12/2015 06:46:39,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[TREATS],[TREATS],therapy in patients with,N/A,173,122,-1,187,131,TWrex-cause,804339-FS1,"United Kingdom Prospective Diabetes Study 24: a 6 year, randomized, controlled trial comparing sulfonylurea, insulin, and METFORMIN therapy in patients with newly diagnosed TYPE 2 DIABETES that could not be controlled with diet therapy.",TYPE 2 DIABETES,METFORMIN
720315679,5/12/2015 06:51:14,1634653995,5/12/2015 06:49:48,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],therapy,n/a,173,122,-1,187,131,TWrex-cause,804339-FS1,"United Kingdom Prospective Diabetes Study 24: a 6 year, randomized, controlled trial comparing sulfonylurea, insulin, and METFORMIN therapy in patients with newly diagnosed TYPE 2 DIABETES that could not be controlled with diet therapy.",TYPE 2 DIABETES,METFORMIN
720315679,5/12/2015 07:03:25,1634659233,5/12/2015 07:03:06,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[TREATS],[TREATS],therapy,N/a,173,122,-1,187,131,TWrex-cause,804339-FS1,"United Kingdom Prospective Diabetes Study 24: a 6 year, randomized, controlled trial comparing sulfonylurea, insulin, and METFORMIN therapy in patients with newly diagnosed TYPE 2 DIABETES that could not be controlled with diet therapy.",TYPE 2 DIABETES,METFORMIN
720315679,5/12/2015 07:53:26,1634690002,5/12/2015 07:53:04,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],therapy,N/A,173,122,-1,187,131,TWrex-cause,804339-FS1,"United Kingdom Prospective Diabetes Study 24: a 6 year, randomized, controlled trial comparing sulfonylurea, insulin, and METFORMIN therapy in patients with newly diagnosed TYPE 2 DIABETES that could not be controlled with diet therapy.",TYPE 2 DIABETES,METFORMIN
720315679,5/12/2015 08:07:46,1634697199,5/12/2015 08:07:06,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[TREATS],[TREATS],therapy,Treated with,173,122,-1,187,131,TWrex-cause,804339-FS1,"United Kingdom Prospective Diabetes Study 24: a 6 year, randomized, controlled trial comparing sulfonylurea, insulin, and METFORMIN therapy in patients with newly diagnosed TYPE 2 DIABETES that could not be controlled with diet therapy.",TYPE 2 DIABETES,METFORMIN
720315679,5/12/2015 08:48:51,1634719184,5/12/2015 08:47:05,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[TREATS],[TREATS],controlled,N/A,173,122,-1,187,131,TWrex-cause,804339-FS1,"United Kingdom Prospective Diabetes Study 24: a 6 year, randomized, controlled trial comparing sulfonylurea, insulin, and METFORMIN therapy in patients with newly diagnosed TYPE 2 DIABETES that could not be controlled with diet therapy.",TYPE 2 DIABETES,METFORMIN
720315680,5/12/2015 06:51:29,1634654146,5/12/2015 06:51:14,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[TREATS],[TREATS],in the treatment of,N/A,57,25,-1,85,36,TWrex-cause,800777-FS1,"Montgomery SA, Manceaux AFLUVOXAMINE in the treatment of OBSESSIVE COMPULSIVE DISORDER",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
720315680,5/12/2015 06:54:28,1634655393,5/12/2015 06:53:57,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[TREATS],[TREATS],treatment,NA,57,25,-1,85,36,TWrex-cause,800777-FS1,"Montgomery SA, Manceaux AFLUVOXAMINE in the treatment of OBSESSIVE COMPULSIVE DISORDER",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
720315680,5/12/2015 07:07:15,1634660979,5/12/2015 07:07:02,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],treatment,n/a,57,25,-1,85,36,TWrex-cause,800777-FS1,"Montgomery SA, Manceaux AFLUVOXAMINE in the treatment of OBSESSIVE COMPULSIVE DISORDER",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
720315680,5/12/2015 08:02:35,1634694547,5/12/2015 08:02:24,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],in the treatment,N/A,57,25,-1,85,36,TWrex-cause,800777-FS1,"Montgomery SA, Manceaux AFLUVOXAMINE in the treatment of OBSESSIVE COMPULSIVE DISORDER",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
720315680,5/12/2015 08:18:14,1634702382,5/12/2015 08:17:52,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[TREATS],[TREATS],treatment,Treated with,57,25,-1,85,36,TWrex-cause,800777-FS1,"Montgomery SA, Manceaux AFLUVOXAMINE in the treatment of OBSESSIVE COMPULSIVE DISORDER",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
720315680,5/12/2015 08:55:45,1634722754,5/12/2015 08:55:31,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[TREATS],[TREATS],treatment,N/A,57,25,-1,85,36,TWrex-cause,800777-FS1,"Montgomery SA, Manceaux AFLUVOXAMINE in the treatment of OBSESSIVE COMPULSIVE DISORDER",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
720315680,5/12/2015 09:02:14,1634725963,5/12/2015 09:01:41,false,inboxpounds,1.0,29059658,GBR,H9,London,79.77.3.89,[TREATS],[TREATS],in the treatment,N/A,57,25,-1,85,36,TWrex-cause,800777-FS1,"Montgomery SA, Manceaux AFLUVOXAMINE in the treatment of OBSESSIVE COMPULSIVE DISORDER",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
720315680,5/12/2015 11:03:36,1634825982,5/12/2015 11:03:22,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],treatment of,n/a,57,25,-1,85,36,TWrex-cause,800777-FS1,"Montgomery SA, Manceaux AFLUVOXAMINE in the treatment of OBSESSIVE COMPULSIVE DISORDER",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
720315680,5/12/2015 11:48:51,1634856234,5/12/2015 11:48:17,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],AFLUVOXAMINE in treatment of OBSESSIVE COMPULSIVE DISORDER,N/A,57,25,-1,85,36,TWrex-cause,800777-FS1,"Montgomery SA, Manceaux AFLUVOXAMINE in the treatment of OBSESSIVE COMPULSIVE DISORDER",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
720315680,5/12/2015 11:56:19,1634859855,5/12/2015 11:56:01,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[TREATS],[TREATS],in the treatment of,N/A,57,25,-1,85,36,TWrex-cause,800777-FS1,"Montgomery SA, Manceaux AFLUVOXAMINE in the treatment of OBSESSIVE COMPULSIVE DISORDER",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
720315680,5/12/2015 11:57:18,1634860402,5/12/2015 11:57:04,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[TREATS],[TREATS],in the treatment of,N/A,57,25,-1,85,36,TWrex-cause,800777-FS1,"Montgomery SA, Manceaux AFLUVOXAMINE in the treatment of OBSESSIVE COMPULSIVE DISORDER",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
720315680,5/12/2015 12:13:28,1634867502,5/12/2015 12:13:10,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[TREATS],[TREATS],treatment,N/A,57,25,-1,85,36,TWrex-cause,800777-FS1,"Montgomery SA, Manceaux AFLUVOXAMINE in the treatment of OBSESSIVE COMPULSIVE DISORDER",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
720315680,5/12/2015 12:40:49,1634879878,5/12/2015 12:40:23,false,clixsense,1.0,27969116,NLD,"","",212.78.195.38,[TREATS],[TREATS],in the treatment of,treats it.,57,25,-1,85,36,TWrex-cause,800777-FS1,"Montgomery SA, Manceaux AFLUVOXAMINE in the treatment of OBSESSIVE COMPULSIVE DISORDER",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
720315680,5/12/2015 13:03:02,1634888591,5/12/2015 13:01:47,false,bitcoinget,1.0,24960279,USA,NY,Bronx,24.184.60.73,[TREATS],[TREATS],treatment,n/a,57,25,-1,85,36,TWrex-cause,800777-FS1,"Montgomery SA, Manceaux AFLUVOXAMINE in the treatment of OBSESSIVE COMPULSIVE DISORDER",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
720315680,5/12/2015 14:30:35,1634928707,5/12/2015 14:30:09,false,neodev,1.0,31726043,USA,DE,"",108.59.8.208,[SYMPTOM],[SYMPTOM],OBSESSIVE,ghg,57,25,-1,85,36,TWrex-cause,800777-FS1,"Montgomery SA, Manceaux AFLUVOXAMINE in the treatment of OBSESSIVE COMPULSIVE DISORDER",OBSESSIVE COMPULSIVE DISORDER,FLUVOXAMINE
720315681,5/11/2015 22:15:32,1634400326,5/11/2015 22:15:17,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],HANTAAN VIRUS causes EPIDEMIC HEMORRHAGIC FEVER,n/a,60,33,1,85,46,TWrex-cause,810337-FS1,"22   The prototype hantavirus is HANTAAN VIRUS which causes EPIDEMIC HEMORRHAGIC FEVER in China and Korea, but many different hantaviruses are now recognized.",EPIDEMIC HEMORRHAGIC FEVER,HANTAAN VIRUS
720315681,5/11/2015 22:16:04,1634400576,5/11/2015 22:13:56,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],HEMORRHAGIC FEVER,N/A,60,33,1,85,46,TWrex-cause,810337-FS1,"22   The prototype hantavirus is HANTAAN VIRUS which causes EPIDEMIC HEMORRHAGIC FEVER in China and Korea, but many different hantaviruses are now recognized.",EPIDEMIC HEMORRHAGIC FEVER,HANTAAN VIRUS
720315681,5/11/2015 22:16:43,1634400885,5/11/2015 22:13:53,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],causes,n/a,60,33,1,85,46,TWrex-cause,810337-FS1,"22   The prototype hantavirus is HANTAAN VIRUS which causes EPIDEMIC HEMORRHAGIC FEVER in China and Korea, but many different hantaviruses are now recognized.",EPIDEMIC HEMORRHAGIC FEVER,HANTAAN VIRUS
720315681,5/11/2015 22:17:26,1634401181,5/11/2015 22:16:38,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],HANTAAN VIRUS which causes EPIDEMIC HEMORRHAGIC FEVER,N/A,60,33,1,85,46,TWrex-cause,810337-FS1,"22   The prototype hantavirus is HANTAAN VIRUS which causes EPIDEMIC HEMORRHAGIC FEVER in China and Korea, but many different hantaviruses are now recognized.",EPIDEMIC HEMORRHAGIC FEVER,HANTAAN VIRUS
720315681,5/11/2015 22:18:13,1634401507,5/11/2015 22:17:46,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],causes,n/a,60,33,1,85,46,TWrex-cause,810337-FS1,"22   The prototype hantavirus is HANTAAN VIRUS which causes EPIDEMIC HEMORRHAGIC FEVER in China and Korea, but many different hantaviruses are now recognized.",EPIDEMIC HEMORRHAGIC FEVER,HANTAAN VIRUS
720315681,5/11/2015 22:30:06,1634406716,5/11/2015 22:29:47,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],causes,n/a,60,33,1,85,46,TWrex-cause,810337-FS1,"22   The prototype hantavirus is HANTAAN VIRUS which causes EPIDEMIC HEMORRHAGIC FEVER in China and Korea, but many different hantaviruses are now recognized.",EPIDEMIC HEMORRHAGIC FEVER,HANTAAN VIRUS
720315681,5/11/2015 22:31:53,1634407473,5/11/2015 22:31:26,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[CAUSES],[CAUSES],which causes,n/a,60,33,1,85,46,TWrex-cause,810337-FS1,"22   The prototype hantavirus is HANTAAN VIRUS which causes EPIDEMIC HEMORRHAGIC FEVER in China and Korea, but many different hantaviruses are now recognized.",EPIDEMIC HEMORRHAGIC FEVER,HANTAAN VIRUS
720315681,5/11/2015 22:31:58,1634407502,5/11/2015 22:30:00,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],HANTAAN VIRUS causes EPIDEMIC HEMORRHAGIC FEVER,n/a,60,33,1,85,46,TWrex-cause,810337-FS1,"22   The prototype hantavirus is HANTAAN VIRUS which causes EPIDEMIC HEMORRHAGIC FEVER in China and Korea, but many different hantaviruses are now recognized.",EPIDEMIC HEMORRHAGIC FEVER,HANTAAN VIRUS
720315681,5/11/2015 22:35:49,1634409444,5/11/2015 22:35:12,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],"prototype hantavirus is HANTAAN VIRUS which causes EPIDEMIC HEMORRHAGIC FEVER in China and Korea,",N/A,60,33,1,85,46,TWrex-cause,810337-FS1,"22   The prototype hantavirus is HANTAAN VIRUS which causes EPIDEMIC HEMORRHAGIC FEVER in China and Korea, but many different hantaviruses are now recognized.",EPIDEMIC HEMORRHAGIC FEVER,HANTAAN VIRUS
720315681,5/11/2015 22:36:35,1634409715,5/11/2015 22:35:42,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[MANIFESTATION] [CAUSES],"[CAUSES]
[MANIFESTATION]",HANTAAN VIRUS which causes EPIDEMIC HEMORRHAGIC FEVER,n/a,60,33,1,85,46,TWrex-cause,810337-FS1,"22   The prototype hantavirus is HANTAAN VIRUS which causes EPIDEMIC HEMORRHAGIC FEVER in China and Korea, but many different hantaviruses are now recognized.",EPIDEMIC HEMORRHAGIC FEVER,HANTAAN VIRUS
720315681,5/11/2015 22:40:48,1634411785,5/11/2015 22:39:30,false,instagc,1.0,28519532,USA,IA,Neola,38.121.112.217,[CAUSES],[CAUSES],causes,na,60,33,1,85,46,TWrex-cause,810337-FS1,"22   The prototype hantavirus is HANTAAN VIRUS which causes EPIDEMIC HEMORRHAGIC FEVER in China and Korea, but many different hantaviruses are now recognized.",EPIDEMIC HEMORRHAGIC FEVER,HANTAAN VIRUS
720315681,5/11/2015 22:44:11,1634413357,5/11/2015 22:43:38,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,75.147.181.53,[CAUSES],[CAUSES],which causes,N/A,60,33,1,85,46,TWrex-cause,810337-FS1,"22   The prototype hantavirus is HANTAAN VIRUS which causes EPIDEMIC HEMORRHAGIC FEVER in China and Korea, but many different hantaviruses are now recognized.",EPIDEMIC HEMORRHAGIC FEVER,HANTAAN VIRUS
720315681,5/11/2015 22:44:59,1634413719,5/11/2015 22:43:20,false,clixsense,1.0,6330007,AUS,06,Hobart,101.178.23.54,[CAUSES],[CAUSES],causes,n/a,60,33,1,85,46,TWrex-cause,810337-FS1,"22   The prototype hantavirus is HANTAAN VIRUS which causes EPIDEMIC HEMORRHAGIC FEVER in China and Korea, but many different hantaviruses are now recognized.",EPIDEMIC HEMORRHAGIC FEVER,HANTAAN VIRUS
720315681,5/11/2015 22:46:53,1634414593,5/11/2015 22:46:26,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],causes,N/A,60,33,1,85,46,TWrex-cause,810337-FS1,"22   The prototype hantavirus is HANTAAN VIRUS which causes EPIDEMIC HEMORRHAGIC FEVER in China and Korea, but many different hantaviruses are now recognized.",EPIDEMIC HEMORRHAGIC FEVER,HANTAAN VIRUS
720315681,5/11/2015 22:53:09,1634417294,5/11/2015 22:52:50,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],causes,N/A,60,33,1,85,46,TWrex-cause,810337-FS1,"22   The prototype hantavirus is HANTAAN VIRUS which causes EPIDEMIC HEMORRHAGIC FEVER in China and Korea, but many different hantaviruses are now recognized.",EPIDEMIC HEMORRHAGIC FEVER,HANTAAN VIRUS
720315682,5/11/2015 23:10:15,1634424025,5/11/2015 23:09:57,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,111,70,-1,121,84,TWrex-cause,804067-FS1,"CONCLUSION  In patients with cancer, itraconazole was as effective as AMPHOTERICIN B for eliminating fever and NEUTROPENIA and led to fewer adverse events.",NEUTROPENIA,AMPHOTERICIN B
720315682,5/11/2015 23:17:54,1634428160,5/11/2015 23:17:22,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],eliminating,N/A,111,70,-1,121,84,TWrex-cause,804067-FS1,"CONCLUSION  In patients with cancer, itraconazole was as effective as AMPHOTERICIN B for eliminating fever and NEUTROPENIA and led to fewer adverse events.",NEUTROPENIA,AMPHOTERICIN B
720315682,5/11/2015 23:17:54,1634428163,5/11/2015 23:17:33,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],eliminating,n/a,111,70,-1,121,84,TWrex-cause,804067-FS1,"CONCLUSION  In patients with cancer, itraconazole was as effective as AMPHOTERICIN B for eliminating fever and NEUTROPENIA and led to fewer adverse events.",NEUTROPENIA,AMPHOTERICIN B
720315682,5/11/2015 23:20:33,1634429302,5/11/2015 23:20:06,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[TREATS],[TREATS],itraconazole was as effective as AMPHOTERICIN B for eliminating NEUTROPENIA,n/a,111,70,-1,121,84,TWrex-cause,804067-FS1,"CONCLUSION  In patients with cancer, itraconazole was as effective as AMPHOTERICIN B for eliminating fever and NEUTROPENIA and led to fewer adverse events.",NEUTROPENIA,AMPHOTERICIN B
720315682,5/11/2015 23:21:06,1634429609,5/11/2015 23:20:27,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],eliminating,it a type of drug used to treat,111,70,-1,121,84,TWrex-cause,804067-FS1,"CONCLUSION  In patients with cancer, itraconazole was as effective as AMPHOTERICIN B for eliminating fever and NEUTROPENIA and led to fewer adverse events.",NEUTROPENIA,AMPHOTERICIN B
720315682,5/11/2015 23:21:13,1634429683,5/11/2015 23:20:52,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],was as effective as,n/a,111,70,-1,121,84,TWrex-cause,804067-FS1,"CONCLUSION  In patients with cancer, itraconazole was as effective as AMPHOTERICIN B for eliminating fever and NEUTROPENIA and led to fewer adverse events.",NEUTROPENIA,AMPHOTERICIN B
720315682,5/11/2015 23:21:36,1634429876,5/11/2015 23:20:08,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],eliminating,N/A,111,70,-1,121,84,TWrex-cause,804067-FS1,"CONCLUSION  In patients with cancer, itraconazole was as effective as AMPHOTERICIN B for eliminating fever and NEUTROPENIA and led to fewer adverse events.",NEUTROPENIA,AMPHOTERICIN B
720315682,5/11/2015 23:22:43,1634430418,5/11/2015 23:19:53,false,clixsense,1.0,6330007,AUS,06,Hobart,101.178.23.54,[TREATS],[TREATS],eliminating fever,n/a,111,70,-1,121,84,TWrex-cause,804067-FS1,"CONCLUSION  In patients with cancer, itraconazole was as effective as AMPHOTERICIN B for eliminating fever and NEUTROPENIA and led to fewer adverse events.",NEUTROPENIA,AMPHOTERICIN B
720315682,5/11/2015 23:23:17,1634430721,5/11/2015 23:21:53,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],for eliminating,N/A,111,70,-1,121,84,TWrex-cause,804067-FS1,"CONCLUSION  In patients with cancer, itraconazole was as effective as AMPHOTERICIN B for eliminating fever and NEUTROPENIA and led to fewer adverse events.",NEUTROPENIA,AMPHOTERICIN B
720315682,5/11/2015 23:25:56,1634431693,5/11/2015 23:25:17,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.48,[PREVENTS] [CAUSES] [LOCATION] [NONE],"[PREVENTS]
[CAUSES]
[LOCATION]
[NONE]",no,no,111,70,-1,121,84,TWrex-cause,804067-FS1,"CONCLUSION  In patients with cancer, itraconazole was as effective as AMPHOTERICIN B for eliminating fever and NEUTROPENIA and led to fewer adverse events.",NEUTROPENIA,AMPHOTERICIN B
720315682,5/11/2015 23:31:07,1634434216,5/11/2015 23:30:05,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[OTHER],[OTHER],eliminating fever,n/a,111,70,-1,121,84,TWrex-cause,804067-FS1,"CONCLUSION  In patients with cancer, itraconazole was as effective as AMPHOTERICIN B for eliminating fever and NEUTROPENIA and led to fewer adverse events.",NEUTROPENIA,AMPHOTERICIN B
720315682,5/11/2015 23:32:30,1634434935,5/11/2015 23:30:51,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],eliminating,n/a,111,70,-1,121,84,TWrex-cause,804067-FS1,"CONCLUSION  In patients with cancer, itraconazole was as effective as AMPHOTERICIN B for eliminating fever and NEUTROPENIA and led to fewer adverse events.",NEUTROPENIA,AMPHOTERICIN B
720315682,5/11/2015 23:33:28,1634435374,5/11/2015 23:32:20,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[PREVENTS],[PREVENTS],eliminating,n/a,111,70,-1,121,84,TWrex-cause,804067-FS1,"CONCLUSION  In patients with cancer, itraconazole was as effective as AMPHOTERICIN B for eliminating fever and NEUTROPENIA and led to fewer adverse events.",NEUTROPENIA,AMPHOTERICIN B
720315682,5/11/2015 23:53:36,1634445455,5/11/2015 23:53:15,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],eliminating,n/a,111,70,-1,121,84,TWrex-cause,804067-FS1,"CONCLUSION  In patients with cancer, itraconazole was as effective as AMPHOTERICIN B for eliminating fever and NEUTROPENIA and led to fewer adverse events.",NEUTROPENIA,AMPHOTERICIN B
720315682,5/12/2015 00:12:11,1634452270,5/12/2015 00:10:57,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],effective for eliminating,treats,111,70,-1,121,84,TWrex-cause,804067-FS1,"CONCLUSION  In patients with cancer, itraconazole was as effective as AMPHOTERICIN B for eliminating fever and NEUTROPENIA and led to fewer adverse events.",NEUTROPENIA,AMPHOTERICIN B
720315683,5/11/2015 23:14:03,1634426500,5/11/2015 23:13:42,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,139,70,-1,147,96,TWrex-cause,802045-FS1,"A table comparing sensorineural to conductive hearing loss   Criteria SENSORINEURAL HEARING LOSS Conductive hearing loss   Anatomical Site INNER EAR cranial nerve VIII, or central processing centers Middle ear (ossicular chain), tympanic membrane, or external ear   Weber Test Sound localizes to normal ear Sound localizes to affected ear (ear with conductive loss)   Rinne Test Positive Rinne; Air conduction.",INNER EAR,SENSORINEURAL HEARING LOSS
720315683,5/11/2015 23:24:25,1634431124,5/11/2015 23:23:27,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[LOCATION],[LOCATION],Anatomical Site,N/A,139,70,-1,147,96,TWrex-cause,802045-FS1,"A table comparing sensorineural to conductive hearing loss   Criteria SENSORINEURAL HEARING LOSS Conductive hearing loss   Anatomical Site INNER EAR cranial nerve VIII, or central processing centers Middle ear (ossicular chain), tympanic membrane, or external ear   Weber Test Sound localizes to normal ear Sound localizes to affected ear (ear with conductive loss)   Rinne Test Positive Rinne; Air conduction.",INNER EAR,SENSORINEURAL HEARING LOSS
720315683,5/11/2015 23:40:11,1634440029,5/11/2015 23:39:28,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[LOCATION],[LOCATION],Site,n/a,139,70,-1,147,96,TWrex-cause,802045-FS1,"A table comparing sensorineural to conductive hearing loss   Criteria SENSORINEURAL HEARING LOSS Conductive hearing loss   Anatomical Site INNER EAR cranial nerve VIII, or central processing centers Middle ear (ossicular chain), tympanic membrane, or external ear   Weber Test Sound localizes to normal ear Sound localizes to affected ear (ear with conductive loss)   Rinne Test Positive Rinne; Air conduction.",INNER EAR,SENSORINEURAL HEARING LOSS
720315683,5/11/2015 23:53:17,1634445360,5/11/2015 23:53:05,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.48,[PREVENTS] [CAUSES] [LOCATION] [NONE],"[PREVENTS]
[CAUSES]
[LOCATION]
[NONE]",no,no,139,70,-1,147,96,TWrex-cause,802045-FS1,"A table comparing sensorineural to conductive hearing loss   Criteria SENSORINEURAL HEARING LOSS Conductive hearing loss   Anatomical Site INNER EAR cranial nerve VIII, or central processing centers Middle ear (ossicular chain), tympanic membrane, or external ear   Weber Test Sound localizes to normal ear Sound localizes to affected ear (ear with conductive loss)   Rinne Test Positive Rinne; Air conduction.",INNER EAR,SENSORINEURAL HEARING LOSS
720315683,5/12/2015 00:32:01,1634459867,5/12/2015 00:30:27,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[LOCATION],[LOCATION],Anatomical Site,location,139,70,-1,147,96,TWrex-cause,802045-FS1,"A table comparing sensorineural to conductive hearing loss   Criteria SENSORINEURAL HEARING LOSS Conductive hearing loss   Anatomical Site INNER EAR cranial nerve VIII, or central processing centers Middle ear (ossicular chain), tympanic membrane, or external ear   Weber Test Sound localizes to normal ear Sound localizes to affected ear (ear with conductive loss)   Rinne Test Positive Rinne; Air conduction.",INNER EAR,SENSORINEURAL HEARING LOSS
720315683,5/12/2015 00:45:39,1634465682,5/12/2015 00:44:27,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[NONE],[NONE],N/A,N/A,139,70,-1,147,96,TWrex-cause,802045-FS1,"A table comparing sensorineural to conductive hearing loss   Criteria SENSORINEURAL HEARING LOSS Conductive hearing loss   Anatomical Site INNER EAR cranial nerve VIII, or central processing centers Middle ear (ossicular chain), tympanic membrane, or external ear   Weber Test Sound localizes to normal ear Sound localizes to affected ear (ear with conductive loss)   Rinne Test Positive Rinne; Air conduction.",INNER EAR,SENSORINEURAL HEARING LOSS
720315683,5/12/2015 00:47:19,1634466289,5/12/2015 00:46:14,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[ASSOCIATED_WITH],[ASSOCIATED_WITH],SENSORINEURAL HEARING LOSS INNER EAR conduction.,n/a,139,70,-1,147,96,TWrex-cause,802045-FS1,"A table comparing sensorineural to conductive hearing loss   Criteria SENSORINEURAL HEARING LOSS Conductive hearing loss   Anatomical Site INNER EAR cranial nerve VIII, or central processing centers Middle ear (ossicular chain), tympanic membrane, or external ear   Weber Test Sound localizes to normal ear Sound localizes to affected ear (ear with conductive loss)   Rinne Test Positive Rinne; Air conduction.",INNER EAR,SENSORINEURAL HEARING LOSS
720315683,5/12/2015 01:06:00,1634474548,5/12/2015 01:05:24,false,elite,1.0,31848723,USA,"","",155.94.185.207,[SYMPTOM],[SYMPTOM],SENSORINEURAL HEARING LOSS INNER EAR,N/A,139,70,-1,147,96,TWrex-cause,802045-FS1,"A table comparing sensorineural to conductive hearing loss   Criteria SENSORINEURAL HEARING LOSS Conductive hearing loss   Anatomical Site INNER EAR cranial nerve VIII, or central processing centers Middle ear (ossicular chain), tympanic membrane, or external ear   Weber Test Sound localizes to normal ear Sound localizes to affected ear (ear with conductive loss)   Rinne Test Positive Rinne; Air conduction.",INNER EAR,SENSORINEURAL HEARING LOSS
720315683,5/12/2015 01:12:43,1634477978,5/12/2015 01:12:18,false,elite,1.0,32306791,NLD,"","",31.3.156.41,[LOCATION],[LOCATION],centers (ear,gdfg,139,70,-1,147,96,TWrex-cause,802045-FS1,"A table comparing sensorineural to conductive hearing loss   Criteria SENSORINEURAL HEARING LOSS Conductive hearing loss   Anatomical Site INNER EAR cranial nerve VIII, or central processing centers Middle ear (ossicular chain), tympanic membrane, or external ear   Weber Test Sound localizes to normal ear Sound localizes to affected ear (ear with conductive loss)   Rinne Test Positive Rinne; Air conduction.",INNER EAR,SENSORINEURAL HEARING LOSS
720315683,5/12/2015 01:24:01,1634484367,5/12/2015 01:23:35,false,instagc,1.0,32556346,USA,PA,Warren,207.255.244.59,[LOCATION],[LOCATION],Site,N/A,139,70,-1,147,96,TWrex-cause,802045-FS1,"A table comparing sensorineural to conductive hearing loss   Criteria SENSORINEURAL HEARING LOSS Conductive hearing loss   Anatomical Site INNER EAR cranial nerve VIII, or central processing centers Middle ear (ossicular chain), tympanic membrane, or external ear   Weber Test Sound localizes to normal ear Sound localizes to affected ear (ear with conductive loss)   Rinne Test Positive Rinne; Air conduction.",INNER EAR,SENSORINEURAL HEARING LOSS
720315683,5/12/2015 01:30:30,1634487545,5/12/2015 01:29:22,false,instagc,1.0,30326470,USA,CA,San Diego,170.213.2.111,[PART_OF],[PART_OF],table comparing,N/A,139,70,-1,147,96,TWrex-cause,802045-FS1,"A table comparing sensorineural to conductive hearing loss   Criteria SENSORINEURAL HEARING LOSS Conductive hearing loss   Anatomical Site INNER EAR cranial nerve VIII, or central processing centers Middle ear (ossicular chain), tympanic membrane, or external ear   Weber Test Sound localizes to normal ear Sound localizes to affected ear (ear with conductive loss)   Rinne Test Positive Rinne; Air conduction.",INNER EAR,SENSORINEURAL HEARING LOSS
720315683,5/12/2015 02:48:31,1634528662,5/12/2015 02:48:06,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[PREVENTS] [DIAGNOSE_BY_TEST_OR_DRUG],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]",conductive hearing loss Criteria SENSORINEURAL,n/a,139,70,-1,147,96,TWrex-cause,802045-FS1,"A table comparing sensorineural to conductive hearing loss   Criteria SENSORINEURAL HEARING LOSS Conductive hearing loss   Anatomical Site INNER EAR cranial nerve VIII, or central processing centers Middle ear (ossicular chain), tympanic membrane, or external ear   Weber Test Sound localizes to normal ear Sound localizes to affected ear (ear with conductive loss)   Rinne Test Positive Rinne; Air conduction.",INNER EAR,SENSORINEURAL HEARING LOSS
720315683,5/12/2015 03:21:22,1634545299,5/12/2015 03:20:52,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[LOCATION],[LOCATION],Site,n/a,139,70,-1,147,96,TWrex-cause,802045-FS1,"A table comparing sensorineural to conductive hearing loss   Criteria SENSORINEURAL HEARING LOSS Conductive hearing loss   Anatomical Site INNER EAR cranial nerve VIII, or central processing centers Middle ear (ossicular chain), tympanic membrane, or external ear   Weber Test Sound localizes to normal ear Sound localizes to affected ear (ear with conductive loss)   Rinne Test Positive Rinne; Air conduction.",INNER EAR,SENSORINEURAL HEARING LOSS
720315683,5/12/2015 03:33:45,1634552134,5/12/2015 03:32:58,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.227,[SIDE_EFFECT],[SIDE_EFFECT],SENSORINEURAL HEARING LOSS INNER EAR,N/A,139,70,-1,147,96,TWrex-cause,802045-FS1,"A table comparing sensorineural to conductive hearing loss   Criteria SENSORINEURAL HEARING LOSS Conductive hearing loss   Anatomical Site INNER EAR cranial nerve VIII, or central processing centers Middle ear (ossicular chain), tympanic membrane, or external ear   Weber Test Sound localizes to normal ear Sound localizes to affected ear (ear with conductive loss)   Rinne Test Positive Rinne; Air conduction.",INNER EAR,SENSORINEURAL HEARING LOSS
720315683,5/12/2015 04:08:43,1634568900,5/12/2015 04:07:25,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[NONE],[NONE],N/A,part of a list of items on the graph table,139,70,-1,147,96,TWrex-cause,802045-FS1,"A table comparing sensorineural to conductive hearing loss   Criteria SENSORINEURAL HEARING LOSS Conductive hearing loss   Anatomical Site INNER EAR cranial nerve VIII, or central processing centers Middle ear (ossicular chain), tympanic membrane, or external ear   Weber Test Sound localizes to normal ear Sound localizes to affected ear (ear with conductive loss)   Rinne Test Positive Rinne; Air conduction.",INNER EAR,SENSORINEURAL HEARING LOSS
720315684,5/12/2015 01:01:13,1634472326,5/12/2015 01:00:56,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[TREATS],[TREATS],TERAZOSIN therapy for BENIGN PROSTATIC HYPERPLASIA,n/a,98,76,-1,125,85,TWrex-cause,804586-FS1,"Lepor H, Meretyk S, Knapp Maloney G. The safety, efficacy and compliance of TERAZOSIN therapy for BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
720315684,5/12/2015 01:03:37,1634473432,5/12/2015 01:02:37,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[SIDE_EFFECT],[SIDE_EFFECT],"The safety, efficacy",N/A,98,76,-1,125,85,TWrex-cause,804586-FS1,"Lepor H, Meretyk S, Knapp Maloney G. The safety, efficacy and compliance of TERAZOSIN therapy for BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
720315684,5/12/2015 01:14:51,1634479172,5/12/2015 01:14:30,false,elite,1.0,31848723,USA,"","",155.94.185.207,[SYMPTOM],[SYMPTOM],TERAZOSIN BENIGN PROSTATIC HYPERPLASIA,N/A,98,76,-1,125,85,TWrex-cause,804586-FS1,"Lepor H, Meretyk S, Knapp Maloney G. The safety, efficacy and compliance of TERAZOSIN therapy for BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
720315684,5/12/2015 01:30:23,1634487515,5/12/2015 01:30:09,false,elite,1.0,32306791,USA,TX,Dallas,69.162.75.37,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],compliance therapy,N/A,98,76,-1,125,85,TWrex-cause,804586-FS1,"Lepor H, Meretyk S, Knapp Maloney G. The safety, efficacy and compliance of TERAZOSIN therapy for BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
720315684,5/12/2015 01:30:50,1634487733,5/12/2015 01:30:39,false,instagc,1.0,32556346,USA,PA,Warren,207.255.244.59,[TREATS],[TREATS],therapy,N/A,98,76,-1,125,85,TWrex-cause,804586-FS1,"Lepor H, Meretyk S, Knapp Maloney G. The safety, efficacy and compliance of TERAZOSIN therapy for BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
720315684,5/12/2015 01:43:09,1634494711,5/12/2015 01:42:47,false,instagc,1.0,30326470,USA,CA,San Diego,170.213.2.111,[TREATS],[TREATS],therapy for,N/A,98,76,-1,125,85,TWrex-cause,804586-FS1,"Lepor H, Meretyk S, Knapp Maloney G. The safety, efficacy and compliance of TERAZOSIN therapy for BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
720315684,5/12/2015 03:26:50,1634548410,5/12/2015 03:26:30,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[TREATS],[TREATS],therapy,n/a,98,76,-1,125,85,TWrex-cause,804586-FS1,"Lepor H, Meretyk S, Knapp Maloney G. The safety, efficacy and compliance of TERAZOSIN therapy for BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
720315684,5/12/2015 03:44:43,1634557320,5/12/2015 03:44:14,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.227,[SYMPTOM],[SYMPTOM],TERAZOSIN BENIGN PROSTATIC HYPERPLASIA,N/A,98,76,-1,125,85,TWrex-cause,804586-FS1,"Lepor H, Meretyk S, Knapp Maloney G. The safety, efficacy and compliance of TERAZOSIN therapy for BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
720315684,5/12/2015 04:17:41,1634573214,5/12/2015 04:17:21,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[TREATS],[TREATS],efficacy therapy for,N/A,98,76,-1,125,85,TWrex-cause,804586-FS1,"Lepor H, Meretyk S, Knapp Maloney G. The safety, efficacy and compliance of TERAZOSIN therapy for BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
720315684,5/12/2015 04:55:24,1634591295,5/12/2015 04:55:04,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],therapy,none,98,76,-1,125,85,TWrex-cause,804586-FS1,"Lepor H, Meretyk S, Knapp Maloney G. The safety, efficacy and compliance of TERAZOSIN therapy for BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
720315684,5/12/2015 05:08:44,1634598790,5/12/2015 05:08:32,false,neodev,1.0,31910622,USA,CA,San Francisco,108.169.6.201,[TREATS],[TREATS],therapy for,I didn´t select none.,98,76,-1,125,85,TWrex-cause,804586-FS1,"Lepor H, Meretyk S, Knapp Maloney G. The safety, efficacy and compliance of TERAZOSIN therapy for BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
720315684,5/12/2015 05:57:45,1634629286,5/12/2015 05:57:23,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],therapy,N/A,98,76,-1,125,85,TWrex-cause,804586-FS1,"Lepor H, Meretyk S, Knapp Maloney G. The safety, efficacy and compliance of TERAZOSIN therapy for BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
720315684,5/12/2015 06:20:01,1634639978,5/12/2015 06:19:42,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[TREATS],[TREATS],therapy for,N/A,98,76,-1,125,85,TWrex-cause,804586-FS1,"Lepor H, Meretyk S, Knapp Maloney G. The safety, efficacy and compliance of TERAZOSIN therapy for BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
720315684,5/12/2015 06:27:26,1634643568,5/12/2015 06:27:05,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[TREATS],[TREATS],compliance of TERAZOSIN therapy for BENIGN PROSTATIC HYPERPLASIA,n/a,98,76,-1,125,85,TWrex-cause,804586-FS1,"Lepor H, Meretyk S, Knapp Maloney G. The safety, efficacy and compliance of TERAZOSIN therapy for BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
720315684,5/12/2015 06:39:13,1634648744,5/12/2015 06:38:08,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[TREATS],[TREATS],efficacy,NA,98,76,-1,125,85,TWrex-cause,804586-FS1,"Lepor H, Meretyk S, Knapp Maloney G. The safety, efficacy and compliance of TERAZOSIN therapy for BENIGN PROSTATIC HYPERPLASIA",BENIGN PROSTATIC HYPERPLASIA,TERAZOSIN
720315685,5/11/2015 22:16:22,1634400720,5/11/2015 22:15:53,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],CEFEPIME for the treatment of NEUTROPENIA,n/a,137,66,-1,147,74,TWrex-cause,800661-FS1,"Uygun V, Karasu GT, Ogunc D et al. Piperacillin/tazobactam versus CEFEPIME for the empirical treatment of pediatric cancer patients with NEUTROPENIA and fever: A randomized and open label study.",NEUTROPENIA,CEFEPIME
720315685,5/11/2015 22:16:39,1634400838,5/11/2015 22:16:26,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],CEFEPIME,N/A,137,66,-1,147,74,TWrex-cause,800661-FS1,"Uygun V, Karasu GT, Ogunc D et al. Piperacillin/tazobactam versus CEFEPIME for the empirical treatment of pediatric cancer patients with NEUTROPENIA and fever: A randomized and open label study.",NEUTROPENIA,CEFEPIME
720315685,5/11/2015 22:18:48,1634401837,5/11/2015 22:18:33,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],empirical treatment,n/a,137,66,-1,147,74,TWrex-cause,800661-FS1,"Uygun V, Karasu GT, Ogunc D et al. Piperacillin/tazobactam versus CEFEPIME for the empirical treatment of pediatric cancer patients with NEUTROPENIA and fever: A randomized and open label study.",NEUTROPENIA,CEFEPIME
720315685,5/11/2015 22:19:07,1634401960,5/11/2015 22:18:27,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],CEFEPIME for the empirical treatment of pediatric cancer patients with NEUTROPENIA,N/A,137,66,-1,147,74,TWrex-cause,800661-FS1,"Uygun V, Karasu GT, Ogunc D et al. Piperacillin/tazobactam versus CEFEPIME for the empirical treatment of pediatric cancer patients with NEUTROPENIA and fever: A randomized and open label study.",NEUTROPENIA,CEFEPIME
720315685,5/11/2015 22:21:32,1634403217,5/11/2015 22:18:54,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],treatment,n/a,137,66,-1,147,74,TWrex-cause,800661-FS1,"Uygun V, Karasu GT, Ogunc D et al. Piperacillin/tazobactam versus CEFEPIME for the empirical treatment of pediatric cancer patients with NEUTROPENIA and fever: A randomized and open label study.",NEUTROPENIA,CEFEPIME
720315685,5/11/2015 22:32:20,1634407587,5/11/2015 22:30:58,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treatment,n/a,137,66,-1,147,74,TWrex-cause,800661-FS1,"Uygun V, Karasu GT, Ogunc D et al. Piperacillin/tazobactam versus CEFEPIME for the empirical treatment of pediatric cancer patients with NEUTROPENIA and fever: A randomized and open label study.",NEUTROPENIA,CEFEPIME
720315685,5/11/2015 22:32:42,1634407710,5/11/2015 22:32:21,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],empirical treatment,n/a,137,66,-1,147,74,TWrex-cause,800661-FS1,"Uygun V, Karasu GT, Ogunc D et al. Piperacillin/tazobactam versus CEFEPIME for the empirical treatment of pediatric cancer patients with NEUTROPENIA and fever: A randomized and open label study.",NEUTROPENIA,CEFEPIME
720315685,5/11/2015 22:34:03,1634408609,5/11/2015 22:33:09,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],CEFEPIME treatment of NEUTROPENIA,n/a,137,66,-1,147,74,TWrex-cause,800661-FS1,"Uygun V, Karasu GT, Ogunc D et al. Piperacillin/tazobactam versus CEFEPIME for the empirical treatment of pediatric cancer patients with NEUTROPENIA and fever: A randomized and open label study.",NEUTROPENIA,CEFEPIME
720315685,5/11/2015 22:38:41,1634410883,5/11/2015 22:37:31,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"Uygun V, Karasu GT, Ogunc D et al. Piperacillin/tazobactam versus CEFEPIME for the empirical treatment of pediatric cancer patients with NEUTROPENIA and fever: A randomized and open label study.",N/A,137,66,-1,147,74,TWrex-cause,800661-FS1,"Uygun V, Karasu GT, Ogunc D et al. Piperacillin/tazobactam versus CEFEPIME for the empirical treatment of pediatric cancer patients with NEUTROPENIA and fever: A randomized and open label study.",NEUTROPENIA,CEFEPIME
720315685,5/11/2015 22:41:34,1634412108,5/11/2015 22:41:14,false,instagc,1.0,28519532,USA,IA,Neola,38.121.112.217,[TREATS],[TREATS],treatment,na,137,66,-1,147,74,TWrex-cause,800661-FS1,"Uygun V, Karasu GT, Ogunc D et al. Piperacillin/tazobactam versus CEFEPIME for the empirical treatment of pediatric cancer patients with NEUTROPENIA and fever: A randomized and open label study.",NEUTROPENIA,CEFEPIME
720315685,5/11/2015 22:46:39,1634414468,5/11/2015 22:46:02,false,clixsense,1.0,6330007,AUS,06,Hobart,101.178.23.54,[TREATS],[TREATS],empirical treatment,n/a,137,66,-1,147,74,TWrex-cause,800661-FS1,"Uygun V, Karasu GT, Ogunc D et al. Piperacillin/tazobactam versus CEFEPIME for the empirical treatment of pediatric cancer patients with NEUTROPENIA and fever: A randomized and open label study.",NEUTROPENIA,CEFEPIME
720315685,5/11/2015 22:46:56,1634414606,5/11/2015 22:45:34,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[TREATS],[TREATS],CEFEPIME for the empirical treatment of pediatric cancer patients with NEUTROPENIA,n/a,137,66,-1,147,74,TWrex-cause,800661-FS1,"Uygun V, Karasu GT, Ogunc D et al. Piperacillin/tazobactam versus CEFEPIME for the empirical treatment of pediatric cancer patients with NEUTROPENIA and fever: A randomized and open label study.",NEUTROPENIA,CEFEPIME
720315685,5/11/2015 22:49:56,1634416068,5/11/2015 22:48:14,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,137,66,-1,147,74,TWrex-cause,800661-FS1,"Uygun V, Karasu GT, Ogunc D et al. Piperacillin/tazobactam versus CEFEPIME for the empirical treatment of pediatric cancer patients with NEUTROPENIA and fever: A randomized and open label study.",NEUTROPENIA,CEFEPIME
720315685,5/11/2015 22:51:05,1634416565,5/11/2015 22:50:21,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,137,66,-1,147,74,TWrex-cause,800661-FS1,"Uygun V, Karasu GT, Ogunc D et al. Piperacillin/tazobactam versus CEFEPIME for the empirical treatment of pediatric cancer patients with NEUTROPENIA and fever: A randomized and open label study.",NEUTROPENIA,CEFEPIME
720315685,5/11/2015 22:51:10,1634416633,5/11/2015 22:50:51,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,75.147.181.53,[TREATS],[TREATS],for the empirical treatment of,N/A,137,66,-1,147,74,TWrex-cause,800661-FS1,"Uygun V, Karasu GT, Ogunc D et al. Piperacillin/tazobactam versus CEFEPIME for the empirical treatment of pediatric cancer patients with NEUTROPENIA and fever: A randomized and open label study.",NEUTROPENIA,CEFEPIME
720315686,5/12/2015 03:30:52,1634550559,5/12/2015 03:29:47,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[OTHER],[OTHER],otherwise,n/a,126,0,1,151,16,TWrex-cause,812640-FS1,"GILBERT SYNDROME is differentiated from hepatitis by fractionation that shows predominantly unconjugated bilirubin, otherwise NORMAL LIVER FUNCTION TEST results, and absence of urinary bilirubin.",NORMAL LIVER FUNCTION TEST,GILBERT SYNDROME
720315686,5/12/2015 03:49:06,1634559099,5/12/2015 03:48:34,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.227,[SIDE_EFFECT],[SIDE_EFFECT],GILBERT SYNDROME NORMAL LIVER FUNCTION TEST,N/A,126,0,1,151,16,TWrex-cause,812640-FS1,"GILBERT SYNDROME is differentiated from hepatitis by fractionation that shows predominantly unconjugated bilirubin, otherwise NORMAL LIVER FUNCTION TEST results, and absence of urinary bilirubin.",NORMAL LIVER FUNCTION TEST,GILBERT SYNDROME
720315686,5/12/2015 04:23:18,1634575890,5/12/2015 04:22:32,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"differentiated by TEST results,",N/A,126,0,1,151,16,TWrex-cause,812640-FS1,"GILBERT SYNDROME is differentiated from hepatitis by fractionation that shows predominantly unconjugated bilirubin, otherwise NORMAL LIVER FUNCTION TEST results, and absence of urinary bilirubin.",NORMAL LIVER FUNCTION TEST,GILBERT SYNDROME
720315686,5/12/2015 05:04:34,1634596387,5/12/2015 05:01:52,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],otherwise,none,126,0,1,151,16,TWrex-cause,812640-FS1,"GILBERT SYNDROME is differentiated from hepatitis by fractionation that shows predominantly unconjugated bilirubin, otherwise NORMAL LIVER FUNCTION TEST results, and absence of urinary bilirubin.",NORMAL LIVER FUNCTION TEST,GILBERT SYNDROME
720315686,5/12/2015 05:12:14,1634600859,5/12/2015 05:11:46,false,neodev,1.0,31910622,USA,CA,San Francisco,108.169.6.201,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"TEST results,",I didn´t select none.,126,0,1,151,16,TWrex-cause,812640-FS1,"GILBERT SYNDROME is differentiated from hepatitis by fractionation that shows predominantly unconjugated bilirubin, otherwise NORMAL LIVER FUNCTION TEST results, and absence of urinary bilirubin.",NORMAL LIVER FUNCTION TEST,GILBERT SYNDROME
720315686,5/12/2015 06:14:23,1634637397,5/12/2015 06:13:03,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"results,",N/A,126,0,1,151,16,TWrex-cause,812640-FS1,"GILBERT SYNDROME is differentiated from hepatitis by fractionation that shows predominantly unconjugated bilirubin, otherwise NORMAL LIVER FUNCTION TEST results, and absence of urinary bilirubin.",NORMAL LIVER FUNCTION TEST,GILBERT SYNDROME
720315686,5/12/2015 06:25:44,1634642846,5/12/2015 06:25:10,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],TEST,N/A,126,0,1,151,16,TWrex-cause,812640-FS1,"GILBERT SYNDROME is differentiated from hepatitis by fractionation that shows predominantly unconjugated bilirubin, otherwise NORMAL LIVER FUNCTION TEST results, and absence of urinary bilirubin.",NORMAL LIVER FUNCTION TEST,GILBERT SYNDROME
720315686,5/12/2015 06:43:20,1634650507,5/12/2015 06:42:00,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],differentiated,NA,126,0,1,151,16,TWrex-cause,812640-FS1,"GILBERT SYNDROME is differentiated from hepatitis by fractionation that shows predominantly unconjugated bilirubin, otherwise NORMAL LIVER FUNCTION TEST results, and absence of urinary bilirubin.",NORMAL LIVER FUNCTION TEST,GILBERT SYNDROME
720315686,5/12/2015 06:43:47,1634650780,5/12/2015 06:42:52,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],GILBERT SYNDROME differentiated from otherwise NORMAL LIVER FUNCTION TEST,n/a,126,0,1,151,16,TWrex-cause,812640-FS1,"GILBERT SYNDROME is differentiated from hepatitis by fractionation that shows predominantly unconjugated bilirubin, otherwise NORMAL LIVER FUNCTION TEST results, and absence of urinary bilirubin.",NORMAL LIVER FUNCTION TEST,GILBERT SYNDROME
720315686,5/12/2015 06:46:38,1634652051,5/12/2015 06:46:18,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"results,",N/A,126,0,1,151,16,TWrex-cause,812640-FS1,"GILBERT SYNDROME is differentiated from hepatitis by fractionation that shows predominantly unconjugated bilirubin, otherwise NORMAL LIVER FUNCTION TEST results, and absence of urinary bilirubin.",NORMAL LIVER FUNCTION TEST,GILBERT SYNDROME
720315686,5/12/2015 06:49:47,1634653329,5/12/2015 06:48:38,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[NONE],[NONE],n/a,GILBERT SYNDROME shows predominantly unconjugated bilirubin and absence of urinary bilirubin,126,0,1,151,16,TWrex-cause,812640-FS1,"GILBERT SYNDROME is differentiated from hepatitis by fractionation that shows predominantly unconjugated bilirubin, otherwise NORMAL LIVER FUNCTION TEST results, and absence of urinary bilirubin.",NORMAL LIVER FUNCTION TEST,GILBERT SYNDROME
720315686,5/12/2015 07:03:05,1634659142,5/12/2015 07:01:44,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[OTHER],[OTHER],otherwise,N/a,126,0,1,151,16,TWrex-cause,812640-FS1,"GILBERT SYNDROME is differentiated from hepatitis by fractionation that shows predominantly unconjugated bilirubin, otherwise NORMAL LIVER FUNCTION TEST results, and absence of urinary bilirubin.",NORMAL LIVER FUNCTION TEST,GILBERT SYNDROME
720315686,5/12/2015 07:53:04,1634689851,5/12/2015 07:52:00,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[MANIFESTATION] [ASSOCIATED_WITH],"[MANIFESTATION]
[ASSOCIATED_WITH]",that shows,N/A,126,0,1,151,16,TWrex-cause,812640-FS1,"GILBERT SYNDROME is differentiated from hepatitis by fractionation that shows predominantly unconjugated bilirubin, otherwise NORMAL LIVER FUNCTION TEST results, and absence of urinary bilirubin.",NORMAL LIVER FUNCTION TEST,GILBERT SYNDROME
720315686,5/12/2015 08:07:04,1634696860,5/12/2015 08:06:07,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[SYMPTOM],[SYMPTOM],"results,",Symptom,126,0,1,151,16,TWrex-cause,812640-FS1,"GILBERT SYNDROME is differentiated from hepatitis by fractionation that shows predominantly unconjugated bilirubin, otherwise NORMAL LIVER FUNCTION TEST results, and absence of urinary bilirubin.",NORMAL LIVER FUNCTION TEST,GILBERT SYNDROME
720315686,5/12/2015 08:29:50,1634708600,5/12/2015 08:28:46,false,clixsense,1,6355877,GBR,J5,Whitley Bay,77.98.220.230,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"results,",n/a,126,0,1,151,16,TWrex-cause,812640-FS1,"GILBERT SYNDROME is differentiated from hepatitis by fractionation that shows predominantly unconjugated bilirubin, otherwise NORMAL LIVER FUNCTION TEST results, and absence of urinary bilirubin.",NORMAL LIVER FUNCTION TEST,GILBERT SYNDROME
720315687,5/12/2015 06:52:46,1634654677,5/12/2015 06:52:10,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",in the,N/A,44,141,-1,57,152,TWrex-cause,800386-FS1,"Sharkey Mathis PK, Velez J, Fetchick R et alHISTOPLASMOSIS in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and FLUCONAZOLE",HISTOPLASMOSIS,FLUCONAZOLE
720315687,5/12/2015 06:56:25,1634656388,5/12/2015 06:55:32,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[TREATS],[TREATS],treatment,NA,44,141,-1,57,152,TWrex-cause,800386-FS1,"Sharkey Mathis PK, Velez J, Fetchick R et alHISTOPLASMOSIS in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and FLUCONAZOLE",HISTOPLASMOSIS,FLUCONAZOLE
720315687,5/12/2015 07:08:42,1634661490,5/12/2015 07:08:09,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],treatment with,n/a,44,141,-1,57,152,TWrex-cause,800386-FS1,"Sharkey Mathis PK, Velez J, Fetchick R et alHISTOPLASMOSIS in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and FLUCONAZOLE",HISTOPLASMOSIS,FLUCONAZOLE
720315687,5/12/2015 08:04:45,1634695600,5/12/2015 08:04:16,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],treatment with,N/A,44,141,-1,57,152,TWrex-cause,800386-FS1,"Sharkey Mathis PK, Velez J, Fetchick R et alHISTOPLASMOSIS in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and FLUCONAZOLE",HISTOPLASMOSIS,FLUCONAZOLE
720315687,5/12/2015 08:19:58,1634703097,5/12/2015 08:19:18,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[TREATS],[TREATS],treatment,Treated with,44,141,-1,57,152,TWrex-cause,800386-FS1,"Sharkey Mathis PK, Velez J, Fetchick R et alHISTOPLASMOSIS in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and FLUCONAZOLE",HISTOPLASMOSIS,FLUCONAZOLE
720315687,5/12/2015 08:57:24,1634723562,5/12/2015 08:56:47,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",treatment,N/A,44,141,-1,57,152,TWrex-cause,800386-FS1,"Sharkey Mathis PK, Velez J, Fetchick R et alHISTOPLASMOSIS in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and FLUCONAZOLE",HISTOPLASMOSIS,FLUCONAZOLE
720315687,5/12/2015 09:03:46,1634726651,5/12/2015 09:03:24,false,inboxpounds,1.0,29059658,GBR,H9,London,79.77.3.89,[TREATS],[TREATS],treatment with itraconazole and,N/A,44,141,-1,57,152,TWrex-cause,800386-FS1,"Sharkey Mathis PK, Velez J, Fetchick R et alHISTOPLASMOSIS in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and FLUCONAZOLE",HISTOPLASMOSIS,FLUCONAZOLE
720315687,5/12/2015 11:04:42,1634827666,5/12/2015 11:04:27,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],acquired immunodeficiency,n/a,44,141,-1,57,152,TWrex-cause,800386-FS1,"Sharkey Mathis PK, Velez J, Fetchick R et alHISTOPLASMOSIS in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and FLUCONAZOLE",HISTOPLASMOSIS,FLUCONAZOLE
720315687,5/12/2015 11:58:27,1634860870,5/12/2015 11:57:43,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[TREATS],[TREATS],with,N/A,44,141,-1,57,152,TWrex-cause,800386-FS1,"Sharkey Mathis PK, Velez J, Fetchick R et alHISTOPLASMOSIS in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and FLUCONAZOLE",HISTOPLASMOSIS,FLUCONAZOLE
720315687,5/12/2015 11:58:47,1634861010,5/12/2015 11:58:25,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[TREATS],[TREATS],treatment with,N/A,44,141,-1,57,152,TWrex-cause,800386-FS1,"Sharkey Mathis PK, Velez J, Fetchick R et alHISTOPLASMOSIS in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and FLUCONAZOLE",HISTOPLASMOSIS,FLUCONAZOLE
720315687,5/12/2015 12:42:54,1634880773,5/12/2015 12:42:21,false,clixsense,1.0,27969116,NLD,"","",212.78.195.38,[TREATS],[TREATS],treatment with,is a part of the treatment.,44,141,-1,57,152,TWrex-cause,800386-FS1,"Sharkey Mathis PK, Velez J, Fetchick R et alHISTOPLASMOSIS in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and FLUCONAZOLE",HISTOPLASMOSIS,FLUCONAZOLE
720315687,5/12/2015 13:06:11,1634889765,5/12/2015 13:05:21,false,bitcoinget,1.0,24960279,USA,NY,Bronx,24.184.60.73,[TREATS],[TREATS],treatment,n/a,44,141,-1,57,152,TWrex-cause,800386-FS1,"Sharkey Mathis PK, Velez J, Fetchick R et alHISTOPLASMOSIS in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and FLUCONAZOLE",HISTOPLASMOSIS,FLUCONAZOLE
720315687,5/12/2015 14:31:36,1634929202,5/12/2015 14:31:23,false,neodev,1.0,31726043,USA,DE,"",108.59.8.208,[SYMPTOM],[SYMPTOM],acquired,gffg,44,141,-1,57,152,TWrex-cause,800386-FS1,"Sharkey Mathis PK, Velez J, Fetchick R et alHISTOPLASMOSIS in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and FLUCONAZOLE",HISTOPLASMOSIS,FLUCONAZOLE
720315687,5/12/2015 14:42:48,1634934467,5/12/2015 14:40:08,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],alHISTOPLASMOSIS in treatment with itraconazole and FLUCONAZOLE,N/A,44,141,-1,57,152,TWrex-cause,800386-FS1,"Sharkey Mathis PK, Velez J, Fetchick R et alHISTOPLASMOSIS in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and FLUCONAZOLE",HISTOPLASMOSIS,FLUCONAZOLE
720315687,5/12/2015 16:07:16,1635021024,5/12/2015 16:06:50,false,prodege,1,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],alHISTOPLASMOSIS treatment with FLUCONAZOLE,N/A,44,141,-1,57,152,TWrex-cause,800386-FS1,"Sharkey Mathis PK, Velez J, Fetchick R et alHISTOPLASMOSIS in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and FLUCONAZOLE",HISTOPLASMOSIS,FLUCONAZOLE
720315688,5/11/2015 23:12:53,1634425793,5/11/2015 23:12:37,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],attacks,N/A,43,83,1,56,104,TWrex-cause,814028-FS1,Treatment with C1 inhibitor concentrate in ABDOMINAL PAIN attacks of patients with HEREDITARY ANGIOEDEMA,ABDOMINAL PAIN,HEREDITARY ANGIOEDEMA
720315688,5/11/2015 23:22:27,1634430254,5/11/2015 23:22:08,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],Treatment,N/A,43,83,1,56,104,TWrex-cause,814028-FS1,Treatment with C1 inhibitor concentrate in ABDOMINAL PAIN attacks of patients with HEREDITARY ANGIOEDEMA,ABDOMINAL PAIN,HEREDITARY ANGIOEDEMA
720315688,5/11/2015 23:38:22,1634439013,5/11/2015 23:37:40,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with,n/a,43,83,1,56,104,TWrex-cause,814028-FS1,Treatment with C1 inhibitor concentrate in ABDOMINAL PAIN attacks of patients with HEREDITARY ANGIOEDEMA,ABDOMINAL PAIN,HEREDITARY ANGIOEDEMA
720315688,5/11/2015 23:44:34,1634442038,5/11/2015 23:43:32,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],Treatment,n/a,43,83,1,56,104,TWrex-cause,814028-FS1,Treatment with C1 inhibitor concentrate in ABDOMINAL PAIN attacks of patients with HEREDITARY ANGIOEDEMA,ABDOMINAL PAIN,HEREDITARY ANGIOEDEMA
720315688,5/11/2015 23:52:19,1634444991,5/11/2015 23:51:58,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.48,[PREVENTS] [CAUSES] [LOCATION] [NONE],"[PREVENTS]
[CAUSES]
[LOCATION]
[NONE]",no,no,43,83,1,56,104,TWrex-cause,814028-FS1,Treatment with C1 inhibitor concentrate in ABDOMINAL PAIN attacks of patients with HEREDITARY ANGIOEDEMA,ABDOMINAL PAIN,HEREDITARY ANGIOEDEMA
720315688,5/11/2015 23:56:08,1634446443,5/11/2015 23:55:55,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],Treatment,n/a,43,83,1,56,104,TWrex-cause,814028-FS1,Treatment with C1 inhibitor concentrate in ABDOMINAL PAIN attacks of patients with HEREDITARY ANGIOEDEMA,ABDOMINAL PAIN,HEREDITARY ANGIOEDEMA
720315688,5/12/2015 00:25:27,1634457315,5/12/2015 00:24:05,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],patients with,symptom,43,83,1,56,104,TWrex-cause,814028-FS1,Treatment with C1 inhibitor concentrate in ABDOMINAL PAIN attacks of patients with HEREDITARY ANGIOEDEMA,ABDOMINAL PAIN,HEREDITARY ANGIOEDEMA
720315688,5/12/2015 00:42:12,1634463866,5/12/2015 00:41:39,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[TREATS],[TREATS],Treatment with C1 inhibitor,None,43,83,1,56,104,TWrex-cause,814028-FS1,Treatment with C1 inhibitor concentrate in ABDOMINAL PAIN attacks of patients with HEREDITARY ANGIOEDEMA,ABDOMINAL PAIN,HEREDITARY ANGIOEDEMA
720315688,5/12/2015 00:44:26,1634465118,5/12/2015 00:43:33,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[ASSOCIATED_WITH],[ASSOCIATED_WITH],ABDOMINAL PAIN of patients with HEREDITARY ANGIOEDEMA,n/a,43,83,1,56,104,TWrex-cause,814028-FS1,Treatment with C1 inhibitor concentrate in ABDOMINAL PAIN attacks of patients with HEREDITARY ANGIOEDEMA,ABDOMINAL PAIN,HEREDITARY ANGIOEDEMA
720315688,5/12/2015 01:04:00,1634473590,5/12/2015 01:03:40,false,elite,1.0,31848723,USA,"","",155.94.185.207,[SYMPTOM],[SYMPTOM],ABDOMINAL PAIN HEREDITARY ANGIOEDEMA,N/A,43,83,1,56,104,TWrex-cause,814028-FS1,Treatment with C1 inhibitor concentrate in ABDOMINAL PAIN attacks of patients with HEREDITARY ANGIOEDEMA,ABDOMINAL PAIN,HEREDITARY ANGIOEDEMA
720315688,5/12/2015 01:11:15,1634477271,5/12/2015 01:10:59,false,elite,1.0,32306791,NLD,"","",31.3.156.41,[CAUSES],[CAUSES],inhibitor concentrate,czcx,43,83,1,56,104,TWrex-cause,814028-FS1,Treatment with C1 inhibitor concentrate in ABDOMINAL PAIN attacks of patients with HEREDITARY ANGIOEDEMA,ABDOMINAL PAIN,HEREDITARY ANGIOEDEMA
720315688,5/12/2015 01:21:16,1634482722,5/12/2015 01:20:42,false,instagc,1.0,32556346,USA,PA,Warren,207.255.244.59,[SYMPTOM],[SYMPTOM],with,N/A,43,83,1,56,104,TWrex-cause,814028-FS1,Treatment with C1 inhibitor concentrate in ABDOMINAL PAIN attacks of patients with HEREDITARY ANGIOEDEMA,ABDOMINAL PAIN,HEREDITARY ANGIOEDEMA
720315688,5/12/2015 01:27:25,1634486053,5/12/2015 01:26:17,false,instagc,1.0,30326470,USA,CA,San Diego,170.213.2.111,[TREATS],[TREATS],Treatment with,N/A,43,83,1,56,104,TWrex-cause,814028-FS1,Treatment with C1 inhibitor concentrate in ABDOMINAL PAIN attacks of patients with HEREDITARY ANGIOEDEMA,ABDOMINAL PAIN,HEREDITARY ANGIOEDEMA
720315688,5/12/2015 02:47:14,1634527951,5/12/2015 02:47:01,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],PAIN attacks of patients with HEREDITARY,n/a,43,83,1,56,104,TWrex-cause,814028-FS1,Treatment with C1 inhibitor concentrate in ABDOMINAL PAIN attacks of patients with HEREDITARY ANGIOEDEMA,ABDOMINAL PAIN,HEREDITARY ANGIOEDEMA
720315688,5/12/2015 02:51:13,1634530021,5/12/2015 02:50:03,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[SYMPTOM],[SYMPTOM],attacks patients,n/a,43,83,1,56,104,TWrex-cause,814028-FS1,Treatment with C1 inhibitor concentrate in ABDOMINAL PAIN attacks of patients with HEREDITARY ANGIOEDEMA,ABDOMINAL PAIN,HEREDITARY ANGIOEDEMA
720315689,5/12/2015 05:06:57,1634597641,5/12/2015 05:06:30,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treatment,none,34,200,-1,49,220,TWrex-cause,803536-FS1,"Treatment  Oral candidiasis   For ORAL CANDIDIASIS, topical nystatin suspension, 200,000 to 400,000 units three to five times a day for 1 to 2 weeks, is usually effective; an alternative treatment is CLOTRIMAZOLE TROCHES.",ORAL CANDIDIASIS,CLOTRIMAZOLE TROCHES
720315689,5/12/2015 05:13:15,1634601394,5/12/2015 05:12:59,false,neodev,1.0,31910622,USA,CA,San Francisco,108.169.6.201,[TREATS],[TREATS],treatment is,I didn´t select none.,34,200,-1,49,220,TWrex-cause,803536-FS1,"Treatment  Oral candidiasis   For ORAL CANDIDIASIS, topical nystatin suspension, 200,000 to 400,000 units three to five times a day for 1 to 2 weeks, is usually effective; an alternative treatment is CLOTRIMAZOLE TROCHES.",ORAL CANDIDIASIS,CLOTRIMAZOLE TROCHES
720315689,5/12/2015 06:17:26,1634638835,5/12/2015 06:16:30,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],alternative treatment,N/A,34,200,-1,49,220,TWrex-cause,803536-FS1,"Treatment  Oral candidiasis   For ORAL CANDIDIASIS, topical nystatin suspension, 200,000 to 400,000 units three to five times a day for 1 to 2 weeks, is usually effective; an alternative treatment is CLOTRIMAZOLE TROCHES.",ORAL CANDIDIASIS,CLOTRIMAZOLE TROCHES
720315689,5/12/2015 06:27:17,1634643486,5/12/2015 06:26:51,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[TREATS],[TREATS],treatment,N/A,34,200,-1,49,220,TWrex-cause,803536-FS1,"Treatment  Oral candidiasis   For ORAL CANDIDIASIS, topical nystatin suspension, 200,000 to 400,000 units three to five times a day for 1 to 2 weeks, is usually effective; an alternative treatment is CLOTRIMAZOLE TROCHES.",ORAL CANDIDIASIS,CLOTRIMAZOLE TROCHES
720315689,5/12/2015 06:44:52,1634651269,5/12/2015 06:44:12,false,prodege,1,16878855,CAN,BC,Fort Saint John,216.232.163.142,[TREATS],[TREATS],treatment,NA,34,200,-1,49,220,TWrex-cause,803536-FS1,"Treatment  Oral candidiasis   For ORAL CANDIDIASIS, topical nystatin suspension, 200,000 to 400,000 units three to five times a day for 1 to 2 weeks, is usually effective; an alternative treatment is CLOTRIMAZOLE TROCHES.",ORAL CANDIDIASIS,CLOTRIMAZOLE TROCHES
720315689,5/12/2015 06:47:34,1634652350,5/12/2015 06:47:11,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[TREATS],[TREATS],an alternative treatment is,N/A,34,200,-1,49,220,TWrex-cause,803536-FS1,"Treatment  Oral candidiasis   For ORAL CANDIDIASIS, topical nystatin suspension, 200,000 to 400,000 units three to five times a day for 1 to 2 weeks, is usually effective; an alternative treatment is CLOTRIMAZOLE TROCHES.",ORAL CANDIDIASIS,CLOTRIMAZOLE TROCHES
720315689,5/12/2015 06:53:01,1634654742,5/12/2015 06:52:31,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],alternative treatment,n/a,34,200,-1,49,220,TWrex-cause,803536-FS1,"Treatment  Oral candidiasis   For ORAL CANDIDIASIS, topical nystatin suspension, 200,000 to 400,000 units three to five times a day for 1 to 2 weeks, is usually effective; an alternative treatment is CLOTRIMAZOLE TROCHES.",ORAL CANDIDIASIS,CLOTRIMAZOLE TROCHES
720315689,5/12/2015 07:04:22,1634659587,5/12/2015 07:04:00,false,instagc,1,24252915,GBR,K6,Portsmouth,89.240.160.95,[TREATS],[TREATS],treatment,N/a,34,200,-1,49,220,TWrex-cause,803536-FS1,"Treatment  Oral candidiasis   For ORAL CANDIDIASIS, topical nystatin suspension, 200,000 to 400,000 units three to five times a day for 1 to 2 weeks, is usually effective; an alternative treatment is CLOTRIMAZOLE TROCHES.",ORAL CANDIDIASIS,CLOTRIMAZOLE TROCHES
720315689,5/12/2015 07:54:50,1634690708,5/12/2015 07:54:18,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],an alternative treatment is,N/A,34,200,-1,49,220,TWrex-cause,803536-FS1,"Treatment  Oral candidiasis   For ORAL CANDIDIASIS, topical nystatin suspension, 200,000 to 400,000 units three to five times a day for 1 to 2 weeks, is usually effective; an alternative treatment is CLOTRIMAZOLE TROCHES.",ORAL CANDIDIASIS,CLOTRIMAZOLE TROCHES
720315689,5/12/2015 08:08:54,1634697802,5/12/2015 08:08:31,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[TREATS],[TREATS],treatment,Treated with,34,200,-1,49,220,TWrex-cause,803536-FS1,"Treatment  Oral candidiasis   For ORAL CANDIDIASIS, topical nystatin suspension, 200,000 to 400,000 units three to five times a day for 1 to 2 weeks, is usually effective; an alternative treatment is CLOTRIMAZOLE TROCHES.",ORAL CANDIDIASIS,CLOTRIMAZOLE TROCHES
720315689,5/12/2015 08:49:28,1634719464,5/12/2015 08:48:51,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[TREATS],[TREATS],treatment,N/A,34,200,-1,49,220,TWrex-cause,803536-FS1,"Treatment  Oral candidiasis   For ORAL CANDIDIASIS, topical nystatin suspension, 200,000 to 400,000 units three to five times a day for 1 to 2 weeks, is usually effective; an alternative treatment is CLOTRIMAZOLE TROCHES.",ORAL CANDIDIASIS,CLOTRIMAZOLE TROCHES
720315689,5/12/2015 08:54:40,1634722324,5/12/2015 08:54:12,false,inboxpounds,1.0,29059658,GBR,H9,London,79.77.3.89,[OTHER],[OTHER],an alternative,This is an alternative relationship,34,200,-1,49,220,TWrex-cause,803536-FS1,"Treatment  Oral candidiasis   For ORAL CANDIDIASIS, topical nystatin suspension, 200,000 to 400,000 units three to five times a day for 1 to 2 weeks, is usually effective; an alternative treatment is CLOTRIMAZOLE TROCHES.",ORAL CANDIDIASIS,CLOTRIMAZOLE TROCHES
720315689,5/12/2015 09:32:29,1634743571,5/12/2015 09:30:17,false,neodev,1,30627835,GBR,H9,London,5.81.27.94,[TREATS],[TREATS],an alternative treatment is,N/A,34,200,-1,49,220,TWrex-cause,803536-FS1,"Treatment  Oral candidiasis   For ORAL CANDIDIASIS, topical nystatin suspension, 200,000 to 400,000 units three to five times a day for 1 to 2 weeks, is usually effective; an alternative treatment is CLOTRIMAZOLE TROCHES.",ORAL CANDIDIASIS,CLOTRIMAZOLE TROCHES
720315689,5/12/2015 10:33:55,1634792596,5/12/2015 10:31:30,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],"For ORAL CANDIDIASIS, alternative treatment is CLOTRIMAZOLE TROCHES.",N/A,34,200,-1,49,220,TWrex-cause,803536-FS1,"Treatment  Oral candidiasis   For ORAL CANDIDIASIS, topical nystatin suspension, 200,000 to 400,000 units three to five times a day for 1 to 2 weeks, is usually effective; an alternative treatment is CLOTRIMAZOLE TROCHES.",ORAL CANDIDIASIS,CLOTRIMAZOLE TROCHES
720315689,5/12/2015 11:00:08,1634821022,5/12/2015 10:59:12,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH] [TREATS],"[TREATS]
[ASSOCIATED_WITH]","ORAL CANDIDIASIS, CLOTRIMAZOLE TROCHES.",n/a,34,200,-1,49,220,TWrex-cause,803536-FS1,"Treatment  Oral candidiasis   For ORAL CANDIDIASIS, topical nystatin suspension, 200,000 to 400,000 units three to five times a day for 1 to 2 weeks, is usually effective; an alternative treatment is CLOTRIMAZOLE TROCHES.",ORAL CANDIDIASIS,CLOTRIMAZOLE TROCHES
720315690,5/11/2015 23:09:56,1634423718,5/11/2015 23:09:37,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,54,70,1,57,88,TWrex-cause,811436-FS1,g  Yaws  Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.,YAWS,TREPONEMA PERTENUE
720315690,5/11/2015 23:17:20,1634427888,5/11/2015 23:16:36,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],caused,N/A,54,70,1,57,88,TWrex-cause,811436-FS1,g  Yaws  Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.,YAWS,TREPONEMA PERTENUE
720315690,5/11/2015 23:17:32,1634427966,5/11/2015 23:17:17,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],caused by,n/a,54,70,1,57,88,TWrex-cause,811436-FS1,g  Yaws  Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.,YAWS,TREPONEMA PERTENUE
720315690,5/11/2015 23:19:51,1634429010,5/11/2015 23:18:33,false,clixsense,1.0,6330007,AUS,06,Hobart,101.178.23.54,[TREATS],[TREATS],treatment of,n/a,54,70,1,57,88,TWrex-cause,811436-FS1,g  Yaws  Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.,YAWS,TREPONEMA PERTENUE
720315690,5/11/2015 23:20:02,1634429145,5/11/2015 23:18:39,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],caused by,N/A,54,70,1,57,88,TWrex-cause,811436-FS1,g  Yaws  Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.,YAWS,TREPONEMA PERTENUE
720315690,5/11/2015 23:20:05,1634429169,5/11/2015 23:19:44,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[CAUSES],[CAUSES],YAWS caused by TREPONEMA PERTENUE.,n/a,54,70,1,57,88,TWrex-cause,811436-FS1,g  Yaws  Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.,YAWS,TREPONEMA PERTENUE
720315690,5/11/2015 23:20:27,1634429245,5/11/2015 23:19:40,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS] [MANIFESTATION] [SYMPTOM],"[TREATS]
[SYMPTOM]
[MANIFESTATION]",Alternative,it is a medication,54,70,1,57,88,TWrex-cause,811436-FS1,g  Yaws  Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.,YAWS,TREPONEMA PERTENUE
720315690,5/11/2015 23:20:52,1634429506,5/11/2015 23:20:33,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[CAUSES],[CAUSES],caused,n/a,54,70,1,57,88,TWrex-cause,811436-FS1,g  Yaws  Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.,YAWS,TREPONEMA PERTENUE
720315690,5/11/2015 23:21:52,1634429961,5/11/2015 23:21:38,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,54,70,1,57,88,TWrex-cause,811436-FS1,g  Yaws  Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.,YAWS,TREPONEMA PERTENUE
720315690,5/11/2015 23:25:00,1634431398,5/11/2015 23:24:40,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.48,[PREVENTS] [LOCATION] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[LOCATION]
[NONE]",no,no,54,70,1,57,88,TWrex-cause,811436-FS1,g  Yaws  Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.,YAWS,TREPONEMA PERTENUE
720315690,5/11/2015 23:30:04,1634433729,5/11/2015 23:29:21,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[OTHER],[OTHER],caused by TREPONEMA PERTENUE.,n/a,54,70,1,57,88,TWrex-cause,811436-FS1,g  Yaws  Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.,YAWS,TREPONEMA PERTENUE
720315690,5/11/2015 23:30:51,1634434110,5/11/2015 23:30:36,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[CAUSES],[CAUSES],caused,n/a,54,70,1,57,88,TWrex-cause,811436-FS1,g  Yaws  Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.,YAWS,TREPONEMA PERTENUE
720315690,5/11/2015 23:32:19,1634434802,5/11/2015 23:31:54,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],caused,n/a,54,70,1,57,88,TWrex-cause,811436-FS1,g  Yaws  Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.,YAWS,TREPONEMA PERTENUE
720315690,5/11/2015 23:53:13,1634445334,5/11/2015 23:52:54,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],caused,n/a,54,70,1,57,88,TWrex-cause,811436-FS1,g  Yaws  Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.,YAWS,TREPONEMA PERTENUE
720315690,5/12/2015 00:00:59,1634448092,5/11/2015 23:59:21,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],YAWS caused by TREPONEMA PERTENUE.,N/A,54,70,1,57,88,TWrex-cause,811436-FS1,g  Yaws  Alternative to penicillin G for treatment of YAWS caused by  TREPONEMA PERTENUE.,YAWS,TREPONEMA PERTENUE
720315691,5/11/2015 23:11:42,1634425121,5/11/2015 23:11:29,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[PREVENTS],[PREVENTS],prevent,N/A,62,9,-1,63,17,TWrex-cause,804506-FS1,Although WARFARIN can prevent 65% of strokes in patients with AF its real world effectiveness averages only about 35%  (2).,AF,WARFARIN
720315691,5/11/2015 23:20:27,1634429258,5/11/2015 23:19:34,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],effectiveness,N/A,62,9,-1,63,17,TWrex-cause,804506-FS1,Although WARFARIN can prevent 65% of strokes in patients with AF its real world effectiveness averages only about 35%  (2).,AF,WARFARIN
720315691,5/11/2015 23:20:57,1634429514,5/11/2015 23:20:28,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[PREVENTS],[PREVENTS],can prevent strokes,n/a,62,9,-1,63,17,TWrex-cause,804506-FS1,Although WARFARIN can prevent 65% of strokes in patients with AF its real world effectiveness averages only about 35%  (2).,AF,WARFARIN
720315691,5/11/2015 23:23:12,1634430686,5/11/2015 23:23:03,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[PREVENTS],[PREVENTS],prevent,n/a,62,9,-1,63,17,TWrex-cause,804506-FS1,Although WARFARIN can prevent 65% of strokes in patients with AF its real world effectiveness averages only about 35%  (2).,AF,WARFARIN
720315691,5/11/2015 23:24:40,1634431252,5/11/2015 23:23:59,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",prevent,drug treats the condition,62,9,-1,63,17,TWrex-cause,804506-FS1,Although WARFARIN can prevent 65% of strokes in patients with AF its real world effectiveness averages only about 35%  (2).,AF,WARFARIN
720315691,5/11/2015 23:29:40,1634433520,5/11/2015 23:29:24,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.48,[PREVENTS] [LOCATION] [NONE],"[PREVENTS]
[LOCATION]
[NONE]",no,no,62,9,-1,63,17,TWrex-cause,804506-FS1,Although WARFARIN can prevent 65% of strokes in patients with AF its real world effectiveness averages only about 35%  (2).,AF,WARFARIN
720315691,5/11/2015 23:31:15,1634434256,5/11/2015 23:29:13,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[PREVENTS],[PREVENTS],can prevent,N/A,62,9,-1,63,17,TWrex-cause,804506-FS1,Although WARFARIN can prevent 65% of strokes in patients with AF its real world effectiveness averages only about 35%  (2).,AF,WARFARIN
720315691,5/11/2015 23:35:40,1634436811,5/11/2015 23:34:50,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[PREVENTS],[PREVENTS],prevent,n/a,62,9,-1,63,17,TWrex-cause,804506-FS1,Although WARFARIN can prevent 65% of strokes in patients with AF its real world effectiveness averages only about 35%  (2).,AF,WARFARIN
720315691,5/11/2015 23:41:42,1634440683,5/11/2015 23:40:52,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[PREVENTS],[PREVENTS],prevent,n/a,62,9,-1,63,17,TWrex-cause,804506-FS1,Although WARFARIN can prevent 65% of strokes in patients with AF its real world effectiveness averages only about 35%  (2).,AF,WARFARIN
720315691,5/11/2015 23:54:56,1634446061,5/11/2015 23:54:45,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[PREVENTS],[PREVENTS],prevent,n/a,62,9,-1,63,17,TWrex-cause,804506-FS1,Although WARFARIN can prevent 65% of strokes in patients with AF its real world effectiveness averages only about 35%  (2).,AF,WARFARIN
720315691,5/12/2015 00:19:37,1634455027,5/12/2015 00:18:31,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],in patients with AF,treats patients with Af,62,9,-1,63,17,TWrex-cause,804506-FS1,Although WARFARIN can prevent 65% of strokes in patients with AF its real world effectiveness averages only about 35%  (2).,AF,WARFARIN
720315691,5/12/2015 00:26:08,1634457595,5/12/2015 00:25:16,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[PREVENTS],[PREVENTS],WARFARIN can prevent AF,N/A,62,9,-1,63,17,TWrex-cause,804506-FS1,Although WARFARIN can prevent 65% of strokes in patients with AF its real world effectiveness averages only about 35%  (2).,AF,WARFARIN
720315691,5/12/2015 00:39:21,1634462646,5/12/2015 00:38:16,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[PREVENTS],[PREVENTS],WARFARIN can prevent,None,62,9,-1,63,17,TWrex-cause,804506-FS1,Although WARFARIN can prevent 65% of strokes in patients with AF its real world effectiveness averages only about 35%  (2).,AF,WARFARIN
720315691,5/12/2015 00:39:25,1634462703,5/12/2015 00:38:24,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[PREVENTS],[PREVENTS],WARFARIN can prevent strokes in AF,n/a,62,9,-1,63,17,TWrex-cause,804506-FS1,Although WARFARIN can prevent 65% of strokes in patients with AF its real world effectiveness averages only about 35%  (2).,AF,WARFARIN
720315691,5/12/2015 01:01:41,1634472447,5/12/2015 01:01:05,false,elite,1.0,31848723,USA,"","",155.94.185.207,[ASSOCIATED_WITH],[ASSOCIATED_WITH],WARFARIN AF,N/A,62,9,-1,63,17,TWrex-cause,804506-FS1,Although WARFARIN can prevent 65% of strokes in patients with AF its real world effectiveness averages only about 35%  (2).,AF,WARFARIN
720315692,5/11/2015 22:16:56,1634400936,5/11/2015 22:16:39,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],Prescribing,N/A,123,156,1,131,167,TWrex-cause,811558-FS1,"Because thalidomide is a known human teratogen and can cause severe, life threatening birth defects if administered during PREGNANCY commercially available THALIDOMIDE must be obtained through a restricted distribution program, the System for Thalidomide Education and Prescribing Safety (STEPS), designed to help ensure that fetal exposure to the drug does not occur.",PREGNANCY,THALIDOMIDE
720315692,5/11/2015 22:17:14,1634401107,5/11/2015 22:16:23,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[NONE],[NONE],n/a,thalidomide is a drug that cannot be given during pregnancy due to birth defects,123,156,1,131,167,TWrex-cause,811558-FS1,"Because thalidomide is a known human teratogen and can cause severe, life threatening birth defects if administered during PREGNANCY commercially available THALIDOMIDE must be obtained through a restricted distribution program, the System for Thalidomide Education and Prescribing Safety (STEPS), designed to help ensure that fetal exposure to the drug does not occur.",PREGNANCY,THALIDOMIDE
720315692,5/11/2015 22:19:12,1634402026,5/11/2015 22:18:49,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CONTRAINDICATES],[CONTRAINDICATES],cause birth defects,n/a,123,156,1,131,167,TWrex-cause,811558-FS1,"Because thalidomide is a known human teratogen and can cause severe, life threatening birth defects if administered during PREGNANCY commercially available THALIDOMIDE must be obtained through a restricted distribution program, the System for Thalidomide Education and Prescribing Safety (STEPS), designed to help ensure that fetal exposure to the drug does not occur.",PREGNANCY,THALIDOMIDE
720315692,5/11/2015 22:20:11,1634402531,5/11/2015 22:19:08,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CONTRAINDICATES],[CONTRAINDICATES],"Because life threatening birth defects if administered during PREGNANCY THALIDOMIDE must be obtained through a restricted distribution program,",N/A,123,156,1,131,167,TWrex-cause,811558-FS1,"Because thalidomide is a known human teratogen and can cause severe, life threatening birth defects if administered during PREGNANCY commercially available THALIDOMIDE must be obtained through a restricted distribution program, the System for Thalidomide Education and Prescribing Safety (STEPS), designed to help ensure that fetal exposure to the drug does not occur.",PREGNANCY,THALIDOMIDE
720315692,5/11/2015 22:23:44,1634404220,5/11/2015 22:21:32,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CONTRAINDICATES],[CONTRAINDICATES],"can cause severe, life threatening birth defects if administered during",n/a,123,156,1,131,167,TWrex-cause,811558-FS1,"Because thalidomide is a known human teratogen and can cause severe, life threatening birth defects if administered during PREGNANCY commercially available THALIDOMIDE must be obtained through a restricted distribution program, the System for Thalidomide Education and Prescribing Safety (STEPS), designed to help ensure that fetal exposure to the drug does not occur.",PREGNANCY,THALIDOMIDE
720315692,5/11/2015 22:33:08,1634407945,5/11/2015 22:32:21,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],cause,n/a,123,156,1,131,167,TWrex-cause,811558-FS1,"Because thalidomide is a known human teratogen and can cause severe, life threatening birth defects if administered during PREGNANCY commercially available THALIDOMIDE must be obtained through a restricted distribution program, the System for Thalidomide Education and Prescribing Safety (STEPS), designed to help ensure that fetal exposure to the drug does not occur.",PREGNANCY,THALIDOMIDE
720315692,5/11/2015 22:33:37,1634408304,5/11/2015 22:32:43,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[SIDE_EFFECT],[SIDE_EFFECT],"can cause severe, life threatening birth defects",n/a,123,156,1,131,167,TWrex-cause,811558-FS1,"Because thalidomide is a known human teratogen and can cause severe, life threatening birth defects if administered during PREGNANCY commercially available THALIDOMIDE must be obtained through a restricted distribution program, the System for Thalidomide Education and Prescribing Safety (STEPS), designed to help ensure that fetal exposure to the drug does not occur.",PREGNANCY,THALIDOMIDE
720315692,5/11/2015 22:35:55,1634409486,5/11/2015 22:34:16,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CONTRAINDICATES],[CONTRAINDICATES],birth defects if administered during PREGNANCY THALIDOMIDE,n/a,123,156,1,131,167,TWrex-cause,811558-FS1,"Because thalidomide is a known human teratogen and can cause severe, life threatening birth defects if administered during PREGNANCY commercially available THALIDOMIDE must be obtained through a restricted distribution program, the System for Thalidomide Education and Prescribing Safety (STEPS), designed to help ensure that fetal exposure to the drug does not occur.",PREGNANCY,THALIDOMIDE
720315692,5/11/2015 22:40:05,1634411551,5/11/2015 22:38:42,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SIDE_EFFECT],[SIDE_EFFECT],"Because thalidomide is a known human teratogen and can cause severe, life threatening birth defects if administered during PREGNANCY commercially available THALIDOMIDE must be obtained through a restricted distribution program, the System for Thalidomide Education and Prescribing Safety (STEPS), designed to help ensure that fetal exposure to the drug does not occur.",N/A,123,156,1,131,167,TWrex-cause,811558-FS1,"Because thalidomide is a known human teratogen and can cause severe, life threatening birth defects if administered during PREGNANCY commercially available THALIDOMIDE must be obtained through a restricted distribution program, the System for Thalidomide Education and Prescribing Safety (STEPS), designed to help ensure that fetal exposure to the drug does not occur.",PREGNANCY,THALIDOMIDE
720315692,5/11/2015 22:42:22,1634412474,5/11/2015 22:41:35,false,instagc,1.0,28519532,USA,IA,Neola,38.121.112.217,[CONTRAINDICATES],[CONTRAINDICATES],"can cause severe, life threatening birth defects",na,123,156,1,131,167,TWrex-cause,811558-FS1,"Because thalidomide is a known human teratogen and can cause severe, life threatening birth defects if administered during PREGNANCY commercially available THALIDOMIDE must be obtained through a restricted distribution program, the System for Thalidomide Education and Prescribing Safety (STEPS), designed to help ensure that fetal exposure to the drug does not occur.",PREGNANCY,THALIDOMIDE
720315692,5/11/2015 22:51:48,1634416884,5/11/2015 22:49:56,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CONTRAINDICATES],[CONTRAINDICATES],fetal exposure to the drug does not occur.,N/A,123,156,1,131,167,TWrex-cause,811558-FS1,"Because thalidomide is a known human teratogen and can cause severe, life threatening birth defects if administered during PREGNANCY commercially available THALIDOMIDE must be obtained through a restricted distribution program, the System for Thalidomide Education and Prescribing Safety (STEPS), designed to help ensure that fetal exposure to the drug does not occur.",PREGNANCY,THALIDOMIDE
720315692,5/11/2015 22:52:01,1634416919,5/11/2015 22:51:11,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[SIDE_EFFECT],[SIDE_EFFECT],can cause,N/A,123,156,1,131,167,TWrex-cause,811558-FS1,"Because thalidomide is a known human teratogen and can cause severe, life threatening birth defects if administered during PREGNANCY commercially available THALIDOMIDE must be obtained through a restricted distribution program, the System for Thalidomide Education and Prescribing Safety (STEPS), designed to help ensure that fetal exposure to the drug does not occur.",PREGNANCY,THALIDOMIDE
720315692,5/11/2015 22:52:32,1634417096,5/11/2015 22:51:11,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,75.147.181.53,[CONTRAINDICATES],[CONTRAINDICATES],can cause,N/A,123,156,1,131,167,TWrex-cause,811558-FS1,"Because thalidomide is a known human teratogen and can cause severe, life threatening birth defects if administered during PREGNANCY commercially available THALIDOMIDE must be obtained through a restricted distribution program, the System for Thalidomide Education and Prescribing Safety (STEPS), designed to help ensure that fetal exposure to the drug does not occur.",PREGNANCY,THALIDOMIDE
720315692,5/11/2015 22:52:57,1634417212,5/11/2015 22:50:37,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[OTHER],[OTHER],thalidomide is known human teratogen cause life threatening birth defects if administered during PREGNANCY help ensure that fetal exposure to the drug does not occur.,n/a,123,156,1,131,167,TWrex-cause,811558-FS1,"Because thalidomide is a known human teratogen and can cause severe, life threatening birth defects if administered during PREGNANCY commercially available THALIDOMIDE must be obtained through a restricted distribution program, the System for Thalidomide Education and Prescribing Safety (STEPS), designed to help ensure that fetal exposure to the drug does not occur.",PREGNANCY,THALIDOMIDE
720315692,5/11/2015 22:54:00,1634417588,5/11/2015 22:51:34,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[NONE],[NONE],na,pregnancy is not related to thalimode,123,156,1,131,167,TWrex-cause,811558-FS1,"Because thalidomide is a known human teratogen and can cause severe, life threatening birth defects if administered during PREGNANCY commercially available THALIDOMIDE must be obtained through a restricted distribution program, the System for Thalidomide Education and Prescribing Safety (STEPS), designed to help ensure that fetal exposure to the drug does not occur.",PREGNANCY,THALIDOMIDE
720315693,5/11/2015 22:18:12,1634401499,5/11/2015 22:17:52,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],life threatening sporotrichosis,N/A,139,24,-1,152,38,TWrex-cause,800548-FS1,"146 ,   429 ,   436  IV AMPHOTERICIN B is the drug of choice for initial treatment of severe, life threatening sporotrichosis and whenever SPOROTRICHOSIS is disseminated or has CNS involvement.",SPOROTRICHOSIS,AMPHOTERICIN B
720315693,5/11/2015 22:20:04,1634402464,5/11/2015 22:19:42,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],AMPHOTERICIN B is the treatment of SPOROTRICHOSIS,n/a,139,24,-1,152,38,TWrex-cause,800548-FS1,"146 ,   429 ,   436  IV AMPHOTERICIN B is the drug of choice for initial treatment of severe, life threatening sporotrichosis and whenever SPOROTRICHOSIS is disseminated or has CNS involvement.",SPOROTRICHOSIS,AMPHOTERICIN B
720315693,5/11/2015 22:20:27,1634402678,5/11/2015 22:20:12,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],drug of choice,n/a,139,24,-1,152,38,TWrex-cause,800548-FS1,"146 ,   429 ,   436  IV AMPHOTERICIN B is the drug of choice for initial treatment of severe, life threatening sporotrichosis and whenever SPOROTRICHOSIS is disseminated or has CNS involvement.",SPOROTRICHOSIS,AMPHOTERICIN B
720315693,5/11/2015 22:26:29,1634405405,5/11/2015 22:25:48,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],AMPHOTERICIN B drug of choice for initial treatment of SPOROTRICHOSIS,N/A,139,24,-1,152,38,TWrex-cause,800548-FS1,"146 ,   429 ,   436  IV AMPHOTERICIN B is the drug of choice for initial treatment of severe, life threatening sporotrichosis and whenever SPOROTRICHOSIS is disseminated or has CNS involvement.",SPOROTRICHOSIS,AMPHOTERICIN B
720315693,5/11/2015 22:28:39,1634406283,5/11/2015 22:28:11,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],treatment,n/a,139,24,-1,152,38,TWrex-cause,800548-FS1,"146 ,   429 ,   436  IV AMPHOTERICIN B is the drug of choice for initial treatment of severe, life threatening sporotrichosis and whenever SPOROTRICHOSIS is disseminated or has CNS involvement.",SPOROTRICHOSIS,AMPHOTERICIN B
720315693,5/11/2015 22:35:51,1634409461,5/11/2015 22:35:21,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],drug,n/a,139,24,-1,152,38,TWrex-cause,800548-FS1,"146 ,   429 ,   436  IV AMPHOTERICIN B is the drug of choice for initial treatment of severe, life threatening sporotrichosis and whenever SPOROTRICHOSIS is disseminated or has CNS involvement.",SPOROTRICHOSIS,AMPHOTERICIN B
720315693,5/11/2015 22:36:12,1634409585,5/11/2015 22:35:35,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],initial treatment,n/a,139,24,-1,152,38,TWrex-cause,800548-FS1,"146 ,   429 ,   436  IV AMPHOTERICIN B is the drug of choice for initial treatment of severe, life threatening sporotrichosis and whenever SPOROTRICHOSIS is disseminated or has CNS involvement.",SPOROTRICHOSIS,AMPHOTERICIN B
720315693,5/11/2015 22:41:08,1634411978,5/11/2015 22:40:05,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],AMPHOTERICIN B is drug choice treatment of SPOROTRICHOSIS,n/a,139,24,-1,152,38,TWrex-cause,800548-FS1,"146 ,   429 ,   436  IV AMPHOTERICIN B is the drug of choice for initial treatment of severe, life threatening sporotrichosis and whenever SPOROTRICHOSIS is disseminated or has CNS involvement.",SPOROTRICHOSIS,AMPHOTERICIN B
720315693,5/11/2015 22:44:35,1634413510,5/11/2015 22:44:08,false,instagc,1.0,28519532,USA,IA,Neola,38.121.112.217,[TREATS],[TREATS],for initial treatment of,na,139,24,-1,152,38,TWrex-cause,800548-FS1,"146 ,   429 ,   436  IV AMPHOTERICIN B is the drug of choice for initial treatment of severe, life threatening sporotrichosis and whenever SPOROTRICHOSIS is disseminated or has CNS involvement.",SPOROTRICHOSIS,AMPHOTERICIN B
720315693,5/11/2015 22:45:47,1634414077,5/11/2015 22:44:37,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"AMPHOTERICIN B is the drug of choice for initial treatment of severe, life threatening sporotrichosis and whenever SPOROTRICHOSIS is disseminated or has CNS involvement.",N/A,139,24,-1,152,38,TWrex-cause,800548-FS1,"146 ,   429 ,   436  IV AMPHOTERICIN B is the drug of choice for initial treatment of severe, life threatening sporotrichosis and whenever SPOROTRICHOSIS is disseminated or has CNS involvement.",SPOROTRICHOSIS,AMPHOTERICIN B
720315693,5/11/2015 22:54:09,1634417644,5/11/2015 22:53:49,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,75.147.181.53,[TREATS],[TREATS],initial treatment of,N/A,139,24,-1,152,38,TWrex-cause,800548-FS1,"146 ,   429 ,   436  IV AMPHOTERICIN B is the drug of choice for initial treatment of severe, life threatening sporotrichosis and whenever SPOROTRICHOSIS is disseminated or has CNS involvement.",SPOROTRICHOSIS,AMPHOTERICIN B
720315693,5/11/2015 22:55:33,1634418138,5/11/2015 22:54:57,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,139,24,-1,152,38,TWrex-cause,800548-FS1,"146 ,   429 ,   436  IV AMPHOTERICIN B is the drug of choice for initial treatment of severe, life threatening sporotrichosis and whenever SPOROTRICHOSIS is disseminated or has CNS involvement.",SPOROTRICHOSIS,AMPHOTERICIN B
720315693,5/11/2015 22:56:04,1634418289,5/11/2015 22:55:09,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[TREATS],[TREATS],AMPHOTERICIN B the drug of choice for life threatening sporotrichosis and whenever SPOROTRICHOSIS is disseminated,n/a,139,24,-1,152,38,TWrex-cause,800548-FS1,"146 ,   429 ,   436  IV AMPHOTERICIN B is the drug of choice for initial treatment of severe, life threatening sporotrichosis and whenever SPOROTRICHOSIS is disseminated or has CNS involvement.",SPOROTRICHOSIS,AMPHOTERICIN B
720315693,5/11/2015 22:57:34,1634418775,5/11/2015 22:55:20,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[NONE],[NONE],na,amphotericin b treats SPOROTRICHOSIS but not the other way around,139,24,-1,152,38,TWrex-cause,800548-FS1,"146 ,   429 ,   436  IV AMPHOTERICIN B is the drug of choice for initial treatment of severe, life threatening sporotrichosis and whenever SPOROTRICHOSIS is disseminated or has CNS involvement.",SPOROTRICHOSIS,AMPHOTERICIN B
720315693,5/11/2015 22:58:00,1634418937,5/11/2015 22:55:34,false,clixsense,1.0,6330007,AUS,06,Hobart,101.178.23.54,[TREATS],[TREATS],initial treatment,n/a,139,24,-1,152,38,TWrex-cause,800548-FS1,"146 ,   429 ,   436  IV AMPHOTERICIN B is the drug of choice for initial treatment of severe, life threatening sporotrichosis and whenever SPOROTRICHOSIS is disseminated or has CNS involvement.",SPOROTRICHOSIS,AMPHOTERICIN B
720315694,5/11/2015 22:22:37,1634403730,5/11/2015 22:22:17,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],HPV,N/A,149,22,1,176,25,TWrex-cause,810508-FS1,Human Papillomavirus (HPV) Infections: External Genital and Perianal Warts  Interferon alfa 2b: Treatment of external genital and perianal exophytic WARTS (CONDYLOMATA ACUMINATA caused by HPV,WARTS (CONDYLOMATA ACUMINATA,HPV
720315694,5/11/2015 22:24:12,1634404433,5/11/2015 22:23:56,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],caused by,n/a,149,22,1,176,25,TWrex-cause,810508-FS1,Human Papillomavirus (HPV) Infections: External Genital and Perianal Warts  Interferon alfa 2b: Treatment of external genital and perianal exophytic WARTS (CONDYLOMATA ACUMINATA caused by HPV,WARTS (CONDYLOMATA ACUMINATA,HPV
720315694,5/11/2015 22:29:09,1634406503,5/11/2015 22:28:40,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],WARTS caused by HPV,na,149,22,1,176,25,TWrex-cause,810508-FS1,Human Papillomavirus (HPV) Infections: External Genital and Perianal Warts  Interferon alfa 2b: Treatment of external genital and perianal exophytic WARTS (CONDYLOMATA ACUMINATA caused by HPV,WARTS (CONDYLOMATA ACUMINATA,HPV
720315694,5/11/2015 22:38:06,1634410533,5/11/2015 22:37:38,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[PART_OF],[PART_OF],caused by,n/a,149,22,1,176,25,TWrex-cause,810508-FS1,Human Papillomavirus (HPV) Infections: External Genital and Perianal Warts  Interferon alfa 2b: Treatment of external genital and perianal exophytic WARTS (CONDYLOMATA ACUMINATA caused by HPV,WARTS (CONDYLOMATA ACUMINATA,HPV
720315694,5/11/2015 22:39:22,1634411205,5/11/2015 22:38:44,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],WARTS (CONDYLOMATA ACUMINATA caused by HPV,N/A,149,22,1,176,25,TWrex-cause,810508-FS1,Human Papillomavirus (HPV) Infections: External Genital and Perianal Warts  Interferon alfa 2b: Treatment of external genital and perianal exophytic WARTS (CONDYLOMATA ACUMINATA caused by HPV,WARTS (CONDYLOMATA ACUMINATA,HPV
720315694,5/11/2015 22:43:07,1634412842,5/11/2015 22:42:31,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[CAUSES],[CAUSES],WARTS (CONDYLOMATA ACUMINATA caused by HPV,n/a,149,22,1,176,25,TWrex-cause,810508-FS1,Human Papillomavirus (HPV) Infections: External Genital and Perianal Warts  Interferon alfa 2b: Treatment of external genital and perianal exophytic WARTS (CONDYLOMATA ACUMINATA caused by HPV,WARTS (CONDYLOMATA ACUMINATA,HPV
720315694,5/11/2015 22:50:54,1634416484,5/11/2015 22:50:15,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],WARTS (CONDYLOMATA ACUMINATA caused by HPV,n/a,149,22,1,176,25,TWrex-cause,810508-FS1,Human Papillomavirus (HPV) Infections: External Genital and Perianal Warts  Interferon alfa 2b: Treatment of external genital and perianal exophytic WARTS (CONDYLOMATA ACUMINATA caused by HPV,WARTS (CONDYLOMATA ACUMINATA,HPV
720315694,5/11/2015 23:00:12,1634419546,5/11/2015 22:58:52,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],Human Papillomavirus (HPV) Infections: External Genital and Perianal Warts Interferon alfa 2b: Treatment of external genital and perianal exophytic WARTS (CONDYLOMATA ACUMINATA caused by HPV,N/A,149,22,1,176,25,TWrex-cause,810508-FS1,Human Papillomavirus (HPV) Infections: External Genital and Perianal Warts  Interferon alfa 2b: Treatment of external genital and perianal exophytic WARTS (CONDYLOMATA ACUMINATA caused by HPV,WARTS (CONDYLOMATA ACUMINATA,HPV
720315694,5/11/2015 23:00:47,1634419718,5/11/2015 23:00:27,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,75.147.181.53,[CAUSES],[CAUSES],caused by,N/A,149,22,1,176,25,TWrex-cause,810508-FS1,Human Papillomavirus (HPV) Infections: External Genital and Perianal Warts  Interferon alfa 2b: Treatment of external genital and perianal exophytic WARTS (CONDYLOMATA ACUMINATA caused by HPV,WARTS (CONDYLOMATA ACUMINATA,HPV
720315694,5/11/2015 23:05:34,1634421373,5/11/2015 23:04:52,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[MANIFESTATION],[MANIFESTATION],caused,n/a,149,22,1,176,25,TWrex-cause,810508-FS1,Human Papillomavirus (HPV) Infections: External Genital and Perianal Warts  Interferon alfa 2b: Treatment of external genital and perianal exophytic WARTS (CONDYLOMATA ACUMINATA caused by HPV,WARTS (CONDYLOMATA ACUMINATA,HPV
720315694,5/11/2015 23:06:10,1634421531,5/11/2015 23:05:42,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[SYMPTOM],[SYMPTOM],caused,warts are caused by HPV,149,22,1,176,25,TWrex-cause,810508-FS1,Human Papillomavirus (HPV) Infections: External Genital and Perianal Warts  Interferon alfa 2b: Treatment of external genital and perianal exophytic WARTS (CONDYLOMATA ACUMINATA caused by HPV,WARTS (CONDYLOMATA ACUMINATA,HPV
720315694,5/11/2015 23:06:22,1634421714,5/11/2015 23:06:07,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],caused,N/A,149,22,1,176,25,TWrex-cause,810508-FS1,Human Papillomavirus (HPV) Infections: External Genital and Perianal Warts  Interferon alfa 2b: Treatment of external genital and perianal exophytic WARTS (CONDYLOMATA ACUMINATA caused by HPV,WARTS (CONDYLOMATA ACUMINATA,HPV
720315694,5/11/2015 23:06:27,1634421755,5/11/2015 23:05:35,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],caused by,n/a,149,22,1,176,25,TWrex-cause,810508-FS1,Human Papillomavirus (HPV) Infections: External Genital and Perianal Warts  Interferon alfa 2b: Treatment of external genital and perianal exophytic WARTS (CONDYLOMATA ACUMINATA caused by HPV,WARTS (CONDYLOMATA ACUMINATA,HPV
720315694,5/11/2015 23:07:35,1634422285,5/11/2015 23:06:38,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],caused by,N/A,149,22,1,176,25,TWrex-cause,810508-FS1,Human Papillomavirus (HPV) Infections: External Genital and Perianal Warts  Interferon alfa 2b: Treatment of external genital and perianal exophytic WARTS (CONDYLOMATA ACUMINATA caused by HPV,WARTS (CONDYLOMATA ACUMINATA,HPV
720315694,5/11/2015 23:08:10,1634422505,5/11/2015 23:05:53,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[CAUSES],[CAUSES],perianal exophytic WARTS (CONDYLOMATA ACUMINATA caused by HPV,n/a,149,22,1,176,25,TWrex-cause,810508-FS1,Human Papillomavirus (HPV) Infections: External Genital and Perianal Warts  Interferon alfa 2b: Treatment of external genital and perianal exophytic WARTS (CONDYLOMATA ACUMINATA caused by HPV,WARTS (CONDYLOMATA ACUMINATA,HPV
720315695,5/11/2015 22:22:56,1634403879,5/11/2015 22:22:39,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[LOCATION],[LOCATION],INTRACRANIAL PRESSURE,N/A,0,22,1,10,53,TWrex-cause,813185-FS1,"PAPILLEDEMA indicates INCREASED INTRACRANIAL PRESSURE which may be due to idiopathic intracranial hypertension, accelerated hypertension, a mass lesion, or sagittal sinus thrombosis.",PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
720315695,5/11/2015 22:24:27,1634404543,5/11/2015 22:24:13,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],indicates,n/a,0,22,1,10,53,TWrex-cause,813185-FS1,"PAPILLEDEMA indicates INCREASED INTRACRANIAL PRESSURE which may be due to idiopathic intracranial hypertension, accelerated hypertension, a mass lesion, or sagittal sinus thrombosis.",PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
720315695,5/11/2015 22:30:09,1634406754,5/11/2015 22:29:10,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],PAPILLEDEMA INCREASED INTRACRANIAL PRESSURE due to,n/a,0,22,1,10,53,TWrex-cause,813185-FS1,"PAPILLEDEMA indicates INCREASED INTRACRANIAL PRESSURE which may be due to idiopathic intracranial hypertension, accelerated hypertension, a mass lesion, or sagittal sinus thrombosis.",PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
720315695,5/11/2015 22:39:16,1634411130,5/11/2015 22:38:08,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[SYMPTOM],[SYMPTOM],indicates,n/a,0,22,1,10,53,TWrex-cause,813185-FS1,"PAPILLEDEMA indicates INCREASED INTRACRANIAL PRESSURE which may be due to idiopathic intracranial hypertension, accelerated hypertension, a mass lesion, or sagittal sinus thrombosis.",PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
720315695,5/11/2015 22:39:58,1634411506,5/11/2015 22:39:25,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[SYMPTOM],[SYMPTOM],PAPILLEDEMA indicates INCREASED INTRACRANIAL PRESSURE,N/A,0,22,1,10,53,TWrex-cause,813185-FS1,"PAPILLEDEMA indicates INCREASED INTRACRANIAL PRESSURE which may be due to idiopathic intracranial hypertension, accelerated hypertension, a mass lesion, or sagittal sinus thrombosis.",PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
720315695,5/11/2015 22:44:04,1634413271,5/11/2015 22:43:09,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[CAUSES],[CAUSES],PAPILLEDEMA indicates INCREASED INTRACRANIAL PRESSURE,n/a,0,22,1,10,53,TWrex-cause,813185-FS1,"PAPILLEDEMA indicates INCREASED INTRACRANIAL PRESSURE which may be due to idiopathic intracranial hypertension, accelerated hypertension, a mass lesion, or sagittal sinus thrombosis.",PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
720315695,5/11/2015 22:52:19,1634417025,5/11/2015 22:50:56,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],PAPILLEDEMA indicates INCREASED INTRACRANIAL PRESSURE,n/a,0,22,1,10,53,TWrex-cause,813185-FS1,"PAPILLEDEMA indicates INCREASED INTRACRANIAL PRESSURE which may be due to idiopathic intracranial hypertension, accelerated hypertension, a mass lesion, or sagittal sinus thrombosis.",PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
720315695,5/11/2015 23:01:10,1634419901,5/11/2015 23:00:49,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,75.147.181.53,[SYMPTOM],[SYMPTOM],indicates,N/A,0,22,1,10,53,TWrex-cause,813185-FS1,"PAPILLEDEMA indicates INCREASED INTRACRANIAL PRESSURE which may be due to idiopathic intracranial hypertension, accelerated hypertension, a mass lesion, or sagittal sinus thrombosis.",PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
720315695,5/11/2015 23:01:48,1634420145,5/11/2015 23:00:13,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],"PAPILLEDEMA indicates INCREASED INTRACRANIAL PRESSURE which may be due to idiopathic intracranial hypertension, accelerated hypertension, a mass lesion, or sagittal sinus thrombosis.",N/A,0,22,1,10,53,TWrex-cause,813185-FS1,"PAPILLEDEMA indicates INCREASED INTRACRANIAL PRESSURE which may be due to idiopathic intracranial hypertension, accelerated hypertension, a mass lesion, or sagittal sinus thrombosis.",PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
720315695,5/11/2015 23:06:02,1634421458,5/11/2015 23:05:36,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[MANIFESTATION],[MANIFESTATION],indicates,n/a,0,22,1,10,53,TWrex-cause,813185-FS1,"PAPILLEDEMA indicates INCREASED INTRACRANIAL PRESSURE which may be due to idiopathic intracranial hypertension, accelerated hypertension, a mass lesion, or sagittal sinus thrombosis.",PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
720315695,5/11/2015 23:06:42,1634421865,5/11/2015 23:06:23,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],indicates,N/A,0,22,1,10,53,TWrex-cause,813185-FS1,"PAPILLEDEMA indicates INCREASED INTRACRANIAL PRESSURE which may be due to idiopathic intracranial hypertension, accelerated hypertension, a mass lesion, or sagittal sinus thrombosis.",PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
720315695,5/11/2015 23:07:17,1634422132,5/11/2015 23:06:11,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",indicates,the pressure is a symptom/manifestation of the condition,0,22,1,10,53,TWrex-cause,813185-FS1,"PAPILLEDEMA indicates INCREASED INTRACRANIAL PRESSURE which may be due to idiopathic intracranial hypertension, accelerated hypertension, a mass lesion, or sagittal sinus thrombosis.",PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
720315695,5/11/2015 23:08:04,1634422494,5/11/2015 23:06:27,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[MANIFESTATION],[MANIFESTATION],indicates,n/a,0,22,1,10,53,TWrex-cause,813185-FS1,"PAPILLEDEMA indicates INCREASED INTRACRANIAL PRESSURE which may be due to idiopathic intracranial hypertension, accelerated hypertension, a mass lesion, or sagittal sinus thrombosis.",PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
720315695,5/11/2015 23:08:44,1634422790,5/11/2015 23:07:09,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[SYMPTOM],[SYMPTOM],indicates,N/A,0,22,1,10,53,TWrex-cause,813185-FS1,"PAPILLEDEMA indicates INCREASED INTRACRANIAL PRESSURE which may be due to idiopathic intracranial hypertension, accelerated hypertension, a mass lesion, or sagittal sinus thrombosis.",PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
720315695,5/11/2015 23:09:40,1634423550,5/11/2015 23:07:40,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[SYMPTOM],[SYMPTOM],indicates,N/A,0,22,1,10,53,TWrex-cause,813185-FS1,"PAPILLEDEMA indicates INCREASED INTRACRANIAL PRESSURE which may be due to idiopathic intracranial hypertension, accelerated hypertension, a mass lesion, or sagittal sinus thrombosis.",PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
720315696,5/12/2015 00:57:33,1634470583,5/12/2015 00:55:09,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[PREVENTS],[PREVENTS],reduced risk for,N/A,111,65,-1,131,75,TWrex-cause,804871-FS1,"CONCLUSION  In patients with ST elevation myocardial infarction, ENOXAPARIN reduced risk for death or nonfatal MYOCARDIAL INFARCTION but increased risk for major bleeding more than unfractionated heparin regardless of type of fibrinolytic agent used.",MYOCARDIAL INFARCTION,ENOXAPARIN
720315696,5/12/2015 01:00:26,1634471892,5/12/2015 00:59:23,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[OTHER] [ASSOCIATED_WITH] [PREVENTS],"[PREVENTS]
[ASSOCIATED_WITH]
[OTHER]",ENOXAPARIN reduced risk for death or MYOCARDIAL INFARCTION,n/a,111,65,-1,131,75,TWrex-cause,804871-FS1,"CONCLUSION  In patients with ST elevation myocardial infarction, ENOXAPARIN reduced risk for death or nonfatal MYOCARDIAL INFARCTION but increased risk for major bleeding more than unfractionated heparin regardless of type of fibrinolytic agent used.",MYOCARDIAL INFARCTION,ENOXAPARIN
720315696,5/12/2015 01:01:11,1634472293,5/12/2015 00:59:46,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[SIDE_EFFECT],[SIDE_EFFECT],reduced risk but increased risk,N/A,111,65,-1,131,75,TWrex-cause,804871-FS1,"CONCLUSION  In patients with ST elevation myocardial infarction, ENOXAPARIN reduced risk for death or nonfatal MYOCARDIAL INFARCTION but increased risk for major bleeding more than unfractionated heparin regardless of type of fibrinolytic agent used.",MYOCARDIAL INFARCTION,ENOXAPARIN
720315696,5/12/2015 01:14:04,1634478674,5/12/2015 01:13:25,false,elite,1.0,31848723,USA,"","",155.94.185.207,[ASSOCIATED_WITH],[ASSOCIATED_WITH],CONCLUSION MYOCARDIAL INFARCTION,N/A,111,65,-1,131,75,TWrex-cause,804871-FS1,"CONCLUSION  In patients with ST elevation myocardial infarction, ENOXAPARIN reduced risk for death or nonfatal MYOCARDIAL INFARCTION but increased risk for major bleeding more than unfractionated heparin regardless of type of fibrinolytic agent used.",MYOCARDIAL INFARCTION,ENOXAPARIN
720315696,5/12/2015 01:29:47,1634487188,5/12/2015 01:29:32,false,elite,1.0,32306791,USA,TX,Dallas,69.162.75.37,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],bleeding unfractionated,N/A,111,65,-1,131,75,TWrex-cause,804871-FS1,"CONCLUSION  In patients with ST elevation myocardial infarction, ENOXAPARIN reduced risk for death or nonfatal MYOCARDIAL INFARCTION but increased risk for major bleeding more than unfractionated heparin regardless of type of fibrinolytic agent used.",MYOCARDIAL INFARCTION,ENOXAPARIN
720315696,5/12/2015 01:30:04,1634487329,5/12/2015 01:29:37,false,instagc,1.0,32556346,USA,PA,Warren,207.255.244.59,[PREVENTS],[PREVENTS],reduced,N/A,111,65,-1,131,75,TWrex-cause,804871-FS1,"CONCLUSION  In patients with ST elevation myocardial infarction, ENOXAPARIN reduced risk for death or nonfatal MYOCARDIAL INFARCTION but increased risk for major bleeding more than unfractionated heparin regardless of type of fibrinolytic agent used.",MYOCARDIAL INFARCTION,ENOXAPARIN
720315696,5/12/2015 01:42:17,1634494200,5/12/2015 01:41:43,false,instagc,1.0,30326470,USA,CA,San Diego,170.213.2.111,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],CONCLUSION reduced risk,N/A,111,65,-1,131,75,TWrex-cause,804871-FS1,"CONCLUSION  In patients with ST elevation myocardial infarction, ENOXAPARIN reduced risk for death or nonfatal MYOCARDIAL INFARCTION but increased risk for major bleeding more than unfractionated heparin regardless of type of fibrinolytic agent used.",MYOCARDIAL INFARCTION,ENOXAPARIN
720315696,5/12/2015 03:26:16,1634548055,5/12/2015 03:25:59,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[PREVENTS],[PREVENTS],reduced,n/a,111,65,-1,131,75,TWrex-cause,804871-FS1,"CONCLUSION  In patients with ST elevation myocardial infarction, ENOXAPARIN reduced risk for death or nonfatal MYOCARDIAL INFARCTION but increased risk for major bleeding more than unfractionated heparin regardless of type of fibrinolytic agent used.",MYOCARDIAL INFARCTION,ENOXAPARIN
720315696,5/12/2015 03:43:48,1634556984,5/12/2015 03:43:14,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.227,[CAUSES],[CAUSES],ENOXAPARIN MYOCARDIAL INFARCTION,N/A,111,65,-1,131,75,TWrex-cause,804871-FS1,"CONCLUSION  In patients with ST elevation myocardial infarction, ENOXAPARIN reduced risk for death or nonfatal MYOCARDIAL INFARCTION but increased risk for major bleeding more than unfractionated heparin regardless of type of fibrinolytic agent used.",MYOCARDIAL INFARCTION,ENOXAPARIN
720315696,5/12/2015 04:16:47,1634572840,5/12/2015 04:16:09,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[TREATS],[TREATS],reduced risk,N/A,111,65,-1,131,75,TWrex-cause,804871-FS1,"CONCLUSION  In patients with ST elevation myocardial infarction, ENOXAPARIN reduced risk for death or nonfatal MYOCARDIAL INFARCTION but increased risk for major bleeding more than unfractionated heparin regardless of type of fibrinolytic agent used.",MYOCARDIAL INFARCTION,ENOXAPARIN
720315696,5/12/2015 04:53:28,1634590284,5/12/2015 04:51:47,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],reduced risk,none,111,65,-1,131,75,TWrex-cause,804871-FS1,"CONCLUSION  In patients with ST elevation myocardial infarction, ENOXAPARIN reduced risk for death or nonfatal MYOCARDIAL INFARCTION but increased risk for major bleeding more than unfractionated heparin regardless of type of fibrinolytic agent used.",MYOCARDIAL INFARCTION,ENOXAPARIN
720315696,5/12/2015 05:07:52,1634598303,5/12/2015 05:05:30,false,neodev,1.0,31910622,USA,CA,San Francisco,108.169.6.201,[PREVENTS],[PREVENTS],reduced risk for,I didn´t select none.,111,65,-1,131,75,TWrex-cause,804871-FS1,"CONCLUSION  In patients with ST elevation myocardial infarction, ENOXAPARIN reduced risk for death or nonfatal MYOCARDIAL INFARCTION but increased risk for major bleeding more than unfractionated heparin regardless of type of fibrinolytic agent used.",MYOCARDIAL INFARCTION,ENOXAPARIN
720315696,5/12/2015 05:56:19,1634628700,5/12/2015 05:54:57,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[PREVENTS],[PREVENTS],reduced risk,N/A,111,65,-1,131,75,TWrex-cause,804871-FS1,"CONCLUSION  In patients with ST elevation myocardial infarction, ENOXAPARIN reduced risk for death or nonfatal MYOCARDIAL INFARCTION but increased risk for major bleeding more than unfractionated heparin regardless of type of fibrinolytic agent used.",MYOCARDIAL INFARCTION,ENOXAPARIN
720315696,5/12/2015 06:19:12,1634639641,5/12/2015 06:18:34,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[PREVENTS],[PREVENTS],reduced risk,N/A,111,65,-1,131,75,TWrex-cause,804871-FS1,"CONCLUSION  In patients with ST elevation myocardial infarction, ENOXAPARIN reduced risk for death or nonfatal MYOCARDIAL INFARCTION but increased risk for major bleeding more than unfractionated heparin regardless of type of fibrinolytic agent used.",MYOCARDIAL INFARCTION,ENOXAPARIN
720315696,5/12/2015 06:23:00,1634641349,5/12/2015 06:22:07,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[TREATS],[TREATS],ENOXAPARIN reduced risk for nonfatal MYOCARDIAL INFARCTION,n/a,111,65,-1,131,75,TWrex-cause,804871-FS1,"CONCLUSION  In patients with ST elevation myocardial infarction, ENOXAPARIN reduced risk for death or nonfatal MYOCARDIAL INFARCTION but increased risk for major bleeding more than unfractionated heparin regardless of type of fibrinolytic agent used.",MYOCARDIAL INFARCTION,ENOXAPARIN
720315697,5/11/2015 22:24:19,1634404481,5/11/2015 22:24:06,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[SYMPTOM],[SYMPTOM],NMDA receptor,N/A,121,151,1,136,155,TWrex-cause,813347-FS1,"99   Ketamine, an NMDA receptor antagonist, has been used topically, orally, and intravenously in various doses to treat NEUROPATHIC PAIN particularly CRPS",NEUROPATHIC PAIN,CRPS
720315697,5/11/2015 22:25:47,1634405085,5/11/2015 22:25:30,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treat,n/a,121,151,1,136,155,TWrex-cause,813347-FS1,"99   Ketamine, an NMDA receptor antagonist, has been used topically, orally, and intravenously in various doses to treat NEUROPATHIC PAIN particularly CRPS",NEUROPATHIC PAIN,CRPS
720315697,5/11/2015 22:33:11,1634408009,5/11/2015 22:32:33,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[ASSOCIATED_WITH],[ASSOCIATED_WITH],NEUROPATHIC PAIN particularly CRPS,n/a,121,151,1,136,155,TWrex-cause,813347-FS1,"99   Ketamine, an NMDA receptor antagonist, has been used topically, orally, and intravenously in various doses to treat NEUROPATHIC PAIN particularly CRPS",NEUROPATHIC PAIN,CRPS
720315697,5/11/2015 22:42:09,1634412312,5/11/2015 22:41:43,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[PART_OF],[PART_OF],particularly,n/a,121,151,1,136,155,TWrex-cause,813347-FS1,"99   Ketamine, an NMDA receptor antagonist, has been used topically, orally, and intravenously in various doses to treat NEUROPATHIC PAIN particularly CRPS",NEUROPATHIC PAIN,CRPS
720315697,5/11/2015 22:44:41,1634413580,5/11/2015 22:43:56,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[IS_A],[IS_A],NEUROPATHIC PAIN CRPS,N/A,121,151,1,136,155,TWrex-cause,813347-FS1,"99   Ketamine, an NMDA receptor antagonist, has been used topically, orally, and intravenously in various doses to treat NEUROPATHIC PAIN particularly CRPS",NEUROPATHIC PAIN,CRPS
720315697,5/11/2015 22:47:51,1634415107,5/11/2015 22:47:23,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],NMDA has been used to treat NEUROPATHIC PAIN,n/a,121,151,1,136,155,TWrex-cause,813347-FS1,"99   Ketamine, an NMDA receptor antagonist, has been used topically, orally, and intravenously in various doses to treat NEUROPATHIC PAIN particularly CRPS",NEUROPATHIC PAIN,CRPS
720315697,5/11/2015 22:57:40,1634418827,5/11/2015 22:56:16,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[PART_OF],[PART_OF],NEUROPATHIC PAIN particularly CRPS,n/a,121,151,1,136,155,TWrex-cause,813347-FS1,"99   Ketamine, an NMDA receptor antagonist, has been used topically, orally, and intravenously in various doses to treat NEUROPATHIC PAIN particularly CRPS",NEUROPATHIC PAIN,CRPS
720315697,5/11/2015 23:03:08,1634420583,5/11/2015 23:02:44,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,75.147.181.53,[ASSOCIATED_WITH],[ASSOCIATED_WITH],particularly,N/A,121,151,1,136,155,TWrex-cause,813347-FS1,"99   Ketamine, an NMDA receptor antagonist, has been used topically, orally, and intravenously in various doses to treat NEUROPATHIC PAIN particularly CRPS",NEUROPATHIC PAIN,CRPS
720315697,5/11/2015 23:07:52,1634422422,5/11/2015 23:06:42,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]","Ketamine, an NMDA receptor antagonist, has been used topically, orally, and intravenously in various doses to treat NEUROPATHIC PAIN particularly CRPS",N/A,121,151,1,136,155,TWrex-cause,813347-FS1,"99   Ketamine, an NMDA receptor antagonist, has been used topically, orally, and intravenously in various doses to treat NEUROPATHIC PAIN particularly CRPS",NEUROPATHIC PAIN,CRPS
720315697,5/11/2015 23:07:55,1634422436,5/11/2015 23:07:40,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treat,N/A,121,151,1,136,155,TWrex-cause,813347-FS1,"99   Ketamine, an NMDA receptor antagonist, has been used topically, orally, and intravenously in various doses to treat NEUROPATHIC PAIN particularly CRPS",NEUROPATHIC PAIN,CRPS
720315697,5/11/2015 23:11:36,1634425082,5/11/2015 23:10:49,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[SYMPTOM],[SYMPTOM],particularly,neuropain is a symptomn,121,151,1,136,155,TWrex-cause,813347-FS1,"99   Ketamine, an NMDA receptor antagonist, has been used topically, orally, and intravenously in various doses to treat NEUROPATHIC PAIN particularly CRPS",NEUROPATHIC PAIN,CRPS
720315697,5/11/2015 23:11:38,1634425092,5/11/2015 23:10:32,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[IS_A],[IS_A],particularly,n/a,121,151,1,136,155,TWrex-cause,813347-FS1,"99   Ketamine, an NMDA receptor antagonist, has been used topically, orally, and intravenously in various doses to treat NEUROPATHIC PAIN particularly CRPS",NEUROPATHIC PAIN,CRPS
720315697,5/11/2015 23:13:03,1634425919,5/11/2015 23:12:11,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[IS_A],[IS_A],particularly,n/a,121,151,1,136,155,TWrex-cause,813347-FS1,"99   Ketamine, an NMDA receptor antagonist, has been used topically, orally, and intravenously in various doses to treat NEUROPATHIC PAIN particularly CRPS",NEUROPATHIC PAIN,CRPS
720315697,5/11/2015 23:13:27,1634426144,5/11/2015 23:12:35,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],particularly,N/A,121,151,1,136,155,TWrex-cause,813347-FS1,"99   Ketamine, an NMDA receptor antagonist, has been used topically, orally, and intravenously in various doses to treat NEUROPATHIC PAIN particularly CRPS",NEUROPATHIC PAIN,CRPS
720315697,5/11/2015 23:13:40,1634426261,5/11/2015 23:12:21,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[PART_OF] [IS_A],"[IS_A]
[PART_OF]",particularly,N/A,121,151,1,136,155,TWrex-cause,813347-FS1,"99   Ketamine, an NMDA receptor antagonist, has been used topically, orally, and intravenously in various doses to treat NEUROPATHIC PAIN particularly CRPS",NEUROPATHIC PAIN,CRPS
720315698,5/12/2015 01:00:54,1634472161,5/12/2015 01:00:26,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[ASSOCIATED_WITH],[ASSOCIATED_WITH],IOSCA present with ATAXIA,n/a,33,14,1,38,19,TWrex-cause,813622-FS1,"Children with IOSCA present with ATAXIA peripheral neuropathy, areflexia, athetosis, and Babinski signs early in the first decade of life.",ATAXIA,IOSCA
720315698,5/12/2015 01:02:35,1634472849,5/12/2015 01:01:11,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[SYMPTOM],[SYMPTOM],present signs early,N/A,33,14,1,38,19,TWrex-cause,813622-FS1,"Children with IOSCA present with ATAXIA peripheral neuropathy, areflexia, athetosis, and Babinski signs early in the first decade of life.",ATAXIA,IOSCA
720315698,5/12/2015 01:14:26,1634478934,5/12/2015 01:14:08,false,elite,1.0,31848723,USA,"","",155.94.185.207,[SYMPTOM],[SYMPTOM],IOSCA ATAXIA,N/A,33,14,1,38,19,TWrex-cause,813622-FS1,"Children with IOSCA present with ATAXIA peripheral neuropathy, areflexia, athetosis, and Babinski signs early in the first decade of life.",ATAXIA,IOSCA
720315698,5/12/2015 01:30:06,1634487365,5/12/2015 01:29:50,false,elite,1.0,32306791,USA,TX,Dallas,69.162.75.37,[TREATS],[TREATS],"ATAXIA neuropathy,",N/A,33,14,1,38,19,TWrex-cause,813622-FS1,"Children with IOSCA present with ATAXIA peripheral neuropathy, areflexia, athetosis, and Babinski signs early in the first decade of life.",ATAXIA,IOSCA
720315698,5/12/2015 01:30:38,1634487580,5/12/2015 01:30:05,false,instagc,1.0,32556346,USA,PA,Warren,207.255.244.59,[ASSOCIATED_WITH],[ASSOCIATED_WITH],present,N/A,33,14,1,38,19,TWrex-cause,813622-FS1,"Children with IOSCA present with ATAXIA peripheral neuropathy, areflexia, athetosis, and Babinski signs early in the first decade of life.",ATAXIA,IOSCA
720315698,5/12/2015 01:42:45,1634494481,5/12/2015 01:42:20,false,instagc,1.0,30326470,USA,CA,San Diego,170.213.2.111,[SYMPTOM],[SYMPTOM],present,N/A,33,14,1,38,19,TWrex-cause,813622-FS1,"Children with IOSCA present with ATAXIA peripheral neuropathy, areflexia, athetosis, and Babinski signs early in the first decade of life.",ATAXIA,IOSCA
720315698,5/12/2015 03:26:29,1634548234,5/12/2015 03:26:17,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[PREVENTS],[PREVENTS],present,n/a,33,14,1,38,19,TWrex-cause,813622-FS1,"Children with IOSCA present with ATAXIA peripheral neuropathy, areflexia, athetosis, and Babinski signs early in the first decade of life.",ATAXIA,IOSCA
720315698,5/12/2015 03:44:11,1634557121,5/12/2015 03:43:50,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.227,[ASSOCIATED_WITH],[ASSOCIATED_WITH],IOSCA ATAXIA,N/A,33,14,1,38,19,TWrex-cause,813622-FS1,"Children with IOSCA present with ATAXIA peripheral neuropathy, areflexia, athetosis, and Babinski signs early in the first decade of life.",ATAXIA,IOSCA
720315698,5/12/2015 04:17:20,1634573052,5/12/2015 04:16:48,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[SYMPTOM],[SYMPTOM],with present with,N/A,33,14,1,38,19,TWrex-cause,813622-FS1,"Children with IOSCA present with ATAXIA peripheral neuropathy, areflexia, athetosis, and Babinski signs early in the first decade of life.",ATAXIA,IOSCA
720315698,5/12/2015 04:55:04,1634591142,5/12/2015 04:53:29,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],present,none,33,14,1,38,19,TWrex-cause,813622-FS1,"Children with IOSCA present with ATAXIA peripheral neuropathy, areflexia, athetosis, and Babinski signs early in the first decade of life.",ATAXIA,IOSCA
720315698,5/12/2015 05:08:31,1634598676,5/12/2015 05:07:53,false,neodev,1.0,31910622,USA,CA,San Francisco,108.169.6.201,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",present with,I didn´t select none.,33,14,1,38,19,TWrex-cause,813622-FS1,"Children with IOSCA present with ATAXIA peripheral neuropathy, areflexia, athetosis, and Babinski signs early in the first decade of life.",ATAXIA,IOSCA
720315698,5/12/2015 05:57:21,1634629119,5/12/2015 05:56:20,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[SYMPTOM],[SYMPTOM],present with,N/A,33,14,1,38,19,TWrex-cause,813622-FS1,"Children with IOSCA present with ATAXIA peripheral neuropathy, areflexia, athetosis, and Babinski signs early in the first decade of life.",ATAXIA,IOSCA
720315698,5/12/2015 06:19:42,1634639833,5/12/2015 06:19:13,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[SYMPTOM],[SYMPTOM],present with,N/A,33,14,1,38,19,TWrex-cause,813622-FS1,"Children with IOSCA present with ATAXIA peripheral neuropathy, areflexia, athetosis, and Babinski signs early in the first decade of life.",ATAXIA,IOSCA
720315698,5/12/2015 06:27:05,1634643389,5/12/2015 06:26:33,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",IOSCA present with ATAXIA,n/a,33,14,1,38,19,TWrex-cause,813622-FS1,"Children with IOSCA present with ATAXIA peripheral neuropathy, areflexia, athetosis, and Babinski signs early in the first decade of life.",ATAXIA,IOSCA
720315698,5/12/2015 06:38:12,1634648340,5/12/2015 06:35:44,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[OTHER],[OTHER],present,n/a,33,14,1,38,19,TWrex-cause,813622-FS1,"Children with IOSCA present with ATAXIA peripheral neuropathy, areflexia, athetosis, and Babinski signs early in the first decade of life.",ATAXIA,IOSCA
720315699,5/11/2015 22:17:14,1634401110,5/11/2015 22:16:58,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],"clinical depression,",N/A,112,0,-1,114,10,TWrex-cause,803547-FS1,"FLUOXETINE for example, is usually prescribed in dosages of 20 mg per day for clinical depression, whereas with OCD the dosage often ranges from 20 mg to 80 mg or higher, if necessary.",OCD,FLUOXETINE
720315699,5/11/2015 22:18:00,1634401443,5/11/2015 22:17:15,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],FLUOXETINE prescribed in dosages OCD,n/a,112,0,-1,114,10,TWrex-cause,803547-FS1,"FLUOXETINE for example, is usually prescribed in dosages of 20 mg per day for clinical depression, whereas with OCD the dosage often ranges from 20 mg to 80 mg or higher, if necessary.",OCD,FLUOXETINE
720315699,5/11/2015 22:19:26,1634402169,5/11/2015 22:19:13,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],prescribed,n/a,112,0,-1,114,10,TWrex-cause,803547-FS1,"FLUOXETINE for example, is usually prescribed in dosages of 20 mg per day for clinical depression, whereas with OCD the dosage often ranges from 20 mg to 80 mg or higher, if necessary.",OCD,FLUOXETINE
720315699,5/11/2015 22:21:20,1634403180,5/11/2015 22:20:13,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],FLUOXETINE usually prescribed with OCD,N/A,112,0,-1,114,10,TWrex-cause,803547-FS1,"FLUOXETINE for example, is usually prescribed in dosages of 20 mg per day for clinical depression, whereas with OCD the dosage often ranges from 20 mg to 80 mg or higher, if necessary.",OCD,FLUOXETINE
720315699,5/11/2015 22:26:37,1634405469,5/11/2015 22:23:46,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],dosage,n/a,112,0,-1,114,10,TWrex-cause,803547-FS1,"FLUOXETINE for example, is usually prescribed in dosages of 20 mg per day for clinical depression, whereas with OCD the dosage often ranges from 20 mg to 80 mg or higher, if necessary.",OCD,FLUOXETINE
720315699,5/11/2015 22:33:48,1634408416,5/11/2015 22:33:09,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],dosage,n/a,112,0,-1,114,10,TWrex-cause,803547-FS1,"FLUOXETINE for example, is usually prescribed in dosages of 20 mg per day for clinical depression, whereas with OCD the dosage often ranges from 20 mg to 80 mg or higher, if necessary.",OCD,FLUOXETINE
720315699,5/11/2015 22:34:01,1634408595,5/11/2015 22:33:38,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],prescribed dosage,n/a,112,0,-1,114,10,TWrex-cause,803547-FS1,"FLUOXETINE for example, is usually prescribed in dosages of 20 mg per day for clinical depression, whereas with OCD the dosage often ranges from 20 mg to 80 mg or higher, if necessary.",OCD,FLUOXETINE
720315699,5/11/2015 22:37:00,1634409973,5/11/2015 22:36:04,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],FLUOXETINE prescribed with OCD,n/a,112,0,-1,114,10,TWrex-cause,803547-FS1,"FLUOXETINE for example, is usually prescribed in dosages of 20 mg per day for clinical depression, whereas with OCD the dosage often ranges from 20 mg to 80 mg or higher, if necessary.",OCD,FLUOXETINE
720315699,5/11/2015 22:41:24,1634412070,5/11/2015 22:40:06,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"FLUOXETINE for example, is usually prescribed in dosages of 20 mg per day for clinical depression, whereas with OCD the dosage often ranges from 20 mg to 80 mg or higher, if necessary.",N/A,112,0,-1,114,10,TWrex-cause,803547-FS1,"FLUOXETINE for example, is usually prescribed in dosages of 20 mg per day for clinical depression, whereas with OCD the dosage often ranges from 20 mg to 80 mg or higher, if necessary.",OCD,FLUOXETINE
720315699,5/11/2015 22:43:14,1634412889,5/11/2015 22:42:23,false,instagc,1.0,28519532,USA,IA,Neola,38.121.112.217,[TREATS],[TREATS],for with OCD the dosage,na,112,0,-1,114,10,TWrex-cause,803547-FS1,"FLUOXETINE for example, is usually prescribed in dosages of 20 mg per day for clinical depression, whereas with OCD the dosage often ranges from 20 mg to 80 mg or higher, if necessary.",OCD,FLUOXETINE
720315699,5/11/2015 22:52:45,1634417164,5/11/2015 22:52:07,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],prescribed,N/A,112,0,-1,114,10,TWrex-cause,803547-FS1,"FLUOXETINE for example, is usually prescribed in dosages of 20 mg per day for clinical depression, whereas with OCD the dosage often ranges from 20 mg to 80 mg or higher, if necessary.",OCD,FLUOXETINE
720315699,5/11/2015 22:53:02,1634417214,5/11/2015 22:52:33,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,75.147.181.53,[TREATS],[TREATS],usually prescribed,N/A,112,0,-1,114,10,TWrex-cause,803547-FS1,"FLUOXETINE for example, is usually prescribed in dosages of 20 mg per day for clinical depression, whereas with OCD the dosage often ranges from 20 mg to 80 mg or higher, if necessary.",OCD,FLUOXETINE
720315699,5/11/2015 22:53:02,1634417254,5/11/2015 22:51:49,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],prescribed,N/A,112,0,-1,114,10,TWrex-cause,803547-FS1,"FLUOXETINE for example, is usually prescribed in dosages of 20 mg per day for clinical depression, whereas with OCD the dosage often ranges from 20 mg to 80 mg or higher, if necessary.",OCD,FLUOXETINE
720315699,5/11/2015 22:54:23,1634417689,5/11/2015 22:52:58,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[NONE],[NONE],n/a,"different doses of the same drug can be used to treat, but otherwise..no connection",112,0,-1,114,10,TWrex-cause,803547-FS1,"FLUOXETINE for example, is usually prescribed in dosages of 20 mg per day for clinical depression, whereas with OCD the dosage often ranges from 20 mg to 80 mg or higher, if necessary.",OCD,FLUOXETINE
720315699,5/11/2015 22:54:59,1634417915,5/11/2015 22:54:03,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],the dosage,n/a,112,0,-1,114,10,TWrex-cause,803547-FS1,"FLUOXETINE for example, is usually prescribed in dosages of 20 mg per day for clinical depression, whereas with OCD the dosage often ranges from 20 mg to 80 mg or higher, if necessary.",OCD,FLUOXETINE
720315700,5/11/2015 23:11:12,1634424837,5/11/2015 23:10:58,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,85,54,-1,96,64,TWrex-cause,803825-FS1,"Uhlir O, Feifusa M, Havanek K et al. Nebivolol versus METOPROLOL in the treatment of HYPERTENSION",HYPERTENSION,METOPROLOL
720315700,5/11/2015 23:19:15,1634428748,5/11/2015 23:18:54,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,N/A,85,54,-1,96,64,TWrex-cause,803825-FS1,"Uhlir O, Feifusa M, Havanek K et al. Nebivolol versus METOPROLOL in the treatment of HYPERTENSION",HYPERTENSION,METOPROLOL
720315700,5/11/2015 23:20:10,1634429204,5/11/2015 23:19:50,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],in the treatment of,n/a,85,54,-1,96,64,TWrex-cause,803825-FS1,"Uhlir O, Feifusa M, Havanek K et al. Nebivolol versus METOPROLOL in the treatment of HYPERTENSION",HYPERTENSION,METOPROLOL
720315700,5/11/2015 23:22:49,1634430451,5/11/2015 23:22:14,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],treatment,n/a,85,54,-1,96,64,TWrex-cause,803825-FS1,"Uhlir O, Feifusa M, Havanek K et al. Nebivolol versus METOPROLOL in the treatment of HYPERTENSION",HYPERTENSION,METOPROLOL
720315700,5/11/2015 23:23:24,1634430762,5/11/2015 23:22:54,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],treatment,its a drug,85,54,-1,96,64,TWrex-cause,803825-FS1,"Uhlir O, Feifusa M, Havanek K et al. Nebivolol versus METOPROLOL in the treatment of HYPERTENSION",HYPERTENSION,METOPROLOL
720315700,5/11/2015 23:27:01,1634432161,5/11/2015 23:26:12,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,85,54,-1,96,64,TWrex-cause,803825-FS1,"Uhlir O, Feifusa M, Havanek K et al. Nebivolol versus METOPROLOL in the treatment of HYPERTENSION",HYPERTENSION,METOPROLOL
720315700,5/11/2015 23:27:59,1634432583,5/11/2015 23:27:24,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.48,[PREVENTS] [LOCATION] [NONE],"[PREVENTS]
[LOCATION]
[NONE]",no,no,85,54,-1,96,64,TWrex-cause,803825-FS1,"Uhlir O, Feifusa M, Havanek K et al. Nebivolol versus METOPROLOL in the treatment of HYPERTENSION",HYPERTENSION,METOPROLOL
720315700,5/11/2015 23:34:23,1634435975,5/11/2015 23:34:11,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treatment,n/a,85,54,-1,96,64,TWrex-cause,803825-FS1,"Uhlir O, Feifusa M, Havanek K et al. Nebivolol versus METOPROLOL in the treatment of HYPERTENSION",HYPERTENSION,METOPROLOL
720315700,5/11/2015 23:39:37,1634439712,5/11/2015 23:38:23,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treatment,n/a,85,54,-1,96,64,TWrex-cause,803825-FS1,"Uhlir O, Feifusa M, Havanek K et al. Nebivolol versus METOPROLOL in the treatment of HYPERTENSION",HYPERTENSION,METOPROLOL
720315700,5/11/2015 23:40:54,1634440335,5/11/2015 23:40:14,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[TREATS],[TREATS],METOPROLOL in the treatment of HYPERTENSION,n/a,85,54,-1,96,64,TWrex-cause,803825-FS1,"Uhlir O, Feifusa M, Havanek K et al. Nebivolol versus METOPROLOL in the treatment of HYPERTENSION",HYPERTENSION,METOPROLOL
720315700,5/11/2015 23:54:31,1634445916,5/11/2015 23:54:19,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,n/a,85,54,-1,96,64,TWrex-cause,803825-FS1,"Uhlir O, Feifusa M, Havanek K et al. Nebivolol versus METOPROLOL in the treatment of HYPERTENSION",HYPERTENSION,METOPROLOL
720315700,5/12/2015 00:17:14,1634454079,5/12/2015 00:15:30,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment of,treats,85,54,-1,96,64,TWrex-cause,803825-FS1,"Uhlir O, Feifusa M, Havanek K et al. Nebivolol versus METOPROLOL in the treatment of HYPERTENSION",HYPERTENSION,METOPROLOL
720315700,5/12/2015 00:21:33,1634455797,5/12/2015 00:20:41,false,neodev,1.0,31066862,USA,CA,San Jose,128.107.241.188,[TREATS],[TREATS],in the treatment of,N/A,85,54,-1,96,64,TWrex-cause,803825-FS1,"Uhlir O, Feifusa M, Havanek K et al. Nebivolol versus METOPROLOL in the treatment of HYPERTENSION",HYPERTENSION,METOPROLOL
720315700,5/12/2015 00:22:37,1634456242,5/12/2015 00:21:48,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],METOPROLOL treatment HYPERTENSION,N/A,85,54,-1,96,64,TWrex-cause,803825-FS1,"Uhlir O, Feifusa M, Havanek K et al. Nebivolol versus METOPROLOL in the treatment of HYPERTENSION",HYPERTENSION,METOPROLOL
720315700,5/12/2015 00:30:30,1634459454,5/12/2015 00:28:50,false,elite,1.0,32306791,CAN,QC,Montréal,205.204.92.233,[LOCATION],[LOCATION],METOPROLOL,fdsatgrdghf,85,54,-1,96,64,TWrex-cause,803825-FS1,"Uhlir O, Feifusa M, Havanek K et al. Nebivolol versus METOPROLOL in the treatment of HYPERTENSION",HYPERTENSION,METOPROLOL
720315701,5/11/2015 23:26:29,1634431923,5/11/2015 23:26:12,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,N/A,68,0,-1,76,14,TWrex-cause,804242-FS1,SODIUM OXYBATE demonstrates long term efficacy for the treatment of CATAPLEXY in patients with narcolepsy.,CATAPLEXY,SODIUM OXYBATE
720315701,5/11/2015 23:41:45,1634440709,5/11/2015 23:41:29,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treatment,n/a,68,0,-1,76,14,TWrex-cause,804242-FS1,SODIUM OXYBATE demonstrates long term efficacy for the treatment of CATAPLEXY in patients with narcolepsy.,CATAPLEXY,SODIUM OXYBATE
720315701,5/11/2015 23:54:19,1634445812,5/11/2015 23:54:07,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.48,[PREVENTS] [LOCATION] [NONE],"[PREVENTS]
[LOCATION]
[NONE]",no,no,68,0,-1,76,14,TWrex-cause,804242-FS1,SODIUM OXYBATE demonstrates long term efficacy for the treatment of CATAPLEXY in patients with narcolepsy.,CATAPLEXY,SODIUM OXYBATE
720315701,5/12/2015 00:36:55,1634461751,5/12/2015 00:36:17,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment,treats,68,0,-1,76,14,TWrex-cause,804242-FS1,SODIUM OXYBATE demonstrates long term efficacy for the treatment of CATAPLEXY in patients with narcolepsy.,CATAPLEXY,SODIUM OXYBATE
720315701,5/12/2015 00:49:33,1634467091,5/12/2015 00:49:06,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[TREATS],[TREATS],demonstrates long term efficacy treatment,N/A,68,0,-1,76,14,TWrex-cause,804242-FS1,SODIUM OXYBATE demonstrates long term efficacy for the treatment of CATAPLEXY in patients with narcolepsy.,CATAPLEXY,SODIUM OXYBATE
720315701,5/12/2015 00:51:18,1634467873,5/12/2015 00:50:58,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[TREATS],[TREATS],SODIUM OXYBATE treatment of CATAPLEXY,n/a,68,0,-1,76,14,TWrex-cause,804242-FS1,SODIUM OXYBATE demonstrates long term efficacy for the treatment of CATAPLEXY in patients with narcolepsy.,CATAPLEXY,SODIUM OXYBATE
720315701,5/12/2015 01:08:01,1634475505,5/12/2015 01:07:33,false,elite,1.0,31848723,USA,"","",155.94.185.207,[ASSOCIATED_WITH],[ASSOCIATED_WITH],SODIUM OXYBATE CATAPLEXY,N/A,68,0,-1,76,14,TWrex-cause,804242-FS1,SODIUM OXYBATE demonstrates long term efficacy for the treatment of CATAPLEXY in patients with narcolepsy.,CATAPLEXY,SODIUM OXYBATE
720315701,5/12/2015 01:15:16,1634479445,5/12/2015 01:15:03,false,elite,1.0,32306791,NLD,"","",31.3.156.41,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],OXYBATE demonstrates,sfd,68,0,-1,76,14,TWrex-cause,804242-FS1,SODIUM OXYBATE demonstrates long term efficacy for the treatment of CATAPLEXY in patients with narcolepsy.,CATAPLEXY,SODIUM OXYBATE
720315701,5/12/2015 01:25:48,1634485298,5/12/2015 01:25:35,false,instagc,1.0,32556346,USA,PA,Warren,207.255.244.59,[TREATS],[TREATS],treatment,N/A,68,0,-1,76,14,TWrex-cause,804242-FS1,SODIUM OXYBATE demonstrates long term efficacy for the treatment of CATAPLEXY in patients with narcolepsy.,CATAPLEXY,SODIUM OXYBATE
720315701,5/12/2015 01:34:26,1634489622,5/12/2015 01:33:58,false,instagc,1.0,30326470,USA,CA,San Diego,170.213.2.111,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],demonstrates long term efficacy,N/A,68,0,-1,76,14,TWrex-cause,804242-FS1,SODIUM OXYBATE demonstrates long term efficacy for the treatment of CATAPLEXY in patients with narcolepsy.,CATAPLEXY,SODIUM OXYBATE
720315701,5/12/2015 03:22:51,1634546146,5/12/2015 03:22:37,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[TREATS],[TREATS],treatment,n/a,68,0,-1,76,14,TWrex-cause,804242-FS1,SODIUM OXYBATE demonstrates long term efficacy for the treatment of CATAPLEXY in patients with narcolepsy.,CATAPLEXY,SODIUM OXYBATE
720315701,5/12/2015 03:36:52,1634553781,5/12/2015 03:36:24,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.227,[MANIFESTATION],[MANIFESTATION],SODIUM OXYBATE CATAPLEXY,N/A,68,0,-1,76,14,TWrex-cause,804242-FS1,SODIUM OXYBATE demonstrates long term efficacy for the treatment of CATAPLEXY in patients with narcolepsy.,CATAPLEXY,SODIUM OXYBATE
720315701,5/12/2015 04:10:56,1634570170,5/12/2015 04:10:41,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[TREATS],[TREATS],treatment,N/A,68,0,-1,76,14,TWrex-cause,804242-FS1,SODIUM OXYBATE demonstrates long term efficacy for the treatment of CATAPLEXY in patients with narcolepsy.,CATAPLEXY,SODIUM OXYBATE
720315701,5/12/2015 04:40:50,1634584159,5/12/2015 04:40:15,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treatment,none,68,0,-1,76,14,TWrex-cause,804242-FS1,SODIUM OXYBATE demonstrates long term efficacy for the treatment of CATAPLEXY in patients with narcolepsy.,CATAPLEXY,SODIUM OXYBATE
720315701,5/12/2015 05:00:06,1634593781,5/12/2015 04:59:39,false,neodev,1.0,31910622,USA,CA,Los Angeles,108.185.211.151,[TREATS],[TREATS],for the treatment,I didn´t select none.,68,0,-1,76,14,TWrex-cause,804242-FS1,SODIUM OXYBATE demonstrates long term efficacy for the treatment of CATAPLEXY in patients with narcolepsy.,CATAPLEXY,SODIUM OXYBATE
720315702,5/12/2015 06:25:27,1634642685,5/12/2015 06:24:52,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[PREVENTS],[PREVENTS],prevent,N/A,96,64,-1,124,76,TWrex-cause,804520-FS1,"The parenteral form of calcitriol, or vitamin D analogs such as PARICALCITOL may better prevent SECONDARY HYPERPARATHYROIDISM in such patients, because the higher attained plasma levels of 1,25(OH) 2 D directly suppress PTH release.",SECONDARY HYPERPARATHYROIDISM,PARICALCITOL
720315702,5/12/2015 06:30:36,1634644997,5/12/2015 06:30:19,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[PREVENTS],[PREVENTS],prevent,N/A,96,64,-1,124,76,TWrex-cause,804520-FS1,"The parenteral form of calcitriol, or vitamin D analogs such as PARICALCITOL may better prevent SECONDARY HYPERPARATHYROIDISM in such patients, because the higher attained plasma levels of 1,25(OH) 2 D directly suppress PTH release.",SECONDARY HYPERPARATHYROIDISM,PARICALCITOL
720315702,5/12/2015 06:49:29,1634653244,5/12/2015 06:49:17,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[PREVENTS],[PREVENTS],may better prevent,N/A,96,64,-1,124,76,TWrex-cause,804520-FS1,"The parenteral form of calcitriol, or vitamin D analogs such as PARICALCITOL may better prevent SECONDARY HYPERPARATHYROIDISM in such patients, because the higher attained plasma levels of 1,25(OH) 2 D directly suppress PTH release.",SECONDARY HYPERPARATHYROIDISM,PARICALCITOL
720315702,5/12/2015 06:49:58,1634653440,5/12/2015 06:49:29,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[PREVENTS],[PREVENTS],prevent,NA,96,64,-1,124,76,TWrex-cause,804520-FS1,"The parenteral form of calcitriol, or vitamin D analogs such as PARICALCITOL may better prevent SECONDARY HYPERPARATHYROIDISM in such patients, because the higher attained plasma levels of 1,25(OH) 2 D directly suppress PTH release.",SECONDARY HYPERPARATHYROIDISM,PARICALCITOL
720315702,5/12/2015 07:02:30,1634658862,5/12/2015 07:02:05,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[PREVENTS],[PREVENTS],better prevent,n/a,96,64,-1,124,76,TWrex-cause,804520-FS1,"The parenteral form of calcitriol, or vitamin D analogs such as PARICALCITOL may better prevent SECONDARY HYPERPARATHYROIDISM in such patients, because the higher attained plasma levels of 1,25(OH) 2 D directly suppress PTH release.",SECONDARY HYPERPARATHYROIDISM,PARICALCITOL
720315702,5/12/2015 07:59:34,1634692956,5/12/2015 07:59:16,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[PREVENTS],[PREVENTS],may better prevent,N/A,96,64,-1,124,76,TWrex-cause,804520-FS1,"The parenteral form of calcitriol, or vitamin D analogs such as PARICALCITOL may better prevent SECONDARY HYPERPARATHYROIDISM in such patients, because the higher attained plasma levels of 1,25(OH) 2 D directly suppress PTH release.",SECONDARY HYPERPARATHYROIDISM,PARICALCITOL
720315702,5/12/2015 08:13:54,1634700164,5/12/2015 08:13:20,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[PREVENTS],[PREVENTS],prevent,Prevented by,96,64,-1,124,76,TWrex-cause,804520-FS1,"The parenteral form of calcitriol, or vitamin D analogs such as PARICALCITOL may better prevent SECONDARY HYPERPARATHYROIDISM in such patients, because the higher attained plasma levels of 1,25(OH) 2 D directly suppress PTH release.",SECONDARY HYPERPARATHYROIDISM,PARICALCITOL
720315702,5/12/2015 08:53:07,1634721524,5/12/2015 08:52:22,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[TREATS],[TREATS],may better prevent,N/A,96,64,-1,124,76,TWrex-cause,804520-FS1,"The parenteral form of calcitriol, or vitamin D analogs such as PARICALCITOL may better prevent SECONDARY HYPERPARATHYROIDISM in such patients, because the higher attained plasma levels of 1,25(OH) 2 D directly suppress PTH release.",SECONDARY HYPERPARATHYROIDISM,PARICALCITOL
720315702,5/12/2015 08:59:27,1634724664,5/12/2015 08:59:05,false,inboxpounds,1.0,29059658,GBR,H9,London,79.77.3.89,[PREVENTS],[PREVENTS],may better prevent,N/A,96,64,-1,124,76,TWrex-cause,804520-FS1,"The parenteral form of calcitriol, or vitamin D analogs such as PARICALCITOL may better prevent SECONDARY HYPERPARATHYROIDISM in such patients, because the higher attained plasma levels of 1,25(OH) 2 D directly suppress PTH release.",SECONDARY HYPERPARATHYROIDISM,PARICALCITOL
720315702,5/12/2015 10:59:10,1634819740,5/12/2015 10:57:42,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[PREVENTS],[PREVENTS],may better prevent,n/a,96,64,-1,124,76,TWrex-cause,804520-FS1,"The parenteral form of calcitriol, or vitamin D analogs such as PARICALCITOL may better prevent SECONDARY HYPERPARATHYROIDISM in such patients, because the higher attained plasma levels of 1,25(OH) 2 D directly suppress PTH release.",SECONDARY HYPERPARATHYROIDISM,PARICALCITOL
720315702,5/12/2015 11:33:13,1634847412,5/12/2015 11:31:47,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[PREVENTS],[PREVENTS],PARICALCITOL may prevent SECONDARY HYPERPARATHYROIDISM,N/A,96,64,-1,124,76,TWrex-cause,804520-FS1,"The parenteral form of calcitriol, or vitamin D analogs such as PARICALCITOL may better prevent SECONDARY HYPERPARATHYROIDISM in such patients, because the higher attained plasma levels of 1,25(OH) 2 D directly suppress PTH release.",SECONDARY HYPERPARATHYROIDISM,PARICALCITOL
720315702,5/12/2015 11:53:17,1634858570,5/12/2015 11:52:54,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[PREVENTS],[PREVENTS],prevent,N/A,96,64,-1,124,76,TWrex-cause,804520-FS1,"The parenteral form of calcitriol, or vitamin D analogs such as PARICALCITOL may better prevent SECONDARY HYPERPARATHYROIDISM in such patients, because the higher attained plasma levels of 1,25(OH) 2 D directly suppress PTH release.",SECONDARY HYPERPARATHYROIDISM,PARICALCITOL
720315702,5/12/2015 11:54:12,1634859019,5/12/2015 11:53:51,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[PREVENTS],[PREVENTS],may better prevent,N/A,96,64,-1,124,76,TWrex-cause,804520-FS1,"The parenteral form of calcitriol, or vitamin D analogs such as PARICALCITOL may better prevent SECONDARY HYPERPARATHYROIDISM in such patients, because the higher attained plasma levels of 1,25(OH) 2 D directly suppress PTH release.",SECONDARY HYPERPARATHYROIDISM,PARICALCITOL
720315702,5/12/2015 12:07:00,1634864673,5/12/2015 12:06:14,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[PREVENTS],[PREVENTS],prevent,N/A,96,64,-1,124,76,TWrex-cause,804520-FS1,"The parenteral form of calcitriol, or vitamin D analogs such as PARICALCITOL may better prevent SECONDARY HYPERPARATHYROIDISM in such patients, because the higher attained plasma levels of 1,25(OH) 2 D directly suppress PTH release.",SECONDARY HYPERPARATHYROIDISM,PARICALCITOL
720315702,5/12/2015 12:36:20,1634877698,5/12/2015 12:35:13,false,clixsense,1.0,27969116,NLD,"","",212.78.195.38,[PREVENTS],[PREVENTS],may better prevent,it might be better in preventing secondary hyperparathyroidism,96,64,-1,124,76,TWrex-cause,804520-FS1,"The parenteral form of calcitriol, or vitamin D analogs such as PARICALCITOL may better prevent SECONDARY HYPERPARATHYROIDISM in such patients, because the higher attained plasma levels of 1,25(OH) 2 D directly suppress PTH release.",SECONDARY HYPERPARATHYROIDISM,PARICALCITOL
720315703,5/11/2015 23:56:43,1634446653,5/11/2015 23:56:30,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.48,[PREVENTS] [CAUSES] [LOCATION] [NONE],"[PREVENTS]
[CAUSES]
[LOCATION]
[NONE]",no,no,212,257,-1,225,266,TWrex-cause,804400-FS1,"For long term therapy of CMV retinitis in patients with HIV infection Valganciclovir  900 mg p.o., b.i.d., for 21 days, then 900 mg p.o., q.d., for maintenance  First choice  For CMV retinitis and other advanced CMV INFECTIONS in immunocompromised patients FOSCARNET  90 mg/kg I.V. b.i.d.",CMV INFECTIONS,FOSCARNET
720315703,5/12/2015 00:53:43,1634468736,5/12/2015 00:52:31,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],therapy of and other advanced CMV INFECTIONS,N/A,212,257,-1,225,266,TWrex-cause,804400-FS1,"For long term therapy of CMV retinitis in patients with HIV infection Valganciclovir  900 mg p.o., b.i.d., for 21 days, then 900 mg p.o., q.d., for maintenance  First choice  For CMV retinitis and other advanced CMV INFECTIONS in immunocompromised patients FOSCARNET  90 mg/kg I.V. b.i.d.",CMV INFECTIONS,FOSCARNET
720315703,5/12/2015 00:57:58,1634470765,5/12/2015 00:57:09,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[TREATS],[TREATS],long term patients,N/A,212,257,-1,225,266,TWrex-cause,804400-FS1,"For long term therapy of CMV retinitis in patients with HIV infection Valganciclovir  900 mg p.o., b.i.d., for 21 days, then 900 mg p.o., q.d., for maintenance  First choice  For CMV retinitis and other advanced CMV INFECTIONS in immunocompromised patients FOSCARNET  90 mg/kg I.V. b.i.d.",CMV INFECTIONS,FOSCARNET
720315703,5/12/2015 00:58:39,1634471135,5/12/2015 00:56:41,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[OTHER] [TREATS],"[TREATS]
[OTHER]",for maintenance CMV INFECTIONS FOSCARNET,n/a,212,257,-1,225,266,TWrex-cause,804400-FS1,"For long term therapy of CMV retinitis in patients with HIV infection Valganciclovir  900 mg p.o., b.i.d., for 21 days, then 900 mg p.o., q.d., for maintenance  First choice  For CMV retinitis and other advanced CMV INFECTIONS in immunocompromised patients FOSCARNET  90 mg/kg I.V. b.i.d.",CMV INFECTIONS,FOSCARNET
720315703,5/12/2015 01:12:56,1634478086,5/12/2015 01:12:36,false,elite,1.0,31848723,USA,"","",155.94.185.207,[SYMPTOM],[SYMPTOM],CMV INFECTIONS,N/A,212,257,-1,225,266,TWrex-cause,804400-FS1,"For long term therapy of CMV retinitis in patients with HIV infection Valganciclovir  900 mg p.o., b.i.d., for 21 days, then 900 mg p.o., q.d., for maintenance  First choice  For CMV retinitis and other advanced CMV INFECTIONS in immunocompromised patients FOSCARNET  90 mg/kg I.V. b.i.d.",CMV INFECTIONS,FOSCARNET
720315703,5/12/2015 01:28:37,1634486621,5/12/2015 01:28:17,false,elite,1.0,32306791,USA,TX,Dallas,69.162.75.37,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],retinitis Valganciclovir,N/A,212,257,-1,225,266,TWrex-cause,804400-FS1,"For long term therapy of CMV retinitis in patients with HIV infection Valganciclovir  900 mg p.o., b.i.d., for 21 days, then 900 mg p.o., q.d., for maintenance  First choice  For CMV retinitis and other advanced CMV INFECTIONS in immunocompromised patients FOSCARNET  90 mg/kg I.V. b.i.d.",CMV INFECTIONS,FOSCARNET
720315703,5/12/2015 01:29:07,1634486832,5/12/2015 01:28:46,false,instagc,1.0,32556346,USA,PA,Warren,207.255.244.59,[TREATS],[TREATS],therapy,N/A,212,257,-1,225,266,TWrex-cause,804400-FS1,"For long term therapy of CMV retinitis in patients with HIV infection Valganciclovir  900 mg p.o., b.i.d., for 21 days, then 900 mg p.o., q.d., for maintenance  First choice  For CMV retinitis and other advanced CMV INFECTIONS in immunocompromised patients FOSCARNET  90 mg/kg I.V. b.i.d.",CMV INFECTIONS,FOSCARNET
720315703,5/12/2015 01:41:08,1634493445,5/12/2015 01:40:34,false,instagc,1.0,30326470,USA,CA,San Diego,170.213.2.111,[TREATS],[TREATS],therapy of,N/A,212,257,-1,225,266,TWrex-cause,804400-FS1,"For long term therapy of CMV retinitis in patients with HIV infection Valganciclovir  900 mg p.o., b.i.d., for 21 days, then 900 mg p.o., q.d., for maintenance  First choice  For CMV retinitis and other advanced CMV INFECTIONS in immunocompromised patients FOSCARNET  90 mg/kg I.V. b.i.d.",CMV INFECTIONS,FOSCARNET
720315703,5/12/2015 03:25:36,1634547726,5/12/2015 03:25:21,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[OTHER],[OTHER],and,n/a,212,257,-1,225,266,TWrex-cause,804400-FS1,"For long term therapy of CMV retinitis in patients with HIV infection Valganciclovir  900 mg p.o., b.i.d., for 21 days, then 900 mg p.o., q.d., for maintenance  First choice  For CMV retinitis and other advanced CMV INFECTIONS in immunocompromised patients FOSCARNET  90 mg/kg I.V. b.i.d.",CMV INFECTIONS,FOSCARNET
720315703,5/12/2015 03:42:32,1634556361,5/12/2015 03:42:02,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.227,[SIDE_EFFECT],[SIDE_EFFECT],CMV INFECTIONS FOSCARNET,N/A,212,257,-1,225,266,TWrex-cause,804400-FS1,"For long term therapy of CMV retinitis in patients with HIV infection Valganciclovir  900 mg p.o., b.i.d., for 21 days, then 900 mg p.o., q.d., for maintenance  First choice  For CMV retinitis and other advanced CMV INFECTIONS in immunocompromised patients FOSCARNET  90 mg/kg I.V. b.i.d.",CMV INFECTIONS,FOSCARNET
720315703,5/12/2015 04:15:38,1634572396,5/12/2015 04:15:02,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[TREATS],[TREATS],For,N/A,212,257,-1,225,266,TWrex-cause,804400-FS1,"For long term therapy of CMV retinitis in patients with HIV infection Valganciclovir  900 mg p.o., b.i.d., for 21 days, then 900 mg p.o., q.d., for maintenance  First choice  For CMV retinitis and other advanced CMV INFECTIONS in immunocompromised patients FOSCARNET  90 mg/kg I.V. b.i.d.",CMV INFECTIONS,FOSCARNET
720315703,5/12/2015 04:50:37,1634588847,5/12/2015 04:49:56,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],therapy,none,212,257,-1,225,266,TWrex-cause,804400-FS1,"For long term therapy of CMV retinitis in patients with HIV infection Valganciclovir  900 mg p.o., b.i.d., for 21 days, then 900 mg p.o., q.d., for maintenance  First choice  For CMV retinitis and other advanced CMV INFECTIONS in immunocompromised patients FOSCARNET  90 mg/kg I.V. b.i.d.",CMV INFECTIONS,FOSCARNET
720315703,5/12/2015 05:05:10,1634596709,5/12/2015 05:04:45,false,neodev,1.0,31910622,USA,CA,Los Angeles,108.185.211.151,[TREATS],[TREATS],maintenance First choice For,I didn´t select none.,212,257,-1,225,266,TWrex-cause,804400-FS1,"For long term therapy of CMV retinitis in patients with HIV infection Valganciclovir  900 mg p.o., b.i.d., for 21 days, then 900 mg p.o., q.d., for maintenance  First choice  For CMV retinitis and other advanced CMV INFECTIONS in immunocompromised patients FOSCARNET  90 mg/kg I.V. b.i.d.",CMV INFECTIONS,FOSCARNET
720315703,5/12/2015 05:54:11,1634627655,5/12/2015 05:52:10,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],maintenance,N/A,212,257,-1,225,266,TWrex-cause,804400-FS1,"For long term therapy of CMV retinitis in patients with HIV infection Valganciclovir  900 mg p.o., b.i.d., for 21 days, then 900 mg p.o., q.d., for maintenance  First choice  For CMV retinitis and other advanced CMV INFECTIONS in immunocompromised patients FOSCARNET  90 mg/kg I.V. b.i.d.",CMV INFECTIONS,FOSCARNET
720315703,5/12/2015 06:18:08,1634639174,5/12/2015 06:17:23,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[TREATS],[TREATS],therapy,N/A,212,257,-1,225,266,TWrex-cause,804400-FS1,"For long term therapy of CMV retinitis in patients with HIV infection Valganciclovir  900 mg p.o., b.i.d., for 21 days, then 900 mg p.o., q.d., for maintenance  First choice  For CMV retinitis and other advanced CMV INFECTIONS in immunocompromised patients FOSCARNET  90 mg/kg I.V. b.i.d.",CMV INFECTIONS,FOSCARNET
720315704,5/12/2015 01:02:43,1634472893,5/12/2015 01:01:58,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[MANIFESTATION] [ASSOCIATED_WITH] [SYMPTOM] [OTHER],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]
[OTHER]",COLON (GRANULOMATOUS COLITIS,n/a,202,214,-1,206,236,TWrex-cause,802222-FS1,"About 35% of Crohn's disease cases involve the ileum alone (ileitis); about 45% involve the ileum and colon (ileocolitis), with a predilection for the right side of the colon; and about 20% involve the COLON alone (GRANULOMATOUS COLITIS most of which, unlike ulcerative colitis (UC), spare the rectum.",COLON,(GRANULOMATOUS COLITIS
720315704,5/12/2015 01:05:47,1634474449,5/12/2015 01:05:00,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[SYMPTOM],[SYMPTOM],involve ileum involve ileum colon involve COLON,N/A,202,214,-1,206,236,TWrex-cause,802222-FS1,"About 35% of Crohn's disease cases involve the ileum alone (ileitis); about 45% involve the ileum and colon (ileocolitis), with a predilection for the right side of the colon; and about 20% involve the COLON alone (GRANULOMATOUS COLITIS most of which, unlike ulcerative colitis (UC), spare the rectum.",COLON,(GRANULOMATOUS COLITIS
720315704,5/12/2015 01:15:40,1634479693,5/12/2015 01:15:20,false,elite,1.0,31848723,USA,"","",155.94.185.207,[ASSOCIATED_WITH],[ASSOCIATED_WITH],COLON (GRANULOMATOUS,N/A,202,214,-1,206,236,TWrex-cause,802222-FS1,"About 35% of Crohn's disease cases involve the ileum alone (ileitis); about 45% involve the ileum and colon (ileocolitis), with a predilection for the right side of the colon; and about 20% involve the COLON alone (GRANULOMATOUS COLITIS most of which, unlike ulcerative colitis (UC), spare the rectum.",COLON,(GRANULOMATOUS COLITIS
720315704,5/12/2015 01:31:06,1634487911,5/12/2015 01:30:45,false,elite,1.0,32306791,USA,TX,Dallas,69.162.75.37,[PREVENTS],[PREVENTS],colon (GRANULOMATOUS,N/A,202,214,-1,206,236,TWrex-cause,802222-FS1,"About 35% of Crohn's disease cases involve the ileum alone (ileitis); about 45% involve the ileum and colon (ileocolitis), with a predilection for the right side of the colon; and about 20% involve the COLON alone (GRANULOMATOUS COLITIS most of which, unlike ulcerative colitis (UC), spare the rectum.",COLON,(GRANULOMATOUS COLITIS
720315704,5/12/2015 01:33:06,1634488860,5/12/2015 01:32:37,false,instagc,1.0,32556346,USA,PA,Warren,207.255.244.59,[LOCATION],[LOCATION],COLON,N/A,202,214,-1,206,236,TWrex-cause,802222-FS1,"About 35% of Crohn's disease cases involve the ileum alone (ileitis); about 45% involve the ileum and colon (ileocolitis), with a predilection for the right side of the colon; and about 20% involve the COLON alone (GRANULOMATOUS COLITIS most of which, unlike ulcerative colitis (UC), spare the rectum.",COLON,(GRANULOMATOUS COLITIS
720315704,5/12/2015 01:44:36,1634495326,5/12/2015 01:43:46,false,instagc,1.0,30326470,USA,CA,San Diego,170.213.2.111,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",involve,N/A,202,214,-1,206,236,TWrex-cause,802222-FS1,"About 35% of Crohn's disease cases involve the ileum alone (ileitis); about 45% involve the ileum and colon (ileocolitis), with a predilection for the right side of the colon; and about 20% involve the COLON alone (GRANULOMATOUS COLITIS most of which, unlike ulcerative colitis (UC), spare the rectum.",COLON,(GRANULOMATOUS COLITIS
720315704,5/12/2015 03:27:24,1634548745,5/12/2015 03:27:10,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[OTHER],[OTHER],alone,n/a,202,214,-1,206,236,TWrex-cause,802222-FS1,"About 35% of Crohn's disease cases involve the ileum alone (ileitis); about 45% involve the ileum and colon (ileocolitis), with a predilection for the right side of the colon; and about 20% involve the COLON alone (GRANULOMATOUS COLITIS most of which, unlike ulcerative colitis (UC), spare the rectum.",COLON,(GRANULOMATOUS COLITIS
720315704,5/12/2015 03:45:39,1634557686,5/12/2015 03:45:11,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.227,[SIDE_EFFECT],[SIDE_EFFECT],COLON (GRANULOMATOUS COLITIS,N/A,202,214,-1,206,236,TWrex-cause,802222-FS1,"About 35% of Crohn's disease cases involve the ileum alone (ileitis); about 45% involve the ileum and colon (ileocolitis), with a predilection for the right side of the colon; and about 20% involve the COLON alone (GRANULOMATOUS COLITIS most of which, unlike ulcerative colitis (UC), spare the rectum.",COLON,(GRANULOMATOUS COLITIS
720315704,5/12/2015 04:19:57,1634574200,5/12/2015 04:18:21,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[LOCATION],[LOCATION],involve the,N/A,202,214,-1,206,236,TWrex-cause,802222-FS1,"About 35% of Crohn's disease cases involve the ileum alone (ileitis); about 45% involve the ileum and colon (ileocolitis), with a predilection for the right side of the colon; and about 20% involve the COLON alone (GRANULOMATOUS COLITIS most of which, unlike ulcerative colitis (UC), spare the rectum.",COLON,(GRANULOMATOUS COLITIS
720315704,5/12/2015 04:58:29,1634592889,5/12/2015 04:57:07,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"most of which,",none,202,214,-1,206,236,TWrex-cause,802222-FS1,"About 35% of Crohn's disease cases involve the ileum alone (ileitis); about 45% involve the ileum and colon (ileocolitis), with a predilection for the right side of the colon; and about 20% involve the COLON alone (GRANULOMATOUS COLITIS most of which, unlike ulcerative colitis (UC), spare the rectum.",COLON,(GRANULOMATOUS COLITIS
720315704,5/12/2015 05:09:39,1634599296,5/12/2015 05:09:21,false,neodev,1.0,31910622,USA,CA,San Francisco,108.169.6.201,[SIDE_EFFECT],[SIDE_EFFECT],involve the,I didn´t select none.,202,214,-1,206,236,TWrex-cause,802222-FS1,"About 35% of Crohn's disease cases involve the ileum alone (ileitis); about 45% involve the ileum and colon (ileocolitis), with a predilection for the right side of the colon; and about 20% involve the COLON alone (GRANULOMATOUS COLITIS most of which, unlike ulcerative colitis (UC), spare the rectum.",COLON,(GRANULOMATOUS COLITIS
720315704,5/12/2015 06:03:19,1634631950,5/12/2015 06:00:25,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[PART_OF],[PART_OF],alone,N/A,202,214,-1,206,236,TWrex-cause,802222-FS1,"About 35% of Crohn's disease cases involve the ileum alone (ileitis); about 45% involve the ileum and colon (ileocolitis), with a predilection for the right side of the colon; and about 20% involve the COLON alone (GRANULOMATOUS COLITIS most of which, unlike ulcerative colitis (UC), spare the rectum.",COLON,(GRANULOMATOUS COLITIS
720315704,5/12/2015 06:22:03,1634640829,5/12/2015 06:21:21,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[LOCATION],[LOCATION],cases involve,N/A,202,214,-1,206,236,TWrex-cause,802222-FS1,"About 35% of Crohn's disease cases involve the ileum alone (ileitis); about 45% involve the ileum and colon (ileocolitis), with a predilection for the right side of the colon; and about 20% involve the COLON alone (GRANULOMATOUS COLITIS most of which, unlike ulcerative colitis (UC), spare the rectum.",COLON,(GRANULOMATOUS COLITIS
720315704,5/12/2015 06:29:53,1634644725,5/12/2015 06:29:10,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[MANIFESTATION] [SYMPTOM],"[SYMPTOM]
[MANIFESTATION]","COLON alone (GRANULOMATOUS COLITIS most which, spare rectum.",n/a,202,214,-1,206,236,TWrex-cause,802222-FS1,"About 35% of Crohn's disease cases involve the ileum alone (ileitis); about 45% involve the ileum and colon (ileocolitis), with a predilection for the right side of the colon; and about 20% involve the COLON alone (GRANULOMATOUS COLITIS most of which, unlike ulcerative colitis (UC), spare the rectum.",COLON,(GRANULOMATOUS COLITIS
720315704,5/12/2015 06:39:56,1634649077,5/12/2015 06:39:14,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[SYMPTOM],[SYMPTOM],involve,NA,202,214,-1,206,236,TWrex-cause,802222-FS1,"About 35% of Crohn's disease cases involve the ileum alone (ileitis); about 45% involve the ileum and colon (ileocolitis), with a predilection for the right side of the colon; and about 20% involve the COLON alone (GRANULOMATOUS COLITIS most of which, unlike ulcerative colitis (UC), spare the rectum.",COLON,(GRANULOMATOUS COLITIS
720315705,5/12/2015 06:51:49,1634654259,5/12/2015 06:51:29,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],causes toxicity,N/A,60,26,1,67,31,TWrex-cause,811695-FS1,"Although effective, these DRUGS are now rarely used because OVERDOSE causes toxicity and they have more adverse effects.",OVERDOSE,DRUGS
720315705,5/12/2015 06:54:58,1634655625,5/12/2015 06:54:29,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[SIDE_EFFECT],[SIDE_EFFECT],effects.,NA,60,26,1,67,31,TWrex-cause,811695-FS1,"Although effective, these DRUGS are now rarely used because OVERDOSE causes toxicity and they have more adverse effects.",OVERDOSE,DRUGS
720315705,5/12/2015 07:07:46,1634661217,5/12/2015 07:07:16,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[CAUSES],[CAUSES],causes toxicity,n/a,60,26,1,67,31,TWrex-cause,811695-FS1,"Although effective, these DRUGS are now rarely used because OVERDOSE causes toxicity and they have more adverse effects.",OVERDOSE,DRUGS
720315705,5/12/2015 08:03:41,1634695062,5/12/2015 08:02:36,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[SIDE_EFFECT],[SIDE_EFFECT],causes toxicity and have adverse effects.,N/A,60,26,1,67,31,TWrex-cause,811695-FS1,"Although effective, these DRUGS are now rarely used because OVERDOSE causes toxicity and they have more adverse effects.",OVERDOSE,DRUGS
720315705,5/12/2015 08:18:46,1634702571,5/12/2015 08:18:15,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[CAUSES],[CAUSES],causes,Causes,60,26,1,67,31,TWrex-cause,811695-FS1,"Although effective, these DRUGS are now rarely used because OVERDOSE causes toxicity and they have more adverse effects.",OVERDOSE,DRUGS
720315705,5/12/2015 08:56:15,1634722983,5/12/2015 08:55:47,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[SIDE_EFFECT],[SIDE_EFFECT],adverse effects.,N/A,60,26,1,67,31,TWrex-cause,811695-FS1,"Although effective, these DRUGS are now rarely used because OVERDOSE causes toxicity and they have more adverse effects.",OVERDOSE,DRUGS
720315705,5/12/2015 09:02:55,1634726362,5/12/2015 09:02:14,false,inboxpounds,1.0,29059658,GBR,H9,London,79.77.3.89,[SIDE_EFFECT],[SIDE_EFFECT],causes toxicity and they have more adverse effects.,N/A,60,26,1,67,31,TWrex-cause,811695-FS1,"Although effective, these DRUGS are now rarely used because OVERDOSE causes toxicity and they have more adverse effects.",OVERDOSE,DRUGS
720315705,5/12/2015 11:03:56,1634826527,5/12/2015 11:03:37,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[CONTRAINDICATES],[CONTRAINDICATES],now rarely used,n/a,60,26,1,67,31,TWrex-cause,811695-FS1,"Although effective, these DRUGS are now rarely used because OVERDOSE causes toxicity and they have more adverse effects.",OVERDOSE,DRUGS
720315705,5/12/2015 11:50:02,1634856909,5/12/2015 11:48:52,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SIDE_EFFECT],[SIDE_EFFECT],DRUGS rarely used OVERDOSE causes toxicity have adverse effects.,N/A,60,26,1,67,31,TWrex-cause,811695-FS1,"Although effective, these DRUGS are now rarely used because OVERDOSE causes toxicity and they have more adverse effects.",OVERDOSE,DRUGS
720315705,5/12/2015 11:57:05,1634860265,5/12/2015 11:56:20,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[SIDE_EFFECT],[SIDE_EFFECT],now rarely used because,N/A,60,26,1,67,31,TWrex-cause,811695-FS1,"Although effective, these DRUGS are now rarely used because OVERDOSE causes toxicity and they have more adverse effects.",OVERDOSE,DRUGS
720315705,5/12/2015 11:57:54,1634860654,5/12/2015 11:57:19,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[CONTRAINDICATES],[CONTRAINDICATES],rarely used because causes,N/A,60,26,1,67,31,TWrex-cause,811695-FS1,"Although effective, these DRUGS are now rarely used because OVERDOSE causes toxicity and they have more adverse effects.",OVERDOSE,DRUGS
720315705,5/12/2015 12:41:47,1634880361,5/12/2015 12:40:50,false,clixsense,1.0,27969116,NLD,"","",212.78.195.38,[OTHER],[OTHER],rarely used,it is not used,60,26,1,67,31,TWrex-cause,811695-FS1,"Although effective, these DRUGS are now rarely used because OVERDOSE causes toxicity and they have more adverse effects.",OVERDOSE,DRUGS
720315705,5/12/2015 13:04:49,1634889211,5/12/2015 13:03:02,false,bitcoinget,1.0,24960279,USA,NY,Bronx,24.184.60.73,[CAUSES],[CAUSES],causes toxicity,n/a,60,26,1,67,31,TWrex-cause,811695-FS1,"Although effective, these DRUGS are now rarely used because OVERDOSE causes toxicity and they have more adverse effects.",OVERDOSE,DRUGS
720315705,5/12/2015 14:30:54,1634928865,5/12/2015 14:30:40,false,neodev,1.0,31726043,USA,DE,"",108.59.8.208,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],OVERDOSE,gfg,60,26,1,67,31,TWrex-cause,811695-FS1,"Although effective, these DRUGS are now rarely used because OVERDOSE causes toxicity and they have more adverse effects.",OVERDOSE,DRUGS
720315705,5/12/2015 15:27:07,1634975454,5/12/2015 15:26:17,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[CAUSES],[CAUSES],OVERDOSE causes toxicity,n/a,60,26,1,67,31,TWrex-cause,811695-FS1,"Although effective, these DRUGS are now rarely used because OVERDOSE causes toxicity and they have more adverse effects.",OVERDOSE,DRUGS
720315706,5/11/2015 23:10:29,1634424231,5/11/2015 23:10:16,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,153,111,-1,189,119,TWrex-cause,803437-FS1,"Van der Willigen AH, van der Hoek JCS, Wagenvoort JHT et al. Comparative double blind study of 200  and 400 mg ENOXACIN given orally in the treatment of ACUTE UNCOMPLICATED URETHRA GONORRHEA in males.",ACUTE UNCOMPLICATED URETHRA GONORRHEA,ENOXACIN
720315706,5/11/2015 23:18:14,1634428309,5/11/2015 23:17:55,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,N/A,153,111,-1,189,119,TWrex-cause,803437-FS1,"Van der Willigen AH, van der Hoek JCS, Wagenvoort JHT et al. Comparative double blind study of 200  and 400 mg ENOXACIN given orally in the treatment of ACUTE UNCOMPLICATED URETHRA GONORRHEA in males.",ACUTE UNCOMPLICATED URETHRA GONORRHEA,ENOXACIN
720315706,5/11/2015 23:18:30,1634428486,5/11/2015 23:17:56,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],in the treatment of,n/a,153,111,-1,189,119,TWrex-cause,803437-FS1,"Van der Willigen AH, van der Hoek JCS, Wagenvoort JHT et al. Comparative double blind study of 200  and 400 mg ENOXACIN given orally in the treatment of ACUTE UNCOMPLICATED URETHRA GONORRHEA in males.",ACUTE UNCOMPLICATED URETHRA GONORRHEA,ENOXACIN
720315706,5/11/2015 23:21:05,1634429593,5/11/2015 23:20:34,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[TREATS],[TREATS],ENOXACIN given orally in treatment of ACUTE UNCOMPLICATED URETHRA GONORRHEA,n/a,153,111,-1,189,119,TWrex-cause,803437-FS1,"Van der Willigen AH, van der Hoek JCS, Wagenvoort JHT et al. Comparative double blind study of 200  and 400 mg ENOXACIN given orally in the treatment of ACUTE UNCOMPLICATED URETHRA GONORRHEA in males.",ACUTE UNCOMPLICATED URETHRA GONORRHEA,ENOXACIN
720315706,5/11/2015 23:21:26,1634429798,5/11/2015 23:21:14,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],treatment,n/a,153,111,-1,189,119,TWrex-cause,803437-FS1,"Van der Willigen AH, van der Hoek JCS, Wagenvoort JHT et al. Comparative double blind study of 200  and 400 mg ENOXACIN given orally in the treatment of ACUTE UNCOMPLICATED URETHRA GONORRHEA in males.",ACUTE UNCOMPLICATED URETHRA GONORRHEA,ENOXACIN
720315706,5/11/2015 23:21:42,1634429900,5/11/2015 23:21:06,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],treatment,the latter treats the former,153,111,-1,189,119,TWrex-cause,803437-FS1,"Van der Willigen AH, van der Hoek JCS, Wagenvoort JHT et al. Comparative double blind study of 200  and 400 mg ENOXACIN given orally in the treatment of ACUTE UNCOMPLICATED URETHRA GONORRHEA in males.",ACUTE UNCOMPLICATED URETHRA GONORRHEA,ENOXACIN
720315706,5/11/2015 23:23:33,1634430802,5/11/2015 23:21:43,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,153,111,-1,189,119,TWrex-cause,803437-FS1,"Van der Willigen AH, van der Hoek JCS, Wagenvoort JHT et al. Comparative double blind study of 200  and 400 mg ENOXACIN given orally in the treatment of ACUTE UNCOMPLICATED URETHRA GONORRHEA in males.",ACUTE UNCOMPLICATED URETHRA GONORRHEA,ENOXACIN
720315706,5/11/2015 23:24:06,1634430987,5/11/2015 23:22:46,false,clixsense,1.0,6330007,AUS,06,Hobart,101.178.23.54,[TREATS],[TREATS],given orally treatment,n/a,153,111,-1,189,119,TWrex-cause,803437-FS1,"Van der Willigen AH, van der Hoek JCS, Wagenvoort JHT et al. Comparative double blind study of 200  and 400 mg ENOXACIN given orally in the treatment of ACUTE UNCOMPLICATED URETHRA GONORRHEA in males.",ACUTE UNCOMPLICATED URETHRA GONORRHEA,ENOXACIN
720315706,5/11/2015 23:24:29,1634431153,5/11/2015 23:23:18,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,153,111,-1,189,119,TWrex-cause,803437-FS1,"Van der Willigen AH, van der Hoek JCS, Wagenvoort JHT et al. Comparative double blind study of 200  and 400 mg ENOXACIN given orally in the treatment of ACUTE UNCOMPLICATED URETHRA GONORRHEA in males.",ACUTE UNCOMPLICATED URETHRA GONORRHEA,ENOXACIN
720315706,5/11/2015 23:26:42,1634432032,5/11/2015 23:26:25,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.48,[CAUSES] [PREVENTS] [LOCATION] [NONE],"[PREVENTS]
[CAUSES]
[LOCATION]
[NONE]",no,no,153,111,-1,189,119,TWrex-cause,803437-FS1,"Van der Willigen AH, van der Hoek JCS, Wagenvoort JHT et al. Comparative double blind study of 200  and 400 mg ENOXACIN given orally in the treatment of ACUTE UNCOMPLICATED URETHRA GONORRHEA in males.",ACUTE UNCOMPLICATED URETHRA GONORRHEA,ENOXACIN
720315706,5/11/2015 23:32:30,1634434934,5/11/2015 23:31:07,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[OTHER],[OTHER],treatment of ACUTE UNCOMPLICATED URETHRA GONORRHEA,n/a,153,111,-1,189,119,TWrex-cause,803437-FS1,"Van der Willigen AH, van der Hoek JCS, Wagenvoort JHT et al. Comparative double blind study of 200  and 400 mg ENOXACIN given orally in the treatment of ACUTE UNCOMPLICATED URETHRA GONORRHEA in males.",ACUTE UNCOMPLICATED URETHRA GONORRHEA,ENOXACIN
720315706,5/11/2015 23:33:38,1634435481,5/11/2015 23:32:30,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treatment,n/a,153,111,-1,189,119,TWrex-cause,803437-FS1,"Van der Willigen AH, van der Hoek JCS, Wagenvoort JHT et al. Comparative double blind study of 200  and 400 mg ENOXACIN given orally in the treatment of ACUTE UNCOMPLICATED URETHRA GONORRHEA in males.",ACUTE UNCOMPLICATED URETHRA GONORRHEA,ENOXACIN
720315706,5/11/2015 23:35:22,1634436597,5/11/2015 23:33:29,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treatment,n/a,153,111,-1,189,119,TWrex-cause,803437-FS1,"Van der Willigen AH, van der Hoek JCS, Wagenvoort JHT et al. Comparative double blind study of 200  and 400 mg ENOXACIN given orally in the treatment of ACUTE UNCOMPLICATED URETHRA GONORRHEA in males.",ACUTE UNCOMPLICATED URETHRA GONORRHEA,ENOXACIN
720315706,5/11/2015 23:53:51,1634445571,5/11/2015 23:53:37,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,n/a,153,111,-1,189,119,TWrex-cause,803437-FS1,"Van der Willigen AH, van der Hoek JCS, Wagenvoort JHT et al. Comparative double blind study of 200  and 400 mg ENOXACIN given orally in the treatment of ACUTE UNCOMPLICATED URETHRA GONORRHEA in males.",ACUTE UNCOMPLICATED URETHRA GONORRHEA,ENOXACIN
720315706,5/12/2015 00:13:29,1634452701,5/12/2015 00:12:12,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],the treatment of,treats,153,111,-1,189,119,TWrex-cause,803437-FS1,"Van der Willigen AH, van der Hoek JCS, Wagenvoort JHT et al. Comparative double blind study of 200  and 400 mg ENOXACIN given orally in the treatment of ACUTE UNCOMPLICATED URETHRA GONORRHEA in males.",ACUTE UNCOMPLICATED URETHRA GONORRHEA,ENOXACIN
720315707,5/12/2015 05:09:06,1634599030,5/12/2015 05:08:32,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],controlled trial,none,68,40,-1,91,50,TWrex-cause,803316-FS1,"Randomised, placebo controlled trial of CARVEDILOL in patients with CONGESTIVE HEART FAILURE due to ischaemic heart disease.",CONGESTIVE HEART FAILURE,CARVEDILOL
720315707,5/12/2015 05:14:30,1634602321,5/12/2015 05:14:11,false,neodev,1.0,31910622,USA,CA,San Francisco,108.169.6.201,[TREATS],[TREATS],in patients with,I didn´t select none.,68,40,-1,91,50,TWrex-cause,803316-FS1,"Randomised, placebo controlled trial of CARVEDILOL in patients with CONGESTIVE HEART FAILURE due to ischaemic heart disease.",CONGESTIVE HEART FAILURE,CARVEDILOL
720315707,5/12/2015 06:23:08,1634641452,5/12/2015 06:22:31,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],placebo controlled trial,N/A,68,40,-1,91,50,TWrex-cause,803316-FS1,"Randomised, placebo controlled trial of CARVEDILOL in patients with CONGESTIVE HEART FAILURE due to ischaemic heart disease.",CONGESTIVE HEART FAILURE,CARVEDILOL
720315707,5/12/2015 06:29:00,1634644306,5/12/2015 06:28:38,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[TREATS],[TREATS],trial of,N/A,68,40,-1,91,50,TWrex-cause,803316-FS1,"Randomised, placebo controlled trial of CARVEDILOL in patients with CONGESTIVE HEART FAILURE due to ischaemic heart disease.",CONGESTIVE HEART FAILURE,CARVEDILOL
720315707,5/12/2015 06:48:08,1634652562,5/12/2015 06:46:57,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],trial,NA,68,40,-1,91,50,TWrex-cause,803316-FS1,"Randomised, placebo controlled trial of CARVEDILOL in patients with CONGESTIVE HEART FAILURE due to ischaemic heart disease.",CONGESTIVE HEART FAILURE,CARVEDILOL
720315707,5/12/2015 06:48:43,1634652864,5/12/2015 06:48:23,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[TREATS],[TREATS],in patients with,N/A,68,40,-1,91,50,TWrex-cause,803316-FS1,"Randomised, placebo controlled trial of CARVEDILOL in patients with CONGESTIVE HEART FAILURE due to ischaemic heart disease.",CONGESTIVE HEART FAILURE,CARVEDILOL
720315707,5/12/2015 06:58:44,1634657346,5/12/2015 06:56:59,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[OTHER],[OTHER],placebo controlled trial,n/a,68,40,-1,91,50,TWrex-cause,803316-FS1,"Randomised, placebo controlled trial of CARVEDILOL in patients with CONGESTIVE HEART FAILURE due to ischaemic heart disease.",CONGESTIVE HEART FAILURE,CARVEDILOL
720315707,5/12/2015 07:06:04,1634660408,5/12/2015 07:05:33,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[TREATS],[TREATS],controlled trial of,N/a,68,40,-1,91,50,TWrex-cause,803316-FS1,"Randomised, placebo controlled trial of CARVEDILOL in patients with CONGESTIVE HEART FAILURE due to ischaemic heart disease.",CONGESTIVE HEART FAILURE,CARVEDILOL
720315707,5/12/2015 07:58:19,1634692350,5/12/2015 07:57:31,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],trial in patients with,N/A,68,40,-1,91,50,TWrex-cause,803316-FS1,"Randomised, placebo controlled trial of CARVEDILOL in patients with CONGESTIVE HEART FAILURE due to ischaemic heart disease.",CONGESTIVE HEART FAILURE,CARVEDILOL
720315707,5/12/2015 08:12:04,1634699378,5/12/2015 08:11:17,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[OTHER],[OTHER],trial,Trial,68,40,-1,91,50,TWrex-cause,803316-FS1,"Randomised, placebo controlled trial of CARVEDILOL in patients with CONGESTIVE HEART FAILURE due to ischaemic heart disease.",CONGESTIVE HEART FAILURE,CARVEDILOL
720315707,5/12/2015 08:51:28,1634720536,5/12/2015 08:50:42,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[TREATS],[TREATS],trial,N/A,68,40,-1,91,50,TWrex-cause,803316-FS1,"Randomised, placebo controlled trial of CARVEDILOL in patients with CONGESTIVE HEART FAILURE due to ischaemic heart disease.",CONGESTIVE HEART FAILURE,CARVEDILOL
720315707,5/12/2015 08:57:08,1634723443,5/12/2015 08:56:36,false,inboxpounds,1.0,29059658,GBR,H9,London,79.77.3.89,[TREATS],[TREATS],controlled trial,n/a,68,40,-1,91,50,TWrex-cause,803316-FS1,"Randomised, placebo controlled trial of CARVEDILOL in patients with CONGESTIVE HEART FAILURE due to ischaemic heart disease.",CONGESTIVE HEART FAILURE,CARVEDILOL
720315707,5/12/2015 10:40:52,1634801661,5/12/2015 10:39:46,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],placebo controlled trial CARVEDILOL,N/A,68,40,-1,91,50,TWrex-cause,803316-FS1,"Randomised, placebo controlled trial of CARVEDILOL in patients with CONGESTIVE HEART FAILURE due to ischaemic heart disease.",CONGESTIVE HEART FAILURE,CARVEDILOL
720315707,5/12/2015 10:57:05,1634817191,5/12/2015 10:56:49,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],in patients with,n/a,68,40,-1,91,50,TWrex-cause,803316-FS1,"Randomised, placebo controlled trial of CARVEDILOL in patients with CONGESTIVE HEART FAILURE due to ischaemic heart disease.",CONGESTIVE HEART FAILURE,CARVEDILOL
720315707,5/12/2015 11:50:50,1634857350,5/12/2015 11:50:02,false,instagc,1.0,29444531,USA,GA,Conyers,184.37.251.52,[PART_OF],[PART_OF],with,NA,68,40,-1,91,50,TWrex-cause,803316-FS1,"Randomised, placebo controlled trial of CARVEDILOL in patients with CONGESTIVE HEART FAILURE due to ischaemic heart disease.",CONGESTIVE HEART FAILURE,CARVEDILOL
720315708,5/11/2015 22:21:18,1634403173,5/11/2015 22:21:01,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],BURKHOLDERIA MALLEI,N/A,43,70,1,50,89,TWrex-cause,811698-FS1,114  Burkholderia Infections  Treatment of GLANDERS   +    caused by  BURKHOLDERIA MALLEI,GLANDERS,BURKHOLDERIA MALLEI
720315708,5/11/2015 22:23:01,1634403921,5/11/2015 22:22:48,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],caused by,n/a,43,70,1,50,89,TWrex-cause,811698-FS1,114  Burkholderia Infections  Treatment of GLANDERS   +    caused by  BURKHOLDERIA MALLEI,GLANDERS,BURKHOLDERIA MALLEI
720315708,5/11/2015 22:25:54,1634405122,5/11/2015 22:25:11,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],GLANDERS caused by BURKHOLDERIA MALLEI,"n/a`
`",43,70,1,50,89,TWrex-cause,811698-FS1,114  Burkholderia Infections  Treatment of GLANDERS   +    caused by  BURKHOLDERIA MALLEI,GLANDERS,BURKHOLDERIA MALLEI
720315708,5/11/2015 22:35:44,1634409403,5/11/2015 22:34:43,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],Burkholderia Infections Treatment GLANDERS caused by BURKHOLDERIA MALLEI,N/A,43,70,1,50,89,TWrex-cause,811698-FS1,114  Burkholderia Infections  Treatment of GLANDERS   +    caused by  BURKHOLDERIA MALLEI,GLANDERS,BURKHOLDERIA MALLEI
720315708,5/11/2015 22:36:09,1634409572,5/11/2015 22:35:32,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],caused by,n/a,43,70,1,50,89,TWrex-cause,811698-FS1,114  Burkholderia Infections  Treatment of GLANDERS   +    caused by  BURKHOLDERIA MALLEI,GLANDERS,BURKHOLDERIA MALLEI
720315708,5/11/2015 22:41:09,1634411991,5/11/2015 22:40:42,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[CAUSES],[CAUSES],GLANDERS caused by BURKHOLDERIA,n/a,43,70,1,50,89,TWrex-cause,811698-FS1,114  Burkholderia Infections  Treatment of GLANDERS   +    caused by  BURKHOLDERIA MALLEI,GLANDERS,BURKHOLDERIA MALLEI
720315708,5/11/2015 22:43:50,1634413142,5/11/2015 22:43:32,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],Treatment,n/a,43,70,1,50,89,TWrex-cause,811698-FS1,114  Burkholderia Infections  Treatment of GLANDERS   +    caused by  BURKHOLDERIA MALLEI,GLANDERS,BURKHOLDERIA MALLEI
720315708,5/11/2015 22:47:32,1634414998,5/11/2015 22:47:08,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],GLANDERS caused by BURKHOLDERIA MALLEI,n/a,43,70,1,50,89,TWrex-cause,811698-FS1,114  Burkholderia Infections  Treatment of GLANDERS   +    caused by  BURKHOLDERIA MALLEI,GLANDERS,BURKHOLDERIA MALLEI
720315708,5/11/2015 22:54:57,1634417887,5/11/2015 22:54:04,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],Burkholderia Infections Treatment of GLANDERS caused by BURKHOLDERIA MALLEI,N/A,43,70,1,50,89,TWrex-cause,811698-FS1,114  Burkholderia Infections  Treatment of GLANDERS   +    caused by  BURKHOLDERIA MALLEI,GLANDERS,BURKHOLDERIA MALLEI
720315708,5/11/2015 22:58:55,1634419213,5/11/2015 22:58:29,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,75.147.181.53,[TREATS],[TREATS],Treatment of,N/A,43,70,1,50,89,TWrex-cause,811698-FS1,114  Burkholderia Infections  Treatment of GLANDERS   +    caused by  BURKHOLDERIA MALLEI,GLANDERS,BURKHOLDERIA MALLEI
720315708,5/11/2015 23:01:28,1634420007,5/11/2015 23:00:50,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[MANIFESTATION],[MANIFESTATION],caused,n/a,43,70,1,50,89,TWrex-cause,811698-FS1,114  Burkholderia Infections  Treatment of GLANDERS   +    caused by  BURKHOLDERIA MALLEI,GLANDERS,BURKHOLDERIA MALLEI
720315708,5/11/2015 23:01:57,1634420181,5/11/2015 23:01:08,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",caused,the former influences the later,43,70,1,50,89,TWrex-cause,811698-FS1,114  Burkholderia Infections  Treatment of GLANDERS   +    caused by  BURKHOLDERIA MALLEI,GLANDERS,BURKHOLDERIA MALLEI
720315708,5/11/2015 23:02:11,1634420263,5/11/2015 23:01:50,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],caused,N/A,43,70,1,50,89,TWrex-cause,811698-FS1,114  Burkholderia Infections  Treatment of GLANDERS   +    caused by  BURKHOLDERIA MALLEI,GLANDERS,BURKHOLDERIA MALLEI
720315708,5/11/2015 23:02:54,1634420521,5/11/2015 23:02:01,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],caused by,n/a,43,70,1,50,89,TWrex-cause,811698-FS1,114  Burkholderia Infections  Treatment of GLANDERS   +    caused by  BURKHOLDERIA MALLEI,GLANDERS,BURKHOLDERIA MALLEI
720315708,5/11/2015 23:02:59,1634420540,5/11/2015 23:02:32,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],caused by,N/A,43,70,1,50,89,TWrex-cause,811698-FS1,114  Burkholderia Infections  Treatment of GLANDERS   +    caused by  BURKHOLDERIA MALLEI,GLANDERS,BURKHOLDERIA MALLEI
720315709,5/11/2015 22:25:48,1634405086,5/11/2015 22:25:17,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],INTERRUPTED URINARY STREAM,N/A,157,91,1,187,135,TWrex-cause,812700-FS1,Patients may have dysuria and suprapubic pain that radiates to the tip of the penis and an INTERRUPTED URINARY STREAM BLADDER CARCINOMA  Usually presents as INTERMITTENT PAINLESS HEMATURIA,INTERMITTENT PAINLESS HEMATURIA,INTERRUPTED URINARY STREAM BLADDER CARCINOMA
720315709,5/11/2015 22:26:58,1634405623,5/11/2015 22:26:42,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],presents as,n/a,157,91,1,187,135,TWrex-cause,812700-FS1,Patients may have dysuria and suprapubic pain that radiates to the tip of the penis and an INTERRUPTED URINARY STREAM BLADDER CARCINOMA  Usually presents as INTERMITTENT PAINLESS HEMATURIA,INTERMITTENT PAINLESS HEMATURIA,INTERRUPTED URINARY STREAM BLADDER CARCINOMA
720315709,5/11/2015 22:36:42,1634409760,5/11/2015 22:35:34,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],INTERRUPTED URINARY STREAM BLADDER CARCINOMA Usually presents as INTERMITTENT PAINLESS HEMATURIA,n/a,157,91,1,187,135,TWrex-cause,812700-FS1,Patients may have dysuria and suprapubic pain that radiates to the tip of the penis and an INTERRUPTED URINARY STREAM BLADDER CARCINOMA  Usually presents as INTERMITTENT PAINLESS HEMATURIA,INTERMITTENT PAINLESS HEMATURIA,INTERRUPTED URINARY STREAM BLADDER CARCINOMA
720315709,5/11/2015 22:44:56,1634413699,5/11/2015 22:44:35,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[MANIFESTATION],[MANIFESTATION],presents as,n/a,157,91,1,187,135,TWrex-cause,812700-FS1,Patients may have dysuria and suprapubic pain that radiates to the tip of the penis and an INTERRUPTED URINARY STREAM BLADDER CARCINOMA  Usually presents as INTERMITTENT PAINLESS HEMATURIA,INTERMITTENT PAINLESS HEMATURIA,INTERRUPTED URINARY STREAM BLADDER CARCINOMA
720315709,5/11/2015 22:48:00,1634415233,5/11/2015 22:47:15,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[SYMPTOM],[SYMPTOM],INTERRUPTED URINARY STREAM BLADDER CARCINOMA Usually presents as INTERMITTENT PAINLESS HEMATURIA,N/A,157,91,1,187,135,TWrex-cause,812700-FS1,Patients may have dysuria and suprapubic pain that radiates to the tip of the penis and an INTERRUPTED URINARY STREAM BLADDER CARCINOMA  Usually presents as INTERMITTENT PAINLESS HEMATURIA,INTERMITTENT PAINLESS HEMATURIA,INTERRUPTED URINARY STREAM BLADDER CARCINOMA
720315709,5/11/2015 22:49:38,1634415961,5/11/2015 22:49:03,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[SYMPTOM],[SYMPTOM],INTERRUPTED URINARY STREAM BLADDER CARCINOMA Usually presents as INTERMITTENT PAINLESS HEMATURIA,n/a,157,91,1,187,135,TWrex-cause,812700-FS1,Patients may have dysuria and suprapubic pain that radiates to the tip of the penis and an INTERRUPTED URINARY STREAM BLADDER CARCINOMA  Usually presents as INTERMITTENT PAINLESS HEMATURIA,INTERMITTENT PAINLESS HEMATURIA,INTERRUPTED URINARY STREAM BLADDER CARCINOMA
720315709,5/11/2015 23:00:13,1634419566,5/11/2015 22:59:31,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],INTERRUPTED URINARY STREAM BLADDER CARCINOMA presents as INTERMITTENT PAINLESS HEMATURIA,n/a,157,91,1,187,135,TWrex-cause,812700-FS1,Patients may have dysuria and suprapubic pain that radiates to the tip of the penis and an INTERRUPTED URINARY STREAM BLADDER CARCINOMA  Usually presents as INTERMITTENT PAINLESS HEMATURIA,INTERMITTENT PAINLESS HEMATURIA,INTERRUPTED URINARY STREAM BLADDER CARCINOMA
720315709,5/11/2015 23:05:38,1634421383,5/11/2015 23:04:55,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,75.147.181.53,[MANIFESTATION],[MANIFESTATION],Patients may have,N/A,157,91,1,187,135,TWrex-cause,812700-FS1,Patients may have dysuria and suprapubic pain that radiates to the tip of the penis and an INTERRUPTED URINARY STREAM BLADDER CARCINOMA  Usually presents as INTERMITTENT PAINLESS HEMATURIA,INTERMITTENT PAINLESS HEMATURIA,INTERRUPTED URINARY STREAM BLADDER CARCINOMA
720315709,5/11/2015 23:09:16,1634423202,5/11/2015 23:08:59,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],presents as,N/A,157,91,1,187,135,TWrex-cause,812700-FS1,Patients may have dysuria and suprapubic pain that radiates to the tip of the penis and an INTERRUPTED URINARY STREAM BLADDER CARCINOMA  Usually presents as INTERMITTENT PAINLESS HEMATURIA,INTERMITTENT PAINLESS HEMATURIA,INTERRUPTED URINARY STREAM BLADDER CARCINOMA
720315709,5/11/2015 23:13:12,1634426012,5/11/2015 23:11:43,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Patients may have dysuria and suprapubic pain that radiates to the tip of the penis and an INTERRUPTED URINARY STREAM BLADDER CARCINOMA Usually presents as INTERMITTENT PAINLESS HEMATURIA,N/A,157,91,1,187,135,TWrex-cause,812700-FS1,Patients may have dysuria and suprapubic pain that radiates to the tip of the penis and an INTERRUPTED URINARY STREAM BLADDER CARCINOMA  Usually presents as INTERMITTENT PAINLESS HEMATURIA,INTERMITTENT PAINLESS HEMATURIA,INTERRUPTED URINARY STREAM BLADDER CARCINOMA
720315709,5/11/2015 23:15:19,1634427130,5/11/2015 23:14:33,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[SYMPTOM],[SYMPTOM],presents,it is a symptom,157,91,1,187,135,TWrex-cause,812700-FS1,Patients may have dysuria and suprapubic pain that radiates to the tip of the penis and an INTERRUPTED URINARY STREAM BLADDER CARCINOMA  Usually presents as INTERMITTENT PAINLESS HEMATURIA,INTERMITTENT PAINLESS HEMATURIA,INTERRUPTED URINARY STREAM BLADDER CARCINOMA
720315709,5/11/2015 23:16:05,1634427449,5/11/2015 23:15:21,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[MANIFESTATION],[MANIFESTATION],presents as,N/A,157,91,1,187,135,TWrex-cause,812700-FS1,Patients may have dysuria and suprapubic pain that radiates to the tip of the penis and an INTERRUPTED URINARY STREAM BLADDER CARCINOMA  Usually presents as INTERMITTENT PAINLESS HEMATURIA,INTERMITTENT PAINLESS HEMATURIA,INTERRUPTED URINARY STREAM BLADDER CARCINOMA
720315709,5/11/2015 23:16:36,1634427562,5/11/2015 23:15:30,false,clixsense,1.0,6330007,AUS,06,Hobart,101.178.23.54,[SYMPTOM],[SYMPTOM],Usually presents as,n/a,157,91,1,187,135,TWrex-cause,812700-FS1,Patients may have dysuria and suprapubic pain that radiates to the tip of the penis and an INTERRUPTED URINARY STREAM BLADDER CARCINOMA  Usually presents as INTERMITTENT PAINLESS HEMATURIA,INTERMITTENT PAINLESS HEMATURIA,INTERRUPTED URINARY STREAM BLADDER CARCINOMA
720315709,5/11/2015 23:18:33,1634428523,5/11/2015 23:17:45,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[MANIFESTATION],[MANIFESTATION],presents as,N/A,157,91,1,187,135,TWrex-cause,812700-FS1,Patients may have dysuria and suprapubic pain that radiates to the tip of the penis and an INTERRUPTED URINARY STREAM BLADDER CARCINOMA  Usually presents as INTERMITTENT PAINLESS HEMATURIA,INTERMITTENT PAINLESS HEMATURIA,INTERRUPTED URINARY STREAM BLADDER CARCINOMA
720315709,5/11/2015 23:19:32,1634428862,5/11/2015 23:19:05,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[MANIFESTATION],[MANIFESTATION],presents as,n/a,157,91,1,187,135,TWrex-cause,812700-FS1,Patients may have dysuria and suprapubic pain that radiates to the tip of the penis and an INTERRUPTED URINARY STREAM BLADDER CARCINOMA  Usually presents as INTERMITTENT PAINLESS HEMATURIA,INTERMITTENT PAINLESS HEMATURIA,INTERRUPTED URINARY STREAM BLADDER CARCINOMA
720315710,5/12/2015 06:27:08,1634643405,5/12/2015 06:26:39,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CAUSES],[CAUSES],caused by,N/A,82,118,1,94,123,TWrex-cause,811736-FS1,"Treatment of dermatophyte infections of the toenail or fingernail (onychomycosis, TINEA UNGUIUM caused by susceptible FUNGI",TINEA UNGUIUM,FUNGI
720315710,5/12/2015 06:33:02,1634646092,5/12/2015 06:32:20,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[CAUSES],[CAUSES],caused,N/A,82,118,1,94,123,TWrex-cause,811736-FS1,"Treatment of dermatophyte infections of the toenail or fingernail (onychomycosis, TINEA UNGUIUM caused by susceptible FUNGI",TINEA UNGUIUM,FUNGI
720315710,5/12/2015 06:50:22,1634653639,5/12/2015 06:50:10,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[CAUSES],[CAUSES],caused by susceptible,N/A,82,118,1,94,123,TWrex-cause,811736-FS1,"Treatment of dermatophyte infections of the toenail or fingernail (onychomycosis, TINEA UNGUIUM caused by susceptible FUNGI",TINEA UNGUIUM,FUNGI
720315710,5/12/2015 06:52:05,1634654353,5/12/2015 06:51:46,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[TREATS],[TREATS],Treatment,NA,82,118,1,94,123,TWrex-cause,811736-FS1,"Treatment of dermatophyte infections of the toenail or fingernail (onychomycosis, TINEA UNGUIUM caused by susceptible FUNGI",TINEA UNGUIUM,FUNGI
720315710,5/12/2015 07:04:43,1634659761,5/12/2015 07:04:19,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[CAUSES],[CAUSES],caused by,n/a,82,118,1,94,123,TWrex-cause,811736-FS1,"Treatment of dermatophyte infections of the toenail or fingernail (onychomycosis, TINEA UNGUIUM caused by susceptible FUNGI",TINEA UNGUIUM,FUNGI
720315710,5/12/2015 08:00:53,1634693661,5/12/2015 08:00:33,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[CAUSES],[CAUSES],caused by,N/A,82,118,1,94,123,TWrex-cause,811736-FS1,"Treatment of dermatophyte infections of the toenail or fingernail (onychomycosis, TINEA UNGUIUM caused by susceptible FUNGI",TINEA UNGUIUM,FUNGI
720315710,5/12/2015 08:16:00,1634701276,5/12/2015 08:15:37,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[CAUSES],[CAUSES],caused,Causes,82,118,1,94,123,TWrex-cause,811736-FS1,"Treatment of dermatophyte infections of the toenail or fingernail (onychomycosis, TINEA UNGUIUM caused by susceptible FUNGI",TINEA UNGUIUM,FUNGI
720315710,5/12/2015 08:54:40,1634722319,5/12/2015 08:53:59,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[ASSOCIATED_WITH] [TREATS],"[TREATS]
[ASSOCIATED_WITH]",Treatment,N/A,82,118,1,94,123,TWrex-cause,811736-FS1,"Treatment of dermatophyte infections of the toenail or fingernail (onychomycosis, TINEA UNGUIUM caused by susceptible FUNGI",TINEA UNGUIUM,FUNGI
720315710,5/12/2015 09:00:30,1634725126,5/12/2015 09:00:12,false,inboxpounds,1.0,29059658,GBR,H9,London,79.77.3.89,[CAUSES],[CAUSES],caused by,N/A,82,118,1,94,123,TWrex-cause,811736-FS1,"Treatment of dermatophyte infections of the toenail or fingernail (onychomycosis, TINEA UNGUIUM caused by susceptible FUNGI",TINEA UNGUIUM,FUNGI
720315710,5/12/2015 11:01:57,1634823506,5/12/2015 11:01:04,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[CAUSES],[CAUSES],caused,n/a,82,118,1,94,123,TWrex-cause,811736-FS1,"Treatment of dermatophyte infections of the toenail or fingernail (onychomycosis, TINEA UNGUIUM caused by susceptible FUNGI",TINEA UNGUIUM,FUNGI
720315710,5/12/2015 11:39:31,1634850807,5/12/2015 11:37:18,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],TINEA UNGUIUM caused by FUNGI,N/A,82,118,1,94,123,TWrex-cause,811736-FS1,"Treatment of dermatophyte infections of the toenail or fingernail (onychomycosis, TINEA UNGUIUM caused by susceptible FUNGI",TINEA UNGUIUM,FUNGI
720315710,5/12/2015 11:54:44,1634859213,5/12/2015 11:54:16,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[CAUSES],[CAUSES],caused by,N/A,82,118,1,94,123,TWrex-cause,811736-FS1,"Treatment of dermatophyte infections of the toenail or fingernail (onychomycosis, TINEA UNGUIUM caused by susceptible FUNGI",TINEA UNGUIUM,FUNGI
720315710,5/12/2015 11:55:47,1634859695,5/12/2015 11:55:23,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[CAUSES],[CAUSES],caused by,N/A,82,118,1,94,123,TWrex-cause,811736-FS1,"Treatment of dermatophyte infections of the toenail or fingernail (onychomycosis, TINEA UNGUIUM caused by susceptible FUNGI",TINEA UNGUIUM,FUNGI
720315710,5/12/2015 12:10:48,1634866380,5/12/2015 12:10:28,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[CAUSES],[CAUSES],caused,N/A,82,118,1,94,123,TWrex-cause,811736-FS1,"Treatment of dermatophyte infections of the toenail or fingernail (onychomycosis, TINEA UNGUIUM caused by susceptible FUNGI",TINEA UNGUIUM,FUNGI
720315710,5/12/2015 12:38:25,1634878646,5/12/2015 12:37:47,false,clixsense,1.0,27969116,NLD,"","",212.78.195.38,[CAUSES],[CAUSES],caused by susceptible FUNGI,it is caused by FUNGI,82,118,1,94,123,TWrex-cause,811736-FS1,"Treatment of dermatophyte infections of the toenail or fingernail (onychomycosis, TINEA UNGUIUM caused by susceptible FUNGI",TINEA UNGUIUM,FUNGI
720315711,5/12/2015 06:26:14,1634643011,5/12/2015 06:25:28,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[MANIFESTATION],[MANIFESTATION],progresses,N/A,61,27,1,83,40,TWrex-cause,812947-FS1,"41   In men (homozygotes), FABRY DISEASE often progresses to NEPHRITIC RENAL FAILURE stroke, and cardiomyopathy.",NEPHRITIC RENAL FAILURE,FABRY DISEASE
720315711,5/12/2015 06:31:59,1634645557,5/12/2015 06:30:38,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[OTHER],[OTHER],progresses to,N/A,61,27,1,83,40,TWrex-cause,812947-FS1,"41   In men (homozygotes), FABRY DISEASE often progresses to NEPHRITIC RENAL FAILURE stroke, and cardiomyopathy.",NEPHRITIC RENAL FAILURE,FABRY DISEASE
720315711,5/12/2015 06:49:55,1634653401,5/12/2015 06:49:30,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[CAUSES] [ASSOCIATED_WITH] [PART_OF],"[CAUSES]
[ASSOCIATED_WITH]
[PART_OF]",often progresses to,N/A,61,27,1,83,40,TWrex-cause,812947-FS1,"41   In men (homozygotes), FABRY DISEASE often progresses to NEPHRITIC RENAL FAILURE stroke, and cardiomyopathy.",NEPHRITIC RENAL FAILURE,FABRY DISEASE
720315711,5/12/2015 06:51:15,1634653997,5/12/2015 06:49:58,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[SYMPTOM],[SYMPTOM],progresses,NA,61,27,1,83,40,TWrex-cause,812947-FS1,"41   In men (homozygotes), FABRY DISEASE often progresses to NEPHRITIC RENAL FAILURE stroke, and cardiomyopathy.",NEPHRITIC RENAL FAILURE,FABRY DISEASE
720315711,5/12/2015 07:03:39,1634659319,5/12/2015 07:02:31,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[SIDE_EFFECT],[SIDE_EFFECT],often progresses to,n/a,61,27,1,83,40,TWrex-cause,812947-FS1,"41   In men (homozygotes), FABRY DISEASE often progresses to NEPHRITIC RENAL FAILURE stroke, and cardiomyopathy.",NEPHRITIC RENAL FAILURE,FABRY DISEASE
720315711,5/12/2015 08:00:16,1634693297,5/12/2015 07:59:35,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[CAUSES] [SYMPTOM],"[CAUSES]
[SYMPTOM]",progresses to,N/A,61,27,1,83,40,TWrex-cause,812947-FS1,"41   In men (homozygotes), FABRY DISEASE often progresses to NEPHRITIC RENAL FAILURE stroke, and cardiomyopathy.",NEPHRITIC RENAL FAILURE,FABRY DISEASE
720315711,5/12/2015 08:15:12,1634700852,5/12/2015 08:13:54,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],progresses,Associated with,61,27,1,83,40,TWrex-cause,812947-FS1,"41   In men (homozygotes), FABRY DISEASE often progresses to NEPHRITIC RENAL FAILURE stroke, and cardiomyopathy.",NEPHRITIC RENAL FAILURE,FABRY DISEASE
720315711,5/12/2015 08:53:32,1634721744,5/12/2015 08:53:08,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[CAUSES],[CAUSES],often progresses,N/A,61,27,1,83,40,TWrex-cause,812947-FS1,"41   In men (homozygotes), FABRY DISEASE often progresses to NEPHRITIC RENAL FAILURE stroke, and cardiomyopathy.",NEPHRITIC RENAL FAILURE,FABRY DISEASE
720315711,5/12/2015 08:59:51,1634724819,5/12/2015 08:59:28,false,inboxpounds,1.0,29059658,GBR,H9,London,79.77.3.89,[OTHER],[OTHER],often progresses,Leads to,61,27,1,83,40,TWrex-cause,812947-FS1,"41   In men (homozygotes), FABRY DISEASE often progresses to NEPHRITIC RENAL FAILURE stroke, and cardiomyopathy.",NEPHRITIC RENAL FAILURE,FABRY DISEASE
720315711,5/12/2015 11:00:39,1634821650,5/12/2015 11:00:09,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[MANIFESTATION],[MANIFESTATION],progresses,n.a,61,27,1,83,40,TWrex-cause,812947-FS1,"41   In men (homozygotes), FABRY DISEASE often progresses to NEPHRITIC RENAL FAILURE stroke, and cardiomyopathy.",NEPHRITIC RENAL FAILURE,FABRY DISEASE
720315711,5/12/2015 11:35:23,1634848499,5/12/2015 11:33:14,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[OTHER],[OTHER],FABRY DISEASE often progresses to NEPHRITIC RENAL FAILURE,N/A,61,27,1,83,40,TWrex-cause,812947-FS1,"41   In men (homozygotes), FABRY DISEASE often progresses to NEPHRITIC RENAL FAILURE stroke, and cardiomyopathy.",NEPHRITIC RENAL FAILURE,FABRY DISEASE
720315711,5/12/2015 11:53:43,1634858758,5/12/2015 11:53:19,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[CAUSES],[CAUSES],often progresses to,N/A,61,27,1,83,40,TWrex-cause,812947-FS1,"41   In men (homozygotes), FABRY DISEASE often progresses to NEPHRITIC RENAL FAILURE stroke, and cardiomyopathy.",NEPHRITIC RENAL FAILURE,FABRY DISEASE
720315711,5/12/2015 11:55:02,1634859382,5/12/2015 11:54:13,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[SYMPTOM],[SYMPTOM],often progresses to,N/A,61,27,1,83,40,TWrex-cause,812947-FS1,"41   In men (homozygotes), FABRY DISEASE often progresses to NEPHRITIC RENAL FAILURE stroke, and cardiomyopathy.",NEPHRITIC RENAL FAILURE,FABRY DISEASE
720315711,5/12/2015 12:09:59,1634865978,5/12/2015 12:07:01,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[OTHER],[OTHER],progresses,N/A,61,27,1,83,40,TWrex-cause,812947-FS1,"41   In men (homozygotes), FABRY DISEASE often progresses to NEPHRITIC RENAL FAILURE stroke, and cardiomyopathy.",NEPHRITIC RENAL FAILURE,FABRY DISEASE
720315711,5/12/2015 12:37:10,1634878017,5/12/2015 12:36:21,false,clixsense,1.0,27969116,NLD,"","",212.78.195.38,[CAUSES],[CAUSES],often progresses to,it  progresses to..,61,27,1,83,40,TWrex-cause,812947-FS1,"41   In men (homozygotes), FABRY DISEASE often progresses to NEPHRITIC RENAL FAILURE stroke, and cardiomyopathy.",NEPHRITIC RENAL FAILURE,FABRY DISEASE
720315712,5/11/2015 22:21:29,1634403197,5/11/2015 22:21:19,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],WHITE PIEDRA,N/A,217,181,1,228,202,TWrex-cause,812309-FS1,"piedra    (            audio )  [Sp., stone] Sheathlike nodular masses in the hair of the beard and mustache from growth of either  Piedraia hortai,  which causes black piedra, or  TRICHOSPORON BEIGELII  which causes WHITE PIEDRA",WHITE PIEDRA,TRICHOSPORON BEIGELII
720315712,5/11/2015 22:23:18,1634404074,5/11/2015 22:23:02,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],which causes,n/a,217,181,1,228,202,TWrex-cause,812309-FS1,"piedra    (            audio )  [Sp., stone] Sheathlike nodular masses in the hair of the beard and mustache from growth of either  Piedraia hortai,  which causes black piedra, or  TRICHOSPORON BEIGELII  which causes WHITE PIEDRA",WHITE PIEDRA,TRICHOSPORON BEIGELII
720315712,5/11/2015 22:27:14,1634405717,5/11/2015 22:25:57,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],TRICHOSPORON BEIGELII causes WHITE PIEDRA,n/a,217,181,1,228,202,TWrex-cause,812309-FS1,"piedra    (            audio )  [Sp., stone] Sheathlike nodular masses in the hair of the beard and mustache from growth of either  Piedraia hortai,  which causes black piedra, or  TRICHOSPORON BEIGELII  which causes WHITE PIEDRA",WHITE PIEDRA,TRICHOSPORON BEIGELII
720315712,5/11/2015 22:36:28,1634409655,5/11/2015 22:35:45,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],TRICHOSPORON BEIGELII which causes WHITE PIEDRA,N/A,217,181,1,228,202,TWrex-cause,812309-FS1,"piedra    (            audio )  [Sp., stone] Sheathlike nodular masses in the hair of the beard and mustache from growth of either  Piedraia hortai,  which causes black piedra, or  TRICHOSPORON BEIGELII  which causes WHITE PIEDRA",WHITE PIEDRA,TRICHOSPORON BEIGELII
720315712,5/11/2015 22:36:39,1634409738,5/11/2015 22:36:11,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],which causes,n/a,217,181,1,228,202,TWrex-cause,812309-FS1,"piedra    (            audio )  [Sp., stone] Sheathlike nodular masses in the hair of the beard and mustache from growth of either  Piedraia hortai,  which causes black piedra, or  TRICHOSPORON BEIGELII  which causes WHITE PIEDRA",WHITE PIEDRA,TRICHOSPORON BEIGELII
720315712,5/11/2015 22:41:36,1634412136,5/11/2015 22:41:10,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[CAUSES],[CAUSES],TRICHOSPORON BEIGELII causes WHITE PIEDRA,n/a,217,181,1,228,202,TWrex-cause,812309-FS1,"piedra    (            audio )  [Sp., stone] Sheathlike nodular masses in the hair of the beard and mustache from growth of either  Piedraia hortai,  which causes black piedra, or  TRICHOSPORON BEIGELII  which causes WHITE PIEDRA",WHITE PIEDRA,TRICHOSPORON BEIGELII
720315712,5/11/2015 22:48:22,1634415410,5/11/2015 22:47:37,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],TRICHOSPORON BEIGELII causes WHITE PIEDRA,n/a,217,181,1,228,202,TWrex-cause,812309-FS1,"piedra    (            audio )  [Sp., stone] Sheathlike nodular masses in the hair of the beard and mustache from growth of either  Piedraia hortai,  which causes black piedra, or  TRICHOSPORON BEIGELII  which causes WHITE PIEDRA",WHITE PIEDRA,TRICHOSPORON BEIGELII
720315712,5/11/2015 22:56:27,1634418420,5/11/2015 22:54:58,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],"Sheathlike nodular masses in the hair of the beard and mustache from growth of either Piedraia hortai, which causes black piedra, or TRICHOSPORON BEIGELII which causes WHITE PIEDRA",N/A,217,181,1,228,202,TWrex-cause,812309-FS1,"piedra    (            audio )  [Sp., stone] Sheathlike nodular masses in the hair of the beard and mustache from growth of either  Piedraia hortai,  which causes black piedra, or  TRICHOSPORON BEIGELII  which causes WHITE PIEDRA",WHITE PIEDRA,TRICHOSPORON BEIGELII
720315712,5/11/2015 22:59:16,1634419314,5/11/2015 22:58:57,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,75.147.181.53,[CAUSES],[CAUSES],which causes,N/A,217,181,1,228,202,TWrex-cause,812309-FS1,"piedra    (            audio )  [Sp., stone] Sheathlike nodular masses in the hair of the beard and mustache from growth of either  Piedraia hortai,  which causes black piedra, or  TRICHOSPORON BEIGELII  which causes WHITE PIEDRA",WHITE PIEDRA,TRICHOSPORON BEIGELII
720315712,5/11/2015 23:02:32,1634420346,5/11/2015 23:01:29,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[MANIFESTATION],[MANIFESTATION],causes,n/a,217,181,1,228,202,TWrex-cause,812309-FS1,"piedra    (            audio )  [Sp., stone] Sheathlike nodular masses in the hair of the beard and mustache from growth of either  Piedraia hortai,  which causes black piedra, or  TRICHOSPORON BEIGELII  which causes WHITE PIEDRA",WHITE PIEDRA,TRICHOSPORON BEIGELII
720315712,5/11/2015 23:02:44,1634420443,5/11/2015 23:02:11,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],causes,N/A,217,181,1,228,202,TWrex-cause,812309-FS1,"piedra    (            audio )  [Sp., stone] Sheathlike nodular masses in the hair of the beard and mustache from growth of either  Piedraia hortai,  which causes black piedra, or  TRICHOSPORON BEIGELII  which causes WHITE PIEDRA",WHITE PIEDRA,TRICHOSPORON BEIGELII
720315712,5/11/2015 23:03:12,1634420626,5/11/2015 23:02:55,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],which causes,n/a,217,181,1,228,202,TWrex-cause,812309-FS1,"piedra    (            audio )  [Sp., stone] Sheathlike nodular masses in the hair of the beard and mustache from growth of either  Piedraia hortai,  which causes black piedra, or  TRICHOSPORON BEIGELII  which causes WHITE PIEDRA",WHITE PIEDRA,TRICHOSPORON BEIGELII
720315712,5/11/2015 23:03:33,1634420681,5/11/2015 23:03:05,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],causes,N/A,217,181,1,228,202,TWrex-cause,812309-FS1,"piedra    (            audio )  [Sp., stone] Sheathlike nodular masses in the hair of the beard and mustache from growth of either  Piedraia hortai,  which causes black piedra, or  TRICHOSPORON BEIGELII  which causes WHITE PIEDRA",WHITE PIEDRA,TRICHOSPORON BEIGELII
720315712,5/11/2015 23:03:34,1634420683,5/11/2015 23:01:58,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[CAUSES],[CAUSES],causes,the former causes the latter,217,181,1,228,202,TWrex-cause,812309-FS1,"piedra    (            audio )  [Sp., stone] Sheathlike nodular masses in the hair of the beard and mustache from growth of either  Piedraia hortai,  which causes black piedra, or  TRICHOSPORON BEIGELII  which causes WHITE PIEDRA",WHITE PIEDRA,TRICHOSPORON BEIGELII
720315712,5/11/2015 23:04:48,1634421087,5/11/2015 23:03:10,false,clixsense,1.0,6330007,AUS,06,Hobart,101.178.23.54,[CAUSES],[CAUSES],causes WHITE PIEDRA,n/a,217,181,1,228,202,TWrex-cause,812309-FS1,"piedra    (            audio )  [Sp., stone] Sheathlike nodular masses in the hair of the beard and mustache from growth of either  Piedraia hortai,  which causes black piedra, or  TRICHOSPORON BEIGELII  which causes WHITE PIEDRA",WHITE PIEDRA,TRICHOSPORON BEIGELII
720315713,5/11/2015 23:11:28,1634424960,5/11/2015 23:11:14,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],cases,N/A,35,105,1,75,114,TWrex-cause,810095-FS1,"Among young children, up to 50% of BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS cases may be caused by this BACTERIUM",BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS,BACTERIUM
720315713,5/11/2015 23:19:33,1634428860,5/11/2015 23:19:16,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],caused,N/A,35,105,1,75,114,TWrex-cause,810095-FS1,"Among young children, up to 50% of BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS cases may be caused by this BACTERIUM",BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS,BACTERIUM
720315713,5/11/2015 23:20:27,1634429250,5/11/2015 23:20:11,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],caused by,n/a,35,105,1,75,114,TWrex-cause,810095-FS1,"Among young children, up to 50% of BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS cases may be caused by this BACTERIUM",BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS,BACTERIUM
720315713,5/11/2015 23:23:02,1634430550,5/11/2015 23:22:49,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[CAUSES],[CAUSES],cases,n/a,35,105,1,75,114,TWrex-cause,810095-FS1,"Among young children, up to 50% of BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS cases may be caused by this BACTERIUM",BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS,BACTERIUM
720315713,5/11/2015 23:23:58,1634430936,5/11/2015 23:23:25,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[CAUSES],[CAUSES],caused,bacteria causes the blood poisoiing,35,105,1,75,114,TWrex-cause,810095-FS1,"Among young children, up to 50% of BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS cases may be caused by this BACTERIUM",BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS,BACTERIUM
720315713,5/11/2015 23:29:11,1634433199,5/11/2015 23:27:02,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],caused by,N/A,35,105,1,75,114,TWrex-cause,810095-FS1,"Among young children, up to 50% of BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS cases may be caused by this BACTERIUM",BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS,BACTERIUM
720315713,5/11/2015 23:29:22,1634433278,5/11/2015 23:29:05,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.48,[PREVENTS] [LOCATION] [NONE],"[PREVENTS]
[LOCATION]
[NONE]",no,no,35,105,1,75,114,TWrex-cause,810095-FS1,"Among young children, up to 50% of BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS cases may be caused by this BACTERIUM",BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS,BACTERIUM
720315713,5/11/2015 23:34:49,1634436299,5/11/2015 23:34:25,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[CAUSES],[CAUSES],caused,n/a,35,105,1,75,114,TWrex-cause,810095-FS1,"Among young children, up to 50% of BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS cases may be caused by this BACTERIUM",BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS,BACTERIUM
720315713,5/11/2015 23:40:51,1634440307,5/11/2015 23:39:37,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],caused,n/a,35,105,1,75,114,TWrex-cause,810095-FS1,"Among young children, up to 50% of BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS cases may be caused by this BACTERIUM",BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS,BACTERIUM
720315713,5/11/2015 23:41:23,1634440558,5/11/2015 23:40:56,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[CAUSES],[CAUSES],50% of BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS cases may be caused by BACTERIUM,n/a,35,105,1,75,114,TWrex-cause,810095-FS1,"Among young children, up to 50% of BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS cases may be caused by this BACTERIUM",BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS,BACTERIUM
720315713,5/11/2015 23:54:44,1634445983,5/11/2015 23:54:32,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],caused,n/a,35,105,1,75,114,TWrex-cause,810095-FS1,"Among young children, up to 50% of BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS cases may be caused by this BACTERIUM",BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS,BACTERIUM
720315713,5/12/2015 00:18:30,1634454645,5/12/2015 00:17:15,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],caused by,up to 50 percent caused by,35,105,1,75,114,TWrex-cause,810095-FS1,"Among young children, up to 50% of BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS cases may be caused by this BACTERIUM",BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS,BACTERIUM
720315713,5/12/2015 00:22:12,1634456090,5/12/2015 00:21:34,false,neodev,1,31066862,USA,CA,San Jose,128.107.241.188,[CAUSES],[CAUSES],caused by this,N/A,35,105,1,75,114,TWrex-cause,810095-FS1,"Among young children, up to 50% of BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS cases may be caused by this BACTERIUM",BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS,BACTERIUM
720315713,5/12/2015 00:23:50,1634456715,5/12/2015 00:22:38,false,gifthulk,1,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS caused by BACTERIUM,N/A,35,105,1,75,114,TWrex-cause,810095-FS1,"Among young children, up to 50% of BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS cases may be caused by this BACTERIUM",BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS,BACTERIUM
720315713,5/12/2015 00:31:14,1634459653,5/12/2015 00:30:32,false,elite,1.0,32306791,CAN,QC,Montréal,205.204.92.233,[PREVENTS] [TREATS] [NONE],"[TREATS]
[PREVENTS]
[NONE]",BACTERIUM,ghxg,35,105,1,75,114,TWrex-cause,810095-FS1,"Among young children, up to 50% of BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS cases may be caused by this BACTERIUM",BACTERIOLOGICALLY PROVEN SEPTIC ARTHRITIS,BACTERIUM
720315714,5/11/2015 22:25:03,1634404764,5/11/2015 22:24:51,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[LOCATION],[LOCATION],fetus.,N/A,35,0,-1,43,12,TWrex-cause,803321-FS1,STREPTOMYCIN is contraindicated in PREGNANCY because it may damage the 8th cranial nerve in the fetus.,PREGNANCY,STREPTOMYCIN
720315714,5/11/2015 22:26:26,1634405403,5/11/2015 22:26:08,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CONTRAINDICATES],[CONTRAINDICATES],contraindicated,n/a,35,0,-1,43,12,TWrex-cause,803321-FS1,STREPTOMYCIN is contraindicated in PREGNANCY because it may damage the 8th cranial nerve in the fetus.,PREGNANCY,STREPTOMYCIN
720315714,5/11/2015 22:35:14,1634409183,5/11/2015 22:34:03,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CONTRAINDICATES],[CONTRAINDICATES],STREPTOMYCIN is contraindicated in PREGNANCY,n/a,35,0,-1,43,12,TWrex-cause,803321-FS1,STREPTOMYCIN is contraindicated in PREGNANCY because it may damage the 8th cranial nerve in the fetus.,PREGNANCY,STREPTOMYCIN
720315714,5/11/2015 22:44:10,1634413354,5/11/2015 22:43:51,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CONTRAINDICATES],[CONTRAINDICATES],contraindicated,n/a,35,0,-1,43,12,TWrex-cause,803321-FS1,STREPTOMYCIN is contraindicated in PREGNANCY because it may damage the 8th cranial nerve in the fetus.,PREGNANCY,STREPTOMYCIN
720315714,5/11/2015 22:46:30,1634414347,5/11/2015 22:46:00,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CONTRAINDICATES],[CONTRAINDICATES],STREPTOMYCIN is contraindicated in PREGNANCY,N/A,35,0,-1,43,12,TWrex-cause,803321-FS1,STREPTOMYCIN is contraindicated in PREGNANCY because it may damage the 8th cranial nerve in the fetus.,PREGNANCY,STREPTOMYCIN
720315714,5/11/2015 22:48:41,1634415581,5/11/2015 22:48:25,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[CONTRAINDICATES],[CONTRAINDICATES],STREPTOMYCIN contraindicated in PREGNANCY,n/a,35,0,-1,43,12,TWrex-cause,803321-FS1,STREPTOMYCIN is contraindicated in PREGNANCY because it may damage the 8th cranial nerve in the fetus.,PREGNANCY,STREPTOMYCIN
720315714,5/11/2015 22:58:51,1634419166,5/11/2015 22:58:29,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CONTRAINDICATES],[CONTRAINDICATES],STREPTOMYCIN contraindicated in PREGNANCY,n/a,35,0,-1,43,12,TWrex-cause,803321-FS1,STREPTOMYCIN is contraindicated in PREGNANCY because it may damage the 8th cranial nerve in the fetus.,PREGNANCY,STREPTOMYCIN
720315714,5/11/2015 23:03:59,1634420848,5/11/2015 23:03:40,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,75.147.181.53,[CONTRAINDICATES],[CONTRAINDICATES],is contraindicated in,N/A,35,0,-1,43,12,TWrex-cause,803321-FS1,STREPTOMYCIN is contraindicated in PREGNANCY because it may damage the 8th cranial nerve in the fetus.,PREGNANCY,STREPTOMYCIN
720315714,5/11/2015 23:08:38,1634422693,5/11/2015 23:08:21,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,35,0,-1,43,12,TWrex-cause,803321-FS1,STREPTOMYCIN is contraindicated in PREGNANCY because it may damage the 8th cranial nerve in the fetus.,PREGNANCY,STREPTOMYCIN
720315714,5/11/2015 23:10:38,1634424365,5/11/2015 23:09:42,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SIDE_EFFECT],[SIDE_EFFECT],STREPTOMYCIN is contraindicated in PREGNANCY because it may damage the 8th cranial nerve in the fetus.,N/A,35,0,-1,43,12,TWrex-cause,803321-FS1,STREPTOMYCIN is contraindicated in PREGNANCY because it may damage the 8th cranial nerve in the fetus.,PREGNANCY,STREPTOMYCIN
720315714,5/11/2015 23:13:33,1634426176,5/11/2015 23:13:01,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[CONTRAINDICATES],[CONTRAINDICATES],contraindicated,n/a,35,0,-1,43,12,TWrex-cause,803321-FS1,STREPTOMYCIN is contraindicated in PREGNANCY because it may damage the 8th cranial nerve in the fetus.,PREGNANCY,STREPTOMYCIN
720315714,5/11/2015 23:13:56,1634426452,5/11/2015 23:12:18,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[CONTRAINDICATES],[CONTRAINDICATES],contraindicated,the drug is not advised in pregnancy,35,0,-1,43,12,TWrex-cause,803321-FS1,STREPTOMYCIN is contraindicated in PREGNANCY because it may damage the 8th cranial nerve in the fetus.,PREGNANCY,STREPTOMYCIN
720315714,5/11/2015 23:14:23,1634426642,5/11/2015 23:13:47,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CONTRAINDICATES],[CONTRAINDICATES],contraindicated in,N/A,35,0,-1,43,12,TWrex-cause,803321-FS1,STREPTOMYCIN is contraindicated in PREGNANCY because it may damage the 8th cranial nerve in the fetus.,PREGNANCY,STREPTOMYCIN
720315714,5/11/2015 23:14:39,1634426803,5/11/2015 23:13:54,false,clixsense,1.0,6330007,AUS,06,Hobart,101.178.23.54,[CONTRAINDICATES],[CONTRAINDICATES],contraindicated in,n/a,35,0,-1,43,12,TWrex-cause,803321-FS1,STREPTOMYCIN is contraindicated in PREGNANCY because it may damage the 8th cranial nerve in the fetus.,PREGNANCY,STREPTOMYCIN
720315714,5/11/2015 23:15:20,1634427143,5/11/2015 23:15:02,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CONTRAINDICATES],[CONTRAINDICATES],contraindicated,N/A,35,0,-1,43,12,TWrex-cause,803321-FS1,STREPTOMYCIN is contraindicated in PREGNANCY because it may damage the 8th cranial nerve in the fetus.,PREGNANCY,STREPTOMYCIN
720315715,5/11/2015 22:17:51,1634401320,5/11/2015 22:17:40,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],VENOUS THROMBOEMBOLISM,N/A,88,42,-1,109,65,TWrex-cause,804895-FS1,2007 11 01  Oral dabigatran etexilate vs. SUBCUTANEOUS ENOXAPARIN for the prevention of VENOUS THROMBOEMBOLISM after total knee replacement: the RE MODEL randomized trial.,VENOUS THROMBOEMBOLISM,SUBCUTANEOUS ENOXAPARIN
720315715,5/11/2015 22:19:40,1634402269,5/11/2015 22:18:48,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[PREVENTS],[PREVENTS],SUBCUTANEOUS ENOXAPARIN for the prevention of VENOUS THROMBOEMBOLISM,na,88,42,-1,109,65,TWrex-cause,804895-FS1,2007 11 01  Oral dabigatran etexilate vs. SUBCUTANEOUS ENOXAPARIN for the prevention of VENOUS THROMBOEMBOLISM after total knee replacement: the RE MODEL randomized trial.,VENOUS THROMBOEMBOLISM,SUBCUTANEOUS ENOXAPARIN
720315715,5/11/2015 22:20:11,1634402514,5/11/2015 22:19:57,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[PREVENTS],[PREVENTS],prevention,n/a,88,42,-1,109,65,TWrex-cause,804895-FS1,2007 11 01  Oral dabigatran etexilate vs. SUBCUTANEOUS ENOXAPARIN for the prevention of VENOUS THROMBOEMBOLISM after total knee replacement: the RE MODEL randomized trial.,VENOUS THROMBOEMBOLISM,SUBCUTANEOUS ENOXAPARIN
720315715,5/11/2015 22:25:47,1634405089,5/11/2015 22:25:12,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[PREVENTS],[PREVENTS],SUBCUTANEOUS ENOXAPARIN for the prevention of VENOUS THROMBOEMBOLISM,N/A,88,42,-1,109,65,TWrex-cause,804895-FS1,2007 11 01  Oral dabigatran etexilate vs. SUBCUTANEOUS ENOXAPARIN for the prevention of VENOUS THROMBOEMBOLISM after total knee replacement: the RE MODEL randomized trial.,VENOUS THROMBOEMBOLISM,SUBCUTANEOUS ENOXAPARIN
720315715,5/11/2015 22:27:52,1634405986,5/11/2015 22:27:17,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[PREVENTS],[PREVENTS],prevention,n/a,88,42,-1,109,65,TWrex-cause,804895-FS1,2007 11 01  Oral dabigatran etexilate vs. SUBCUTANEOUS ENOXAPARIN for the prevention of VENOUS THROMBOEMBOLISM after total knee replacement: the RE MODEL randomized trial.,VENOUS THROMBOEMBOLISM,SUBCUTANEOUS ENOXAPARIN
720315715,5/11/2015 22:35:20,1634409220,5/11/2015 22:35:00,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[PREVENTS],[PREVENTS],prevention,n/a,88,42,-1,109,65,TWrex-cause,804895-FS1,2007 11 01  Oral dabigatran etexilate vs. SUBCUTANEOUS ENOXAPARIN for the prevention of VENOUS THROMBOEMBOLISM after total knee replacement: the RE MODEL randomized trial.,VENOUS THROMBOEMBOLISM,SUBCUTANEOUS ENOXAPARIN
720315715,5/11/2015 22:35:34,1634409339,5/11/2015 22:35:15,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[PREVENTS],[PREVENTS],for the prevention of,n/a,88,42,-1,109,65,TWrex-cause,804895-FS1,2007 11 01  Oral dabigatran etexilate vs. SUBCUTANEOUS ENOXAPARIN for the prevention of VENOUS THROMBOEMBOLISM after total knee replacement: the RE MODEL randomized trial.,VENOUS THROMBOEMBOLISM,SUBCUTANEOUS ENOXAPARIN
720315715,5/11/2015 22:39:58,1634411525,5/11/2015 22:39:13,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[PREVENTS],[PREVENTS],SUBCUTANEOUS ENOXAPARIN for prevention of VENOUS THROMBOEMBOLISM,n/a,88,42,-1,109,65,TWrex-cause,804895-FS1,2007 11 01  Oral dabigatran etexilate vs. SUBCUTANEOUS ENOXAPARIN for the prevention of VENOUS THROMBOEMBOLISM after total knee replacement: the RE MODEL randomized trial.,VENOUS THROMBOEMBOLISM,SUBCUTANEOUS ENOXAPARIN
720315715,5/11/2015 22:44:06,1634413313,5/11/2015 22:43:46,false,instagc,1.0,28519532,USA,IA,Neola,38.121.112.217,[PREVENTS],[PREVENTS],for the prevention of,na,88,42,-1,109,65,TWrex-cause,804895-FS1,2007 11 01  Oral dabigatran etexilate vs. SUBCUTANEOUS ENOXAPARIN for the prevention of VENOUS THROMBOEMBOLISM after total knee replacement: the RE MODEL randomized trial.,VENOUS THROMBOEMBOLISM,SUBCUTANEOUS ENOXAPARIN
720315715,5/11/2015 22:44:35,1634413541,5/11/2015 22:43:24,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[LOCATION],[LOCATION],Oral dabigatran etexilate vs. SUBCUTANEOUS ENOXAPARIN for the prevention of VENOUS THROMBOEMBOLISM after total knee replacement: the RE MODEL randomized trial.,N/A,88,42,-1,109,65,TWrex-cause,804895-FS1,2007 11 01  Oral dabigatran etexilate vs. SUBCUTANEOUS ENOXAPARIN for the prevention of VENOUS THROMBOEMBOLISM after total knee replacement: the RE MODEL randomized trial.,VENOUS THROMBOEMBOLISM,SUBCUTANEOUS ENOXAPARIN
720315715,5/11/2015 22:53:48,1634417527,5/11/2015 22:53:29,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,75.147.181.53,[PREVENTS],[PREVENTS],for the prevention of,N/A,88,42,-1,109,65,TWrex-cause,804895-FS1,2007 11 01  Oral dabigatran etexilate vs. SUBCUTANEOUS ENOXAPARIN for the prevention of VENOUS THROMBOEMBOLISM after total knee replacement: the RE MODEL randomized trial.,VENOUS THROMBOEMBOLISM,SUBCUTANEOUS ENOXAPARIN
720315715,5/11/2015 22:54:50,1634417879,5/11/2015 22:54:26,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[PREVENTS],[PREVENTS],prevention of,N/A,88,42,-1,109,65,TWrex-cause,804895-FS1,2007 11 01  Oral dabigatran etexilate vs. SUBCUTANEOUS ENOXAPARIN for the prevention of VENOUS THROMBOEMBOLISM after total knee replacement: the RE MODEL randomized trial.,VENOUS THROMBOEMBOLISM,SUBCUTANEOUS ENOXAPARIN
720315715,5/11/2015 22:55:08,1634417930,5/11/2015 22:54:24,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[PREVENTS],[PREVENTS],SUBCUTANEOUS ENOXAPARIN for prevention of VENOUS THROMBOEMBOLISM,n/a,88,42,-1,109,65,TWrex-cause,804895-FS1,2007 11 01  Oral dabigatran etexilate vs. SUBCUTANEOUS ENOXAPARIN for the prevention of VENOUS THROMBOEMBOLISM after total knee replacement: the RE MODEL randomized trial.,VENOUS THROMBOEMBOLISM,SUBCUTANEOUS ENOXAPARIN
720315715,5/11/2015 22:56:11,1634418322,5/11/2015 22:55:01,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[PREVENTS],[PREVENTS],prevention of,N/A,88,42,-1,109,65,TWrex-cause,804895-FS1,2007 11 01  Oral dabigatran etexilate vs. SUBCUTANEOUS ENOXAPARIN for the prevention of VENOUS THROMBOEMBOLISM after total knee replacement: the RE MODEL randomized trial.,VENOUS THROMBOEMBOLISM,SUBCUTANEOUS ENOXAPARIN
720315715,5/11/2015 22:56:50,1634418574,5/11/2015 22:55:00,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[PREVENTS],[PREVENTS],for the prevention of,n/a,88,42,-1,109,65,TWrex-cause,804895-FS1,2007 11 01  Oral dabigatran etexilate vs. SUBCUTANEOUS ENOXAPARIN for the prevention of VENOUS THROMBOEMBOLISM after total knee replacement: the RE MODEL randomized trial.,VENOUS THROMBOEMBOLISM,SUBCUTANEOUS ENOXAPARIN
720315716,5/12/2015 01:01:57,1634472597,5/12/2015 01:01:15,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[SIDE_EFFECT] [OTHER],"[SIDE_EFFECT]
[OTHER]",MEDICATION developed TOLERANCE,n/a,80,20,1,88,30,TWrex-cause,811066-FS1,He usually took the MEDICATION within the prescribed limits but developed rapid TOLERANCE and found himself taking 'a few more here and there',TOLERANCE,MEDICATION
720315716,5/12/2015 01:04:59,1634474025,5/12/2015 01:03:38,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[NONE],[NONE],N/A,N/A,80,20,1,88,30,TWrex-cause,811066-FS1,He usually took the MEDICATION within the prescribed limits but developed rapid TOLERANCE and found himself taking 'a few more here and there',TOLERANCE,MEDICATION
720315716,5/12/2015 01:15:16,1634479433,5/12/2015 01:14:55,false,elite,1.0,31848723,USA,"","",155.94.185.207,[SYMPTOM],[SYMPTOM],MEDICATION TOLERANCE,N/A,80,20,1,88,30,TWrex-cause,811066-FS1,He usually took the MEDICATION within the prescribed limits but developed rapid TOLERANCE and found himself taking 'a few more here and there',TOLERANCE,MEDICATION
720315716,5/12/2015 01:30:43,1634487603,5/12/2015 01:30:25,false,elite,1.0,32306791,USA,TX,Dallas,69.162.75.37,[PREVENTS],[PREVENTS],but found,N/A,80,20,1,88,30,TWrex-cause,811066-FS1,He usually took the MEDICATION within the prescribed limits but developed rapid TOLERANCE and found himself taking 'a few more here and there',TOLERANCE,MEDICATION
720315716,5/12/2015 01:32:36,1634488638,5/12/2015 01:30:51,false,instagc,1.0,32556346,USA,PA,Warren,207.255.244.59,[OTHER],[OTHER],developed,"This is not a side effect of something, but rather a tolerance for it, which I didn't see in any of the options.",80,20,1,88,30,TWrex-cause,811066-FS1,He usually took the MEDICATION within the prescribed limits but developed rapid TOLERANCE and found himself taking 'a few more here and there',TOLERANCE,MEDICATION
720315716,5/12/2015 01:43:42,1634494986,5/12/2015 01:43:13,false,instagc,1.0,30326470,USA,CA,San Diego,170.213.2.111,[SIDE_EFFECT],[SIDE_EFFECT],developed rapid,N/A,80,20,1,88,30,TWrex-cause,811066-FS1,He usually took the MEDICATION within the prescribed limits but developed rapid TOLERANCE and found himself taking 'a few more here and there',TOLERANCE,MEDICATION
720315716,5/12/2015 03:27:10,1634548636,5/12/2015 03:26:51,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[CAUSES],[CAUSES],developed,n/a,80,20,1,88,30,TWrex-cause,811066-FS1,He usually took the MEDICATION within the prescribed limits but developed rapid TOLERANCE and found himself taking 'a few more here and there',TOLERANCE,MEDICATION
720315716,5/12/2015 03:45:10,1634557515,5/12/2015 03:44:45,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.227,[SYMPTOM],[SYMPTOM],MEDICATION TOLERANCE,N/A,80,20,1,88,30,TWrex-cause,811066-FS1,He usually took the MEDICATION within the prescribed limits but developed rapid TOLERANCE and found himself taking 'a few more here and there',TOLERANCE,MEDICATION
720315716,5/12/2015 04:18:20,1634573504,5/12/2015 04:17:42,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[MANIFESTATION],[MANIFESTATION],developed rapid,N/A,80,20,1,88,30,TWrex-cause,811066-FS1,He usually took the MEDICATION within the prescribed limits but developed rapid TOLERANCE and found himself taking 'a few more here and there',TOLERANCE,MEDICATION
720315716,5/12/2015 04:57:05,1634592141,5/12/2015 04:55:25,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[SIDE_EFFECT],[SIDE_EFFECT],developed,none,80,20,1,88,30,TWrex-cause,811066-FS1,He usually took the MEDICATION within the prescribed limits but developed rapid TOLERANCE and found himself taking 'a few more here and there',TOLERANCE,MEDICATION
720315716,5/12/2015 05:09:19,1634599126,5/12/2015 05:08:46,false,neodev,1.0,31910622,USA,CA,San Francisco,108.169.6.201,[MANIFESTATION],[MANIFESTATION],developed rapid,I didn´t select none.,80,20,1,88,30,TWrex-cause,811066-FS1,He usually took the MEDICATION within the prescribed limits but developed rapid TOLERANCE and found himself taking 'a few more here and there',TOLERANCE,MEDICATION
720315716,5/12/2015 06:00:24,1634630499,5/12/2015 05:57:46,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[SIDE_EFFECT],[SIDE_EFFECT],developed,N/A,80,20,1,88,30,TWrex-cause,811066-FS1,He usually took the MEDICATION within the prescribed limits but developed rapid TOLERANCE and found himself taking 'a few more here and there',TOLERANCE,MEDICATION
720315716,5/12/2015 06:21:21,1634640517,5/12/2015 06:20:02,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[ASSOCIATED_WITH],[ASSOCIATED_WITH],developed,N/A,80,20,1,88,30,TWrex-cause,811066-FS1,He usually took the MEDICATION within the prescribed limits but developed rapid TOLERANCE and found himself taking 'a few more here and there',TOLERANCE,MEDICATION
720315716,5/12/2015 06:29:08,1634644384,5/12/2015 06:27:27,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[MANIFESTATION] [SIDE_EFFECT],"[MANIFESTATION]
[SIDE_EFFECT]",took the MEDICATION but developed rapid TOLERANCE,n/a,80,20,1,88,30,TWrex-cause,811066-FS1,He usually took the MEDICATION within the prescribed limits but developed rapid TOLERANCE and found himself taking 'a few more here and there',TOLERANCE,MEDICATION
720315716,5/12/2015 06:39:32,1634648853,5/12/2015 06:38:13,false,neodev,1,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],usually within the prescribed limits,n/a,80,20,1,88,30,TWrex-cause,811066-FS1,He usually took the MEDICATION within the prescribed limits but developed rapid TOLERANCE and found himself taking 'a few more here and there',TOLERANCE,MEDICATION
720315717,5/11/2015 23:55:59,1634446406,5/11/2015 23:55:43,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.48,[PREVENTS] [DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES] [NONE],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[NONE]",no,no,156,97,-1,184,106,TWrex-cause,803721-FS1,"Northfelt DW, Dezube B, Miller B et al. Randomized comparative trial of Doxil ®  vs. Adriamycin, BLEOMYCIN and vincristine (ABV) in the treatment of severe AIDS RELATED KAPOSI'S SARCOMA (AIDS KS.",AIDS RELATED KAPOSI'S SARCOMA,BLEOMYCIN
720315717,5/12/2015 00:48:10,1634466603,5/12/2015 00:47:03,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment of,N/A,156,97,-1,184,106,TWrex-cause,803721-FS1,"Northfelt DW, Dezube B, Miller B et al. Randomized comparative trial of Doxil ®  vs. Adriamycin, BLEOMYCIN and vincristine (ABV) in the treatment of severe AIDS RELATED KAPOSI'S SARCOMA (AIDS KS.",AIDS RELATED KAPOSI'S SARCOMA,BLEOMYCIN
720315717,5/12/2015 00:54:41,1634469093,5/12/2015 00:54:12,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[TREATS],[TREATS],BLEOMYCIN treatment of AIDS RELATED KAPOSI'S SARCOMA,n/a,156,97,-1,184,106,TWrex-cause,803721-FS1,"Northfelt DW, Dezube B, Miller B et al. Randomized comparative trial of Doxil ®  vs. Adriamycin, BLEOMYCIN and vincristine (ABV) in the treatment of severe AIDS RELATED KAPOSI'S SARCOMA (AIDS KS.",AIDS RELATED KAPOSI'S SARCOMA,BLEOMYCIN
720315717,5/12/2015 00:55:04,1634469247,5/12/2015 00:53:07,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[TREATS],[TREATS],treatment of severe,N/A,156,97,-1,184,106,TWrex-cause,803721-FS1,"Northfelt DW, Dezube B, Miller B et al. Randomized comparative trial of Doxil ®  vs. Adriamycin, BLEOMYCIN and vincristine (ABV) in the treatment of severe AIDS RELATED KAPOSI'S SARCOMA (AIDS KS.",AIDS RELATED KAPOSI'S SARCOMA,BLEOMYCIN
720315717,5/12/2015 01:11:23,1634477322,5/12/2015 01:10:52,false,elite,1.0,31848723,USA,"","",155.94.185.207,[SYMPTOM],[SYMPTOM],Dezube BLEOMYCIN KAPOSI'S (AIDS,N/A,156,97,-1,184,106,TWrex-cause,803721-FS1,"Northfelt DW, Dezube B, Miller B et al. Randomized comparative trial of Doxil ®  vs. Adriamycin, BLEOMYCIN and vincristine (ABV) in the treatment of severe AIDS RELATED KAPOSI'S SARCOMA (AIDS KS.",AIDS RELATED KAPOSI'S SARCOMA,BLEOMYCIN
720315717,5/12/2015 01:27:16,1634485953,5/12/2015 01:26:58,false,elite,1.0,32306791,USA,TX,Dallas,69.162.75.37,[LOCATION],[LOCATION],Randomized SARCOMA,na,156,97,-1,184,106,TWrex-cause,803721-FS1,"Northfelt DW, Dezube B, Miller B et al. Randomized comparative trial of Doxil ®  vs. Adriamycin, BLEOMYCIN and vincristine (ABV) in the treatment of severe AIDS RELATED KAPOSI'S SARCOMA (AIDS KS.",AIDS RELATED KAPOSI'S SARCOMA,BLEOMYCIN
720315717,5/12/2015 01:27:53,1634486296,5/12/2015 01:27:39,false,instagc,1.0,32556346,USA,PA,Warren,207.255.244.59,[TREATS],[TREATS],treatment,N/A,156,97,-1,184,106,TWrex-cause,803721-FS1,"Northfelt DW, Dezube B, Miller B et al. Randomized comparative trial of Doxil ®  vs. Adriamycin, BLEOMYCIN and vincristine (ABV) in the treatment of severe AIDS RELATED KAPOSI'S SARCOMA (AIDS KS.",AIDS RELATED KAPOSI'S SARCOMA,BLEOMYCIN
720315717,5/12/2015 01:38:24,1634491945,5/12/2015 01:37:54,false,instagc,1.0,30326470,USA,CA,San Diego,170.213.2.111,[TREATS],[TREATS],treatment of,N/A,156,97,-1,184,106,TWrex-cause,803721-FS1,"Northfelt DW, Dezube B, Miller B et al. Randomized comparative trial of Doxil ®  vs. Adriamycin, BLEOMYCIN and vincristine (ABV) in the treatment of severe AIDS RELATED KAPOSI'S SARCOMA (AIDS KS.",AIDS RELATED KAPOSI'S SARCOMA,BLEOMYCIN
720315717,5/12/2015 03:24:43,1634547257,5/12/2015 03:24:22,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[TREATS],[TREATS],treatment,n/a,156,97,-1,184,106,TWrex-cause,803721-FS1,"Northfelt DW, Dezube B, Miller B et al. Randomized comparative trial of Doxil ®  vs. Adriamycin, BLEOMYCIN and vincristine (ABV) in the treatment of severe AIDS RELATED KAPOSI'S SARCOMA (AIDS KS.",AIDS RELATED KAPOSI'S SARCOMA,BLEOMYCIN
720315717,5/12/2015 03:40:43,1634555530,5/12/2015 03:40:06,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.227,[ASSOCIATED_WITH],[ASSOCIATED_WITH],BLEOMYCIN AIDS RELATED KAPOSI'S SARCOMA,N/A,156,97,-1,184,106,TWrex-cause,803721-FS1,"Northfelt DW, Dezube B, Miller B et al. Randomized comparative trial of Doxil ®  vs. Adriamycin, BLEOMYCIN and vincristine (ABV) in the treatment of severe AIDS RELATED KAPOSI'S SARCOMA (AIDS KS.",AIDS RELATED KAPOSI'S SARCOMA,BLEOMYCIN
720315717,5/12/2015 04:13:11,1634571340,5/12/2015 04:12:58,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[TREATS],[TREATS],treatment,N/A,156,97,-1,184,106,TWrex-cause,803721-FS1,"Northfelt DW, Dezube B, Miller B et al. Randomized comparative trial of Doxil ®  vs. Adriamycin, BLEOMYCIN and vincristine (ABV) in the treatment of severe AIDS RELATED KAPOSI'S SARCOMA (AIDS KS.",AIDS RELATED KAPOSI'S SARCOMA,BLEOMYCIN
720315717,5/12/2015 04:47:40,1634587541,5/12/2015 04:47:05,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treatment,none,156,97,-1,184,106,TWrex-cause,803721-FS1,"Northfelt DW, Dezube B, Miller B et al. Randomized comparative trial of Doxil ®  vs. Adriamycin, BLEOMYCIN and vincristine (ABV) in the treatment of severe AIDS RELATED KAPOSI'S SARCOMA (AIDS KS.",AIDS RELATED KAPOSI'S SARCOMA,BLEOMYCIN
720315717,5/12/2015 05:03:17,1634595610,5/12/2015 05:03:01,false,neodev,1.0,31910622,USA,CA,Los Angeles,108.185.211.151,[TREATS],[TREATS],treatment of severe,I didn´t select none.,156,97,-1,184,106,TWrex-cause,803721-FS1,"Northfelt DW, Dezube B, Miller B et al. Randomized comparative trial of Doxil ®  vs. Adriamycin, BLEOMYCIN and vincristine (ABV) in the treatment of severe AIDS RELATED KAPOSI'S SARCOMA (AIDS KS.",AIDS RELATED KAPOSI'S SARCOMA,BLEOMYCIN
720315717,5/12/2015 05:50:28,1634625644,5/12/2015 05:48:10,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treatment,N/A,156,97,-1,184,106,TWrex-cause,803721-FS1,"Northfelt DW, Dezube B, Miller B et al. Randomized comparative trial of Doxil ®  vs. Adriamycin, BLEOMYCIN and vincristine (ABV) in the treatment of severe AIDS RELATED KAPOSI'S SARCOMA (AIDS KS.",AIDS RELATED KAPOSI'S SARCOMA,BLEOMYCIN
720315717,5/12/2015 06:15:26,1634637839,5/12/2015 06:14:33,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[TREATS],[TREATS],treatment of,N/A,156,97,-1,184,106,TWrex-cause,803721-FS1,"Northfelt DW, Dezube B, Miller B et al. Randomized comparative trial of Doxil ®  vs. Adriamycin, BLEOMYCIN and vincristine (ABV) in the treatment of severe AIDS RELATED KAPOSI'S SARCOMA (AIDS KS.",AIDS RELATED KAPOSI'S SARCOMA,BLEOMYCIN
720315718,5/11/2015 23:26:10,1634431815,5/11/2015 23:25:41,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[SYMPTOM],[SYMPTOM],symptoms,N/A,97,133,1,100,135,TWrex-cause,814734-FS1,"PATHOPHYSIOLOGY  Enormous progress in our understanding of the pathophysiologic underpinnings of PAIN fatigue, and other symptoms in FM has been made in the last few years.",PAIN,FM
720315718,5/11/2015 23:41:27,1634440624,5/11/2015 23:40:51,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[SYMPTOM],[SYMPTOM],symptoms,n/a,97,133,1,100,135,TWrex-cause,814734-FS1,"PATHOPHYSIOLOGY  Enormous progress in our understanding of the pathophysiologic underpinnings of PAIN fatigue, and other symptoms in FM has been made in the last few years.",PAIN,FM
720315718,5/11/2015 23:54:05,1634445690,5/11/2015 23:53:52,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.48,[PREVENTS] [CAUSES] [LOCATION] [NONE],"[PREVENTS]
[CAUSES]
[LOCATION]
[NONE]",no,no,97,133,1,100,135,TWrex-cause,814734-FS1,"PATHOPHYSIOLOGY  Enormous progress in our understanding of the pathophysiologic underpinnings of PAIN fatigue, and other symptoms in FM has been made in the last few years.",PAIN,FM
720315718,5/12/2015 00:36:15,1634461535,5/12/2015 00:34:29,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],symptoms,symptom,97,133,1,100,135,TWrex-cause,814734-FS1,"PATHOPHYSIOLOGY  Enormous progress in our understanding of the pathophysiologic underpinnings of PAIN fatigue, and other symptoms in FM has been made in the last few years.",PAIN,FM
720315718,5/12/2015 00:49:06,1634466922,5/12/2015 00:47:49,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[NONE],[NONE],N/A,None,97,133,1,100,135,TWrex-cause,814734-FS1,"PATHOPHYSIOLOGY  Enormous progress in our understanding of the pathophysiologic underpinnings of PAIN fatigue, and other symptoms in FM has been made in the last few years.",PAIN,FM
720315718,5/12/2015 00:50:57,1634467689,5/12/2015 00:50:12,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[SYMPTOM] [ASSOCIATED_WITH] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]","PAIN fatigue, and other symptoms in FM",n/a,97,133,1,100,135,TWrex-cause,814734-FS1,"PATHOPHYSIOLOGY  Enormous progress in our understanding of the pathophysiologic underpinnings of PAIN fatigue, and other symptoms in FM has been made in the last few years.",PAIN,FM
720315718,5/12/2015 01:07:29,1634475295,5/12/2015 01:07:06,false,elite,1.0,31848723,USA,"","",155.94.185.207,[TREATS],[TREATS],PATHOPHYSIOLOGY PAIN,N/A,97,133,1,100,135,TWrex-cause,814734-FS1,"PATHOPHYSIOLOGY  Enormous progress in our understanding of the pathophysiologic underpinnings of PAIN fatigue, and other symptoms in FM has been made in the last few years.",PAIN,FM
720315718,5/12/2015 01:15:01,1634479293,5/12/2015 01:14:40,false,elite,1.0,32306791,NLD,"","",31.3.156.41,[LOCATION],[LOCATION],Enormous understanding,gdf,97,133,1,100,135,TWrex-cause,814734-FS1,"PATHOPHYSIOLOGY  Enormous progress in our understanding of the pathophysiologic underpinnings of PAIN fatigue, and other symptoms in FM has been made in the last few years.",PAIN,FM
720315718,5/12/2015 01:25:35,1634485176,5/12/2015 01:25:16,false,instagc,1.0,32556346,USA,PA,Warren,207.255.244.59,[SYMPTOM],[SYMPTOM],symptoms,N/A,97,133,1,100,135,TWrex-cause,814734-FS1,"PATHOPHYSIOLOGY  Enormous progress in our understanding of the pathophysiologic underpinnings of PAIN fatigue, and other symptoms in FM has been made in the last few years.",PAIN,FM
720315718,5/12/2015 01:33:55,1634489296,5/12/2015 01:33:07,false,instagc,1.0,30326470,USA,CA,San Diego,170.213.2.111,[OTHER],[OTHER],"underpinnings of PAIN fatigue, and other symptoms",N/A,97,133,1,100,135,TWrex-cause,814734-FS1,"PATHOPHYSIOLOGY  Enormous progress in our understanding of the pathophysiologic underpinnings of PAIN fatigue, and other symptoms in FM has been made in the last few years.",PAIN,FM
720315718,5/12/2015 03:22:36,1634545992,5/12/2015 03:22:19,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[SYMPTOM],[SYMPTOM],symptoms,n/a,97,133,1,100,135,TWrex-cause,814734-FS1,"PATHOPHYSIOLOGY  Enormous progress in our understanding of the pathophysiologic underpinnings of PAIN fatigue, and other symptoms in FM has been made in the last few years.",PAIN,FM
720315718,5/12/2015 03:36:21,1634553504,5/12/2015 03:35:33,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.227,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],PATHOPHYSIOLOGY PAIN FM,N/A,97,133,1,100,135,TWrex-cause,814734-FS1,"PATHOPHYSIOLOGY  Enormous progress in our understanding of the pathophysiologic underpinnings of PAIN fatigue, and other symptoms in FM has been made in the last few years.",PAIN,FM
720315718,5/12/2015 04:10:40,1634570088,5/12/2015 04:10:07,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[SYMPTOM],[SYMPTOM],other symptoms in,N/A,97,133,1,100,135,TWrex-cause,814734-FS1,"PATHOPHYSIOLOGY  Enormous progress in our understanding of the pathophysiologic underpinnings of PAIN fatigue, and other symptoms in FM has been made in the last few years.",PAIN,FM
720315718,5/12/2015 04:40:14,1634583897,5/12/2015 04:39:26,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],understanding,none,97,133,1,100,135,TWrex-cause,814734-FS1,"PATHOPHYSIOLOGY  Enormous progress in our understanding of the pathophysiologic underpinnings of PAIN fatigue, and other symptoms in FM has been made in the last few years.",PAIN,FM
720315718,5/12/2015 04:59:37,1634593513,5/12/2015 04:59:13,false,neodev,1.0,31910622,USA,CA,Los Angeles,108.185.211.151,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",other symptoms in,I didn´t select none.,97,133,1,100,135,TWrex-cause,814734-FS1,"PATHOPHYSIOLOGY  Enormous progress in our understanding of the pathophysiologic underpinnings of PAIN fatigue, and other symptoms in FM has been made in the last few years.",PAIN,FM
720315719,5/11/2015 22:20:02,1634402428,5/11/2015 22:19:43,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[PREVENTS],[PREVENTS],"neuropathy,",N/A,92,125,1,95,137,TWrex-cause,812711-FS1,"MAIN RESULTS  Pregabalin, ≥ 300 mg/d, reduced pain in patients with postherpetic neuralgia, PAINful diabetic neuropathy, and FIBROMYALGIA; 600 mg/d reduced pain in patients with central neuropathic pain (Table.",PAIN,FIBROMYALGIA
720315719,5/11/2015 22:22:04,1634403508,5/11/2015 22:21:40,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],pain,n/a,92,125,1,95,137,TWrex-cause,812711-FS1,"MAIN RESULTS  Pregabalin, ≥ 300 mg/d, reduced pain in patients with postherpetic neuralgia, PAINful diabetic neuropathy, and FIBROMYALGIA; 600 mg/d reduced pain in patients with central neuropathic pain (Table.",PAIN,FIBROMYALGIA
720315719,5/11/2015 22:23:57,1634404307,5/11/2015 22:23:40,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],PAINful and FIBROMYALGIA;,n/a,92,125,1,95,137,TWrex-cause,812711-FS1,"MAIN RESULTS  Pregabalin, ≥ 300 mg/d, reduced pain in patients with postherpetic neuralgia, PAINful diabetic neuropathy, and FIBROMYALGIA; 600 mg/d reduced pain in patients with central neuropathic pain (Table.",PAIN,FIBROMYALGIA
720315719,5/11/2015 22:32:54,1634407812,5/11/2015 22:30:50,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[NONE],[NONE],N/A,There doesn't appear to be any relation between the two terms...they are mentioned together and treated by the same drug only.,92,125,1,95,137,TWrex-cause,812711-FS1,"MAIN RESULTS  Pregabalin, ≥ 300 mg/d, reduced pain in patients with postherpetic neuralgia, PAINful diabetic neuropathy, and FIBROMYALGIA; 600 mg/d reduced pain in patients with central neuropathic pain (Table.",PAIN,FIBROMYALGIA
720315719,5/11/2015 22:32:59,1634407885,5/11/2015 22:32:21,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[MANIFESTATION],[MANIFESTATION],reduced pain in patients with FIBROMYALGIA;,n/a,92,125,1,95,137,TWrex-cause,812711-FS1,"MAIN RESULTS  Pregabalin, ≥ 300 mg/d, reduced pain in patients with postherpetic neuralgia, PAINful diabetic neuropathy, and FIBROMYALGIA; 600 mg/d reduced pain in patients with central neuropathic pain (Table.",PAIN,FIBROMYALGIA
720315719,5/11/2015 22:38:45,1634410934,5/11/2015 22:37:51,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[OTHER],[OTHER],"reduced pain in PAINful diabetic neuropathy, and FIBROMYALGIA;",n/a,92,125,1,95,137,TWrex-cause,812711-FS1,"MAIN RESULTS  Pregabalin, ≥ 300 mg/d, reduced pain in patients with postherpetic neuralgia, PAINful diabetic neuropathy, and FIBROMYALGIA; 600 mg/d reduced pain in patients with central neuropathic pain (Table.",PAIN,FIBROMYALGIA
720315719,5/11/2015 22:42:07,1634412304,5/11/2015 22:40:21,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[PREVENTS],[PREVENTS],reduced,n/a,92,125,1,95,137,TWrex-cause,812711-FS1,"MAIN RESULTS  Pregabalin, ≥ 300 mg/d, reduced pain in patients with postherpetic neuralgia, PAINful diabetic neuropathy, and FIBROMYALGIA; 600 mg/d reduced pain in patients with central neuropathic pain (Table.",PAIN,FIBROMYALGIA
720315719,5/11/2015 22:45:04,1634413733,5/11/2015 22:44:23,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],PAINful and FIBROMYALGIA;,n/a,92,125,1,95,137,TWrex-cause,812711-FS1,"MAIN RESULTS  Pregabalin, ≥ 300 mg/d, reduced pain in patients with postherpetic neuralgia, PAINful diabetic neuropathy, and FIBROMYALGIA; 600 mg/d reduced pain in patients with central neuropathic pain (Table.",PAIN,FIBROMYALGIA
720315719,5/11/2015 22:47:02,1634414656,5/11/2015 22:46:27,false,instagc,1.0,28519532,USA,IA,Neola,38.121.112.217,[SYMPTOM],[SYMPTOM],reduced pain in patients with FIBROMYALGIA;,na,92,125,1,95,137,TWrex-cause,812711-FS1,"MAIN RESULTS  Pregabalin, ≥ 300 mg/d, reduced pain in patients with postherpetic neuralgia, PAINful diabetic neuropathy, and FIBROMYALGIA; 600 mg/d reduced pain in patients with central neuropathic pain (Table.",PAIN,FIBROMYALGIA
720315719,5/11/2015 22:51:35,1634416815,5/11/2015 22:50:25,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"MAIN RESULTS Pregabalin, ≥ 300 mg/d, reduced pain in patients with postherpetic neuralgia, PAINful diabetic neuropathy, and FIBROMYALGIA; 600 mg/d reduced pain in patients with central neuropathic pain",N/A,92,125,1,95,137,TWrex-cause,812711-FS1,"MAIN RESULTS  Pregabalin, ≥ 300 mg/d, reduced pain in patients with postherpetic neuralgia, PAINful diabetic neuropathy, and FIBROMYALGIA; 600 mg/d reduced pain in patients with central neuropathic pain (Table.",PAIN,FIBROMYALGIA
720315719,5/11/2015 22:57:16,1634418714,5/11/2015 22:56:24,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,75.147.181.53,[CAUSES] [SYMPTOM],"[CAUSES]
[SYMPTOM]",pain in pain in,N/A,92,125,1,95,137,TWrex-cause,812711-FS1,"MAIN RESULTS  Pregabalin, ≥ 300 mg/d, reduced pain in patients with postherpetic neuralgia, PAINful diabetic neuropathy, and FIBROMYALGIA; 600 mg/d reduced pain in patients with central neuropathic pain (Table.",PAIN,FIBROMYALGIA
720315719,5/11/2015 22:59:48,1634419458,5/11/2015 22:58:23,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],and,N/A,92,125,1,95,137,TWrex-cause,812711-FS1,"MAIN RESULTS  Pregabalin, ≥ 300 mg/d, reduced pain in patients with postherpetic neuralgia, PAINful diabetic neuropathy, and FIBROMYALGIA; 600 mg/d reduced pain in patients with central neuropathic pain (Table.",PAIN,FIBROMYALGIA
720315719,5/11/2015 23:00:17,1634419572,5/11/2015 22:58:45,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[MANIFESTATION],[MANIFESTATION],reduced pain,n/a,92,125,1,95,137,TWrex-cause,812711-FS1,"MAIN RESULTS  Pregabalin, ≥ 300 mg/d, reduced pain in patients with postherpetic neuralgia, PAINful diabetic neuropathy, and FIBROMYALGIA; 600 mg/d reduced pain in patients with central neuropathic pain (Table.",PAIN,FIBROMYALGIA
720315719,5/11/2015 23:00:28,1634419622,5/11/2015 22:59:37,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",reduced,pain is a mainfestation and is reduced by the medication,92,125,1,95,137,TWrex-cause,812711-FS1,"MAIN RESULTS  Pregabalin, ≥ 300 mg/d, reduced pain in patients with postherpetic neuralgia, PAINful diabetic neuropathy, and FIBROMYALGIA; 600 mg/d reduced pain in patients with central neuropathic pain (Table.",PAIN,FIBROMYALGIA
720315719,5/11/2015 23:01:31,1634420028,5/11/2015 22:58:56,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[NONE],[NONE],n/a,two different conditions,92,125,1,95,137,TWrex-cause,812711-FS1,"MAIN RESULTS  Pregabalin, ≥ 300 mg/d, reduced pain in patients with postherpetic neuralgia, PAINful diabetic neuropathy, and FIBROMYALGIA; 600 mg/d reduced pain in patients with central neuropathic pain (Table.",PAIN,FIBROMYALGIA
720315720,5/12/2015 06:30:30,1634644937,5/12/2015 06:27:53,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[OTHER],[OTHER],or,N/A,114,45,1,122,58,TWrex-cause,810897-FS1,"41   However, those who develop varicella or HERPES ZOSTER  after  transplantation should be considered immune to VARICELLA",VARICELLA,HERPES ZOSTER
720315720,5/12/2015 06:34:40,1634646950,5/12/2015 06:33:36,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[ASSOCIATED_WITH],[ASSOCIATED_WITH],transplantation,N/A,114,45,1,122,58,TWrex-cause,810897-FS1,"41   However, those who develop varicella or HERPES ZOSTER  after  transplantation should be considered immune to VARICELLA",VARICELLA,HERPES ZOSTER
720315720,5/12/2015 06:51:12,1634653989,5/12/2015 06:50:47,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],varicella or,N/A,114,45,1,122,58,TWrex-cause,810897-FS1,"41   However, those who develop varicella or HERPES ZOSTER  after  transplantation should be considered immune to VARICELLA",VARICELLA,HERPES ZOSTER
720315720,5/12/2015 06:53:57,1634655136,5/12/2015 06:52:38,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[ASSOCIATED_WITH],[ASSOCIATED_WITH],after,NA,114,45,1,122,58,TWrex-cause,810897-FS1,"41   However, those who develop varicella or HERPES ZOSTER  after  transplantation should be considered immune to VARICELLA",VARICELLA,HERPES ZOSTER
720315720,5/12/2015 07:07:01,1634660891,5/12/2015 07:05:56,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[MANIFESTATION],[MANIFESTATION],immune to,n/a,114,45,1,122,58,TWrex-cause,810897-FS1,"41   However, those who develop varicella or HERPES ZOSTER  after  transplantation should be considered immune to VARICELLA",VARICELLA,HERPES ZOSTER
720315720,5/12/2015 08:02:23,1634694432,5/12/2015 08:01:32,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[PREVENTS] [SYMPTOM],"[PREVENTS]
[SYMPTOM]",should considered immune to,N/A,114,45,1,122,58,TWrex-cause,810897-FS1,"41   However, those who develop varicella or HERPES ZOSTER  after  transplantation should be considered immune to VARICELLA",VARICELLA,HERPES ZOSTER
720315720,5/12/2015 08:17:50,1634702214,5/12/2015 08:17:07,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[OTHER],[OTHER],immune,Immune,114,45,1,122,58,TWrex-cause,810897-FS1,"41   However, those who develop varicella or HERPES ZOSTER  after  transplantation should be considered immune to VARICELLA",VARICELLA,HERPES ZOSTER
720315720,5/12/2015 08:55:31,1634722641,5/12/2015 08:55:01,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[CAUSES],[CAUSES],develop,N/A,114,45,1,122,58,TWrex-cause,810897-FS1,"41   However, those who develop varicella or HERPES ZOSTER  after  transplantation should be considered immune to VARICELLA",VARICELLA,HERPES ZOSTER
720315720,5/12/2015 09:01:40,1634725694,5/12/2015 09:01:04,false,inboxpounds,1.0,29059658,GBR,H9,London,79.77.3.89,[CAUSES],[CAUSES],after transplantation should be considered immune,N/A,114,45,1,122,58,TWrex-cause,810897-FS1,"41   However, those who develop varicella or HERPES ZOSTER  after  transplantation should be considered immune to VARICELLA",VARICELLA,HERPES ZOSTER
720315720,5/12/2015 11:03:21,1634825579,5/12/2015 11:03:00,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],considered immune,n/a,114,45,1,122,58,TWrex-cause,810897-FS1,"41   However, those who develop varicella or HERPES ZOSTER  after  transplantation should be considered immune to VARICELLA",VARICELLA,HERPES ZOSTER
720315720,5/12/2015 11:48:16,1634855917,5/12/2015 11:46:26,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],develop varicella HERPES ZOSTER after,N/A,114,45,1,122,58,TWrex-cause,810897-FS1,"41   However, those who develop varicella or HERPES ZOSTER  after  transplantation should be considered immune to VARICELLA",VARICELLA,HERPES ZOSTER
720315720,5/12/2015 11:55:59,1634859751,5/12/2015 11:55:13,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[OTHER],[OTHER],or,N/A,114,45,1,122,58,TWrex-cause,810897-FS1,"41   However, those who develop varicella or HERPES ZOSTER  after  transplantation should be considered immune to VARICELLA",VARICELLA,HERPES ZOSTER
720315720,5/12/2015 11:57:03,1634860260,5/12/2015 11:56:30,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[SIDE_EFFECT],[SIDE_EFFECT],should be considered immune to,N/A,114,45,1,122,58,TWrex-cause,810897-FS1,"41   However, those who develop varicella or HERPES ZOSTER  after  transplantation should be considered immune to VARICELLA",VARICELLA,HERPES ZOSTER
720315720,5/12/2015 12:13:09,1634867357,5/12/2015 12:12:05,false,neodev,1,30588889,NLD,07,Amsterdam,77.248.175.222,[ASSOCIATED_WITH],[ASSOCIATED_WITH],considered immune,N/A,114,45,1,122,58,TWrex-cause,810897-FS1,"41   However, those who develop varicella or HERPES ZOSTER  after  transplantation should be considered immune to VARICELLA",VARICELLA,HERPES ZOSTER
720315720,5/12/2015 12:40:22,1634879601,5/12/2015 12:39:03,false,clixsense,1.0,27969116,NLD,"","",212.78.195.38,[OTHER],[OTHER],considered immune,should be immune to it.,114,45,1,122,58,TWrex-cause,810897-FS1,"41   However, those who develop varicella or HERPES ZOSTER  after  transplantation should be considered immune to VARICELLA",VARICELLA,HERPES ZOSTER
720315721,5/11/2015 22:19:42,1634402278,5/11/2015 22:19:22,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],LIVER,N/A,155,0,-1,176,21,TWrex-cause,802518-FS1,"SYSTEMIC MASTOCYTOSIS most commonly occurs in adults and is characterized by multifocal bone marrow lesions; it often involves other organs, most commonly SKIN LYMPH NODES LIVER spleen, or GI tract.",SKIN LYMPH NODES LIVER,SYSTEMIC MASTOCYTOSIS
720315721,5/11/2015 22:21:39,1634403306,5/11/2015 22:21:21,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],characterized by,n/a,155,0,-1,176,21,TWrex-cause,802518-FS1,"SYSTEMIC MASTOCYTOSIS most commonly occurs in adults and is characterized by multifocal bone marrow lesions; it often involves other organs, most commonly SKIN LYMPH NODES LIVER spleen, or GI tract.",SKIN LYMPH NODES LIVER,SYSTEMIC MASTOCYTOSIS
720315721,5/11/2015 22:22:33,1634403695,5/11/2015 22:21:55,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[ASSOCIATED_WITH],[ASSOCIATED_WITH],SYSTEMIC MASTOCYTOSIS characterized by SKIN LYMPH NODES LIVER,n/a,155,0,-1,176,21,TWrex-cause,802518-FS1,"SYSTEMIC MASTOCYTOSIS most commonly occurs in adults and is characterized by multifocal bone marrow lesions; it often involves other organs, most commonly SKIN LYMPH NODES LIVER spleen, or GI tract.",SKIN LYMPH NODES LIVER,SYSTEMIC MASTOCYTOSIS
720315721,5/11/2015 22:30:49,1634407056,5/11/2015 22:29:54,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"SYSTEMIC MASTOCYTOSIS involves other organs, most commonly SKIN LYMPH NODES LIVER",N/A,155,0,-1,176,21,TWrex-cause,802518-FS1,"SYSTEMIC MASTOCYTOSIS most commonly occurs in adults and is characterized by multifocal bone marrow lesions; it often involves other organs, most commonly SKIN LYMPH NODES LIVER spleen, or GI tract.",SKIN LYMPH NODES LIVER,SYSTEMIC MASTOCYTOSIS
720315721,5/11/2015 22:32:21,1634407595,5/11/2015 22:31:19,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[PART_OF],[PART_OF],involves,n/a,155,0,-1,176,21,TWrex-cause,802518-FS1,"SYSTEMIC MASTOCYTOSIS most commonly occurs in adults and is characterized by multifocal bone marrow lesions; it often involves other organs, most commonly SKIN LYMPH NODES LIVER spleen, or GI tract.",SKIN LYMPH NODES LIVER,SYSTEMIC MASTOCYTOSIS
720315721,5/11/2015 22:37:51,1634410381,5/11/2015 22:37:33,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[ASSOCIATED_WITH],[ASSOCIATED_WITH],often involves,n/a,155,0,-1,176,21,TWrex-cause,802518-FS1,"SYSTEMIC MASTOCYTOSIS most commonly occurs in adults and is characterized by multifocal bone marrow lesions; it often involves other organs, most commonly SKIN LYMPH NODES LIVER spleen, or GI tract.",SKIN LYMPH NODES LIVER,SYSTEMIC MASTOCYTOSIS
720315721,5/11/2015 22:40:20,1634411640,5/11/2015 22:37:57,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[SYMPTOM],[SYMPTOM],occurs,n/a,155,0,-1,176,21,TWrex-cause,802518-FS1,"SYSTEMIC MASTOCYTOSIS most commonly occurs in adults and is characterized by multifocal bone marrow lesions; it often involves other organs, most commonly SKIN LYMPH NODES LIVER spleen, or GI tract.",SKIN LYMPH NODES LIVER,SYSTEMIC MASTOCYTOSIS
720315721,5/11/2015 22:44:10,1634413350,5/11/2015 22:43:34,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],SYSTEMIC MASTOCYTOSIS characterized by SKIN LYMPH NODES LIVER,n/a,155,0,-1,176,21,TWrex-cause,802518-FS1,"SYSTEMIC MASTOCYTOSIS most commonly occurs in adults and is characterized by multifocal bone marrow lesions; it often involves other organs, most commonly SKIN LYMPH NODES LIVER spleen, or GI tract.",SKIN LYMPH NODES LIVER,SYSTEMIC MASTOCYTOSIS
720315721,5/11/2015 22:46:26,1634414315,5/11/2015 22:45:47,false,instagc,1.0,28519532,USA,IA,Neola,38.121.112.217,[LOCATION],[LOCATION],"involves other organs,",na,155,0,-1,176,21,TWrex-cause,802518-FS1,"SYSTEMIC MASTOCYTOSIS most commonly occurs in adults and is characterized by multifocal bone marrow lesions; it often involves other organs, most commonly SKIN LYMPH NODES LIVER spleen, or GI tract.",SKIN LYMPH NODES LIVER,SYSTEMIC MASTOCYTOSIS
720315721,5/11/2015 22:50:24,1634416265,5/11/2015 22:49:03,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[LOCATION],[LOCATION],"SYSTEMIC MASTOCYTOSIS most commonly occurs in adults and is characterized by multifocal bone marrow lesions; it often involves other organs, most commonly SKIN LYMPH NODES LIVER spleen, or GI tract.",N/A,155,0,-1,176,21,TWrex-cause,802518-FS1,"SYSTEMIC MASTOCYTOSIS most commonly occurs in adults and is characterized by multifocal bone marrow lesions; it often involves other organs, most commonly SKIN LYMPH NODES LIVER spleen, or GI tract.",SKIN LYMPH NODES LIVER,SYSTEMIC MASTOCYTOSIS
720315721,5/11/2015 22:56:23,1634418371,5/11/2015 22:55:48,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,75.147.181.53,[LOCATION],[LOCATION],it often involves other,N/A,155,0,-1,176,21,TWrex-cause,802518-FS1,"SYSTEMIC MASTOCYTOSIS most commonly occurs in adults and is characterized by multifocal bone marrow lesions; it often involves other organs, most commonly SKIN LYMPH NODES LIVER spleen, or GI tract.",SKIN LYMPH NODES LIVER,SYSTEMIC MASTOCYTOSIS
720315721,5/11/2015 22:58:43,1634419124,5/11/2015 22:57:35,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[MANIFESTATION],[MANIFESTATION],involves,n/a,155,0,-1,176,21,TWrex-cause,802518-FS1,"SYSTEMIC MASTOCYTOSIS most commonly occurs in adults and is characterized by multifocal bone marrow lesions; it often involves other organs, most commonly SKIN LYMPH NODES LIVER spleen, or GI tract.",SKIN LYMPH NODES LIVER,SYSTEMIC MASTOCYTOSIS
720315721,5/11/2015 22:58:55,1634419194,5/11/2015 22:57:56,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[LOCATION],[LOCATION],"it often involves other organs,",n/a,155,0,-1,176,21,TWrex-cause,802518-FS1,"SYSTEMIC MASTOCYTOSIS most commonly occurs in adults and is characterized by multifocal bone marrow lesions; it often involves other organs, most commonly SKIN LYMPH NODES LIVER spleen, or GI tract.",SKIN LYMPH NODES LIVER,SYSTEMIC MASTOCYTOSIS
720315721,5/11/2015 22:59:09,1634419257,5/11/2015 22:58:02,false,clixsense,1.0,6330007,AUS,06,Hobart,101.178.23.54,[MANIFESTATION],[MANIFESTATION],commonly occurs,n/a,155,0,-1,176,21,TWrex-cause,802518-FS1,"SYSTEMIC MASTOCYTOSIS most commonly occurs in adults and is characterized by multifocal bone marrow lesions; it often involves other organs, most commonly SKIN LYMPH NODES LIVER spleen, or GI tract.",SKIN LYMPH NODES LIVER,SYSTEMIC MASTOCYTOSIS
720315721,5/11/2015 22:59:35,1634419389,5/11/2015 22:58:06,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",characterized,the former is a manifestation or symptom of the latter,155,0,-1,176,21,TWrex-cause,802518-FS1,"SYSTEMIC MASTOCYTOSIS most commonly occurs in adults and is characterized by multifocal bone marrow lesions; it often involves other organs, most commonly SKIN LYMPH NODES LIVER spleen, or GI tract.",SKIN LYMPH NODES LIVER,SYSTEMIC MASTOCYTOSIS
720315722,5/11/2015 23:10:57,1634424592,5/11/2015 23:10:46,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,89,40,-1,112,54,TWrex-cause,800060-FS1,"Bastyr EJ, Johnson ME, Trautman ME et alINSULIN LISPRO in the treatment of patients with TYPE 2 DIABETES MELLITUS after oral agent failure.",TYPE 2 DIABETES MELLITUS,INSULIN LISPRO
720315722,5/11/2015 23:18:53,1634428573,5/11/2015 23:18:36,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,N/A,89,40,-1,112,54,TWrex-cause,800060-FS1,"Bastyr EJ, Johnson ME, Trautman ME et alINSULIN LISPRO in the treatment of patients with TYPE 2 DIABETES MELLITUS after oral agent failure.",TYPE 2 DIABETES MELLITUS,INSULIN LISPRO
720315722,5/11/2015 23:19:49,1634429009,5/11/2015 23:18:49,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],in the treatment of,n/a,89,40,-1,112,54,TWrex-cause,800060-FS1,"Bastyr EJ, Johnson ME, Trautman ME et alINSULIN LISPRO in the treatment of patients with TYPE 2 DIABETES MELLITUS after oral agent failure.",TYPE 2 DIABETES MELLITUS,INSULIN LISPRO
720315722,5/11/2015 23:22:12,1634430154,5/11/2015 23:22:00,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[TREATS],[TREATS],treatment,n/a,89,40,-1,112,54,TWrex-cause,800060-FS1,"Bastyr EJ, Johnson ME, Trautman ME et alINSULIN LISPRO in the treatment of patients with TYPE 2 DIABETES MELLITUS after oral agent failure.",TYPE 2 DIABETES MELLITUS,INSULIN LISPRO
720315722,5/11/2015 23:22:53,1634430508,5/11/2015 23:22:16,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],treatment,it treats the diabetes,89,40,-1,112,54,TWrex-cause,800060-FS1,"Bastyr EJ, Johnson ME, Trautman ME et alINSULIN LISPRO in the treatment of patients with TYPE 2 DIABETES MELLITUS after oral agent failure.",TYPE 2 DIABETES MELLITUS,INSULIN LISPRO
720315722,5/11/2015 23:26:10,1634431813,5/11/2015 23:25:57,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,89,40,-1,112,54,TWrex-cause,800060-FS1,"Bastyr EJ, Johnson ME, Trautman ME et alINSULIN LISPRO in the treatment of patients with TYPE 2 DIABETES MELLITUS after oral agent failure.",TYPE 2 DIABETES MELLITUS,INSULIN LISPRO
720315722,5/11/2015 23:27:22,1634432273,5/11/2015 23:27:08,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.48,[PREVENTS] [LOCATION] [NONE],"[PREVENTS]
[LOCATION]
[NONE]",no,no,89,40,-1,112,54,TWrex-cause,800060-FS1,"Bastyr EJ, Johnson ME, Trautman ME et alINSULIN LISPRO in the treatment of patients with TYPE 2 DIABETES MELLITUS after oral agent failure.",TYPE 2 DIABETES MELLITUS,INSULIN LISPRO
720315722,5/11/2015 23:30:48,1634434096,5/11/2015 23:30:25,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[TREATS],[TREATS],alINSULIN LISPRO in treatment with TYPE 2 DIABETES MELLITUS,n/a,89,40,-1,112,54,TWrex-cause,800060-FS1,"Bastyr EJ, Johnson ME, Trautman ME et alINSULIN LISPRO in the treatment of patients with TYPE 2 DIABETES MELLITUS after oral agent failure.",TYPE 2 DIABETES MELLITUS,INSULIN LISPRO
720315722,5/11/2015 23:34:09,1634435781,5/11/2015 23:33:52,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],treatment,n/a,89,40,-1,112,54,TWrex-cause,800060-FS1,"Bastyr EJ, Johnson ME, Trautman ME et alINSULIN LISPRO in the treatment of patients with TYPE 2 DIABETES MELLITUS after oral agent failure.",TYPE 2 DIABETES MELLITUS,INSULIN LISPRO
720315722,5/11/2015 23:34:29,1634436048,5/11/2015 23:33:19,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[OTHER],[OTHER],treatment TYPE 2 DIABETES MELLITUS,n/a,89,40,-1,112,54,TWrex-cause,800060-FS1,"Bastyr EJ, Johnson ME, Trautman ME et alINSULIN LISPRO in the treatment of patients with TYPE 2 DIABETES MELLITUS after oral agent failure.",TYPE 2 DIABETES MELLITUS,INSULIN LISPRO
720315722,5/11/2015 23:38:23,1634439028,5/11/2015 23:37:19,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],treatment,n/a,89,40,-1,112,54,TWrex-cause,800060-FS1,"Bastyr EJ, Johnson ME, Trautman ME et alINSULIN LISPRO in the treatment of patients with TYPE 2 DIABETES MELLITUS after oral agent failure.",TYPE 2 DIABETES MELLITUS,INSULIN LISPRO
720315722,5/11/2015 23:54:18,1634445802,5/11/2015 23:54:05,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,n/a,89,40,-1,112,54,TWrex-cause,800060-FS1,"Bastyr EJ, Johnson ME, Trautman ME et alINSULIN LISPRO in the treatment of patients with TYPE 2 DIABETES MELLITUS after oral agent failure.",TYPE 2 DIABETES MELLITUS,INSULIN LISPRO
720315722,5/12/2015 00:15:29,1634453431,5/12/2015 00:14:11,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],in the treatment,treats,89,40,-1,112,54,TWrex-cause,800060-FS1,"Bastyr EJ, Johnson ME, Trautman ME et alINSULIN LISPRO in the treatment of patients with TYPE 2 DIABETES MELLITUS after oral agent failure.",TYPE 2 DIABETES MELLITUS,INSULIN LISPRO
720315722,5/12/2015 00:19:02,1634454827,5/12/2015 00:16:44,false,prodege,1,31546390,GBR,P7,Leigh,109.153.81.168,[TREATS],[TREATS],treatment,N/A,89,40,-1,112,54,TWrex-cause,800060-FS1,"Bastyr EJ, Johnson ME, Trautman ME et alINSULIN LISPRO in the treatment of patients with TYPE 2 DIABETES MELLITUS after oral agent failure.",TYPE 2 DIABETES MELLITUS,INSULIN LISPRO
720315722,5/12/2015 00:25:16,1634457212,5/12/2015 00:23:51,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],alINSULIN LISPRO in the treatment of patients with TYPE 2 DIABETES MELLITUS after oral agent failure.,N/A,89,40,-1,112,54,TWrex-cause,800060-FS1,"Bastyr EJ, Johnson ME, Trautman ME et alINSULIN LISPRO in the treatment of patients with TYPE 2 DIABETES MELLITUS after oral agent failure.",TYPE 2 DIABETES MELLITUS,INSULIN LISPRO
720315723,5/11/2015 22:24:05,1634404389,5/11/2015 22:23:54,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],IBUPROFEN,N/A,66,28,-1,71,37,TWrex-cause,803295-FS1,Fewer patients who received IBUPROFEN had an outpatient visit for ASTHMA than did patients who received acetaminophen (Table.,ASTHMA,IBUPROFEN
720315723,5/11/2015 22:25:29,1634404943,5/11/2015 22:25:11,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],Fewer patients who received outpatient,n/a,66,28,-1,71,37,TWrex-cause,803295-FS1,Fewer patients who received IBUPROFEN had an outpatient visit for ASTHMA than did patients who received acetaminophen (Table.,ASTHMA,IBUPROFEN
720315723,5/11/2015 22:32:31,1634407623,5/11/2015 22:32:12,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[PREVENTS],[PREVENTS],IBUPROFEN ASTHMA,n/a,66,28,-1,71,37,TWrex-cause,803295-FS1,Fewer patients who received IBUPROFEN had an outpatient visit for ASTHMA than did patients who received acetaminophen (Table.,ASTHMA,IBUPROFEN
720315723,5/11/2015 22:41:42,1634412163,5/11/2015 22:41:00,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],had an outpatient visit for,n/a,66,28,-1,71,37,TWrex-cause,803295-FS1,Fewer patients who received IBUPROFEN had an outpatient visit for ASTHMA than did patients who received acetaminophen (Table.,ASTHMA,IBUPROFEN
720315723,5/11/2015 22:43:55,1634413202,5/11/2015 22:43:00,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],Fewer patients who received IBUPROFEN had an outpatient visit for ASTHMA,N/A,66,28,-1,71,37,TWrex-cause,803295-FS1,Fewer patients who received IBUPROFEN had an outpatient visit for ASTHMA than did patients who received acetaminophen (Table.,ASTHMA,IBUPROFEN
720315723,5/11/2015 22:47:22,1634414872,5/11/2015 22:46:56,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[PREVENTS],[PREVENTS],Fewer patients who received IBUPROFEN had an outpatient visit for ASTHMA,n/a,66,28,-1,71,37,TWrex-cause,803295-FS1,Fewer patients who received IBUPROFEN had an outpatient visit for ASTHMA than did patients who received acetaminophen (Table.,ASTHMA,IBUPROFEN
720315723,5/11/2015 22:56:12,1634418339,5/11/2015 22:54:55,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[PREVENTS],[PREVENTS],Fewer patients who received IBUPROFEN had ASTHMA,n/a,66,28,-1,71,37,TWrex-cause,803295-FS1,Fewer patients who received IBUPROFEN had an outpatient visit for ASTHMA than did patients who received acetaminophen (Table.,ASTHMA,IBUPROFEN
720315723,5/11/2015 23:02:42,1634420432,5/11/2015 23:02:16,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,75.147.181.53,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],who received,N/A,66,28,-1,71,37,TWrex-cause,803295-FS1,Fewer patients who received IBUPROFEN had an outpatient visit for ASTHMA than did patients who received acetaminophen (Table.,ASTHMA,IBUPROFEN
720315723,5/11/2015 23:06:41,1634421858,5/11/2015 23:05:28,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SIDE_EFFECT] [CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[SIDE_EFFECT]",Fewer patients who received IBUPROFEN had an outpatient visit for ASTHMA than did patients who received acetaminophen,N/A,66,28,-1,71,37,TWrex-cause,803295-FS1,Fewer patients who received IBUPROFEN had an outpatient visit for ASTHMA than did patients who received acetaminophen (Table.,ASTHMA,IBUPROFEN
720315723,5/11/2015 23:07:40,1634422310,5/11/2015 23:07:27,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,66,28,-1,71,37,TWrex-cause,803295-FS1,Fewer patients who received IBUPROFEN had an outpatient visit for ASTHMA than did patients who received acetaminophen (Table.,ASTHMA,IBUPROFEN
720315723,5/11/2015 23:10:30,1634424241,5/11/2015 23:09:32,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[TREATS],[TREATS],Fewer who received,n/a,66,28,-1,71,37,TWrex-cause,803295-FS1,Fewer patients who received IBUPROFEN had an outpatient visit for ASTHMA than did patients who received acetaminophen (Table.,ASTHMA,IBUPROFEN
720315723,5/11/2015 23:10:48,1634424432,5/11/2015 23:10:11,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],received,ibrupforen is a drug,66,28,-1,71,37,TWrex-cause,803295-FS1,Fewer patients who received IBUPROFEN had an outpatient visit for ASTHMA than did patients who received acetaminophen (Table.,ASTHMA,IBUPROFEN
720315723,5/11/2015 23:12:10,1634425406,5/11/2015 23:11:46,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],patients who received,n/a,66,28,-1,71,37,TWrex-cause,803295-FS1,Fewer patients who received IBUPROFEN had an outpatient visit for ASTHMA than did patients who received acetaminophen (Table.,ASTHMA,IBUPROFEN
720315723,5/11/2015 23:12:15,1634425421,5/11/2015 23:11:05,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],received,N/A,66,28,-1,71,37,TWrex-cause,803295-FS1,Fewer patients who received IBUPROFEN had an outpatient visit for ASTHMA than did patients who received acetaminophen (Table.,ASTHMA,IBUPROFEN
720315723,5/11/2015 23:13:50,1634426384,5/11/2015 23:11:47,false,clixsense,1.0,6330007,AUS,06,Hobart,101.178.23.54,[PREVENTS],[PREVENTS],Fewer visit,n/a,66,28,-1,71,37,TWrex-cause,803295-FS1,Fewer patients who received IBUPROFEN had an outpatient visit for ASTHMA than did patients who received acetaminophen (Table.,ASTHMA,IBUPROFEN
720315724,5/11/2015 23:29:04,1634433130,5/11/2015 23:27:43,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],NIT comb comb out LICE,N/A,120,99,1,123,102,TWrex-cause,815154-FS1,"Parents were to wash the hair, apply lots of conditioner, comb the hair straight, and then use the NIT comb to comb out LICE until none were found.",LICE,NIT
720315724,5/11/2015 23:43:20,1634441460,5/11/2015 23:43:00,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],use,n/a,120,99,1,123,102,TWrex-cause,815154-FS1,"Parents were to wash the hair, apply lots of conditioner, comb the hair straight, and then use the NIT comb to comb out LICE until none were found.",LICE,NIT
720315724,5/11/2015 23:55:25,1634446248,5/11/2015 23:55:09,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.48,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,120,99,1,123,102,TWrex-cause,815154-FS1,"Parents were to wash the hair, apply lots of conditioner, comb the hair straight, and then use the NIT comb to comb out LICE until none were found.",LICE,NIT
720315724,5/12/2015 00:45:46,1634465726,5/12/2015 00:44:29,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[IS_A],[IS_A],NIT comb to comb out LICE,N/A,120,99,1,123,102,TWrex-cause,815154-FS1,"Parents were to wash the hair, apply lots of conditioner, comb the hair straight, and then use the NIT comb to comb out LICE until none were found.",LICE,NIT
720315724,5/12/2015 00:52:10,1634468170,5/12/2015 00:51:10,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[TREATS],[TREATS],comb out,N/A,120,99,1,123,102,TWrex-cause,815154-FS1,"Parents were to wash the hair, apply lots of conditioner, comb the hair straight, and then use the NIT comb to comb out LICE until none were found.",LICE,NIT
720315724,5/12/2015 00:53:48,1634468762,5/12/2015 00:53:04,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[OTHER],[OTHER],NIT comb to comb out LICE,n/a,120,99,1,123,102,TWrex-cause,815154-FS1,"Parents were to wash the hair, apply lots of conditioner, comb the hair straight, and then use the NIT comb to comb out LICE until none were found.",LICE,NIT
720315724,5/12/2015 01:10:02,1634476645,5/12/2015 01:09:37,false,elite,1.0,31848723,USA,"","",155.94.185.207,[ASSOCIATED_WITH],[ASSOCIATED_WITH],NIT LICE,N/A,120,99,1,123,102,TWrex-cause,815154-FS1,"Parents were to wash the hair, apply lots of conditioner, comb the hair straight, and then use the NIT comb to comb out LICE until none were found.",LICE,NIT
720315724,5/12/2015 01:26:21,1634485574,5/12/2015 01:26:06,false,elite,1.0,32306791,USA,TX,Dallas,69.162.75.37,[PREVENTS],[PREVENTS],"lots conditioner,",re,120,99,1,123,102,TWrex-cause,815154-FS1,"Parents were to wash the hair, apply lots of conditioner, comb the hair straight, and then use the NIT comb to comb out LICE until none were found.",LICE,NIT
720315724,5/12/2015 01:27:19,1634486021,5/12/2015 01:26:51,false,instagc,1.0,32556346,USA,PA,Warren,207.255.244.59,[TREATS],[TREATS],use,N/A,120,99,1,123,102,TWrex-cause,815154-FS1,"Parents were to wash the hair, apply lots of conditioner, comb the hair straight, and then use the NIT comb to comb out LICE until none were found.",LICE,NIT
720315724,5/12/2015 01:37:26,1634491293,5/12/2015 01:36:46,false,instagc,1.0,30326470,USA,CA,San Diego,170.213.2.111,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",use,N/A,120,99,1,123,102,TWrex-cause,815154-FS1,"Parents were to wash the hair, apply lots of conditioner, comb the hair straight, and then use the NIT comb to comb out LICE until none were found.",LICE,NIT
720315724,5/12/2015 03:24:06,1634546923,5/12/2015 03:23:51,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[PART_OF],[PART_OF],out,n/a,120,99,1,123,102,TWrex-cause,815154-FS1,"Parents were to wash the hair, apply lots of conditioner, comb the hair straight, and then use the NIT comb to comb out LICE until none were found.",LICE,NIT
720315724,5/12/2015 03:39:11,1634554857,5/12/2015 03:38:34,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.227,[SYMPTOM],[SYMPTOM],NIT LICE,N/A,120,99,1,123,102,TWrex-cause,815154-FS1,"Parents were to wash the hair, apply lots of conditioner, comb the hair straight, and then use the NIT comb to comb out LICE until none were found.",LICE,NIT
720315724,5/12/2015 04:12:43,1634571088,5/12/2015 04:11:46,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[OTHER] [NONE],"[OTHER]
[NONE]",N/A,Nit comb used to comb out lice. Not a treatment or anything.,120,99,1,123,102,TWrex-cause,815154-FS1,"Parents were to wash the hair, apply lots of conditioner, comb the hair straight, and then use the NIT comb to comb out LICE until none were found.",LICE,NIT
720315724,5/12/2015 04:46:38,1634587114,5/12/2015 04:45:41,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],comb,none,120,99,1,123,102,TWrex-cause,815154-FS1,"Parents were to wash the hair, apply lots of conditioner, comb the hair straight, and then use the NIT comb to comb out LICE until none were found.",LICE,NIT
720315724,5/12/2015 05:01:47,1634594770,5/12/2015 05:01:21,false,neodev,1.0,31910622,USA,CA,Los Angeles,108.185.211.151,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",comb to comb out,I didn´t select none.,120,99,1,123,102,TWrex-cause,815154-FS1,"Parents were to wash the hair, apply lots of conditioner, comb the hair straight, and then use the NIT comb to comb out LICE until none were found.",LICE,NIT
720315725,5/12/2015 06:53:21,1634654887,5/12/2015 06:52:48,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[TREATS],[TREATS],for patients with,N/A,43,15,-1,61,24,TWrex-cause,800980-FS1,Interferon and RIBAVIRIN for patients with CHRONIC HEPATITIS C who did not respond to previous interferon therapy: a meta analysis of controlled and uncontrolled trials.,CHRONIC HEPATITIS C,RIBAVIRIN
720315725,5/12/2015 06:56:58,1634656608,5/12/2015 06:56:27,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],trials.,NA,43,15,-1,61,24,TWrex-cause,800980-FS1,Interferon and RIBAVIRIN for patients with CHRONIC HEPATITIS C who did not respond to previous interferon therapy: a meta analysis of controlled and uncontrolled trials.,CHRONIC HEPATITIS C,RIBAVIRIN
720315725,5/12/2015 07:10:45,1634662478,5/12/2015 07:08:43,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],for patients with interferon therapy:,n/a,43,15,-1,61,24,TWrex-cause,800980-FS1,Interferon and RIBAVIRIN for patients with CHRONIC HEPATITIS C who did not respond to previous interferon therapy: a meta analysis of controlled and uncontrolled trials.,CHRONIC HEPATITIS C,RIBAVIRIN
720315725,5/12/2015 08:06:14,1634696267,5/12/2015 08:04:46,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],for patients with,N/A,43,15,-1,61,24,TWrex-cause,800980-FS1,Interferon and RIBAVIRIN for patients with CHRONIC HEPATITIS C who did not respond to previous interferon therapy: a meta analysis of controlled and uncontrolled trials.,CHRONIC HEPATITIS C,RIBAVIRIN
720315725,5/12/2015 08:20:47,1634703558,5/12/2015 08:19:59,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[TREATS],[TREATS],therapy:,Treated with,43,15,-1,61,24,TWrex-cause,800980-FS1,Interferon and RIBAVIRIN for patients with CHRONIC HEPATITIS C who did not respond to previous interferon therapy: a meta analysis of controlled and uncontrolled trials.,CHRONIC HEPATITIS C,RIBAVIRIN
720315725,5/12/2015 08:57:57,1634723839,5/12/2015 08:57:26,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[TREATS],[TREATS],therapy:,N/A,43,15,-1,61,24,TWrex-cause,800980-FS1,Interferon and RIBAVIRIN for patients with CHRONIC HEPATITIS C who did not respond to previous interferon therapy: a meta analysis of controlled and uncontrolled trials.,CHRONIC HEPATITIS C,RIBAVIRIN
720315725,5/12/2015 09:04:14,1634726908,5/12/2015 09:03:47,false,inboxpounds,1.0,29059658,GBR,H9,London,79.77.3.89,[TREATS],[TREATS],previous interferon therapy:,N/A,43,15,-1,61,24,TWrex-cause,800980-FS1,Interferon and RIBAVIRIN for patients with CHRONIC HEPATITIS C who did not respond to previous interferon therapy: a meta analysis of controlled and uncontrolled trials.,CHRONIC HEPATITIS C,RIBAVIRIN
720315725,5/12/2015 11:04:59,1634828014,5/12/2015 11:04:43,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],patients with,n/a,43,15,-1,61,24,TWrex-cause,800980-FS1,Interferon and RIBAVIRIN for patients with CHRONIC HEPATITIS C who did not respond to previous interferon therapy: a meta analysis of controlled and uncontrolled trials.,CHRONIC HEPATITIS C,RIBAVIRIN
720315725,5/12/2015 11:58:56,1634861071,5/12/2015 11:58:29,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[TREATS],[TREATS],for patients with,N/A,43,15,-1,61,24,TWrex-cause,800980-FS1,Interferon and RIBAVIRIN for patients with CHRONIC HEPATITIS C who did not respond to previous interferon therapy: a meta analysis of controlled and uncontrolled trials.,CHRONIC HEPATITIS C,RIBAVIRIN
720315725,5/12/2015 11:59:11,1634861158,5/12/2015 11:58:48,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[TREATS],[TREATS],therapy:,N/A,43,15,-1,61,24,TWrex-cause,800980-FS1,Interferon and RIBAVIRIN for patients with CHRONIC HEPATITIS C who did not respond to previous interferon therapy: a meta analysis of controlled and uncontrolled trials.,CHRONIC HEPATITIS C,RIBAVIRIN
720315725,5/12/2015 12:43:44,1634881078,5/12/2015 12:42:55,false,clixsense,1.0,27969116,NLD,"","",212.78.195.38,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],controlled and uncontrolled trials.,found out by trails,43,15,-1,61,24,TWrex-cause,800980-FS1,Interferon and RIBAVIRIN for patients with CHRONIC HEPATITIS C who did not respond to previous interferon therapy: a meta analysis of controlled and uncontrolled trials.,CHRONIC HEPATITIS C,RIBAVIRIN
720315725,5/12/2015 13:07:11,1634890155,5/12/2015 13:06:13,false,bitcoinget,1.0,24960279,USA,NY,Bronx,24.184.60.73,[TREATS],[TREATS],for patients with,n/a,43,15,-1,61,24,TWrex-cause,800980-FS1,Interferon and RIBAVIRIN for patients with CHRONIC HEPATITIS C who did not respond to previous interferon therapy: a meta analysis of controlled and uncontrolled trials.,CHRONIC HEPATITIS C,RIBAVIRIN
720315725,5/12/2015 14:31:55,1634929295,5/12/2015 14:31:44,false,neodev,1.0,31726043,USA,VA,Manassas,207.244.77.4,[CAUSES],[CAUSES],not,gfdg,43,15,-1,61,24,TWrex-cause,800980-FS1,Interferon and RIBAVIRIN for patients with CHRONIC HEPATITIS C who did not respond to previous interferon therapy: a meta analysis of controlled and uncontrolled trials.,CHRONIC HEPATITIS C,RIBAVIRIN
720315725,5/12/2015 14:45:05,1634935347,5/12/2015 14:42:50,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",Interferon RIBAVIRIN patients CHRONIC HEPATITIS C who did not respond to previous interferon therapy: meta analysis controlled and uncontrolled trials.,N/A,43,15,-1,61,24,TWrex-cause,800980-FS1,Interferon and RIBAVIRIN for patients with CHRONIC HEPATITIS C who did not respond to previous interferon therapy: a meta analysis of controlled and uncontrolled trials.,CHRONIC HEPATITIS C,RIBAVIRIN
720315725,5/12/2015 15:28:57,1634977775,5/12/2015 15:28:38,false,prodege,1.0,13300986,CAN,AB,Edmonton,68.150.40.134,[TREATS],[TREATS],for patients with,n/a,43,15,-1,61,24,TWrex-cause,800980-FS1,Interferon and RIBAVIRIN for patients with CHRONIC HEPATITIS C who did not respond to previous interferon therapy: a meta analysis of controlled and uncontrolled trials.,CHRONIC HEPATITIS C,RIBAVIRIN
720315726,5/11/2015 22:25:16,1634404871,5/11/2015 22:25:04,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],SODIUM OXYBATE,N/A,63,44,-1,71,58,TWrex-cause,804940-FS1,"• When discontinuing medications other than SODIUM OXYBATE for CATAPLEXY and other REM related symptoms, slowly taper dose over several weeks rather than stopping abruptly.",CATAPLEXY,SODIUM OXYBATE
720315726,5/11/2015 22:26:41,1634405541,5/11/2015 22:26:27,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],for,n/a,63,44,-1,71,58,TWrex-cause,804940-FS1,"• When discontinuing medications other than SODIUM OXYBATE for CATAPLEXY and other REM related symptoms, slowly taper dose over several weeks rather than stopping abruptly.",CATAPLEXY,SODIUM OXYBATE
720315726,5/11/2015 22:35:33,1634409328,5/11/2015 22:35:16,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],SODIUM OXYBATE for CATAPLEXY,n/a,63,44,-1,71,58,TWrex-cause,804940-FS1,"• When discontinuing medications other than SODIUM OXYBATE for CATAPLEXY and other REM related symptoms, slowly taper dose over several weeks rather than stopping abruptly.",CATAPLEXY,SODIUM OXYBATE
720315726,5/11/2015 22:44:33,1634413511,5/11/2015 22:44:11,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],medications for,n/a,63,44,-1,71,58,TWrex-cause,804940-FS1,"• When discontinuing medications other than SODIUM OXYBATE for CATAPLEXY and other REM related symptoms, slowly taper dose over several weeks rather than stopping abruptly.",CATAPLEXY,SODIUM OXYBATE
720315726,5/11/2015 22:47:13,1634414743,5/11/2015 22:46:30,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],medications SODIUM OXYBATE for CATAPLEXY,N/A,63,44,-1,71,58,TWrex-cause,804940-FS1,"• When discontinuing medications other than SODIUM OXYBATE for CATAPLEXY and other REM related symptoms, slowly taper dose over several weeks rather than stopping abruptly.",CATAPLEXY,SODIUM OXYBATE
720315726,5/11/2015 22:49:02,1634415718,5/11/2015 22:48:42,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],medications SODIUM OXYBATE for CATAPLEXY,n/a,63,44,-1,71,58,TWrex-cause,804940-FS1,"• When discontinuing medications other than SODIUM OXYBATE for CATAPLEXY and other REM related symptoms, slowly taper dose over several weeks rather than stopping abruptly.",CATAPLEXY,SODIUM OXYBATE
720315726,5/11/2015 22:59:26,1634419356,5/11/2015 22:58:54,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],discontinuing medications SODIUM OXYBATE for CATAPLEXY,n/a,63,44,-1,71,58,TWrex-cause,804940-FS1,"• When discontinuing medications other than SODIUM OXYBATE for CATAPLEXY and other REM related symptoms, slowly taper dose over several weeks rather than stopping abruptly.",CATAPLEXY,SODIUM OXYBATE
720315726,5/11/2015 23:04:53,1634421109,5/11/2015 23:04:01,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,75.147.181.53,[TREATS] [SYMPTOM],"[TREATS]
[SYMPTOM]","for and other related symptoms,",N/A,63,44,-1,71,58,TWrex-cause,804940-FS1,"• When discontinuing medications other than SODIUM OXYBATE for CATAPLEXY and other REM related symptoms, slowly taper dose over several weeks rather than stopping abruptly.",CATAPLEXY,SODIUM OXYBATE
720315726,5/11/2015 23:08:57,1634422921,5/11/2015 23:08:38,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],"symptoms,",N/A,63,44,-1,71,58,TWrex-cause,804940-FS1,"• When discontinuing medications other than SODIUM OXYBATE for CATAPLEXY and other REM related symptoms, slowly taper dose over several weeks rather than stopping abruptly.",CATAPLEXY,SODIUM OXYBATE
720315726,5/11/2015 23:11:42,1634425122,5/11/2015 23:10:40,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SYMPTOM] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SYMPTOM]","When discontinuing medications other than SODIUM OXYBATE for CATAPLEXY and other REM related symptoms, slowly taper dose over several weeks rather than stopping abruptly.",N/A,63,44,-1,71,58,TWrex-cause,804940-FS1,"• When discontinuing medications other than SODIUM OXYBATE for CATAPLEXY and other REM related symptoms, slowly taper dose over several weeks rather than stopping abruptly.",CATAPLEXY,SODIUM OXYBATE
720315726,5/11/2015 23:14:32,1634426723,5/11/2015 23:13:34,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[OTHER],[OTHER],medications for,n/a,63,44,-1,71,58,TWrex-cause,804940-FS1,"• When discontinuing medications other than SODIUM OXYBATE for CATAPLEXY and other REM related symptoms, slowly taper dose over several weeks rather than stopping abruptly.",CATAPLEXY,SODIUM OXYBATE
720315726,5/11/2015 23:14:32,1634426724,5/11/2015 23:13:57,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],medications,it is a medication used to treat the condition,63,44,-1,71,58,TWrex-cause,804940-FS1,"• When discontinuing medications other than SODIUM OXYBATE for CATAPLEXY and other REM related symptoms, slowly taper dose over several weeks rather than stopping abruptly.",CATAPLEXY,SODIUM OXYBATE
720315726,5/11/2015 23:15:27,1634427208,5/11/2015 23:14:40,false,clixsense,1.0,6330007,AUS,06,Hobart,101.178.23.54,[TREATS],[TREATS],medications other than,n/a,63,44,-1,71,58,TWrex-cause,804940-FS1,"• When discontinuing medications other than SODIUM OXYBATE for CATAPLEXY and other REM related symptoms, slowly taper dose over several weeks rather than stopping abruptly.",CATAPLEXY,SODIUM OXYBATE
720315726,5/11/2015 23:16:03,1634427452,5/11/2015 23:15:17,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],for,n/a,63,44,-1,71,58,TWrex-cause,804940-FS1,"• When discontinuing medications other than SODIUM OXYBATE for CATAPLEXY and other REM related symptoms, slowly taper dose over several weeks rather than stopping abruptly.",CATAPLEXY,SODIUM OXYBATE
720315726,5/11/2015 23:16:35,1634427567,5/11/2015 23:14:30,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],for,N/A,63,44,-1,71,58,TWrex-cause,804940-FS1,"• When discontinuing medications other than SODIUM OXYBATE for CATAPLEXY and other REM related symptoms, slowly taper dose over several weeks rather than stopping abruptly.",CATAPLEXY,SODIUM OXYBATE
720315727,5/11/2015 22:17:39,1634401262,5/11/2015 22:17:15,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],pelvic pain:,N/A,148,239,1,158,252,TWrex-cause,814348-FS1,Evidence: • A review article ( 19 ) describes three criteria that must be met to indicate that endometriosis is the cause of chronic pelvic pain: ◊ PELVIC PAIN must be cyclic ◊ Endometriosis must be diagnosed surgically ◊ The treatment of ENDOMETRIOSIS results in prolonged pain relief  Comments: • None.,PELVIC PAIN,ENDOMETRIOSIS
720315727,5/11/2015 22:18:47,1634401836,5/11/2015 22:18:02,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],PELVIC PAIN treatment ENDOMETRIOSIS,n/a,148,239,1,158,252,TWrex-cause,814348-FS1,Evidence: • A review article ( 19 ) describes three criteria that must be met to indicate that endometriosis is the cause of chronic pelvic pain: ◊ PELVIC PAIN must be cyclic ◊ Endometriosis must be diagnosed surgically ◊ The treatment of ENDOMETRIOSIS results in prolonged pain relief  Comments: • None.,PELVIC PAIN,ENDOMETRIOSIS
720315727,5/11/2015 22:19:56,1634402362,5/11/2015 22:19:27,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[SYMPTOM],[SYMPTOM],results in,n/a,148,239,1,158,252,TWrex-cause,814348-FS1,Evidence: • A review article ( 19 ) describes three criteria that must be met to indicate that endometriosis is the cause of chronic pelvic pain: ◊ PELVIC PAIN must be cyclic ◊ Endometriosis must be diagnosed surgically ◊ The treatment of ENDOMETRIOSIS results in prolonged pain relief  Comments: • None.,PELVIC PAIN,ENDOMETRIOSIS
720315727,5/11/2015 22:25:12,1634404827,5/11/2015 22:24:33,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[SYMPTOM],[SYMPTOM],endometriosis is the cause of chronic PELVIC PAIN ENDOMETRIOSIS,N/A,148,239,1,158,252,TWrex-cause,814348-FS1,Evidence: • A review article ( 19 ) describes three criteria that must be met to indicate that endometriosis is the cause of chronic pelvic pain: ◊ PELVIC PAIN must be cyclic ◊ Endometriosis must be diagnosed surgically ◊ The treatment of ENDOMETRIOSIS results in prolonged pain relief  Comments: • None.,PELVIC PAIN,ENDOMETRIOSIS
720315727,5/11/2015 22:27:15,1634405716,5/11/2015 22:26:43,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],results in,n/a,148,239,1,158,252,TWrex-cause,814348-FS1,Evidence: • A review article ( 19 ) describes three criteria that must be met to indicate that endometriosis is the cause of chronic pelvic pain: ◊ PELVIC PAIN must be cyclic ◊ Endometriosis must be diagnosed surgically ◊ The treatment of ENDOMETRIOSIS results in prolonged pain relief  Comments: • None.,PELVIC PAIN,ENDOMETRIOSIS
720315727,5/11/2015 22:34:59,1634409078,5/11/2015 22:33:49,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],cause,n/a,148,239,1,158,252,TWrex-cause,814348-FS1,Evidence: • A review article ( 19 ) describes three criteria that must be met to indicate that endometriosis is the cause of chronic pelvic pain: ◊ PELVIC PAIN must be cyclic ◊ Endometriosis must be diagnosed surgically ◊ The treatment of ENDOMETRIOSIS results in prolonged pain relief  Comments: • None.,PELVIC PAIN,ENDOMETRIOSIS
720315727,5/11/2015 22:35:14,1634409184,5/11/2015 22:34:03,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[CAUSES],[CAUSES],cause of,n/a,148,239,1,158,252,TWrex-cause,814348-FS1,Evidence: • A review article ( 19 ) describes three criteria that must be met to indicate that endometriosis is the cause of chronic pelvic pain: ◊ PELVIC PAIN must be cyclic ◊ Endometriosis must be diagnosed surgically ◊ The treatment of ENDOMETRIOSIS results in prolonged pain relief  Comments: • None.,PELVIC PAIN,ENDOMETRIOSIS
720315727,5/11/2015 22:38:53,1634410979,5/11/2015 22:37:04,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],criteria indicate PELVIC PAIN ENDOMETRIOSIS,n/a,148,239,1,158,252,TWrex-cause,814348-FS1,Evidence: • A review article ( 19 ) describes three criteria that must be met to indicate that endometriosis is the cause of chronic pelvic pain: ◊ PELVIC PAIN must be cyclic ◊ Endometriosis must be diagnosed surgically ◊ The treatment of ENDOMETRIOSIS results in prolonged pain relief  Comments: • None.,PELVIC PAIN,ENDOMETRIOSIS
720315727,5/11/2015 22:43:23,1634412968,5/11/2015 22:41:25,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[LOCATION],[LOCATION],describes three criteria that must be met to indicate that endometriosis is the cause of chronic pelvic pain: PELVIC PAIN must be cyclic Endometriosis must be diagnosed surgically The treatment of ENDOMETRIOSIS results in prolonged pain relief Comments:,N/A,148,239,1,158,252,TWrex-cause,814348-FS1,Evidence: • A review article ( 19 ) describes three criteria that must be met to indicate that endometriosis is the cause of chronic pelvic pain: ◊ PELVIC PAIN must be cyclic ◊ Endometriosis must be diagnosed surgically ◊ The treatment of ENDOMETRIOSIS results in prolonged pain relief  Comments: • None.,PELVIC PAIN,ENDOMETRIOSIS
720315727,5/11/2015 22:43:44,1634413086,5/11/2015 22:43:15,false,instagc,1.0,28519532,USA,IA,Neola,38.121.112.217,[CAUSES],[CAUSES],is the cause of,na,148,239,1,158,252,TWrex-cause,814348-FS1,Evidence: • A review article ( 19 ) describes three criteria that must be met to indicate that endometriosis is the cause of chronic pelvic pain: ◊ PELVIC PAIN must be cyclic ◊ Endometriosis must be diagnosed surgically ◊ The treatment of ENDOMETRIOSIS results in prolonged pain relief  Comments: • None.,PELVIC PAIN,ENDOMETRIOSIS
720315727,5/11/2015 22:53:27,1634417442,5/11/2015 22:53:04,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,75.147.181.53,[CAUSES],[CAUSES],the cause of,N/A,148,239,1,158,252,TWrex-cause,814348-FS1,Evidence: • A review article ( 19 ) describes three criteria that must be met to indicate that endometriosis is the cause of chronic pelvic pain: ◊ PELVIC PAIN must be cyclic ◊ Endometriosis must be diagnosed surgically ◊ The treatment of ENDOMETRIOSIS results in prolonged pain relief  Comments: • None.,PELVIC PAIN,ENDOMETRIOSIS
720315727,5/11/2015 22:54:21,1634417685,5/11/2015 22:53:15,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],criteria that must be met,N/A,148,239,1,158,252,TWrex-cause,814348-FS1,Evidence: • A review article ( 19 ) describes three criteria that must be met to indicate that endometriosis is the cause of chronic pelvic pain: ◊ PELVIC PAIN must be cyclic ◊ Endometriosis must be diagnosed surgically ◊ The treatment of ENDOMETRIOSIS results in prolonged pain relief  Comments: • None.,PELVIC PAIN,ENDOMETRIOSIS
720315727,5/11/2015 22:55:00,1634417903,5/11/2015 22:53:03,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[NONE],[NONE],N/A,"There may be completely unrelated or related depending on the results, so this does not really say one or another about a relationship. There could be mutually exclusive or not.",148,239,1,158,252,TWrex-cause,814348-FS1,Evidence: • A review article ( 19 ) describes three criteria that must be met to indicate that endometriosis is the cause of chronic pelvic pain: ◊ PELVIC PAIN must be cyclic ◊ Endometriosis must be diagnosed surgically ◊ The treatment of ENDOMETRIOSIS results in prolonged pain relief  Comments: • None.,PELVIC PAIN,ENDOMETRIOSIS
720315727,5/11/2015 22:55:20,1634418035,5/11/2015 22:54:47,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[CAUSES],[CAUSES],cause,n/a,148,239,1,158,252,TWrex-cause,814348-FS1,Evidence: • A review article ( 19 ) describes three criteria that must be met to indicate that endometriosis is the cause of chronic pelvic pain: ◊ PELVIC PAIN must be cyclic ◊ Endometriosis must be diagnosed surgically ◊ The treatment of ENDOMETRIOSIS results in prolonged pain relief  Comments: • None.,PELVIC PAIN,ENDOMETRIOSIS
720315727,5/11/2015 22:55:31,1634418127,5/11/2015 22:54:07,false,clixsense,1.0,6330007,AUS,06,Hobart,101.178.23.54,[CAUSES] [SYMPTOM],"[CAUSES]
[SYMPTOM]",cause,n/a,148,239,1,158,252,TWrex-cause,814348-FS1,Evidence: • A review article ( 19 ) describes three criteria that must be met to indicate that endometriosis is the cause of chronic pelvic pain: ◊ PELVIC PAIN must be cyclic ◊ Endometriosis must be diagnosed surgically ◊ The treatment of ENDOMETRIOSIS results in prolonged pain relief  Comments: • None.,PELVIC PAIN,ENDOMETRIOSIS
720315728,5/11/2015 22:21:57,1634403418,5/11/2015 22:21:30,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],HEMOLYTIC ANEMIA,N/A,105,33,1,113,49,TWrex-cause,813259-FS1,"In all of these pathway defects, HEMOLYTIC ANEMIA occurs only in homozygotes, and the exact mechanism of HEMOLYSIS is unknown.",HEMOLYSIS,HEMOLYTIC ANEMIA
720315728,5/11/2015 22:23:37,1634404176,5/11/2015 22:23:18,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],mechanism unknown.,n/a,105,33,1,113,49,TWrex-cause,813259-FS1,"In all of these pathway defects, HEMOLYTIC ANEMIA occurs only in homozygotes, and the exact mechanism of HEMOLYSIS is unknown.",HEMOLYSIS,HEMOLYTIC ANEMIA
720315728,5/11/2015 22:27:44,1634405937,5/11/2015 22:27:15,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[NONE],[NONE],n/a,not quite sure what the relationship would be from reading this,105,33,1,113,49,TWrex-cause,813259-FS1,"In all of these pathway defects, HEMOLYTIC ANEMIA occurs only in homozygotes, and the exact mechanism of HEMOLYSIS is unknown.",HEMOLYSIS,HEMOLYTIC ANEMIA
720315728,5/11/2015 22:37:12,1634410119,5/11/2015 22:36:40,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[PART_OF],[PART_OF],mechanism,n/a,105,33,1,113,49,TWrex-cause,813259-FS1,"In all of these pathway defects, HEMOLYTIC ANEMIA occurs only in homozygotes, and the exact mechanism of HEMOLYSIS is unknown.",HEMOLYSIS,HEMOLYTIC ANEMIA
720315728,5/11/2015 22:38:02,1634410489,5/11/2015 22:36:29,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[MANIFESTATION],[MANIFESTATION],"HEMOLYTIC ANEMIA occurs in homozygotes, exact mechanism HEMOLYSIS unknown.",N/A,105,33,1,113,49,TWrex-cause,813259-FS1,"In all of these pathway defects, HEMOLYTIC ANEMIA occurs only in homozygotes, and the exact mechanism of HEMOLYSIS is unknown.",HEMOLYSIS,HEMOLYTIC ANEMIA
720315728,5/11/2015 22:42:05,1634412300,5/11/2015 22:41:37,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[IS_A],[IS_A],HEMOLYTIC ANEMIA HEMOLYSIS,n/a,105,33,1,113,49,TWrex-cause,813259-FS1,"In all of these pathway defects, HEMOLYTIC ANEMIA occurs only in homozygotes, and the exact mechanism of HEMOLYSIS is unknown.",HEMOLYSIS,HEMOLYTIC ANEMIA
720315728,5/11/2015 22:49:13,1634415834,5/11/2015 22:48:27,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"pathway defects, HEMOLYTIC ANEMIA and HEMOLYSIS",n/a,105,33,1,113,49,TWrex-cause,813259-FS1,"In all of these pathway defects, HEMOLYTIC ANEMIA occurs only in homozygotes, and the exact mechanism of HEMOLYSIS is unknown.",HEMOLYSIS,HEMOLYTIC ANEMIA
720315728,5/11/2015 22:57:44,1634418856,5/11/2015 22:56:28,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[OTHER],[OTHER],"In all of these pathway defects, HEMOLYTIC ANEMIA occurs only in homozygotes, and the exact mechanism of HEMOLYSIS is unknown.",N/A,105,33,1,113,49,TWrex-cause,813259-FS1,"In all of these pathway defects, HEMOLYTIC ANEMIA occurs only in homozygotes, and the exact mechanism of HEMOLYSIS is unknown.",HEMOLYSIS,HEMOLYTIC ANEMIA
720315728,5/11/2015 22:59:53,1634419472,5/11/2015 22:59:17,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,75.147.181.53,[ASSOCIATED_WITH],[ASSOCIATED_WITH],occurs only in,N/A,105,33,1,113,49,TWrex-cause,813259-FS1,"In all of these pathway defects, HEMOLYTIC ANEMIA occurs only in homozygotes, and the exact mechanism of HEMOLYSIS is unknown.",HEMOLYSIS,HEMOLYTIC ANEMIA
720315728,5/11/2015 23:04:02,1634420875,5/11/2015 23:02:33,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[IS_A],[IS_A],HEMOLYTIC HEMOLYSIS,n/a,105,33,1,113,49,TWrex-cause,813259-FS1,"In all of these pathway defects, HEMOLYTIC ANEMIA occurs only in homozygotes, and the exact mechanism of HEMOLYSIS is unknown.",HEMOLYSIS,HEMOLYTIC ANEMIA
720315728,5/11/2015 23:04:50,1634421092,5/11/2015 23:03:34,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[ASSOCIATED_WITH],[ASSOCIATED_WITH],occurs,HEMOLYSIS ----related-to----   HEMOLYTIC ANEMIA? In some cases it is an associated problem,105,33,1,113,49,TWrex-cause,813259-FS1,"In all of these pathway defects, HEMOLYTIC ANEMIA occurs only in homozygotes, and the exact mechanism of HEMOLYSIS is unknown.",HEMOLYSIS,HEMOLYTIC ANEMIA
720315728,5/11/2015 23:05:20,1634421308,5/11/2015 23:03:40,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[NONE],[NONE],N/A,There's no relation between the terms in this sentence.,105,33,1,113,49,TWrex-cause,813259-FS1,"In all of these pathway defects, HEMOLYTIC ANEMIA occurs only in homozygotes, and the exact mechanism of HEMOLYSIS is unknown.",HEMOLYSIS,HEMOLYTIC ANEMIA
720315728,5/11/2015 23:05:23,1634421320,5/11/2015 23:02:45,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[ASSOCIATED_WITH],[ASSOCIATED_WITH],occurs only in,N/A,105,33,1,113,49,TWrex-cause,813259-FS1,"In all of these pathway defects, HEMOLYTIC ANEMIA occurs only in homozygotes, and the exact mechanism of HEMOLYSIS is unknown.",HEMOLYSIS,HEMOLYTIC ANEMIA
720315728,5/11/2015 23:05:34,1634421362,5/11/2015 23:03:14,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[MANIFESTATION],[MANIFESTATION],exact mechanism,n/a,105,33,1,113,49,TWrex-cause,813259-FS1,"In all of these pathway defects, HEMOLYTIC ANEMIA occurs only in homozygotes, and the exact mechanism of HEMOLYSIS is unknown.",HEMOLYSIS,HEMOLYTIC ANEMIA
720315728,5/11/2015 23:05:52,1634421439,5/11/2015 23:03:45,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[NONE],[NONE],n/a,I can not understand the statement,105,33,1,113,49,TWrex-cause,813259-FS1,"In all of these pathway defects, HEMOLYTIC ANEMIA occurs only in homozygotes, and the exact mechanism of HEMOLYSIS is unknown.",HEMOLYSIS,HEMOLYTIC ANEMIA
720315729,5/11/2015 23:12:36,1634425603,5/11/2015 23:12:20,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],in early,N/A,75,53,-1,91,65,TWrex-cause,803217-FS1,1994 10 28  Transvaginal intra amniotic injection of METHOTREXATE in early ECTOPIC PREGNANCY,ECTOPIC PREGNANCY,METHOTREXATE
720315729,5/11/2015 23:22:08,1634430101,5/11/2015 23:21:25,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],injection of METHOTREXATE,N/A,75,53,-1,91,65,TWrex-cause,803217-FS1,1994 10 28  Transvaginal intra amniotic injection of METHOTREXATE in early ECTOPIC PREGNANCY,ECTOPIC PREGNANCY,METHOTREXATE
720315729,5/11/2015 23:24:08,1634431016,5/11/2015 23:23:16,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],injection of,n/a,75,53,-1,91,65,TWrex-cause,803217-FS1,1994 10 28  Transvaginal intra amniotic injection of METHOTREXATE in early ECTOPIC PREGNANCY,ECTOPIC PREGNANCY,METHOTREXATE
720315729,5/11/2015 23:37:39,1634438404,5/11/2015 23:36:32,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],injection,n/a,75,53,-1,91,65,TWrex-cause,803217-FS1,1994 10 28  Transvaginal intra amniotic injection of METHOTREXATE in early ECTOPIC PREGNANCY,ECTOPIC PREGNANCY,METHOTREXATE
720315729,5/11/2015 23:43:31,1634441565,5/11/2015 23:43:01,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],injection,n/a,75,53,-1,91,65,TWrex-cause,803217-FS1,1994 10 28  Transvaginal intra amniotic injection of METHOTREXATE in early ECTOPIC PREGNANCY,ECTOPIC PREGNANCY,METHOTREXATE
720315729,5/11/2015 23:51:56,1634444862,5/11/2015 23:51:44,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.48,[PREVENTS] [CAUSES] [LOCATION] [NONE],"[PREVENTS]
[CAUSES]
[LOCATION]
[NONE]",no,no,75,53,-1,91,65,TWrex-cause,803217-FS1,1994 10 28  Transvaginal intra amniotic injection of METHOTREXATE in early ECTOPIC PREGNANCY,ECTOPIC PREGNANCY,METHOTREXATE
720315729,5/11/2015 23:55:54,1634446399,5/11/2015 23:55:36,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[PART_OF],[PART_OF],in,n/a,75,53,-1,91,65,TWrex-cause,803217-FS1,1994 10 28  Transvaginal intra amniotic injection of METHOTREXATE in early ECTOPIC PREGNANCY,ECTOPIC PREGNANCY,METHOTREXATE
720315729,5/12/2015 00:24:04,1634456786,5/12/2015 00:22:24,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],injection of in early,treats,75,53,-1,91,65,TWrex-cause,803217-FS1,1994 10 28  Transvaginal intra amniotic injection of METHOTREXATE in early ECTOPIC PREGNANCY,ECTOPIC PREGNANCY,METHOTREXATE
720315729,5/12/2015 00:41:38,1634463656,5/12/2015 00:40:42,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[OTHER],[OTHER],METHOTREXATE,N/A,75,53,-1,91,65,TWrex-cause,803217-FS1,1994 10 28  Transvaginal intra amniotic injection of METHOTREXATE in early ECTOPIC PREGNANCY,ECTOPIC PREGNANCY,METHOTREXATE
720315729,5/12/2015 00:43:32,1634464664,5/12/2015 00:43:09,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[TREATS],[TREATS],injection of METHOTREXATE in ECTOPIC PREGNANCY,n/a,75,53,-1,91,65,TWrex-cause,803217-FS1,1994 10 28  Transvaginal intra amniotic injection of METHOTREXATE in early ECTOPIC PREGNANCY,ECTOPIC PREGNANCY,METHOTREXATE
720315729,5/12/2015 01:03:37,1634473418,5/12/2015 01:03:12,false,elite,1.0,31848723,USA,"","",155.94.185.207,[TREATS],[TREATS],METHOTREXATE ECTOPIC PREGNANCY,N/A,75,53,-1,91,65,TWrex-cause,803217-FS1,1994 10 28  Transvaginal intra amniotic injection of METHOTREXATE in early ECTOPIC PREGNANCY,ECTOPIC PREGNANCY,METHOTREXATE
720315729,5/12/2015 01:10:57,1634477141,5/12/2015 01:10:44,false,elite,1.0,32306791,NLD,"","",31.3.156.41,[PREVENTS],[PREVENTS],Transvaginal amniotic,fcdsf,75,53,-1,91,65,TWrex-cause,803217-FS1,1994 10 28  Transvaginal intra amniotic injection of METHOTREXATE in early ECTOPIC PREGNANCY,ECTOPIC PREGNANCY,METHOTREXATE
720315729,5/12/2015 01:20:41,1634482435,5/12/2015 01:20:01,false,instagc,1.0,32556346,USA,PA,Warren,207.255.244.59,[TREATS],[TREATS],injection,N/A,75,53,-1,91,65,TWrex-cause,803217-FS1,1994 10 28  Transvaginal intra amniotic injection of METHOTREXATE in early ECTOPIC PREGNANCY,ECTOPIC PREGNANCY,METHOTREXATE
720315729,5/12/2015 01:26:12,1634485486,5/12/2015 01:25:16,false,instagc,1.0,30326470,USA,CA,San Diego,170.213.2.111,[TREATS],[TREATS],injection of,N/A,75,53,-1,91,65,TWrex-cause,803217-FS1,1994 10 28  Transvaginal intra amniotic injection of METHOTREXATE in early ECTOPIC PREGNANCY,ECTOPIC PREGNANCY,METHOTREXATE
720315729,5/12/2015 02:47:00,1634527813,5/12/2015 02:45:28,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],intra amniotic injection of METHOTREXATE,n/a,75,53,-1,91,65,TWrex-cause,803217-FS1,1994 10 28  Transvaginal intra amniotic injection of METHOTREXATE in early ECTOPIC PREGNANCY,ECTOPIC PREGNANCY,METHOTREXATE
720315730,5/11/2015 23:12:00,1634425297,5/11/2015 23:11:43,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],provides more effective,N/A,144,74,-1,149,85,TWrex-cause,804945-FS1,"1]  Nelson HS, Busse WW, Kerwin E, Church N, Emmett A, Rickard K, Knobil KFLUTICASONE propionate/salmeterol combination provides more effective ASTHMA control than low dose inhaled corticosteroid plus montelukast.",ASTHMA,FLUTICASONE
720315730,5/11/2015 23:20:59,1634429573,5/11/2015 23:20:28,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],control,N/A,144,74,-1,149,85,TWrex-cause,804945-FS1,"1]  Nelson HS, Busse WW, Kerwin E, Church N, Emmett A, Rickard K, Knobil KFLUTICASONE propionate/salmeterol combination provides more effective ASTHMA control than low dose inhaled corticosteroid plus montelukast.",ASTHMA,FLUTICASONE
720315730,5/11/2015 23:22:34,1634430349,5/11/2015 23:20:58,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],provides effective control,n/a,144,74,-1,149,85,TWrex-cause,804945-FS1,"1]  Nelson HS, Busse WW, Kerwin E, Church N, Emmett A, Rickard K, Knobil KFLUTICASONE propionate/salmeterol combination provides more effective ASTHMA control than low dose inhaled corticosteroid plus montelukast.",ASTHMA,FLUTICASONE
720315730,5/11/2015 23:25:10,1634431446,5/11/2015 23:24:40,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],effective,drug treats asthma,144,74,-1,149,85,TWrex-cause,804945-FS1,"1]  Nelson HS, Busse WW, Kerwin E, Church N, Emmett A, Rickard K, Knobil KFLUTICASONE propionate/salmeterol combination provides more effective ASTHMA control than low dose inhaled corticosteroid plus montelukast.",ASTHMA,FLUTICASONE
720315730,5/11/2015 23:30:37,1634434009,5/11/2015 23:30:21,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.48,[PREVENTS] [LOCATION] [NONE],"[PREVENTS]
[LOCATION]
[NONE]",no,no,144,74,-1,149,85,TWrex-cause,804945-FS1,"1]  Nelson HS, Busse WW, Kerwin E, Church N, Emmett A, Rickard K, Knobil KFLUTICASONE propionate/salmeterol combination provides more effective ASTHMA control than low dose inhaled corticosteroid plus montelukast.",ASTHMA,FLUTICASONE
720315730,5/11/2015 23:32:51,1634435078,5/11/2015 23:31:16,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],control,N/A,144,74,-1,149,85,TWrex-cause,804945-FS1,"1]  Nelson HS, Busse WW, Kerwin E, Church N, Emmett A, Rickard K, Knobil KFLUTICASONE propionate/salmeterol combination provides more effective ASTHMA control than low dose inhaled corticosteroid plus montelukast.",ASTHMA,FLUTICASONE
720315730,5/11/2015 23:36:17,1634437349,5/11/2015 23:35:41,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],control,n/a,144,74,-1,149,85,TWrex-cause,804945-FS1,"1]  Nelson HS, Busse WW, Kerwin E, Church N, Emmett A, Rickard K, Knobil KFLUTICASONE propionate/salmeterol combination provides more effective ASTHMA control than low dose inhaled corticosteroid plus montelukast.",ASTHMA,FLUTICASONE
720315730,5/11/2015 23:42:22,1634441014,5/11/2015 23:41:44,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[TREATS],[TREATS],effective,n/a,144,74,-1,149,85,TWrex-cause,804945-FS1,"1]  Nelson HS, Busse WW, Kerwin E, Church N, Emmett A, Rickard K, Knobil KFLUTICASONE propionate/salmeterol combination provides more effective ASTHMA control than low dose inhaled corticosteroid plus montelukast.",ASTHMA,FLUTICASONE
720315730,5/11/2015 23:55:13,1634446151,5/11/2015 23:54:57,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[PREVENTS],[PREVENTS],control,n/a,144,74,-1,149,85,TWrex-cause,804945-FS1,"1]  Nelson HS, Busse WW, Kerwin E, Church N, Emmett A, Rickard K, Knobil KFLUTICASONE propionate/salmeterol combination provides more effective ASTHMA control than low dose inhaled corticosteroid plus montelukast.",ASTHMA,FLUTICASONE
720315730,5/12/2015 00:21:06,1634455600,5/12/2015 00:19:38,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],provides more effective ASTHMA control,treats,144,74,-1,149,85,TWrex-cause,804945-FS1,"1]  Nelson HS, Busse WW, Kerwin E, Church N, Emmett A, Rickard K, Knobil KFLUTICASONE propionate/salmeterol combination provides more effective ASTHMA control than low dose inhaled corticosteroid plus montelukast.",ASTHMA,FLUTICASONE
720315730,5/12/2015 00:27:11,1634458037,5/12/2015 00:26:09,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],KFLUTICASONE provides effective ASTHMA control,N/A,144,74,-1,149,85,TWrex-cause,804945-FS1,"1]  Nelson HS, Busse WW, Kerwin E, Church N, Emmett A, Rickard K, Knobil KFLUTICASONE propionate/salmeterol combination provides more effective ASTHMA control than low dose inhaled corticosteroid plus montelukast.",ASTHMA,FLUTICASONE
720315730,5/12/2015 00:40:13,1634463057,5/12/2015 00:39:22,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[PREVENTS],[PREVENTS],combination provides effective control,None,144,74,-1,149,85,TWrex-cause,804945-FS1,"1]  Nelson HS, Busse WW, Kerwin E, Church N, Emmett A, Rickard K, Knobil KFLUTICASONE propionate/salmeterol combination provides more effective ASTHMA control than low dose inhaled corticosteroid plus montelukast.",ASTHMA,FLUTICASONE
720315730,5/12/2015 00:40:26,1634463131,5/12/2015 00:39:27,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[TREATS],[TREATS],KFLUTICASONE provides ASTHMA control,n/A,144,74,-1,149,85,TWrex-cause,804945-FS1,"1]  Nelson HS, Busse WW, Kerwin E, Church N, Emmett A, Rickard K, Knobil KFLUTICASONE propionate/salmeterol combination provides more effective ASTHMA control than low dose inhaled corticosteroid plus montelukast.",ASTHMA,FLUTICASONE
720315730,5/12/2015 01:02:20,1634472742,5/12/2015 01:01:45,false,elite,1.0,31848723,USA,"","",155.94.185.207,[CAUSES],[CAUSES],KFLUTICASONE ASTHMA,N/A,144,74,-1,149,85,TWrex-cause,804945-FS1,"1]  Nelson HS, Busse WW, Kerwin E, Church N, Emmett A, Rickard K, Knobil KFLUTICASONE propionate/salmeterol combination provides more effective ASTHMA control than low dose inhaled corticosteroid plus montelukast.",ASTHMA,FLUTICASONE
720315730,5/12/2015 01:10:21,1634476887,5/12/2015 01:09:48,false,elite,1.0,32306791,NLD,"","",31.3.156.41,[MANIFESTATION],[MANIFESTATION],Knobil KFLUTICASONE,faf,144,74,-1,149,85,TWrex-cause,804945-FS1,"1]  Nelson HS, Busse WW, Kerwin E, Church N, Emmett A, Rickard K, Knobil KFLUTICASONE propionate/salmeterol combination provides more effective ASTHMA control than low dose inhaled corticosteroid plus montelukast.",ASTHMA,FLUTICASONE
720315731,5/12/2015 06:27:52,1634643750,5/12/2015 06:27:09,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[IS_A],[IS_A],specific,N/A,157,178,1,165,199,TWrex-cause,814746-FS1,Table    History and Physical Examination Elements for Tension type Headache  Laboratory Tests  3.3 Reserve laboratory testing for the exclusion of specific HEADACHES other than TENSION TYPE HEADACHE,HEADACHES,TENSION TYPE HEADACHE
720315731,5/12/2015 06:33:34,1634646400,5/12/2015 06:33:04,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[IS_A],[IS_A],HEADACHE,N/A,157,178,1,165,199,TWrex-cause,814746-FS1,Table    History and Physical Examination Elements for Tension type Headache  Laboratory Tests  3.3 Reserve laboratory testing for the exclusion of specific HEADACHES other than TENSION TYPE HEADACHE,HEADACHES,TENSION TYPE HEADACHE
720315731,5/12/2015 06:50:46,1634653810,5/12/2015 06:50:23,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[OTHER],[OTHER],other than,N/A,157,178,1,165,199,TWrex-cause,814746-FS1,Table    History and Physical Examination Elements for Tension type Headache  Laboratory Tests  3.3 Reserve laboratory testing for the exclusion of specific HEADACHES other than TENSION TYPE HEADACHE,HEADACHES,TENSION TYPE HEADACHE
720315731,5/12/2015 06:52:38,1634654608,5/12/2015 06:52:06,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],testing,NA,157,178,1,165,199,TWrex-cause,814746-FS1,Table    History and Physical Examination Elements for Tension type Headache  Laboratory Tests  3.3 Reserve laboratory testing for the exclusion of specific HEADACHES other than TENSION TYPE HEADACHE,HEADACHES,TENSION TYPE HEADACHE
720315731,5/12/2015 07:05:55,1634660331,5/12/2015 07:04:45,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[PART_OF],[PART_OF],other than,n/a,157,178,1,165,199,TWrex-cause,814746-FS1,Table    History and Physical Examination Elements for Tension type Headache  Laboratory Tests  3.3 Reserve laboratory testing for the exclusion of specific HEADACHES other than TENSION TYPE HEADACHE,HEADACHES,TENSION TYPE HEADACHE
720315731,5/12/2015 08:01:31,1634693937,5/12/2015 08:00:54,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[PART_OF],[PART_OF],specific other than,N/A,157,178,1,165,199,TWrex-cause,814746-FS1,Table    History and Physical Examination Elements for Tension type Headache  Laboratory Tests  3.3 Reserve laboratory testing for the exclusion of specific HEADACHES other than TENSION TYPE HEADACHE,HEADACHES,TENSION TYPE HEADACHE
720315731,5/12/2015 08:17:06,1634701885,5/12/2015 08:16:01,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],specific,Associated with,157,178,1,165,199,TWrex-cause,814746-FS1,Table    History and Physical Examination Elements for Tension type Headache  Laboratory Tests  3.3 Reserve laboratory testing for the exclusion of specific HEADACHES other than TENSION TYPE HEADACHE,HEADACHES,TENSION TYPE HEADACHE
720315731,5/12/2015 08:55:00,1634722436,5/12/2015 08:54:41,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[MANIFESTATION],[MANIFESTATION],specific,N/A,157,178,1,165,199,TWrex-cause,814746-FS1,Table    History and Physical Examination Elements for Tension type Headache  Laboratory Tests  3.3 Reserve laboratory testing for the exclusion of specific HEADACHES other than TENSION TYPE HEADACHE,HEADACHES,TENSION TYPE HEADACHE
720315731,5/12/2015 09:01:04,1634725380,5/12/2015 09:00:32,false,inboxpounds,1.0,29059658,GBR,H9,London,79.77.3.89,[OTHER],[OTHER],other than,Exclusion,157,178,1,165,199,TWrex-cause,814746-FS1,Table    History and Physical Examination Elements for Tension type Headache  Laboratory Tests  3.3 Reserve laboratory testing for the exclusion of specific HEADACHES other than TENSION TYPE HEADACHE,HEADACHES,TENSION TYPE HEADACHE
720315731,5/12/2015 11:02:59,1634825011,5/12/2015 11:01:59,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[SYMPTOM],[SYMPTOM],other than,n/a,157,178,1,165,199,TWrex-cause,814746-FS1,Table    History and Physical Examination Elements for Tension type Headache  Laboratory Tests  3.3 Reserve laboratory testing for the exclusion of specific HEADACHES other than TENSION TYPE HEADACHE,HEADACHES,TENSION TYPE HEADACHE
720315731,5/12/2015 11:41:35,1634852153,5/12/2015 11:39:32,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[IS_A],[IS_A],HEADACHES TENSION TYPE HEADACHE,N/A,157,178,1,165,199,TWrex-cause,814746-FS1,Table    History and Physical Examination Elements for Tension type Headache  Laboratory Tests  3.3 Reserve laboratory testing for the exclusion of specific HEADACHES other than TENSION TYPE HEADACHE,HEADACHES,TENSION TYPE HEADACHE
720315731,5/12/2015 11:55:12,1634859427,5/12/2015 11:54:44,false,prodege,1.0,14848125,GBR,L6,Shrewsbury,86.138.223.142,[IS_A],[IS_A],other than,N/A,157,178,1,165,199,TWrex-cause,814746-FS1,Table    History and Physical Examination Elements for Tension type Headache  Laboratory Tests  3.3 Reserve laboratory testing for the exclusion of specific HEADACHES other than TENSION TYPE HEADACHE,HEADACHES,TENSION TYPE HEADACHE
720315731,5/12/2015 11:56:28,1634859972,5/12/2015 11:55:49,false,clixsense,1.0,29594612,NLD,11,Rotterdam,82.156.132.195,[IS_A],[IS_A],other than,N/A,157,178,1,165,199,TWrex-cause,814746-FS1,Table    History and Physical Examination Elements for Tension type Headache  Laboratory Tests  3.3 Reserve laboratory testing for the exclusion of specific HEADACHES other than TENSION TYPE HEADACHE,HEADACHES,TENSION TYPE HEADACHE
720315731,5/12/2015 12:12:04,1634866840,5/12/2015 12:10:50,false,neodev,1.0,30588889,NLD,07,Amsterdam,77.248.175.222,[ASSOCIATED_WITH],[ASSOCIATED_WITH],specific,N/A,157,178,1,165,199,TWrex-cause,814746-FS1,Table    History and Physical Examination Elements for Tension type Headache  Laboratory Tests  3.3 Reserve laboratory testing for the exclusion of specific HEADACHES other than TENSION TYPE HEADACHE,HEADACHES,TENSION TYPE HEADACHE
720315731,5/12/2015 12:39:02,1634878893,5/12/2015 12:38:26,false,clixsense,1.0,27969116,NLD,"","",212.78.195.38,[OTHER],[OTHER],other than TENSION TYPE HEADACHE,other headache than ...,157,178,1,165,199,TWrex-cause,814746-FS1,Table    History and Physical Examination Elements for Tension type Headache  Laboratory Tests  3.3 Reserve laboratory testing for the exclusion of specific HEADACHES other than TENSION TYPE HEADACHE,HEADACHES,TENSION TYPE HEADACHE
720315732,5/11/2015 22:19:04,1634401938,5/11/2015 22:18:49,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[LOCATION],[LOCATION],PHEOCHROMOCYTOMA,N/A,56,86,1,67,102,TWrex-cause,812968-FS1,"In elderly patients, severe weight loss with persistent HYPERTENSION is suggestive of PHEOCHROMOCYTOMA",HYPERTENSION,PHEOCHROMOCYTOMA
720315732,5/11/2015 22:20:57,1634402957,5/11/2015 22:20:43,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],suggestive of,n/a,56,86,1,67,102,TWrex-cause,812968-FS1,"In elderly patients, severe weight loss with persistent HYPERTENSION is suggestive of PHEOCHROMOCYTOMA",HYPERTENSION,PHEOCHROMOCYTOMA
720315732,5/11/2015 22:21:11,1634403107,5/11/2015 22:20:51,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],HYPERTENSION is suggestive of PHEOCHROMOCYTOMA,n/a,56,86,1,67,102,TWrex-cause,812968-FS1,"In elderly patients, severe weight loss with persistent HYPERTENSION is suggestive of PHEOCHROMOCYTOMA",HYPERTENSION,PHEOCHROMOCYTOMA
720315732,5/11/2015 22:28:02,1634406033,5/11/2015 22:27:23,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[SYMPTOM],[SYMPTOM],HYPERTENSION suggestive of PHEOCHROMOCYTOMA,N/A,56,86,1,67,102,TWrex-cause,812968-FS1,"In elderly patients, severe weight loss with persistent HYPERTENSION is suggestive of PHEOCHROMOCYTOMA",HYPERTENSION,PHEOCHROMOCYTOMA
720315732,5/11/2015 22:29:58,1634406682,5/11/2015 22:29:24,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[MANIFESTATION],[MANIFESTATION],suggestive of,n/a,56,86,1,67,102,TWrex-cause,812968-FS1,"In elderly patients, severe weight loss with persistent HYPERTENSION is suggestive of PHEOCHROMOCYTOMA",HYPERTENSION,PHEOCHROMOCYTOMA
720315732,5/11/2015 22:36:47,1634409813,5/11/2015 22:36:33,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[SYMPTOM],[SYMPTOM],suggestive of,n/a,56,86,1,67,102,TWrex-cause,812968-FS1,"In elderly patients, severe weight loss with persistent HYPERTENSION is suggestive of PHEOCHROMOCYTOMA",HYPERTENSION,PHEOCHROMOCYTOMA
720315732,5/11/2015 22:37:02,1634409984,5/11/2015 22:36:34,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[ASSOCIATED_WITH],[ASSOCIATED_WITH],suggestive,n/a,56,86,1,67,102,TWrex-cause,812968-FS1,"In elderly patients, severe weight loss with persistent HYPERTENSION is suggestive of PHEOCHROMOCYTOMA",HYPERTENSION,PHEOCHROMOCYTOMA
720315732,5/11/2015 22:42:40,1634412627,5/11/2015 22:42:16,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],HYPERTENSION suggestive of PHEOCHROMOCYTOMA,n/a,56,86,1,67,102,TWrex-cause,812968-FS1,"In elderly patients, severe weight loss with persistent HYPERTENSION is suggestive of PHEOCHROMOCYTOMA",HYPERTENSION,PHEOCHROMOCYTOMA
720315732,5/11/2015 22:45:17,1634413853,5/11/2015 22:44:54,false,instagc,1.0,28519532,USA,IA,Neola,38.121.112.217,[MANIFESTATION],[MANIFESTATION],suggestive of,na,56,86,1,67,102,TWrex-cause,812968-FS1,"In elderly patients, severe weight loss with persistent HYPERTENSION is suggestive of PHEOCHROMOCYTOMA",HYPERTENSION,PHEOCHROMOCYTOMA
720315732,5/11/2015 22:47:35,1634415001,5/11/2015 22:46:43,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SYMPTOM],[SYMPTOM],"In elderly patients, severe weight loss with persistent HYPERTENSION is suggestive of PHEOCHROMOCYTOMA",N/A,56,86,1,67,102,TWrex-cause,812968-FS1,"In elderly patients, severe weight loss with persistent HYPERTENSION is suggestive of PHEOCHROMOCYTOMA",HYPERTENSION,PHEOCHROMOCYTOMA
720315732,5/11/2015 22:54:59,1634417912,5/11/2015 22:54:33,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,75.147.181.53,[ASSOCIATED_WITH],[ASSOCIATED_WITH],is suggestive of,N/A,56,86,1,67,102,TWrex-cause,812968-FS1,"In elderly patients, severe weight loss with persistent HYPERTENSION is suggestive of PHEOCHROMOCYTOMA",HYPERTENSION,PHEOCHROMOCYTOMA
720315732,5/11/2015 22:57:14,1634418684,5/11/2015 22:56:33,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",suggestive of,N/A,56,86,1,67,102,TWrex-cause,812968-FS1,"In elderly patients, severe weight loss with persistent HYPERTENSION is suggestive of PHEOCHROMOCYTOMA",HYPERTENSION,PHEOCHROMOCYTOMA
720315732,5/11/2015 22:57:26,1634418747,5/11/2015 22:56:47,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",weight loss with HYPERTENSION is suggestive of PHEOCHROMOCYTOMA,n/a,56,86,1,67,102,TWrex-cause,812968-FS1,"In elderly patients, severe weight loss with persistent HYPERTENSION is suggestive of PHEOCHROMOCYTOMA",HYPERTENSION,PHEOCHROMOCYTOMA
720315732,5/11/2015 22:57:33,1634418768,5/11/2015 22:56:30,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[SYMPTOM],[SYMPTOM],suggestive of,N/A,56,86,1,67,102,TWrex-cause,812968-FS1,"In elderly patients, severe weight loss with persistent HYPERTENSION is suggestive of PHEOCHROMOCYTOMA",HYPERTENSION,PHEOCHROMOCYTOMA
720315732,5/11/2015 22:58:05,1634418963,5/11/2015 22:56:39,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[CAUSES],[CAUSES],suggestive,the hypertension is indicative of an underlying condition,56,86,1,67,102,TWrex-cause,812968-FS1,"In elderly patients, severe weight loss with persistent HYPERTENSION is suggestive of PHEOCHROMOCYTOMA",HYPERTENSION,PHEOCHROMOCYTOMA
720315733,5/11/2015 23:13:24,1634426133,5/11/2015 23:13:06,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],are highly specific for,N/A,29,98,1,47,102,TWrex-cause,814905-FS1,"Nonendocrine tumors, such as FACIAL ANGIOFIBROMA and truncal collagenoma, are highly specific for MEN1",FACIAL ANGIOFIBROMA,MEN1
720315733,5/11/2015 23:23:05,1634430597,5/11/2015 23:22:44,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[SYMPTOM],[SYMPTOM],highly specific,N/A,29,98,1,47,102,TWrex-cause,814905-FS1,"Nonendocrine tumors, such as FACIAL ANGIOFIBROMA and truncal collagenoma, are highly specific for MEN1",FACIAL ANGIOFIBROMA,MEN1
720315733,5/11/2015 23:39:10,1634439528,5/11/2015 23:38:40,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[SYMPTOM],[SYMPTOM],highly specific for,n/a,29,98,1,47,102,TWrex-cause,814905-FS1,"Nonendocrine tumors, such as FACIAL ANGIOFIBROMA and truncal collagenoma, are highly specific for MEN1",FACIAL ANGIOFIBROMA,MEN1
720315733,5/11/2015 23:52:50,1634445194,5/11/2015 23:52:36,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.48,[CAUSES] [PREVENTS] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,29,98,1,47,102,TWrex-cause,814905-FS1,"Nonendocrine tumors, such as FACIAL ANGIOFIBROMA and truncal collagenoma, are highly specific for MEN1",FACIAL ANGIOFIBROMA,MEN1
720315733,5/12/2015 00:28:38,1634458640,5/12/2015 00:26:57,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],highly specific for,causes,29,98,1,47,102,TWrex-cause,814905-FS1,"Nonendocrine tumors, such as FACIAL ANGIOFIBROMA and truncal collagenoma, are highly specific for MEN1",FACIAL ANGIOFIBROMA,MEN1
720315733,5/12/2015 00:43:28,1634464589,5/12/2015 00:42:44,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[NONE],[NONE],N/A,None,29,98,1,47,102,TWrex-cause,814905-FS1,"Nonendocrine tumors, such as FACIAL ANGIOFIBROMA and truncal collagenoma, are highly specific for MEN1",FACIAL ANGIOFIBROMA,MEN1
720315733,5/12/2015 00:45:32,1634465641,5/12/2015 00:44:51,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[ASSOCIATED_WITH],[ASSOCIATED_WITH],FACIAL ANGIOFIBROMA highly specific for MEN1,n/a,29,98,1,47,102,TWrex-cause,814905-FS1,"Nonendocrine tumors, such as FACIAL ANGIOFIBROMA and truncal collagenoma, are highly specific for MEN1",FACIAL ANGIOFIBROMA,MEN1
720315733,5/12/2015 01:04:53,1634473983,5/12/2015 01:04:30,false,elite,1.0,31848723,USA,"","",155.94.185.207,[CAUSES],[CAUSES],FACIAL ANGIOFIBROMA MEN1,N/A,29,98,1,47,102,TWrex-cause,814905-FS1,"Nonendocrine tumors, such as FACIAL ANGIOFIBROMA and truncal collagenoma, are highly specific for MEN1",FACIAL ANGIOFIBROMA,MEN1
720315733,5/12/2015 01:11:56,1634477613,5/12/2015 01:11:43,false,elite,1.0,32306791,NLD,"","",31.3.156.41,[PREVENTS],[PREVENTS],"tumors, ANGIOFIBROMA",dsg,29,98,1,47,102,TWrex-cause,814905-FS1,"Nonendocrine tumors, such as FACIAL ANGIOFIBROMA and truncal collagenoma, are highly specific for MEN1",FACIAL ANGIOFIBROMA,MEN1
720315733,5/12/2015 01:23:10,1634483986,5/12/2015 01:21:50,false,instagc,1.0,32556346,USA,PA,Warren,207.255.244.59,[ASSOCIATED_WITH],[ASSOCIATED_WITH],specific,N/A,29,98,1,47,102,TWrex-cause,814905-FS1,"Nonendocrine tumors, such as FACIAL ANGIOFIBROMA and truncal collagenoma, are highly specific for MEN1",FACIAL ANGIOFIBROMA,MEN1
720315733,5/12/2015 01:28:31,1634486580,5/12/2015 01:27:56,false,instagc,1.0,30326470,USA,CA,San Diego,170.213.2.111,[IS_A],[IS_A],highly specific,N/A,29,98,1,47,102,TWrex-cause,814905-FS1,"Nonendocrine tumors, such as FACIAL ANGIOFIBROMA and truncal collagenoma, are highly specific for MEN1",FACIAL ANGIOFIBROMA,MEN1
720315733,5/12/2015 02:47:46,1634528254,5/12/2015 02:47:30,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[DIAGNOSE_BY_TEST_OR_DRUG] [PREVENTS],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]","and truncal collagenoma,",n/a,29,98,1,47,102,TWrex-cause,814905-FS1,"Nonendocrine tumors, such as FACIAL ANGIOFIBROMA and truncal collagenoma, are highly specific for MEN1",FACIAL ANGIOFIBROMA,MEN1
720315733,5/12/2015 03:20:21,1634544874,5/12/2015 03:19:47,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[SYMPTOM],[SYMPTOM],specific,n/a,29,98,1,47,102,TWrex-cause,814905-FS1,"Nonendocrine tumors, such as FACIAL ANGIOFIBROMA and truncal collagenoma, are highly specific for MEN1",FACIAL ANGIOFIBROMA,MEN1
720315733,5/12/2015 03:32:24,1634551392,5/12/2015 03:30:41,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.227,[PREVENTS],[PREVENTS],FACIAL ANGIOFIBROMA MEN1,N/A,29,98,1,47,102,TWrex-cause,814905-FS1,"Nonendocrine tumors, such as FACIAL ANGIOFIBROMA and truncal collagenoma, are highly specific for MEN1",FACIAL ANGIOFIBROMA,MEN1
720315733,5/12/2015 04:07:09,1634568093,5/12/2015 04:06:22,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[LOCATION],[LOCATION],highly specific for,N/A,29,98,1,47,102,TWrex-cause,814905-FS1,"Nonendocrine tumors, such as FACIAL ANGIOFIBROMA and truncal collagenoma, are highly specific for MEN1",FACIAL ANGIOFIBROMA,MEN1
720315734,5/11/2015 23:12:19,1634425463,5/11/2015 23:12:02,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],may present as,N/A,58,0,1,78,18,TWrex-cause,813938-FS1,• WILSON'S DISEASE may present as acute hepatic injury or ACUTE HEPATIC FAILURE,ACUTE HEPATIC FAILURE,• WILSON'S DISEASE
720315734,5/11/2015 23:21:24,1634429760,5/11/2015 23:21:01,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[SYMPTOM],[SYMPTOM],present,N/A,58,0,1,78,18,TWrex-cause,813938-FS1,• WILSON'S DISEASE may present as acute hepatic injury or ACUTE HEPATIC FAILURE,ACUTE HEPATIC FAILURE,• WILSON'S DISEASE
720315734,5/11/2015 23:23:16,1634430713,5/11/2015 23:22:34,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[MANIFESTATION],[MANIFESTATION],may present,n/a,58,0,1,78,18,TWrex-cause,813938-FS1,• WILSON'S DISEASE may present as acute hepatic injury or ACUTE HEPATIC FAILURE,ACUTE HEPATIC FAILURE,• WILSON'S DISEASE
720315734,5/11/2015 23:25:42,1634431626,5/11/2015 23:25:12,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",present,its a way the problem shows up,58,0,1,78,18,TWrex-cause,813938-FS1,• WILSON'S DISEASE may present as acute hepatic injury or ACUTE HEPATIC FAILURE,ACUTE HEPATIC FAILURE,• WILSON'S DISEASE
720315734,5/11/2015 23:33:46,1634435588,5/11/2015 23:32:51,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[SYMPTOM],[SYMPTOM],present as,N/A,58,0,1,78,18,TWrex-cause,813938-FS1,• WILSON'S DISEASE may present as acute hepatic injury or ACUTE HEPATIC FAILURE,ACUTE HEPATIC FAILURE,• WILSON'S DISEASE
720315734,5/11/2015 23:36:31,1634437504,5/11/2015 23:36:17,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[MANIFESTATION],[MANIFESTATION],present,n/a,58,0,1,78,18,TWrex-cause,813938-FS1,• WILSON'S DISEASE may present as acute hepatic injury or ACUTE HEPATIC FAILURE,ACUTE HEPATIC FAILURE,• WILSON'S DISEASE
720315734,5/11/2015 23:43:00,1634441331,5/11/2015 23:42:23,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],present,n/a,58,0,1,78,18,TWrex-cause,813938-FS1,• WILSON'S DISEASE may present as acute hepatic injury or ACUTE HEPATIC FAILURE,ACUTE HEPATIC FAILURE,• WILSON'S DISEASE
720315734,5/11/2015 23:51:42,1634444784,5/11/2015 23:51:25,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.48,[PREVENTS] [CAUSES] [LOCATION] [NONE],"[PREVENTS]
[CAUSES]
[LOCATION]
[NONE]",no,no,58,0,1,78,18,TWrex-cause,813938-FS1,• WILSON'S DISEASE may present as acute hepatic injury or ACUTE HEPATIC FAILURE,ACUTE HEPATIC FAILURE,• WILSON'S DISEASE
720315734,5/11/2015 23:55:35,1634446305,5/11/2015 23:55:15,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],present,n/a,58,0,1,78,18,TWrex-cause,813938-FS1,• WILSON'S DISEASE may present as acute hepatic injury or ACUTE HEPATIC FAILURE,ACUTE HEPATIC FAILURE,• WILSON'S DISEASE
720315734,5/12/2015 00:22:23,1634456149,5/12/2015 00:21:07,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],may present as,symptom,58,0,1,78,18,TWrex-cause,813938-FS1,• WILSON'S DISEASE may present as acute hepatic injury or ACUTE HEPATIC FAILURE,ACUTE HEPATIC FAILURE,• WILSON'S DISEASE
720315734,5/12/2015 00:40:42,1634463243,5/12/2015 00:40:14,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[MANIFESTATION],[MANIFESTATION],may present as,None,58,0,1,78,18,TWrex-cause,813938-FS1,• WILSON'S DISEASE may present as acute hepatic injury or ACUTE HEPATIC FAILURE,ACUTE HEPATIC FAILURE,• WILSON'S DISEASE
720315734,5/12/2015 00:41:11,1634463457,5/12/2015 00:40:28,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[MANIFESTATION],[MANIFESTATION],WILSON'S DISEASE may present as ACUTE HEPATIC FAILURE,n/a,58,0,1,78,18,TWrex-cause,813938-FS1,• WILSON'S DISEASE may present as acute hepatic injury or ACUTE HEPATIC FAILURE,ACUTE HEPATIC FAILURE,• WILSON'S DISEASE
720315734,5/12/2015 01:02:58,1634473070,5/12/2015 01:02:24,false,elite,1.0,31848723,USA,"","",155.94.185.207,[SYMPTOM],[SYMPTOM],WILSON'S DISEASE ACUTE HEPATIC FAILURE,N/A,58,0,1,78,18,TWrex-cause,813938-FS1,• WILSON'S DISEASE may present as acute hepatic injury or ACUTE HEPATIC FAILURE,ACUTE HEPATIC FAILURE,• WILSON'S DISEASE
720315734,5/12/2015 01:10:42,1634477018,5/12/2015 01:10:23,false,elite,1.0,32306791,NLD,"","",31.3.156.41,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],DISEASE ACUTE,dfcvs,58,0,1,78,18,TWrex-cause,813938-FS1,• WILSON'S DISEASE may present as acute hepatic injury or ACUTE HEPATIC FAILURE,ACUTE HEPATIC FAILURE,• WILSON'S DISEASE
720315734,5/12/2015 01:19:59,1634481978,5/12/2015 01:18:18,false,instagc,1.0,32556346,USA,PA,Warren,207.255.244.59,[ASSOCIATED_WITH],[ASSOCIATED_WITH],present,N/A,58,0,1,78,18,TWrex-cause,813938-FS1,• WILSON'S DISEASE may present as acute hepatic injury or ACUTE HEPATIC FAILURE,ACUTE HEPATIC FAILURE,• WILSON'S DISEASE
720315735,5/12/2015 01:34:19,1634489569,5/12/2015 01:33:59,false,instagc,1.0,32556346,USA,PA,Warren,207.255.244.59,[TREATS],[TREATS],used prescription reduce,N/A,183,13,-1,186,26,TWrex-cause,800628-FS1,"BACKGROUND:  ACETAMINOPHEN one of the most commonly used drugs in the United States, is widely and effectively used in both prescription and over the counter (OTC) products to reduce PAIN and fever.",PAIN,ACETAMINOPHEN
720315735,5/12/2015 01:46:00,1634495993,5/12/2015 01:45:27,false,instagc,1.0,30326470,USA,CA,San Diego,170.213.2.111,[TREATS],[TREATS],commonly used drugs,N/A,183,13,-1,186,26,TWrex-cause,800628-FS1,"BACKGROUND:  ACETAMINOPHEN one of the most commonly used drugs in the United States, is widely and effectively used in both prescription and over the counter (OTC) products to reduce PAIN and fever.",PAIN,ACETAMINOPHEN
720315735,5/12/2015 03:28:34,1634549366,5/12/2015 03:28:03,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[PREVENTS],[PREVENTS],reduce,n/a,183,13,-1,186,26,TWrex-cause,800628-FS1,"BACKGROUND:  ACETAMINOPHEN one of the most commonly used drugs in the United States, is widely and effectively used in both prescription and over the counter (OTC) products to reduce PAIN and fever.",PAIN,ACETAMINOPHEN
720315735,5/12/2015 03:47:34,1634558467,5/12/2015 03:46:51,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.227,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],ACETAMINOPHEN PAIN,N/A,183,13,-1,186,26,TWrex-cause,800628-FS1,"BACKGROUND:  ACETAMINOPHEN one of the most commonly used drugs in the United States, is widely and effectively used in both prescription and over the counter (OTC) products to reduce PAIN and fever.",PAIN,ACETAMINOPHEN
720315735,5/12/2015 04:21:59,1634575191,5/12/2015 04:21:34,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[TREATS],[TREATS],reduce,N/A,183,13,-1,186,26,TWrex-cause,800628-FS1,"BACKGROUND:  ACETAMINOPHEN one of the most commonly used drugs in the United States, is widely and effectively used in both prescription and over the counter (OTC) products to reduce PAIN and fever.",PAIN,ACETAMINOPHEN
720315735,5/12/2015 05:01:03,1634594351,5/12/2015 05:00:37,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],reduce,none,183,13,-1,186,26,TWrex-cause,800628-FS1,"BACKGROUND:  ACETAMINOPHEN one of the most commonly used drugs in the United States, is widely and effectively used in both prescription and over the counter (OTC) products to reduce PAIN and fever.",PAIN,ACETAMINOPHEN
720315735,5/12/2015 05:11:02,1634600025,5/12/2015 05:10:26,false,neodev,1.0,31910622,USA,CA,San Francisco,108.169.6.201,[TREATS],[TREATS],most commonly used drugs to reduce,I didn´t select none.,183,13,-1,186,26,TWrex-cause,800628-FS1,"BACKGROUND:  ACETAMINOPHEN one of the most commonly used drugs in the United States, is widely and effectively used in both prescription and over the counter (OTC) products to reduce PAIN and fever.",PAIN,ACETAMINOPHEN
720315735,5/12/2015 06:10:40,1634635564,5/12/2015 06:09:33,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],prescription,N/A,183,13,-1,186,26,TWrex-cause,800628-FS1,"BACKGROUND:  ACETAMINOPHEN one of the most commonly used drugs in the United States, is widely and effectively used in both prescription and over the counter (OTC) products to reduce PAIN and fever.",PAIN,ACETAMINOPHEN
720315735,5/12/2015 06:24:31,1634642067,5/12/2015 06:24:08,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[TREATS],[TREATS],reduce,N/A,183,13,-1,186,26,TWrex-cause,800628-FS1,"BACKGROUND:  ACETAMINOPHEN one of the most commonly used drugs in the United States, is widely and effectively used in both prescription and over the counter (OTC) products to reduce PAIN and fever.",PAIN,ACETAMINOPHEN
720315735,5/12/2015 06:36:12,1634647640,5/12/2015 06:33:42,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[TREATS],[TREATS],ACETAMINOPHEN commonly used drugs effectively used products reduce PAIN,n/a,183,13,-1,186,26,TWrex-cause,800628-FS1,"BACKGROUND:  ACETAMINOPHEN one of the most commonly used drugs in the United States, is widely and effectively used in both prescription and over the counter (OTC) products to reduce PAIN and fever.",PAIN,ACETAMINOPHEN
720315735,5/12/2015 06:40:49,1634649498,5/12/2015 06:40:26,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[TREATS],[TREATS],used,NA,183,13,-1,186,26,TWrex-cause,800628-FS1,"BACKGROUND:  ACETAMINOPHEN one of the most commonly used drugs in the United States, is widely and effectively used in both prescription and over the counter (OTC) products to reduce PAIN and fever.",PAIN,ACETAMINOPHEN
720315735,5/12/2015 06:41:42,1634649810,5/12/2015 06:41:14,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[TREATS],[TREATS],ACETAMINOPHEN effectively used to reduce PAIN,n/a,183,13,-1,186,26,TWrex-cause,800628-FS1,"BACKGROUND:  ACETAMINOPHEN one of the most commonly used drugs in the United States, is widely and effectively used in both prescription and over the counter (OTC) products to reduce PAIN and fever.",PAIN,ACETAMINOPHEN
720315735,5/12/2015 06:42:02,1634650011,5/12/2015 06:41:26,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[PREVENTS],[PREVENTS],reduce PAIN,n/a,183,13,-1,186,26,TWrex-cause,800628-FS1,"BACKGROUND:  ACETAMINOPHEN one of the most commonly used drugs in the United States, is widely and effectively used in both prescription and over the counter (OTC) products to reduce PAIN and fever.",PAIN,ACETAMINOPHEN
720315735,5/12/2015 06:45:14,1634651440,5/12/2015 06:44:51,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[TREATS],[TREATS],to reduce,N/A,183,13,-1,186,26,TWrex-cause,800628-FS1,"BACKGROUND:  ACETAMINOPHEN one of the most commonly used drugs in the United States, is widely and effectively used in both prescription and over the counter (OTC) products to reduce PAIN and fever.",PAIN,ACETAMINOPHEN
720315735,5/12/2015 06:59:43,1634657778,5/12/2015 06:59:09,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[TREATS],[TREATS],to reduce,N/a,183,13,-1,186,26,TWrex-cause,800628-FS1,"BACKGROUND:  ACETAMINOPHEN one of the most commonly used drugs in the United States, is widely and effectively used in both prescription and over the counter (OTC) products to reduce PAIN and fever.",PAIN,ACETAMINOPHEN
720315736,5/11/2015 23:56:28,1634446557,5/11/2015 23:56:14,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.48,[PREVENTS] [CAUSES] [SYMPTOM] [NONE],"[PREVENTS]
[CAUSES]
[SYMPTOM]
[NONE]",no,no,62,107,-1,86,116,TWrex-cause,804033-FS1,"Rahhal FM, Arevalo JF, Chavez de la Paz E et al. Treatment of CYTOMEGALOVIRUS RETINITIS with intravitreous CIDOFOVIR in patients with AIDS.",CYTOMEGALOVIRUS RETINITIS,CIDOFOVIR
720315736,5/12/2015 00:52:27,1634468243,5/12/2015 00:50:49,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],Treatment with,N/A,62,107,-1,86,116,TWrex-cause,804033-FS1,"Rahhal FM, Arevalo JF, Chavez de la Paz E et al. Treatment of CYTOMEGALOVIRUS RETINITIS with intravitreous CIDOFOVIR in patients with AIDS.",CYTOMEGALOVIRUS RETINITIS,CIDOFOVIR
720315736,5/12/2015 00:56:39,1634470113,5/12/2015 00:55:42,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[TREATS],[TREATS],Treatment of CYTOMEGALOVIRUS RETINITIS with CIDOFOVIR,n/a,62,107,-1,86,116,TWrex-cause,804033-FS1,"Rahhal FM, Arevalo JF, Chavez de la Paz E et al. Treatment of CYTOMEGALOVIRUS RETINITIS with intravitreous CIDOFOVIR in patients with AIDS.",CYTOMEGALOVIRUS RETINITIS,CIDOFOVIR
720315736,5/12/2015 00:57:08,1634470376,5/12/2015 00:55:51,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[TREATS],[TREATS],Treatment of,N/A,62,107,-1,86,116,TWrex-cause,804033-FS1,"Rahhal FM, Arevalo JF, Chavez de la Paz E et al. Treatment of CYTOMEGALOVIRUS RETINITIS with intravitreous CIDOFOVIR in patients with AIDS.",CYTOMEGALOVIRUS RETINITIS,CIDOFOVIR
720315736,5/12/2015 01:12:27,1634477826,5/12/2015 01:12:01,false,elite,1.0,31848723,USA,"","",155.94.185.207,[CAUSES],[CAUSES],CYTOMEGALOVIRUS RETINITIS CIDOFOVIR,N/A,62,107,-1,86,116,TWrex-cause,804033-FS1,"Rahhal FM, Arevalo JF, Chavez de la Paz E et al. Treatment of CYTOMEGALOVIRUS RETINITIS with intravitreous CIDOFOVIR in patients with AIDS.",CYTOMEGALOVIRUS RETINITIS,CIDOFOVIR
720315736,5/12/2015 01:28:14,1634486456,5/12/2015 01:27:44,false,elite,1.0,32306791,USA,TX,Dallas,69.162.75.37,[PREVENTS],[PREVENTS],Treatment CYTOMEGALOVIRUS,N/A,62,107,-1,86,116,TWrex-cause,804033-FS1,"Rahhal FM, Arevalo JF, Chavez de la Paz E et al. Treatment of CYTOMEGALOVIRUS RETINITIS with intravitreous CIDOFOVIR in patients with AIDS.",CYTOMEGALOVIRUS RETINITIS,CIDOFOVIR
720315736,5/12/2015 01:28:45,1634486651,5/12/2015 01:28:32,false,instagc,1.0,32556346,USA,PA,Warren,207.255.244.59,[TREATS],[TREATS],Treatment,N/A,62,107,-1,86,116,TWrex-cause,804033-FS1,"Rahhal FM, Arevalo JF, Chavez de la Paz E et al. Treatment of CYTOMEGALOVIRUS RETINITIS with intravitreous CIDOFOVIR in patients with AIDS.",CYTOMEGALOVIRUS RETINITIS,CIDOFOVIR
720315736,5/12/2015 01:40:29,1634493102,5/12/2015 01:39:59,false,instagc,1.0,30326470,USA,CA,San Diego,170.213.2.111,[TREATS],[TREATS],Treatment of,N/A,62,107,-1,86,116,TWrex-cause,804033-FS1,"Rahhal FM, Arevalo JF, Chavez de la Paz E et al. Treatment of CYTOMEGALOVIRUS RETINITIS with intravitreous CIDOFOVIR in patients with AIDS.",CYTOMEGALOVIRUS RETINITIS,CIDOFOVIR
720315736,5/12/2015 03:25:20,1634547575,5/12/2015 03:25:05,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[OTHER],[OTHER],with,n/a,62,107,-1,86,116,TWrex-cause,804033-FS1,"Rahhal FM, Arevalo JF, Chavez de la Paz E et al. Treatment of CYTOMEGALOVIRUS RETINITIS with intravitreous CIDOFOVIR in patients with AIDS.",CYTOMEGALOVIRUS RETINITIS,CIDOFOVIR
720315736,5/12/2015 03:41:59,1634556042,5/12/2015 03:41:15,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.227,[ASSOCIATED_WITH],[ASSOCIATED_WITH],CYTOMEGALOVIRUS RETINITIS CIDOFOVIR,N/A,62,107,-1,86,116,TWrex-cause,804033-FS1,"Rahhal FM, Arevalo JF, Chavez de la Paz E et al. Treatment of CYTOMEGALOVIRUS RETINITIS with intravitreous CIDOFOVIR in patients with AIDS.",CYTOMEGALOVIRUS RETINITIS,CIDOFOVIR
720315736,5/12/2015 04:15:01,1634572115,5/12/2015 04:14:44,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[TREATS],[TREATS],Treatment with,N/A,62,107,-1,86,116,TWrex-cause,804033-FS1,"Rahhal FM, Arevalo JF, Chavez de la Paz E et al. Treatment of CYTOMEGALOVIRUS RETINITIS with intravitreous CIDOFOVIR in patients with AIDS.",CYTOMEGALOVIRUS RETINITIS,CIDOFOVIR
720315736,5/12/2015 04:49:55,1634588576,5/12/2015 04:49:28,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],Treatment,none,62,107,-1,86,116,TWrex-cause,804033-FS1,"Rahhal FM, Arevalo JF, Chavez de la Paz E et al. Treatment of CYTOMEGALOVIRUS RETINITIS with intravitreous CIDOFOVIR in patients with AIDS.",CYTOMEGALOVIRUS RETINITIS,CIDOFOVIR
720315736,5/12/2015 05:04:43,1634596486,5/12/2015 05:04:28,false,neodev,1.0,31910622,USA,CA,Los Angeles,108.185.211.151,[TREATS],[TREATS],Treatment with,I didn´t select none.,62,107,-1,86,116,TWrex-cause,804033-FS1,"Rahhal FM, Arevalo JF, Chavez de la Paz E et al. Treatment of CYTOMEGALOVIRUS RETINITIS with intravitreous CIDOFOVIR in patients with AIDS.",CYTOMEGALOVIRUS RETINITIS,CIDOFOVIR
720315736,5/12/2015 05:52:09,1634626514,5/12/2015 05:51:49,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],Treatment,N/A,62,107,-1,86,116,TWrex-cause,804033-FS1,"Rahhal FM, Arevalo JF, Chavez de la Paz E et al. Treatment of CYTOMEGALOVIRUS RETINITIS with intravitreous CIDOFOVIR in patients with AIDS.",CYTOMEGALOVIRUS RETINITIS,CIDOFOVIR
720315736,5/12/2015 06:17:22,1634638805,5/12/2015 06:16:45,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[TREATS],[TREATS],Treatment,N/A,62,107,-1,86,116,TWrex-cause,804033-FS1,"Rahhal FM, Arevalo JF, Chavez de la Paz E et al. Treatment of CYTOMEGALOVIRUS RETINITIS with intravitreous CIDOFOVIR in patients with AIDS.",CYTOMEGALOVIRUS RETINITIS,CIDOFOVIR
720315737,5/11/2015 23:09:35,1634423508,5/11/2015 23:09:17,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[PART_OF],[PART_OF],may be,N/A,0,62,1,21,75,TWrex-cause,811361-FS1,"ASYMPTOMATIC GONORRHEA occurs in 5 to 10% of pregnancies, so  N GONORRHOEAE  may be a pathogen.",ASYMPTOMATIC GONORRHEA,N GONORRHOEAE
720315737,5/11/2015 23:16:35,1634427561,5/11/2015 23:16:06,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],pathogen.,N/A,0,62,1,21,75,TWrex-cause,811361-FS1,"ASYMPTOMATIC GONORRHEA occurs in 5 to 10% of pregnancies, so  N GONORRHOEAE  may be a pathogen.",ASYMPTOMATIC GONORRHEA,N GONORRHOEAE
720315737,5/11/2015 23:17:17,1634427867,5/11/2015 23:16:04,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[ASSOCIATED_WITH],[ASSOCIATED_WITH],may be a pathogen.,n/a,0,62,1,21,75,TWrex-cause,811361-FS1,"ASYMPTOMATIC GONORRHEA occurs in 5 to 10% of pregnancies, so  N GONORRHOEAE  may be a pathogen.",ASYMPTOMATIC GONORRHEA,N GONORRHOEAE
720315737,5/11/2015 23:17:38,1634428004,5/11/2015 23:16:40,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],pathogen.,N/A,0,62,1,21,75,TWrex-cause,811361-FS1,"ASYMPTOMATIC GONORRHEA occurs in 5 to 10% of pregnancies, so  N GONORRHOEAE  may be a pathogen.",ASYMPTOMATIC GONORRHEA,N GONORRHOEAE
720315737,5/11/2015 23:18:31,1634428478,5/11/2015 23:16:38,false,clixsense,1.0,6330007,AUS,06,Hobart,101.178.23.54,[ASSOCIATED_WITH],[ASSOCIATED_WITH],pathogen.,n/a,0,62,1,21,75,TWrex-cause,811361-FS1,"ASYMPTOMATIC GONORRHEA occurs in 5 to 10% of pregnancies, so  N GONORRHOEAE  may be a pathogen.",ASYMPTOMATIC GONORRHEA,N GONORRHOEAE
720315737,5/11/2015 23:19:38,1634428909,5/11/2015 23:19:14,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[SYMPTOM],[SYMPTOM],occurs,it occurs in some situations,0,62,1,21,75,TWrex-cause,811361-FS1,"ASYMPTOMATIC GONORRHEA occurs in 5 to 10% of pregnancies, so  N GONORRHOEAE  may be a pathogen.",ASYMPTOMATIC GONORRHEA,N GONORRHOEAE
720315737,5/11/2015 23:19:43,1634428950,5/11/2015 23:18:43,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[CAUSES] [SYMPTOM],"[CAUSES]
[SYMPTOM]","ASYMPTOMATIC GONORRHEA occurs in 10% of pregnancies, N GONORRHOEAE may be a pathogen.",n/a,0,62,1,21,75,TWrex-cause,811361-FS1,"ASYMPTOMATIC GONORRHEA occurs in 5 to 10% of pregnancies, so  N GONORRHOEAE  may be a pathogen.",ASYMPTOMATIC GONORRHEA,N GONORRHOEAE
720315737,5/11/2015 23:20:32,1634429288,5/11/2015 23:19:33,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[CAUSES],[CAUSES],may be a pathogen.,n/a,0,62,1,21,75,TWrex-cause,811361-FS1,"ASYMPTOMATIC GONORRHEA occurs in 5 to 10% of pregnancies, so  N GONORRHOEAE  may be a pathogen.",ASYMPTOMATIC GONORRHEA,N GONORRHOEAE
720315737,5/11/2015 23:21:37,1634429895,5/11/2015 23:20:11,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],may be a pathogen.,N/A,0,62,1,21,75,TWrex-cause,811361-FS1,"ASYMPTOMATIC GONORRHEA occurs in 5 to 10% of pregnancies, so  N GONORRHOEAE  may be a pathogen.",ASYMPTOMATIC GONORRHEA,N GONORRHOEAE
720315737,5/11/2015 23:24:39,1634431245,5/11/2015 23:24:24,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.48,[PREVENTS] [CAUSES] [LOCATION] [NONE],"[PREVENTS]
[CAUSES]
[LOCATION]
[NONE]",NO,NO,0,62,1,21,75,TWrex-cause,811361-FS1,"ASYMPTOMATIC GONORRHEA occurs in 5 to 10% of pregnancies, so  N GONORRHOEAE  may be a pathogen.",ASYMPTOMATIC GONORRHEA,N GONORRHOEAE
720315737,5/11/2015 23:29:19,1634433247,5/11/2015 23:28:10,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[MANIFESTATION],[MANIFESTATION],may be a pathogen.,n/a,0,62,1,21,75,TWrex-cause,811361-FS1,"ASYMPTOMATIC GONORRHEA occurs in 5 to 10% of pregnancies, so  N GONORRHOEAE  may be a pathogen.",ASYMPTOMATIC GONORRHEA,N GONORRHOEAE
720315737,5/11/2015 23:30:35,1634434014,5/11/2015 23:30:15,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[IS_A],[IS_A],so,n/a,0,62,1,21,75,TWrex-cause,811361-FS1,"ASYMPTOMATIC GONORRHEA occurs in 5 to 10% of pregnancies, so  N GONORRHOEAE  may be a pathogen.",ASYMPTOMATIC GONORRHEA,N GONORRHOEAE
720315737,5/11/2015 23:31:53,1634434594,5/11/2015 23:29:52,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[ASSOCIATED_WITH],[ASSOCIATED_WITH],occurs,n/a,0,62,1,21,75,TWrex-cause,811361-FS1,"ASYMPTOMATIC GONORRHEA occurs in 5 to 10% of pregnancies, so  N GONORRHOEAE  may be a pathogen.",ASYMPTOMATIC GONORRHEA,N GONORRHOEAE
720315737,5/11/2015 23:52:52,1634445215,5/11/2015 23:52:18,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[ASSOCIATED_WITH],[ASSOCIATED_WITH],may be,n/a,0,62,1,21,75,TWrex-cause,811361-FS1,"ASYMPTOMATIC GONORRHEA occurs in 5 to 10% of pregnancies, so  N GONORRHOEAE  may be a pathogen.",ASYMPTOMATIC GONORRHEA,N GONORRHOEAE
720315737,5/12/2015 00:02:25,1634448632,5/12/2015 00:01:00,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],"ASYMPTOMATIC GONORRHEA occurs in pregnancies, so N GONORRHOEAE may be a pathogen.",N/A,0,62,1,21,75,TWrex-cause,811361-FS1,"ASYMPTOMATIC GONORRHEA occurs in 5 to 10% of pregnancies, so  N GONORRHOEAE  may be a pathogen.",ASYMPTOMATIC GONORRHEA,N GONORRHOEAE
720315738,5/12/2015 05:08:30,1634598684,5/12/2015 05:07:31,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION] [CAUSES],"[CAUSES]
[MANIFESTATION]",underlying causes,none,89,52,1,108,55,TWrex-cause,814595-FS1,"BC]  Specific recommendation: • Consider underlying SLE mixed connective tissue disease, RHEUMATOID ARTHRITIS and other collagen vascular diseases as possible causes of pleuritic chest pain.",RHEUMATOID ARTHRITIS,SLE
720315738,5/12/2015 05:14:08,1634602024,5/12/2015 05:13:40,false,neodev,1,31910622,USA,CA,San Francisco,108.169.6.201,[ASSOCIATED_WITH],[ASSOCIATED_WITH],mixed connective,I didn´t select none.,89,52,1,108,55,TWrex-cause,814595-FS1,"BC]  Specific recommendation: • Consider underlying SLE mixed connective tissue disease, RHEUMATOID ARTHRITIS and other collagen vascular diseases as possible causes of pleuritic chest pain.",RHEUMATOID ARTHRITIS,SLE
720315738,5/12/2015 06:22:30,1634641096,5/12/2015 06:21:09,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,[OTHER],[OTHER],other,N/A,89,52,1,108,55,TWrex-cause,814595-FS1,"BC]  Specific recommendation: • Consider underlying SLE mixed connective tissue disease, RHEUMATOID ARTHRITIS and other collagen vascular diseases as possible causes of pleuritic chest pain.",RHEUMATOID ARTHRITIS,SLE
720315738,5/12/2015 06:28:37,1634644109,5/12/2015 06:27:39,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.56,[OTHER],[OTHER],collagen vascular diseases,N/A,89,52,1,108,55,TWrex-cause,814595-FS1,"BC]  Specific recommendation: • Consider underlying SLE mixed connective tissue disease, RHEUMATOID ARTHRITIS and other collagen vascular diseases as possible causes of pleuritic chest pain.",RHEUMATOID ARTHRITIS,SLE
720315738,5/12/2015 06:46:56,1634652177,5/12/2015 06:45:37,false,prodege,1,16878855,CAN,BC,Fort Saint John,216.232.163.142,[SYMPTOM],[SYMPTOM],underlying,NA,89,52,1,108,55,TWrex-cause,814595-FS1,"BC]  Specific recommendation: • Consider underlying SLE mixed connective tissue disease, RHEUMATOID ARTHRITIS and other collagen vascular diseases as possible causes of pleuritic chest pain.",RHEUMATOID ARTHRITIS,SLE
720315738,5/12/2015 06:48:22,1634652665,5/12/2015 06:47:56,false,elite,1,31856422,GBR,C9,Workington,92.18.169.149,[OTHER],[OTHER],Consider underlying,N/A,89,52,1,108,55,TWrex-cause,814595-FS1,"BC]  Specific recommendation: • Consider underlying SLE mixed connective tissue disease, RHEUMATOID ARTHRITIS and other collagen vascular diseases as possible causes of pleuritic chest pain.",RHEUMATOID ARTHRITIS,SLE
720315738,5/12/2015 06:56:57,1634656587,5/12/2015 06:54:07,false,neodev,1,31706957,NLD,07,Amsterdam,145.100.72.165,[OTHER],[OTHER],"mixed connective tissue disease, as possible causes",n/a,89,52,1,108,55,TWrex-cause,814595-FS1,"BC]  Specific recommendation: • Consider underlying SLE mixed connective tissue disease, RHEUMATOID ARTHRITIS and other collagen vascular diseases as possible causes of pleuritic chest pain.",RHEUMATOID ARTHRITIS,SLE
720315738,5/12/2015 07:05:32,1634660095,5/12/2015 07:04:49,false,instagc,1,24252915,GBR,K6,Portsmouth,89.240.160.95,[NONE],[NONE],N/a,Two unrelated conditions.,89,52,1,108,55,TWrex-cause,814595-FS1,"BC]  Specific recommendation: • Consider underlying SLE mixed connective tissue disease, RHEUMATOID ARTHRITIS and other collagen vascular diseases as possible causes of pleuritic chest pain.",RHEUMATOID ARTHRITIS,SLE
720315738,5/12/2015 07:57:30,1634691961,5/12/2015 07:55:12,false,elite,1,32732290,GBR,A7,Birmingham,86.147.79.250,[OTHER] [NONE],"[OTHER]
[NONE]",N/A,They are both causes of diseases.,89,52,1,108,55,TWrex-cause,814595-FS1,"BC]  Specific recommendation: • Consider underlying SLE mixed connective tissue disease, RHEUMATOID ARTHRITIS and other collagen vascular diseases as possible causes of pleuritic chest pain.",RHEUMATOID ARTHRITIS,SLE
720315738,5/12/2015 08:11:15,1634699045,5/12/2015 08:09:35,false,prodege,1,16101132,GBR,F9,Hayes,2.223.214.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],other,Associated with,89,52,1,108,55,TWrex-cause,814595-FS1,"BC]  Specific recommendation: • Consider underlying SLE mixed connective tissue disease, RHEUMATOID ARTHRITIS and other collagen vascular diseases as possible causes of pleuritic chest pain.",RHEUMATOID ARTHRITIS,SLE
720315738,5/12/2015 08:50:40,1634720131,5/12/2015 08:49:58,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[ASSOCIATED_WITH],[ASSOCIATED_WITH],other collagen vascular diseases,N/A,89,52,1,108,55,TWrex-cause,814595-FS1,"BC]  Specific recommendation: • Consider underlying SLE mixed connective tissue disease, RHEUMATOID ARTHRITIS and other collagen vascular diseases as possible causes of pleuritic chest pain.",RHEUMATOID ARTHRITIS,SLE
720315738,5/12/2015 08:56:34,1634723148,5/12/2015 08:55:19,false,inboxpounds,1.0,29059658,GBR,H9,London,79.77.3.89,[IS_A],[IS_A],Consider underlying,N/A,89,52,1,108,55,TWrex-cause,814595-FS1,"BC]  Specific recommendation: • Consider underlying SLE mixed connective tissue disease, RHEUMATOID ARTHRITIS and other collagen vascular diseases as possible causes of pleuritic chest pain.",RHEUMATOID ARTHRITIS,SLE
720315738,5/12/2015 09:34:46,1634745377,5/12/2015 09:33:21,false,neodev,1.0,30627835,GBR,H9,London,5.81.27.94,[CAUSES],[CAUSES],causes,N/A,89,52,1,108,55,TWrex-cause,814595-FS1,"BC]  Specific recommendation: • Consider underlying SLE mixed connective tissue disease, RHEUMATOID ARTHRITIS and other collagen vascular diseases as possible causes of pleuritic chest pain.",RHEUMATOID ARTHRITIS,SLE
720315738,5/12/2015 10:39:45,1634800268,5/12/2015 10:38:48,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[IS_A],[IS_A],SLE mixed connective tissue RHEUMATOID ARTHRITIS,N/A,89,52,1,108,55,TWrex-cause,814595-FS1,"BC]  Specific recommendation: • Consider underlying SLE mixed connective tissue disease, RHEUMATOID ARTHRITIS and other collagen vascular diseases as possible causes of pleuritic chest pain.",RHEUMATOID ARTHRITIS,SLE
720315738,5/12/2015 10:56:47,1634816848,5/12/2015 10:56:30,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,89,52,1,108,55,TWrex-cause,814595-FS1,"BC]  Specific recommendation: • Consider underlying SLE mixed connective tissue disease, RHEUMATOID ARTHRITIS and other collagen vascular diseases as possible causes of pleuritic chest pain.",RHEUMATOID ARTHRITIS,SLE
720315739,5/11/2015 22:19:20,1634402113,5/11/2015 22:19:05,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],Hypersensitivity Vasculitis),N/A,167,24,-1,183,34,TWrex-cause,802254-FS1,PREDOMINANTLY CUTANEOUS VASCULITIS  (Leukocytoclastic Vasculitis; Hypersensitivity Vasculitis)  Primarily cutaneous vasculitis is VASCULITIS that affects mainly small CUTANEOUS VESSELS causing skin lesions.,CUTANEOUS VESSELS,VASCULITIS
720315739,5/11/2015 22:21:20,1634403179,5/11/2015 22:20:57,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],affects,n/a,167,24,-1,183,34,TWrex-cause,802254-FS1,PREDOMINANTLY CUTANEOUS VASCULITIS  (Leukocytoclastic Vasculitis; Hypersensitivity Vasculitis)  Primarily cutaneous vasculitis is VASCULITIS that affects mainly small CUTANEOUS VESSELS causing skin lesions.,CUTANEOUS VESSELS,VASCULITIS
720315739,5/11/2015 22:21:54,1634403419,5/11/2015 22:21:12,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],VASCULITIS affects small CUTANEOUS VESSELS,n/a,167,24,-1,183,34,TWrex-cause,802254-FS1,PREDOMINANTLY CUTANEOUS VASCULITIS  (Leukocytoclastic Vasculitis; Hypersensitivity Vasculitis)  Primarily cutaneous vasculitis is VASCULITIS that affects mainly small CUTANEOUS VESSELS causing skin lesions.,CUTANEOUS VESSELS,VASCULITIS
720315739,5/11/2015 22:29:53,1634406673,5/11/2015 22:28:03,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],VASCULITIS affects mainly small CUTANEOUS VESSELS,N/A,167,24,-1,183,34,TWrex-cause,802254-FS1,PREDOMINANTLY CUTANEOUS VASCULITIS  (Leukocytoclastic Vasculitis; Hypersensitivity Vasculitis)  Primarily cutaneous vasculitis is VASCULITIS that affects mainly small CUTANEOUS VESSELS causing skin lesions.,CUTANEOUS VESSELS,VASCULITIS
720315739,5/11/2015 22:31:18,1634407211,5/11/2015 22:29:59,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[ASSOCIATED_WITH],[ASSOCIATED_WITH],affects,n/a,167,24,-1,183,34,TWrex-cause,802254-FS1,PREDOMINANTLY CUTANEOUS VASCULITIS  (Leukocytoclastic Vasculitis; Hypersensitivity Vasculitis)  Primarily cutaneous vasculitis is VASCULITIS that affects mainly small CUTANEOUS VESSELS causing skin lesions.,CUTANEOUS VESSELS,VASCULITIS
720315739,5/11/2015 22:37:31,1634410215,5/11/2015 22:36:48,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[IS_A],[IS_A],is,n/a,167,24,-1,183,34,TWrex-cause,802254-FS1,PREDOMINANTLY CUTANEOUS VASCULITIS  (Leukocytoclastic Vasculitis; Hypersensitivity Vasculitis)  Primarily cutaneous vasculitis is VASCULITIS that affects mainly small CUTANEOUS VESSELS causing skin lesions.,CUTANEOUS VESSELS,VASCULITIS
720315739,5/11/2015 22:37:56,1634410439,5/11/2015 22:37:02,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],affects,n/a,167,24,-1,183,34,TWrex-cause,802254-FS1,PREDOMINANTLY CUTANEOUS VASCULITIS  (Leukocytoclastic Vasculitis; Hypersensitivity Vasculitis)  Primarily cutaneous vasculitis is VASCULITIS that affects mainly small CUTANEOUS VESSELS causing skin lesions.,CUTANEOUS VESSELS,VASCULITIS
720315739,5/11/2015 22:43:28,1634413004,5/11/2015 22:42:43,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SIDE_EFFECT],[SIDE_EFFECT],VASCULITIS affects CUTANEOUS VESSELS,n/a,167,24,-1,183,34,TWrex-cause,802254-FS1,PREDOMINANTLY CUTANEOUS VASCULITIS  (Leukocytoclastic Vasculitis; Hypersensitivity Vasculitis)  Primarily cutaneous vasculitis is VASCULITIS that affects mainly small CUTANEOUS VESSELS causing skin lesions.,CUTANEOUS VESSELS,VASCULITIS
720315739,5/11/2015 22:45:46,1634414072,5/11/2015 22:45:18,false,instagc,1.0,28519532,USA,IA,Neola,38.121.112.217,[PART_OF],[PART_OF],is,na,167,24,-1,183,34,TWrex-cause,802254-FS1,PREDOMINANTLY CUTANEOUS VASCULITIS  (Leukocytoclastic Vasculitis; Hypersensitivity Vasculitis)  Primarily cutaneous vasculitis is VASCULITIS that affects mainly small CUTANEOUS VESSELS causing skin lesions.,CUTANEOUS VESSELS,VASCULITIS
720315739,5/11/2015 22:49:02,1634415716,5/11/2015 22:47:35,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES] [PREVENTS],"[PREVENTS]
[CAUSES]",PREDOMINANTLY CUTANEOUS VASCULITIS (Leukocytoclastic Vasculitis; Hypersensitivity Vasculitis) Primarily cutaneous vasculitis is VASCULITIS that affects mainly small CUTANEOUS VESSELS causing skin lesions.,N/A,167,24,-1,183,34,TWrex-cause,802254-FS1,PREDOMINANTLY CUTANEOUS VASCULITIS  (Leukocytoclastic Vasculitis; Hypersensitivity Vasculitis)  Primarily cutaneous vasculitis is VASCULITIS that affects mainly small CUTANEOUS VESSELS causing skin lesions.,CUTANEOUS VESSELS,VASCULITIS
720315739,5/11/2015 22:55:45,1634418215,5/11/2015 22:55:01,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,75.147.181.53,[LOCATION],[LOCATION],that affects,N/A,167,24,-1,183,34,TWrex-cause,802254-FS1,PREDOMINANTLY CUTANEOUS VASCULITIS  (Leukocytoclastic Vasculitis; Hypersensitivity Vasculitis)  Primarily cutaneous vasculitis is VASCULITIS that affects mainly small CUTANEOUS VESSELS causing skin lesions.,CUTANEOUS VESSELS,VASCULITIS
720315739,5/11/2015 22:57:55,1634418923,5/11/2015 22:56:51,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[MANIFESTATION],[MANIFESTATION],that affects,n/a,167,24,-1,183,34,TWrex-cause,802254-FS1,PREDOMINANTLY CUTANEOUS VASCULITIS  (Leukocytoclastic Vasculitis; Hypersensitivity Vasculitis)  Primarily cutaneous vasculitis is VASCULITIS that affects mainly small CUTANEOUS VESSELS causing skin lesions.,CUTANEOUS VESSELS,VASCULITIS
720315739,5/11/2015 22:58:17,1634419060,5/11/2015 22:57:20,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],affects,N/A,167,24,-1,183,34,TWrex-cause,802254-FS1,PREDOMINANTLY CUTANEOUS VASCULITIS  (Leukocytoclastic Vasculitis; Hypersensitivity Vasculitis)  Primarily cutaneous vasculitis is VASCULITIS that affects mainly small CUTANEOUS VESSELS causing skin lesions.,CUTANEOUS VESSELS,VASCULITIS
720315739,5/11/2015 23:00:01,1634419501,5/11/2015 22:57:27,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[IS_A],[IS_A],PREDOMINANTLY CUTANEOUS VASCULITIS is VASCULITIS that affects mainly small CUTANEOUS VESSELS,n/a,167,24,-1,183,34,TWrex-cause,802254-FS1,PREDOMINANTLY CUTANEOUS VASCULITIS  (Leukocytoclastic Vasculitis; Hypersensitivity Vasculitis)  Primarily cutaneous vasculitis is VASCULITIS that affects mainly small CUTANEOUS VESSELS causing skin lesions.,CUTANEOUS VESSELS,VASCULITIS
720315739,5/11/2015 23:00:02,1634419502,5/11/2015 22:57:34,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[MANIFESTATION],[MANIFESTATION],that affects,N/A,167,24,-1,183,34,TWrex-cause,802254-FS1,PREDOMINANTLY CUTANEOUS VASCULITIS  (Leukocytoclastic Vasculitis; Hypersensitivity Vasculitis)  Primarily cutaneous vasculitis is VASCULITIS that affects mainly small CUTANEOUS VESSELS causing skin lesions.,CUTANEOUS VESSELS,VASCULITIS
720315740,5/11/2015 23:10:44,1634424400,5/11/2015 23:10:31,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],cause,N/A,67,18,1,94,35,TWrex-cause,813147-FS1,"CLUSTER HEADACHE  CLUSTER HEADACHES cause excruciating, unilateral PERIORBITAL OR TEMPORAL PAIN with ipsilateral autonomic symptoms (ptosis, lacrimation, rhinorrhea, nasal congestion.",PERIORBITAL OR TEMPORAL PAIN,CLUSTER HEADACHES
720315740,5/11/2015 23:18:35,1634428526,5/11/2015 23:18:15,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],cause,N/A,67,18,1,94,35,TWrex-cause,813147-FS1,"CLUSTER HEADACHE  CLUSTER HEADACHES cause excruciating, unilateral PERIORBITAL OR TEMPORAL PAIN with ipsilateral autonomic symptoms (ptosis, lacrimation, rhinorrhea, nasal congestion.",PERIORBITAL OR TEMPORAL PAIN,CLUSTER HEADACHES
720315740,5/11/2015 23:18:48,1634428557,5/11/2015 23:18:31,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],cause,n/a,67,18,1,94,35,TWrex-cause,813147-FS1,"CLUSTER HEADACHE  CLUSTER HEADACHES cause excruciating, unilateral PERIORBITAL OR TEMPORAL PAIN with ipsilateral autonomic symptoms (ptosis, lacrimation, rhinorrhea, nasal congestion.",PERIORBITAL OR TEMPORAL PAIN,CLUSTER HEADACHES
720315740,5/11/2015 23:21:59,1634430032,5/11/2015 23:21:27,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[CAUSES],[CAUSES],cause,n/a,67,18,1,94,35,TWrex-cause,813147-FS1,"CLUSTER HEADACHE  CLUSTER HEADACHES cause excruciating, unilateral PERIORBITAL OR TEMPORAL PAIN with ipsilateral autonomic symptoms (ptosis, lacrimation, rhinorrhea, nasal congestion.",PERIORBITAL OR TEMPORAL PAIN,CLUSTER HEADACHES
720315740,5/11/2015 23:22:15,1634430176,5/11/2015 23:21:43,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[CAUSES] [SYMPTOM],"[CAUSES]
[SYMPTOM]",cause,headaches cause the pain,67,18,1,94,35,TWrex-cause,813147-FS1,"CLUSTER HEADACHE  CLUSTER HEADACHES cause excruciating, unilateral PERIORBITAL OR TEMPORAL PAIN with ipsilateral autonomic symptoms (ptosis, lacrimation, rhinorrhea, nasal congestion.",PERIORBITAL OR TEMPORAL PAIN,CLUSTER HEADACHES
720315740,5/11/2015 23:24:48,1634431308,5/11/2015 23:23:39,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],cause,N/A,67,18,1,94,35,TWrex-cause,813147-FS1,"CLUSTER HEADACHE  CLUSTER HEADACHES cause excruciating, unilateral PERIORBITAL OR TEMPORAL PAIN with ipsilateral autonomic symptoms (ptosis, lacrimation, rhinorrhea, nasal congestion.",PERIORBITAL OR TEMPORAL PAIN,CLUSTER HEADACHES
720315740,5/11/2015 23:25:56,1634431694,5/11/2015 23:24:30,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],cause,N/A,67,18,1,94,35,TWrex-cause,813147-FS1,"CLUSTER HEADACHE  CLUSTER HEADACHES cause excruciating, unilateral PERIORBITAL OR TEMPORAL PAIN with ipsilateral autonomic symptoms (ptosis, lacrimation, rhinorrhea, nasal congestion.",PERIORBITAL OR TEMPORAL PAIN,CLUSTER HEADACHES
720315740,5/11/2015 23:27:05,1634432189,5/11/2015 23:26:45,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.48,[PREVENTS] [CAUSES] [LOCATION] [NONE],"[PREVENTS]
[CAUSES]
[LOCATION]
[NONE]",no,no,67,18,1,94,35,TWrex-cause,813147-FS1,"CLUSTER HEADACHE  CLUSTER HEADACHES cause excruciating, unilateral PERIORBITAL OR TEMPORAL PAIN with ipsilateral autonomic symptoms (ptosis, lacrimation, rhinorrhea, nasal congestion.",PERIORBITAL OR TEMPORAL PAIN,CLUSTER HEADACHES
720315740,5/11/2015 23:30:23,1634433888,5/11/2015 23:29:51,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[CAUSES],[CAUSES],"CLUSTER HEADACHES cause excruciating, PERIORBITAL OR TEMPORAL PAIN",n/a,67,18,1,94,35,TWrex-cause,813147-FS1,"CLUSTER HEADACHE  CLUSTER HEADACHES cause excruciating, unilateral PERIORBITAL OR TEMPORAL PAIN with ipsilateral autonomic symptoms (ptosis, lacrimation, rhinorrhea, nasal congestion.",PERIORBITAL OR TEMPORAL PAIN,CLUSTER HEADACHES
720315740,5/11/2015 23:33:18,1634435307,5/11/2015 23:32:31,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[OTHER],[OTHER],cause PERIORBITAL OR TEMPORAL PAIN,n/a,67,18,1,94,35,TWrex-cause,813147-FS1,"CLUSTER HEADACHE  CLUSTER HEADACHES cause excruciating, unilateral PERIORBITAL OR TEMPORAL PAIN with ipsilateral autonomic symptoms (ptosis, lacrimation, rhinorrhea, nasal congestion.",PERIORBITAL OR TEMPORAL PAIN,CLUSTER HEADACHES
720315740,5/11/2015 23:33:51,1634435653,5/11/2015 23:33:38,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[CAUSES],[CAUSES],cause,n/a,67,18,1,94,35,TWrex-cause,813147-FS1,"CLUSTER HEADACHE  CLUSTER HEADACHES cause excruciating, unilateral PERIORBITAL OR TEMPORAL PAIN with ipsilateral autonomic symptoms (ptosis, lacrimation, rhinorrhea, nasal congestion.",PERIORBITAL OR TEMPORAL PAIN,CLUSTER HEADACHES
720315740,5/11/2015 23:37:18,1634438105,5/11/2015 23:36:58,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],cause,n/a,67,18,1,94,35,TWrex-cause,813147-FS1,"CLUSTER HEADACHE  CLUSTER HEADACHES cause excruciating, unilateral PERIORBITAL OR TEMPORAL PAIN with ipsilateral autonomic symptoms (ptosis, lacrimation, rhinorrhea, nasal congestion.",PERIORBITAL OR TEMPORAL PAIN,CLUSTER HEADACHES
720315740,5/11/2015 23:54:05,1634445682,5/11/2015 23:53:53,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],cause,n/a,67,18,1,94,35,TWrex-cause,813147-FS1,"CLUSTER HEADACHE  CLUSTER HEADACHES cause excruciating, unilateral PERIORBITAL OR TEMPORAL PAIN with ipsilateral autonomic symptoms (ptosis, lacrimation, rhinorrhea, nasal congestion.",PERIORBITAL OR TEMPORAL PAIN,CLUSTER HEADACHES
720315740,5/12/2015 00:14:10,1634452916,5/12/2015 00:13:33,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],cause,causes,67,18,1,94,35,TWrex-cause,813147-FS1,"CLUSTER HEADACHE  CLUSTER HEADACHES cause excruciating, unilateral PERIORBITAL OR TEMPORAL PAIN with ipsilateral autonomic symptoms (ptosis, lacrimation, rhinorrhea, nasal congestion.",PERIORBITAL OR TEMPORAL PAIN,CLUSTER HEADACHES
720315740,5/12/2015 00:16:43,1634453938,5/12/2015 00:14:29,false,prodege,1,31546390,GBR,P7,Leigh,109.153.81.168,[SYMPTOM],[SYMPTOM],cause,N/A,67,18,1,94,35,TWrex-cause,813147-FS1,"CLUSTER HEADACHE  CLUSTER HEADACHES cause excruciating, unilateral PERIORBITAL OR TEMPORAL PAIN with ipsilateral autonomic symptoms (ptosis, lacrimation, rhinorrhea, nasal congestion.",PERIORBITAL OR TEMPORAL PAIN,CLUSTER HEADACHES
720315741,5/12/2015 01:03:38,1634473436,5/12/2015 01:03:21,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[CAUSES],[CAUSES],BONE METASTASES cause PATHOLOGIC FRACTURES,n/a,38,0,1,57,15,TWrex-cause,812732-FS1,BONE METASTASES cause severe pain and PATHOLOGIC FRACTURES,PATHOLOGIC FRACTURES,BONE METASTASES
720315741,5/12/2015 01:06:54,1634474941,5/12/2015 01:06:24,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[SYMPTOM],[SYMPTOM],cause severe pain PATHOLOGIC FRACTURES,N/A,38,0,1,57,15,TWrex-cause,812732-FS1,BONE METASTASES cause severe pain and PATHOLOGIC FRACTURES,PATHOLOGIC FRACTURES,BONE METASTASES
720315741,5/12/2015 01:16:44,1634480319,5/12/2015 01:16:24,false,elite,1.0,31848723,USA,"","",155.94.185.207,[ASSOCIATED_WITH],[ASSOCIATED_WITH],METASTASES PATHOLOGIC FRACTURES,N/A,38,0,1,57,15,TWrex-cause,812732-FS1,BONE METASTASES cause severe pain and PATHOLOGIC FRACTURES,PATHOLOGIC FRACTURES,BONE METASTASES
720315741,5/12/2015 01:33:58,1634489336,5/12/2015 01:33:36,false,instagc,1.0,32556346,USA,PA,Warren,207.255.244.59,[SYMPTOM],[SYMPTOM],cause pain and,N/A,38,0,1,57,15,TWrex-cause,812732-FS1,BONE METASTASES cause severe pain and PATHOLOGIC FRACTURES,PATHOLOGIC FRACTURES,BONE METASTASES
720315741,5/12/2015 01:45:23,1634495617,5/12/2015 01:45:05,false,instagc,1.0,30326470,USA,CA,San Diego,170.213.2.111,[CAUSES],[CAUSES],cause,N/A,38,0,1,57,15,TWrex-cause,812732-FS1,BONE METASTASES cause severe pain and PATHOLOGIC FRACTURES,PATHOLOGIC FRACTURES,BONE METASTASES
720315741,5/12/2015 03:28:01,1634549045,5/12/2015 03:27:40,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[CAUSES],[CAUSES],cause,n/a,38,0,1,57,15,TWrex-cause,812732-FS1,BONE METASTASES cause severe pain and PATHOLOGIC FRACTURES,PATHOLOGIC FRACTURES,BONE METASTASES
720315741,5/12/2015 03:46:48,1634558191,5/12/2015 03:46:09,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.227,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],BONE METASTASES PATHOLOGIC FRACTURES,N/A,38,0,1,57,15,TWrex-cause,812732-FS1,BONE METASTASES cause severe pain and PATHOLOGIC FRACTURES,PATHOLOGIC FRACTURES,BONE METASTASES
720315741,5/12/2015 04:21:33,1634574974,5/12/2015 04:21:03,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[PART_OF]",cause and,N/A,38,0,1,57,15,TWrex-cause,812732-FS1,BONE METASTASES cause severe pain and PATHOLOGIC FRACTURES,PATHOLOGIC FRACTURES,BONE METASTASES
720315741,5/12/2015 05:00:36,1634594057,5/12/2015 05:00:17,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],cause,none,38,0,1,57,15,TWrex-cause,812732-FS1,BONE METASTASES cause severe pain and PATHOLOGIC FRACTURES,PATHOLOGIC FRACTURES,BONE METASTASES
720315741,5/12/2015 05:10:25,1634599684,5/12/2015 05:10:01,false,neodev,1.0,31910622,USA,CA,San Francisco,108.169.6.201,[CAUSES],[CAUSES],cause severe,I didn´t select none.,38,0,1,57,15,TWrex-cause,812732-FS1,BONE METASTASES cause severe pain and PATHOLOGIC FRACTURES,PATHOLOGIC FRACTURES,BONE METASTASES
720315741,5/12/2015 06:09:32,1634635055,5/12/2015 06:09:13,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[CAUSES],[CAUSES],cause,N/A,38,0,1,57,15,TWrex-cause,812732-FS1,BONE METASTASES cause severe pain and PATHOLOGIC FRACTURES,PATHOLOGIC FRACTURES,BONE METASTASES
720315741,5/12/2015 06:24:07,1634641893,5/12/2015 06:23:48,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[CAUSES],[CAUSES],cause,N/A,38,0,1,57,15,TWrex-cause,812732-FS1,BONE METASTASES cause severe pain and PATHOLOGIC FRACTURES,PATHOLOGIC FRACTURES,BONE METASTASES
720315741,5/12/2015 06:33:37,1634646413,5/12/2015 06:32:03,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[SYMPTOM] [SIDE_EFFECT],"[SYMPTOM]
[SIDE_EFFECT]",BONE METASTASES cause PATHOLOGIC FRACTURES,n/a,38,0,1,57,15,TWrex-cause,812732-FS1,BONE METASTASES cause severe pain and PATHOLOGIC FRACTURES,PATHOLOGIC FRACTURES,BONE METASTASES
720315741,5/12/2015 06:40:25,1634649308,5/12/2015 06:39:57,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[CAUSES],[CAUSES],cause,NA,38,0,1,57,15,TWrex-cause,812732-FS1,BONE METASTASES cause severe pain and PATHOLOGIC FRACTURES,PATHOLOGIC FRACTURES,BONE METASTASES
720315741,5/12/2015 06:41:25,1634649709,5/12/2015 06:40:51,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[CAUSES],[CAUSES],cause,n/a,38,0,1,57,15,TWrex-cause,812732-FS1,BONE METASTASES cause severe pain and PATHOLOGIC FRACTURES,PATHOLOGIC FRACTURES,BONE METASTASES
720315742,5/11/2015 23:13:40,1634426257,5/11/2015 23:13:27,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],cause,N/A,113,55,1,121,67,TWrex-cause,811765-FS1,"2.3 Recognize that certain metabolic diseases, such as GALACTOSEMIA diabetes, and genetic aberrations, can cause CATARACTS in the neonatal period and early childhood.",CATARACTS,GALACTOSEMIA
720315742,5/11/2015 23:23:26,1634430773,5/11/2015 23:23:06,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],can cause,N/A,113,55,1,121,67,TWrex-cause,811765-FS1,"2.3 Recognize that certain metabolic diseases, such as GALACTOSEMIA diabetes, and genetic aberrations, can cause CATARACTS in the neonatal period and early childhood.",CATARACTS,GALACTOSEMIA
720315742,5/11/2015 23:39:27,1634439621,5/11/2015 23:39:10,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[CAUSES],[CAUSES],cause,n/a,113,55,1,121,67,TWrex-cause,811765-FS1,"2.3 Recognize that certain metabolic diseases, such as GALACTOSEMIA diabetes, and genetic aberrations, can cause CATARACTS in the neonatal period and early childhood.",CATARACTS,GALACTOSEMIA
720315742,5/11/2015 23:53:03,1634445261,5/11/2015 23:52:51,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.48,[PREVENTS] [CAUSES] [NONE],"[PREVENTS]
[CAUSES]
[NONE]",no,no,113,55,1,121,67,TWrex-cause,811765-FS1,"2.3 Recognize that certain metabolic diseases, such as GALACTOSEMIA diabetes, and genetic aberrations, can cause CATARACTS in the neonatal period and early childhood.",CATARACTS,GALACTOSEMIA
720315742,5/12/2015 00:30:26,1634459415,5/12/2015 00:28:39,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],can cause,causes,113,55,1,121,67,TWrex-cause,811765-FS1,"2.3 Recognize that certain metabolic diseases, such as GALACTOSEMIA diabetes, and genetic aberrations, can cause CATARACTS in the neonatal period and early childhood.",CATARACTS,GALACTOSEMIA
720315742,5/12/2015 00:44:26,1634465094,5/12/2015 00:43:29,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[MANIFESTATION] [LOCATION],"[LOCATION]
[MANIFESTATION]","Recognize certain diseases, cause childhood.",None,113,55,1,121,67,TWrex-cause,811765-FS1,"2.3 Recognize that certain metabolic diseases, such as GALACTOSEMIA diabetes, and genetic aberrations, can cause CATARACTS in the neonatal period and early childhood.",CATARACTS,GALACTOSEMIA
720315742,5/12/2015 00:46:13,1634465907,5/12/2015 00:45:34,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[CAUSES],[CAUSES],"GALACTOSEMIA diabetes, can cause CATARACTS",n/a,113,55,1,121,67,TWrex-cause,811765-FS1,"2.3 Recognize that certain metabolic diseases, such as GALACTOSEMIA diabetes, and genetic aberrations, can cause CATARACTS in the neonatal period and early childhood.",CATARACTS,GALACTOSEMIA
720315742,5/12/2015 01:05:20,1634474207,5/12/2015 01:04:57,false,elite,1.0,31848723,USA,"","",155.94.185.207,[ASSOCIATED_WITH],[ASSOCIATED_WITH],GALACTOSEMIA CATARACTS,N/A,113,55,1,121,67,TWrex-cause,811765-FS1,"2.3 Recognize that certain metabolic diseases, such as GALACTOSEMIA diabetes, and genetic aberrations, can cause CATARACTS in the neonatal period and early childhood.",CATARACTS,GALACTOSEMIA
720315742,5/12/2015 01:12:16,1634477776,5/12/2015 01:11:58,false,elite,1.0,32306791,NLD,"","",31.3.156.41,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"certain diseases,",fsa,113,55,1,121,67,TWrex-cause,811765-FS1,"2.3 Recognize that certain metabolic diseases, such as GALACTOSEMIA diabetes, and genetic aberrations, can cause CATARACTS in the neonatal period and early childhood.",CATARACTS,GALACTOSEMIA
720315742,5/12/2015 01:23:35,1634484151,5/12/2015 01:23:11,false,instagc,1.0,32556346,USA,PA,Warren,207.255.244.59,[CAUSES],[CAUSES],cause,N/A,113,55,1,121,67,TWrex-cause,811765-FS1,"2.3 Recognize that certain metabolic diseases, such as GALACTOSEMIA diabetes, and genetic aberrations, can cause CATARACTS in the neonatal period and early childhood.",CATARACTS,GALACTOSEMIA
720315742,5/12/2015 01:29:19,1634486945,5/12/2015 01:28:35,false,instagc,1.0,30326470,USA,CA,San Diego,170.213.2.111,[CAUSES],[CAUSES],can cause,N/A,113,55,1,121,67,TWrex-cause,811765-FS1,"2.3 Recognize that certain metabolic diseases, such as GALACTOSEMIA diabetes, and genetic aberrations, can cause CATARACTS in the neonatal period and early childhood.",CATARACTS,GALACTOSEMIA
720315742,5/12/2015 02:48:05,1634528394,5/12/2015 02:47:47,false,neodev,1.0,30749660,USA,NC,Durham,24.211.188.217,[PREVENTS] [DIAGNOSE_BY_TEST_OR_DRUG],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]","and genetic aberrations, can cause CATARACTS in the neonatal period and early",n/a,113,55,1,121,67,TWrex-cause,811765-FS1,"2.3 Recognize that certain metabolic diseases, such as GALACTOSEMIA diabetes, and genetic aberrations, can cause CATARACTS in the neonatal period and early childhood.",CATARACTS,GALACTOSEMIA
720315742,5/12/2015 03:20:51,1634545113,5/12/2015 03:20:21,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[CAUSES],[CAUSES],cause,n/a,113,55,1,121,67,TWrex-cause,811765-FS1,"2.3 Recognize that certain metabolic diseases, such as GALACTOSEMIA diabetes, and genetic aberrations, can cause CATARACTS in the neonatal period and early childhood.",CATARACTS,GALACTOSEMIA
720315742,5/12/2015 03:32:56,1634551743,5/12/2015 03:32:26,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.227,[ASSOCIATED_WITH],[ASSOCIATED_WITH],GALACTOSEMIA CATARACTS,N/A,113,55,1,121,67,TWrex-cause,811765-FS1,"2.3 Recognize that certain metabolic diseases, such as GALACTOSEMIA diabetes, and genetic aberrations, can cause CATARACTS in the neonatal period and early childhood.",CATARACTS,GALACTOSEMIA
720315742,5/12/2015 04:07:24,1634568213,5/12/2015 04:07:10,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[CAUSES],[CAUSES],cause,N/A,113,55,1,121,67,TWrex-cause,811765-FS1,"2.3 Recognize that certain metabolic diseases, such as GALACTOSEMIA diabetes, and genetic aberrations, can cause CATARACTS in the neonatal period and early childhood.",CATARACTS,GALACTOSEMIA
720315743,5/12/2015 06:24:52,1634642263,5/12/2015 06:23:50,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[PREVENTS],[PREVENTS],reducing the incidence,N/A,194,123,-1,214,130,TWrex-cause,803626-FS1,"The ESPS 2 and ESPRIT trials demonstrated the benefit of extended release dipyridamole and aspirin together, compared with ASPIRIN alone, in reducing the incidence of vascular death, stroke, or MYOCARDIAL INFARCTION after stroke or TIA.",MYOCARDIAL INFARCTION,ASPIRIN
720315743,5/12/2015 06:30:17,1634644883,5/12/2015 06:29:23,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[PREVENTS],[PREVENTS],reducing incidence,N/A,194,123,-1,214,130,TWrex-cause,803626-FS1,"The ESPS 2 and ESPRIT trials demonstrated the benefit of extended release dipyridamole and aspirin together, compared with ASPIRIN alone, in reducing the incidence of vascular death, stroke, or MYOCARDIAL INFARCTION after stroke or TIA.",MYOCARDIAL INFARCTION,ASPIRIN
720315743,5/12/2015 06:49:16,1634653159,5/12/2015 06:49:00,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[TREATS],[TREATS],compared with,N/A,194,123,-1,214,130,TWrex-cause,803626-FS1,"The ESPS 2 and ESPRIT trials demonstrated the benefit of extended release dipyridamole and aspirin together, compared with ASPIRIN alone, in reducing the incidence of vascular death, stroke, or MYOCARDIAL INFARCTION after stroke or TIA.",MYOCARDIAL INFARCTION,ASPIRIN
720315743,5/12/2015 06:49:28,1634653251,5/12/2015 06:48:59,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[PREVENTS],[PREVENTS],reducing,NA,194,123,-1,214,130,TWrex-cause,803626-FS1,"The ESPS 2 and ESPRIT trials demonstrated the benefit of extended release dipyridamole and aspirin together, compared with ASPIRIN alone, in reducing the incidence of vascular death, stroke, or MYOCARDIAL INFARCTION after stroke or TIA.",MYOCARDIAL INFARCTION,ASPIRIN
720315743,5/12/2015 07:02:04,1634658721,5/12/2015 06:59:18,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[PREVENTS],[PREVENTS],"reducing the incidence of vascular death,",n/a,194,123,-1,214,130,TWrex-cause,803626-FS1,"The ESPS 2 and ESPRIT trials demonstrated the benefit of extended release dipyridamole and aspirin together, compared with ASPIRIN alone, in reducing the incidence of vascular death, stroke, or MYOCARDIAL INFARCTION after stroke or TIA.",MYOCARDIAL INFARCTION,ASPIRIN
720315743,5/12/2015 07:59:15,1634692828,5/12/2015 07:58:41,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",reducing the incidence of,N/A,194,123,-1,214,130,TWrex-cause,803626-FS1,"The ESPS 2 and ESPRIT trials demonstrated the benefit of extended release dipyridamole and aspirin together, compared with ASPIRIN alone, in reducing the incidence of vascular death, stroke, or MYOCARDIAL INFARCTION after stroke or TIA.",MYOCARDIAL INFARCTION,ASPIRIN
720315743,5/12/2015 08:13:18,1634699917,5/12/2015 08:12:42,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[TREATS],[TREATS],benefit,Treated with,194,123,-1,214,130,TWrex-cause,803626-FS1,"The ESPS 2 and ESPRIT trials demonstrated the benefit of extended release dipyridamole and aspirin together, compared with ASPIRIN alone, in reducing the incidence of vascular death, stroke, or MYOCARDIAL INFARCTION after stroke or TIA.",MYOCARDIAL INFARCTION,ASPIRIN
720315743,5/12/2015 08:52:20,1634721151,5/12/2015 08:52:01,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[PREVENTS],[PREVENTS],reducing incidence,N/A,194,123,-1,214,130,TWrex-cause,803626-FS1,"The ESPS 2 and ESPRIT trials demonstrated the benefit of extended release dipyridamole and aspirin together, compared with ASPIRIN alone, in reducing the incidence of vascular death, stroke, or MYOCARDIAL INFARCTION after stroke or TIA.",MYOCARDIAL INFARCTION,ASPIRIN
720315743,5/12/2015 08:59:03,1634724448,5/12/2015 08:57:41,false,inboxpounds,1.0,29059658,GBR,H9,London,79.77.3.89,[OTHER],[OTHER],compared with,The results are a comparrison  of drugs,194,123,-1,214,130,TWrex-cause,803626-FS1,"The ESPS 2 and ESPRIT trials demonstrated the benefit of extended release dipyridamole and aspirin together, compared with ASPIRIN alone, in reducing the incidence of vascular death, stroke, or MYOCARDIAL INFARCTION after stroke or TIA.",MYOCARDIAL INFARCTION,ASPIRIN
720315743,5/12/2015 10:57:40,1634817836,5/12/2015 10:57:27,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],ASPIRIN,n/a,194,123,-1,214,130,TWrex-cause,803626-FS1,"The ESPS 2 and ESPRIT trials demonstrated the benefit of extended release dipyridamole and aspirin together, compared with ASPIRIN alone, in reducing the incidence of vascular death, stroke, or MYOCARDIAL INFARCTION after stroke or TIA.",MYOCARDIAL INFARCTION,ASPIRIN
720315743,5/12/2015 11:31:47,1634846526,5/12/2015 11:30:22,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[PREVENTS],[PREVENTS],"ASPIRIN in reducing the incidence of vascular death, MYOCARDIAL INFARCTION",N/A,194,123,-1,214,130,TWrex-cause,803626-FS1,"The ESPS 2 and ESPRIT trials demonstrated the benefit of extended release dipyridamole and aspirin together, compared with ASPIRIN alone, in reducing the incidence of vascular death, stroke, or MYOCARDIAL INFARCTION after stroke or TIA.",MYOCARDIAL INFARCTION,ASPIRIN
720315743,5/12/2015 11:52:53,1634858364,5/12/2015 11:52:04,false,prodege,1,14848125,GBR,L6,Shrewsbury,86.138.223.142,[PREVENTS],[PREVENTS],demonstrated the benefit in reducing,N/A,194,123,-1,214,130,TWrex-cause,803626-FS1,"The ESPS 2 and ESPRIT trials demonstrated the benefit of extended release dipyridamole and aspirin together, compared with ASPIRIN alone, in reducing the incidence of vascular death, stroke, or MYOCARDIAL INFARCTION after stroke or TIA.",MYOCARDIAL INFARCTION,ASPIRIN
720315743,5/12/2015 11:53:49,1634858866,5/12/2015 11:53:19,false,clixsense,1,29594612,NLD,11,Rotterdam,82.156.132.195,[PREVENTS],[PREVENTS],in reducing,N/A,194,123,-1,214,130,TWrex-cause,803626-FS1,"The ESPS 2 and ESPRIT trials demonstrated the benefit of extended release dipyridamole and aspirin together, compared with ASPIRIN alone, in reducing the incidence of vascular death, stroke, or MYOCARDIAL INFARCTION after stroke or TIA.",MYOCARDIAL INFARCTION,ASPIRIN
720315743,5/12/2015 12:06:12,1634864374,5/12/2015 12:05:18,false,neodev,1,30588889,NLD,07,Amsterdam,77.248.175.222,[PREVENTS],[PREVENTS],incidence,N/A,194,123,-1,214,130,TWrex-cause,803626-FS1,"The ESPS 2 and ESPRIT trials demonstrated the benefit of extended release dipyridamole and aspirin together, compared with ASPIRIN alone, in reducing the incidence of vascular death, stroke, or MYOCARDIAL INFARCTION after stroke or TIA.",MYOCARDIAL INFARCTION,ASPIRIN
720315743,5/12/2015 12:35:11,1634877219,5/12/2015 12:33:22,false,clixsense,1,27969116,NLD,"","",212.78.195.38,[SYMPTOM],[SYMPTOM],compared with ASPIRIN,only aspirin is less effective,194,123,-1,214,130,TWrex-cause,803626-FS1,"The ESPS 2 and ESPRIT trials demonstrated the benefit of extended release dipyridamole and aspirin together, compared with ASPIRIN alone, in reducing the incidence of vascular death, stroke, or MYOCARDIAL INFARCTION after stroke or TIA.",MYOCARDIAL INFARCTION,ASPIRIN
720315744,5/11/2015 23:27:04,1634432203,5/11/2015 23:26:31,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],infection with,N/A,0,91,1,13,110,TWrex-cause,812182-FS1,ONCHOCERCIASIS  (River Blindness)  ONCHOCERCIASIS is infection with the filarial nematode  ONCHOCERCA VOLVULUS,ONCHOCERCIASIS,ONCHOCERCA VOLVULUS
720315744,5/11/2015 23:42:33,1634441073,5/11/2015 23:41:46,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[PART_OF],[PART_OF],is infection with,n/a,0,91,1,13,110,TWrex-cause,812182-FS1,ONCHOCERCIASIS  (River Blindness)  ONCHOCERCIASIS is infection with the filarial nematode  ONCHOCERCA VOLVULUS,ONCHOCERCIASIS,ONCHOCERCA VOLVULUS
720315744,5/11/2015 23:54:37,1634445967,5/11/2015 23:54:20,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.48,[CAUSES] [PREVENTS] [SYMPTOM] [NONE],"[PREVENTS]
[CAUSES]
[SYMPTOM]
[NONE]",no,no,0,91,1,13,110,TWrex-cause,812182-FS1,ONCHOCERCIASIS  (River Blindness)  ONCHOCERCIASIS is infection with the filarial nematode  ONCHOCERCA VOLVULUS,ONCHOCERCIASIS,ONCHOCERCA VOLVULUS
720315744,5/12/2015 00:38:23,1634462250,5/12/2015 00:36:56,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],with the filarial nematode ONCHOCERCA VOLVULUS,causes,0,91,1,13,110,TWrex-cause,812182-FS1,ONCHOCERCIASIS  (River Blindness)  ONCHOCERCIASIS is infection with the filarial nematode  ONCHOCERCA VOLVULUS,ONCHOCERCIASIS,ONCHOCERCA VOLVULUS
720315744,5/12/2015 00:50:04,1634467330,5/12/2015 00:49:35,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],infection filarial nematode ONCHOCERCA VOLVULUS,N/A,0,91,1,13,110,TWrex-cause,812182-FS1,ONCHOCERCIASIS  (River Blindness)  ONCHOCERCIASIS is infection with the filarial nematode  ONCHOCERCA VOLVULUS,ONCHOCERCIASIS,ONCHOCERCA VOLVULUS
720315744,5/12/2015 00:51:51,1634468024,5/12/2015 00:51:19,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[MANIFESTATION] [ASSOCIATED_WITH],"[MANIFESTATION]
[ASSOCIATED_WITH]",ONCHOCERCIASIS is infection with ONCHOCERCA VOLVULUS,n/a,0,91,1,13,110,TWrex-cause,812182-FS1,ONCHOCERCIASIS  (River Blindness)  ONCHOCERCIASIS is infection with the filarial nematode  ONCHOCERCA VOLVULUS,ONCHOCERCIASIS,ONCHOCERCA VOLVULUS
720315744,5/12/2015 01:08:31,1634475735,5/12/2015 01:08:05,false,elite,1.0,31848723,USA,"","",155.94.185.207,[ASSOCIATED_WITH],[ASSOCIATED_WITH],ONCHOCERCIASIS ONCHOCERCIASIS ONCHOCERCA VOLVULUS,N/A,0,91,1,13,110,TWrex-cause,812182-FS1,ONCHOCERCIASIS  (River Blindness)  ONCHOCERCIASIS is infection with the filarial nematode  ONCHOCERCA VOLVULUS,ONCHOCERCIASIS,ONCHOCERCA VOLVULUS
720315744,5/12/2015 01:15:36,1634479667,5/12/2015 01:15:18,false,elite,1.0,32306791,NLD,"","",31.3.156.41,[PREVENTS],[PREVENTS],ONCHOCERCIASIS Blindness),fs,0,91,1,13,110,TWrex-cause,812182-FS1,ONCHOCERCIASIS  (River Blindness)  ONCHOCERCIASIS is infection with the filarial nematode  ONCHOCERCA VOLVULUS,ONCHOCERCIASIS,ONCHOCERCA VOLVULUS
720315744,5/12/2015 01:26:15,1634485525,5/12/2015 01:25:49,false,instagc,1.0,32556346,USA,PA,Warren,207.255.244.59,[CAUSES],[CAUSES],infection,N/A,0,91,1,13,110,TWrex-cause,812182-FS1,ONCHOCERCIASIS  (River Blindness)  ONCHOCERCIASIS is infection with the filarial nematode  ONCHOCERCA VOLVULUS,ONCHOCERCIASIS,ONCHOCERCA VOLVULUS
720315744,5/12/2015 01:35:26,1634490154,5/12/2015 01:34:30,false,instagc,1.0,30326470,USA,CA,San Diego,170.213.2.111,[MANIFESTATION],[MANIFESTATION],is infection,N/A,0,91,1,13,110,TWrex-cause,812182-FS1,ONCHOCERCIASIS  (River Blindness)  ONCHOCERCIASIS is infection with the filarial nematode  ONCHOCERCA VOLVULUS,ONCHOCERCIASIS,ONCHOCERCA VOLVULUS
720315744,5/12/2015 03:23:16,1634546435,5/12/2015 03:22:52,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[LOCATION],[LOCATION],with,n/a,0,91,1,13,110,TWrex-cause,812182-FS1,ONCHOCERCIASIS  (River Blindness)  ONCHOCERCIASIS is infection with the filarial nematode  ONCHOCERCA VOLVULUS,ONCHOCERCIASIS,ONCHOCERCA VOLVULUS
720315744,5/12/2015 03:37:20,1634553952,5/12/2015 03:36:54,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.227,[CONTRAINDICATES],[CONTRAINDICATES],ONCHOCERCIASIS ONCHOCERCA VOLVULUS,N/A,0,91,1,13,110,TWrex-cause,812182-FS1,ONCHOCERCIASIS  (River Blindness)  ONCHOCERCIASIS is infection with the filarial nematode  ONCHOCERCA VOLVULUS,ONCHOCERCIASIS,ONCHOCERCA VOLVULUS
720315744,5/12/2015 04:11:15,1634570323,5/12/2015 04:10:57,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[IS_A],[IS_A],is infection,N/A,0,91,1,13,110,TWrex-cause,812182-FS1,ONCHOCERCIASIS  (River Blindness)  ONCHOCERCIASIS is infection with the filarial nematode  ONCHOCERCA VOLVULUS,ONCHOCERCIASIS,ONCHOCERCA VOLVULUS
720315744,5/12/2015 04:44:38,1634586222,5/12/2015 04:44:04,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],is infection,none,0,91,1,13,110,TWrex-cause,812182-FS1,ONCHOCERCIASIS  (River Blindness)  ONCHOCERCIASIS is infection with the filarial nematode  ONCHOCERCA VOLVULUS,ONCHOCERCIASIS,ONCHOCERCA VOLVULUS
720315744,5/12/2015 05:00:30,1634594018,5/12/2015 05:00:08,false,neodev,1.0,31910622,USA,CA,Los Angeles,108.185.211.151,[CAUSES],[CAUSES],is infection with,I didn´t select none.,0,91,1,13,110,TWrex-cause,812182-FS1,ONCHOCERCIASIS  (River Blindness)  ONCHOCERCIASIS is infection with the filarial nematode  ONCHOCERCA VOLVULUS,ONCHOCERCIASIS,ONCHOCERCA VOLVULUS
720315745,5/11/2015 23:27:42,1634432450,5/11/2015 23:27:24,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],therapy for,N/A,98,72,-1,112,85,TWrex-cause,800482-FS1,"Genentech, Inc. Patient information booklet: your guide to Pulmozyme ®  (DORNASE ALFA therapy for CYSTIC FIBROSIS (CF.",CYSTIC FIBROSIS,(DORNASE ALFA
720315745,5/11/2015 23:42:59,1634441318,5/11/2015 23:42:46,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],therapy,n/a,98,72,-1,112,85,TWrex-cause,800482-FS1,"Genentech, Inc. Patient information booklet: your guide to Pulmozyme ®  (DORNASE ALFA therapy for CYSTIC FIBROSIS (CF.",CYSTIC FIBROSIS,(DORNASE ALFA
720315745,5/11/2015 23:55:08,1634446118,5/11/2015 23:54:55,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.48,[CAUSES] [LOCATION] [NONE],"[CAUSES]
[LOCATION]
[NONE]",no,no,98,72,-1,112,85,TWrex-cause,800482-FS1,"Genentech, Inc. Patient information booklet: your guide to Pulmozyme ®  (DORNASE ALFA therapy for CYSTIC FIBROSIS (CF.",CYSTIC FIBROSIS,(DORNASE ALFA
720315745,5/12/2015 00:44:28,1634465152,5/12/2015 00:43:45,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],therapy for,N/A,98,72,-1,112,85,TWrex-cause,800482-FS1,"Genentech, Inc. Patient information booklet: your guide to Pulmozyme ®  (DORNASE ALFA therapy for CYSTIC FIBROSIS (CF.",CYSTIC FIBROSIS,(DORNASE ALFA
720315745,5/12/2015 00:51:09,1634467767,5/12/2015 00:50:34,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[NONE],[NONE],N/A,None,98,72,-1,112,85,TWrex-cause,800482-FS1,"Genentech, Inc. Patient information booklet: your guide to Pulmozyme ®  (DORNASE ALFA therapy for CYSTIC FIBROSIS (CF.",CYSTIC FIBROSIS,(DORNASE ALFA
720315745,5/12/2015 00:53:01,1634468457,5/12/2015 00:52:29,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[TREATS],[TREATS],(DORNASE ALFA therapy for CYSTIC FIBROSIS (CF.,n/a,98,72,-1,112,85,TWrex-cause,800482-FS1,"Genentech, Inc. Patient information booklet: your guide to Pulmozyme ®  (DORNASE ALFA therapy for CYSTIC FIBROSIS (CF.",CYSTIC FIBROSIS,(DORNASE ALFA
720315745,5/12/2015 01:09:33,1634476364,5/12/2015 01:09:04,false,elite,1.0,31848723,USA,"","",155.94.185.207,[SYMPTOM],[SYMPTOM],(DORNASE ALFA CYSTIC FIBROSIS (CF.,N/A,98,72,-1,112,85,TWrex-cause,800482-FS1,"Genentech, Inc. Patient information booklet: your guide to Pulmozyme ®  (DORNASE ALFA therapy for CYSTIC FIBROSIS (CF.",CYSTIC FIBROSIS,(DORNASE ALFA
720315745,5/12/2015 01:26:04,1634485414,5/12/2015 01:25:49,false,elite,1.0,32306791,USA,TX,Dallas,69.162.75.37,[PREVENTS],[PREVENTS],booklet: guide,hjg,98,72,-1,112,85,TWrex-cause,800482-FS1,"Genentech, Inc. Patient information booklet: your guide to Pulmozyme ®  (DORNASE ALFA therapy for CYSTIC FIBROSIS (CF.",CYSTIC FIBROSIS,(DORNASE ALFA
720315745,5/12/2015 01:26:50,1634485743,5/12/2015 01:26:33,false,instagc,1.0,32556346,USA,PA,Warren,207.255.244.59,[TREATS],[TREATS],therapy,N/A,98,72,-1,112,85,TWrex-cause,800482-FS1,"Genentech, Inc. Patient information booklet: your guide to Pulmozyme ®  (DORNASE ALFA therapy for CYSTIC FIBROSIS (CF.",CYSTIC FIBROSIS,(DORNASE ALFA
720315745,5/12/2015 01:36:43,1634490871,5/12/2015 01:36:23,false,instagc,1.0,30326470,USA,CA,San Diego,170.213.2.111,[TREATS],[TREATS],therapy for,N/A,98,72,-1,112,85,TWrex-cause,800482-FS1,"Genentech, Inc. Patient information booklet: your guide to Pulmozyme ®  (DORNASE ALFA therapy for CYSTIC FIBROSIS (CF.",CYSTIC FIBROSIS,(DORNASE ALFA
720315745,5/12/2015 03:23:50,1634546774,5/12/2015 03:23:31,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[OTHER],[OTHER],for,n/a,98,72,-1,112,85,TWrex-cause,800482-FS1,"Genentech, Inc. Patient information booklet: your guide to Pulmozyme ®  (DORNASE ALFA therapy for CYSTIC FIBROSIS (CF.",CYSTIC FIBROSIS,(DORNASE ALFA
720315745,5/12/2015 03:38:33,1634554497,5/12/2015 03:37:47,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.227,[TREATS],[TREATS],(DORNASE ALFA CYSTIC FIBROSIS,N/A,98,72,-1,112,85,TWrex-cause,800482-FS1,"Genentech, Inc. Patient information booklet: your guide to Pulmozyme ®  (DORNASE ALFA therapy for CYSTIC FIBROSIS (CF.",CYSTIC FIBROSIS,(DORNASE ALFA
720315745,5/12/2015 04:11:45,1634570577,5/12/2015 04:11:31,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[TREATS],[TREATS],therapy for,N/A,98,72,-1,112,85,TWrex-cause,800482-FS1,"Genentech, Inc. Patient information booklet: your guide to Pulmozyme ®  (DORNASE ALFA therapy for CYSTIC FIBROSIS (CF.",CYSTIC FIBROSIS,(DORNASE ALFA
720315745,5/12/2015 04:45:40,1634586636,5/12/2015 04:45:10,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],therapy,none,98,72,-1,112,85,TWrex-cause,800482-FS1,"Genentech, Inc. Patient information booklet: your guide to Pulmozyme ®  (DORNASE ALFA therapy for CYSTIC FIBROSIS (CF.",CYSTIC FIBROSIS,(DORNASE ALFA
720315745,5/12/2015 05:01:18,1634594521,5/12/2015 05:00:50,false,neodev,1.0,31910622,USA,CA,Los Angeles,108.185.211.151,[TREATS],[TREATS],therapy for,I didn´t select none.,98,72,-1,112,85,TWrex-cause,800482-FS1,"Genentech, Inc. Patient information booklet: your guide to Pulmozyme ®  (DORNASE ALFA therapy for CYSTIC FIBROSIS (CF.",CYSTIC FIBROSIS,(DORNASE ALFA
720315746,5/12/2015 03:31:33,1634550959,5/12/2015 03:31:13,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[OTHER],[OTHER],form,n/a,39,104,1,50,126,TWrex-cause,813275-FS1,These patients tend to have persistent TACHYCARDIAS that have been referred to as the permanent form of JUNCTIONAL TACHYCARDIA (PJRT.,TACHYCARDIAS,JUNCTIONAL TACHYCARDIA
720315746,5/12/2015 03:50:08,1634559615,5/12/2015 03:49:46,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.227,[PREVENTS],[PREVENTS],TACHYCARDIAS JUNCTIONAL TACHYCARDIA,N/A,39,104,1,50,126,TWrex-cause,813275-FS1,These patients tend to have persistent TACHYCARDIAS that have been referred to as the permanent form of JUNCTIONAL TACHYCARDIA (PJRT.,TACHYCARDIAS,JUNCTIONAL TACHYCARDIA
720315746,5/12/2015 04:24:05,1634576259,5/12/2015 04:23:39,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[IS_A] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]",referred to,N/A,39,104,1,50,126,TWrex-cause,813275-FS1,These patients tend to have persistent TACHYCARDIAS that have been referred to as the permanent form of JUNCTIONAL TACHYCARDIA (PJRT.,TACHYCARDIAS,JUNCTIONAL TACHYCARDIA
720315746,5/12/2015 05:06:29,1634597375,5/12/2015 05:05:29,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],permanent form,none,39,104,1,50,126,TWrex-cause,813275-FS1,These patients tend to have persistent TACHYCARDIAS that have been referred to as the permanent form of JUNCTIONAL TACHYCARDIA (PJRT.,TACHYCARDIAS,JUNCTIONAL TACHYCARDIA
720315746,5/12/2015 05:12:57,1634601247,5/12/2015 05:12:34,false,neodev,1.0,31910622,USA,CA,San Francisco,108.169.6.201,[ASSOCIATED_WITH],[ASSOCIATED_WITH],that have been referred,I didn´t select none.,39,104,1,50,126,TWrex-cause,813275-FS1,These patients tend to have persistent TACHYCARDIAS that have been referred to as the permanent form of JUNCTIONAL TACHYCARDIA (PJRT.,TACHYCARDIAS,JUNCTIONAL TACHYCARDIA
720315746,5/12/2015 06:16:30,1634638272,5/12/2015 06:15:28,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[IS_A],[IS_A],referred to,N/A,39,104,1,50,126,TWrex-cause,813275-FS1,These patients tend to have persistent TACHYCARDIAS that have been referred to as the permanent form of JUNCTIONAL TACHYCARDIA (PJRT.,TACHYCARDIAS,JUNCTIONAL TACHYCARDIA
720315746,5/12/2015 06:26:50,1634643294,5/12/2015 06:26:08,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[IS_A],[IS_A],permanent form of,N/A,39,104,1,50,126,TWrex-cause,813275-FS1,These patients tend to have persistent TACHYCARDIAS that have been referred to as the permanent form of JUNCTIONAL TACHYCARDIA (PJRT.,TACHYCARDIAS,JUNCTIONAL TACHYCARDIA
720315746,5/12/2015 06:44:11,1634650965,5/12/2015 06:43:46,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[SYMPTOM],[SYMPTOM],persistent,NA,39,104,1,50,126,TWrex-cause,813275-FS1,These patients tend to have persistent TACHYCARDIAS that have been referred to as the permanent form of JUNCTIONAL TACHYCARDIA (PJRT.,TACHYCARDIAS,JUNCTIONAL TACHYCARDIA
720315746,5/12/2015 06:44:37,1634651170,5/12/2015 06:44:11,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH] [PART_OF],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]
[PART_OF]",TACHYCARDIAS form of JUNCTIONAL TACHYCARDIA,n/a,39,104,1,50,126,TWrex-cause,813275-FS1,These patients tend to have persistent TACHYCARDIAS that have been referred to as the permanent form of JUNCTIONAL TACHYCARDIA (PJRT.,TACHYCARDIAS,JUNCTIONAL TACHYCARDIA
720315746,5/12/2015 06:47:10,1634652214,5/12/2015 06:46:55,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[MANIFESTATION],[MANIFESTATION],the permanent form of,N/A,39,104,1,50,126,TWrex-cause,813275-FS1,These patients tend to have persistent TACHYCARDIAS that have been referred to as the permanent form of JUNCTIONAL TACHYCARDIA (PJRT.,TACHYCARDIAS,JUNCTIONAL TACHYCARDIA
720315746,5/12/2015 06:52:31,1634654532,5/12/2015 06:51:15,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[ASSOCIATED_WITH],[ASSOCIATED_WITH],referred to as the permanent form,n/a,39,104,1,50,126,TWrex-cause,813275-FS1,These patients tend to have persistent TACHYCARDIAS that have been referred to as the permanent form of JUNCTIONAL TACHYCARDIA (PJRT.,TACHYCARDIAS,JUNCTIONAL TACHYCARDIA
720315746,5/12/2015 07:03:59,1634659423,5/12/2015 07:03:27,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[PART_OF],[PART_OF],the permanent form of,N/a,39,104,1,50,126,TWrex-cause,813275-FS1,These patients tend to have persistent TACHYCARDIAS that have been referred to as the permanent form of JUNCTIONAL TACHYCARDIA (PJRT.,TACHYCARDIAS,JUNCTIONAL TACHYCARDIA
720315746,5/12/2015 07:54:16,1634690465,5/12/2015 07:53:27,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[PART_OF],[PART_OF],permanent form of,N/A,39,104,1,50,126,TWrex-cause,813275-FS1,These patients tend to have persistent TACHYCARDIAS that have been referred to as the permanent form of JUNCTIONAL TACHYCARDIA (PJRT.,TACHYCARDIAS,JUNCTIONAL TACHYCARDIA
720315746,5/12/2015 08:08:29,1634697556,5/12/2015 08:07:47,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],referred,Associated with,39,104,1,50,126,TWrex-cause,813275-FS1,These patients tend to have persistent TACHYCARDIAS that have been referred to as the permanent form of JUNCTIONAL TACHYCARDIA (PJRT.,TACHYCARDIAS,JUNCTIONAL TACHYCARDIA
720315746,5/12/2015 08:50:07,1634719872,5/12/2015 08:48:04,false,inboxpounds,1.0,29059658,GBR,H9,London,79.77.3.89,[ASSOCIATED_WITH],[ASSOCIATED_WITH],been referred to,N/A,39,104,1,50,126,TWrex-cause,813275-FS1,These patients tend to have persistent TACHYCARDIAS that have been referred to as the permanent form of JUNCTIONAL TACHYCARDIA (PJRT.,TACHYCARDIAS,JUNCTIONAL TACHYCARDIA
720315747,5/11/2015 22:23:53,1634404286,5/11/2015 22:23:34,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],TYPHOID FEVER,N/A,62,135,1,74,137,TWrex-cause,814883-FS1,167  Typhoid Fever and Other Salmonella Infections   +  >     TYPHOID FEVER or Septicemia caused by S. typhi or S. paratyphi  +  IV or IM:  2 4 g once daily.,TYPHOID FEVER,IM
720315747,5/11/2015 22:25:11,1634404816,5/11/2015 22:24:56,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],caused by,n/a,62,135,1,74,137,TWrex-cause,814883-FS1,167  Typhoid Fever and Other Salmonella Infections   +  >     TYPHOID FEVER or Septicemia caused by S. typhi or S. paratyphi  +  IV or IM:  2 4 g once daily.,TYPHOID FEVER,IM
720315747,5/11/2015 22:32:11,1634407550,5/11/2015 22:30:56,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[NONE],[NONE],na,hard to tell the relationship,62,135,1,74,137,TWrex-cause,814883-FS1,167  Typhoid Fever and Other Salmonella Infections   +  >     TYPHOID FEVER or Septicemia caused by S. typhi or S. paratyphi  +  IV or IM:  2 4 g once daily.,TYPHOID FEVER,IM
720315747,5/11/2015 22:40:59,1634411914,5/11/2015 22:40:29,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],once daily.,n/a,62,135,1,74,137,TWrex-cause,814883-FS1,167  Typhoid Fever and Other Salmonella Infections   +  >     TYPHOID FEVER or Septicemia caused by S. typhi or S. paratyphi  +  IV or IM:  2 4 g once daily.,TYPHOID FEVER,IM
720315747,5/11/2015 22:42:59,1634412761,5/11/2015 22:41:09,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[CAUSES],[CAUSES],TYPHOID FEVER caused by IM:,N/A,62,135,1,74,137,TWrex-cause,814883-FS1,167  Typhoid Fever and Other Salmonella Infections   +  >     TYPHOID FEVER or Septicemia caused by S. typhi or S. paratyphi  +  IV or IM:  2 4 g once daily.,TYPHOID FEVER,IM
720315747,5/11/2015 22:46:55,1634414600,5/11/2015 22:46:00,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],TYPHOID FEVER IM: 2 4 g once daily.,n/a,62,135,1,74,137,TWrex-cause,814883-FS1,167  Typhoid Fever and Other Salmonella Infections   +  >     TYPHOID FEVER or Septicemia caused by S. typhi or S. paratyphi  +  IV or IM:  2 4 g once daily.,TYPHOID FEVER,IM
720315747,5/11/2015 22:54:48,1634417852,5/11/2015 22:54:03,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],TYPHOID FEVER caused by IM:,n/a,62,135,1,74,137,TWrex-cause,814883-FS1,167  Typhoid Fever and Other Salmonella Infections   +  >     TYPHOID FEVER or Septicemia caused by S. typhi or S. paratyphi  +  IV or IM:  2 4 g once daily.,TYPHOID FEVER,IM
720315747,5/11/2015 23:02:13,1634420289,5/11/2015 23:01:53,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,75.147.181.53,[CAUSES],[CAUSES],caused by,N/A,62,135,1,74,137,TWrex-cause,814883-FS1,167  Typhoid Fever and Other Salmonella Infections   +  >     TYPHOID FEVER or Septicemia caused by S. typhi or S. paratyphi  +  IV or IM:  2 4 g once daily.,TYPHOID FEVER,IM
720315747,5/11/2015 23:05:27,1634421334,5/11/2015 23:04:22,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],TYPHOID FEVER or Septicemia caused by S. typhi or S. paratyphi + IV or IM: 2 4 g once daily.,N/A,62,135,1,74,137,TWrex-cause,814883-FS1,167  Typhoid Fever and Other Salmonella Infections   +  >     TYPHOID FEVER or Septicemia caused by S. typhi or S. paratyphi  +  IV or IM:  2 4 g once daily.,TYPHOID FEVER,IM
720315747,5/11/2015 23:07:25,1634422158,5/11/2015 23:07:11,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES],[CAUSES],caused,N/A,62,135,1,74,137,TWrex-cause,814883-FS1,167  Typhoid Fever and Other Salmonella Infections   +  >     TYPHOID FEVER or Septicemia caused by S. typhi or S. paratyphi  +  IV or IM:  2 4 g once daily.,TYPHOID FEVER,IM
720315747,5/11/2015 23:09:31,1634423438,5/11/2015 23:07:40,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[OTHER],[OTHER],once,n/a,62,135,1,74,137,TWrex-cause,814883-FS1,167  Typhoid Fever and Other Salmonella Infections   +  >     TYPHOID FEVER or Septicemia caused by S. typhi or S. paratyphi  +  IV or IM:  2 4 g once daily.,TYPHOID FEVER,IM
720315747,5/11/2015 23:10:10,1634423978,5/11/2015 23:08:43,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],once daily.,the fever can be treated by IM - intra muscular therapy,62,135,1,74,137,TWrex-cause,814883-FS1,167  Typhoid Fever and Other Salmonella Infections   +  >     TYPHOID FEVER or Septicemia caused by S. typhi or S. paratyphi  +  IV or IM:  2 4 g once daily.,TYPHOID FEVER,IM
720315747,5/11/2015 23:11:45,1634425126,5/11/2015 23:10:04,false,clixsense,1.0,6330007,AUS,06,Hobart,101.178.23.54,[CAUSES],[CAUSES],caused by,n/a,62,135,1,74,137,TWrex-cause,814883-FS1,167  Typhoid Fever and Other Salmonella Infections   +  >     TYPHOID FEVER or Septicemia caused by S. typhi or S. paratyphi  +  IV or IM:  2 4 g once daily.,TYPHOID FEVER,IM
720315747,5/11/2015 23:11:46,1634425152,5/11/2015 23:09:00,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],caused by,n/a,62,135,1,74,137,TWrex-cause,814883-FS1,167  Typhoid Fever and Other Salmonella Infections   +  >     TYPHOID FEVER or Septicemia caused by S. typhi or S. paratyphi  +  IV or IM:  2 4 g once daily.,TYPHOID FEVER,IM
720315747,5/11/2015 23:11:59,1634425285,5/11/2015 23:10:06,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],caused by,N/A,62,135,1,74,137,TWrex-cause,814883-FS1,167  Typhoid Fever and Other Salmonella Infections   +  >     TYPHOID FEVER or Septicemia caused by S. typhi or S. paratyphi  +  IV or IM:  2 4 g once daily.,TYPHOID FEVER,IM
720315748,5/11/2015 23:25:41,1634431627,5/11/2015 23:25:02,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],lowering IOP,N/A,137,40,-1,155,50,TWrex-cause,803872-FS1,"Ratliff M, Fellman RL, Sullivan EK et alTRAVOPROST a new prostaglandin analogue, is superior to timolol in lowering IOP in patients with OPEN ANGLE GLAUCOMA or ocular hypertension.",OPEN ANGLE GLAUCOMA,TRAVOPROST
720315748,5/11/2015 23:40:50,1634440296,5/11/2015 23:40:32,false,instagc,1.0,27914150,USA,TX,Dallas,72.190.59.224,[TREATS],[TREATS],lowering,n/a,137,40,-1,155,50,TWrex-cause,803872-FS1,"Ratliff M, Fellman RL, Sullivan EK et alTRAVOPROST a new prostaglandin analogue, is superior to timolol in lowering IOP in patients with OPEN ANGLE GLAUCOMA or ocular hypertension.",OPEN ANGLE GLAUCOMA,TRAVOPROST
720315748,5/11/2015 23:53:49,1634445567,5/11/2015 23:53:34,false,neodev,1.0,32103286,USA,CA,San Jose,23.27.248.48,[PREVENTS] [CAUSES] [LOCATION] [NONE],"[PREVENTS]
[CAUSES]
[LOCATION]
[NONE]",no,no,137,40,-1,155,50,TWrex-cause,803872-FS1,"Ratliff M, Fellman RL, Sullivan EK et alTRAVOPROST a new prostaglandin analogue, is superior to timolol in lowering IOP in patients with OPEN ANGLE GLAUCOMA or ocular hypertension.",OPEN ANGLE GLAUCOMA,TRAVOPROST
720315748,5/12/2015 00:34:28,1634460757,5/12/2015 00:33:19,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],lowering IOP in patients with,treats,137,40,-1,155,50,TWrex-cause,803872-FS1,"Ratliff M, Fellman RL, Sullivan EK et alTRAVOPROST a new prostaglandin analogue, is superior to timolol in lowering IOP in patients with OPEN ANGLE GLAUCOMA or ocular hypertension.",OPEN ANGLE GLAUCOMA,TRAVOPROST
720315748,5/12/2015 00:47:49,1634466487,5/12/2015 00:47:10,false,instagc,1.0,29411108,USA,OH,Fairfield,71.79.16.89,[TREATS],[TREATS],alTRAVOPROST new prostaglandin superior lowering,N/A,137,40,-1,155,50,TWrex-cause,803872-FS1,"Ratliff M, Fellman RL, Sullivan EK et alTRAVOPROST a new prostaglandin analogue, is superior to timolol in lowering IOP in patients with OPEN ANGLE GLAUCOMA or ocular hypertension.",OPEN ANGLE GLAUCOMA,TRAVOPROST
720315748,5/12/2015 00:50:11,1634467351,5/12/2015 00:48:06,false,clixsense,1.0,22947672,GBR,"","",88.144.126.61,[TREATS],[TREATS],alTRAVOPROST lowering IOP in OPEN ANGLE GLAUCOMA,n/a,137,40,-1,155,50,TWrex-cause,803872-FS1,"Ratliff M, Fellman RL, Sullivan EK et alTRAVOPROST a new prostaglandin analogue, is superior to timolol in lowering IOP in patients with OPEN ANGLE GLAUCOMA or ocular hypertension.",OPEN ANGLE GLAUCOMA,TRAVOPROST
720315748,5/12/2015 01:07:02,1634474974,5/12/2015 01:06:34,false,elite,1.0,31848723,USA,"","",155.94.185.207,[SYMPTOM],[SYMPTOM],alTRAVOPROST OPEN ANGLE GLAUCOMA,N/A,137,40,-1,155,50,TWrex-cause,803872-FS1,"Ratliff M, Fellman RL, Sullivan EK et alTRAVOPROST a new prostaglandin analogue, is superior to timolol in lowering IOP in patients with OPEN ANGLE GLAUCOMA or ocular hypertension.",OPEN ANGLE GLAUCOMA,TRAVOPROST
720315748,5/12/2015 01:14:38,1634479051,5/12/2015 01:13:07,false,elite,1.0,32306791,NLD,"","",31.3.156.41,[TREATS],[TREATS],EK new,gdfg,137,40,-1,155,50,TWrex-cause,803872-FS1,"Ratliff M, Fellman RL, Sullivan EK et alTRAVOPROST a new prostaglandin analogue, is superior to timolol in lowering IOP in patients with OPEN ANGLE GLAUCOMA or ocular hypertension.",OPEN ANGLE GLAUCOMA,TRAVOPROST
720315748,5/12/2015 01:25:15,1634484935,5/12/2015 01:24:34,false,instagc,1.0,32556346,USA,PA,Warren,207.255.244.59,[TREATS],[TREATS],lowering,N/A,137,40,-1,155,50,TWrex-cause,803872-FS1,"Ratliff M, Fellman RL, Sullivan EK et alTRAVOPROST a new prostaglandin analogue, is superior to timolol in lowering IOP in patients with OPEN ANGLE GLAUCOMA or ocular hypertension.",OPEN ANGLE GLAUCOMA,TRAVOPROST
720315748,5/12/2015 01:33:03,1634488855,5/12/2015 01:31:48,false,instagc,1.0,30326470,USA,CA,San Diego,170.213.2.111,[ASSOCIATED_WITH],[ASSOCIATED_WITH],lowering,N/A,137,40,-1,155,50,TWrex-cause,803872-FS1,"Ratliff M, Fellman RL, Sullivan EK et alTRAVOPROST a new prostaglandin analogue, is superior to timolol in lowering IOP in patients with OPEN ANGLE GLAUCOMA or ocular hypertension.",OPEN ANGLE GLAUCOMA,TRAVOPROST
720315748,5/12/2015 03:22:18,1634545797,5/12/2015 03:21:45,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[CAUSES],[CAUSES],with,n/a,137,40,-1,155,50,TWrex-cause,803872-FS1,"Ratliff M, Fellman RL, Sullivan EK et alTRAVOPROST a new prostaglandin analogue, is superior to timolol in lowering IOP in patients with OPEN ANGLE GLAUCOMA or ocular hypertension.",OPEN ANGLE GLAUCOMA,TRAVOPROST
720315748,5/12/2015 03:35:11,1634552984,5/12/2015 03:34:34,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.227,[CONTRAINDICATES],[CONTRAINDICATES],alTRAVOPROST OPEN ANGLE GLAUCOMA,N/A,137,40,-1,155,50,TWrex-cause,803872-FS1,"Ratliff M, Fellman RL, Sullivan EK et alTRAVOPROST a new prostaglandin analogue, is superior to timolol in lowering IOP in patients with OPEN ANGLE GLAUCOMA or ocular hypertension.",OPEN ANGLE GLAUCOMA,TRAVOPROST
720315748,5/12/2015 04:10:07,1634569792,5/12/2015 04:09:27,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[TREATS],[TREATS],lowering IOP,N/A,137,40,-1,155,50,TWrex-cause,803872-FS1,"Ratliff M, Fellman RL, Sullivan EK et alTRAVOPROST a new prostaglandin analogue, is superior to timolol in lowering IOP in patients with OPEN ANGLE GLAUCOMA or ocular hypertension.",OPEN ANGLE GLAUCOMA,TRAVOPROST
720315748,5/12/2015 04:39:26,1634583502,5/12/2015 04:38:38,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],superior,none,137,40,-1,155,50,TWrex-cause,803872-FS1,"Ratliff M, Fellman RL, Sullivan EK et alTRAVOPROST a new prostaglandin analogue, is superior to timolol in lowering IOP in patients with OPEN ANGLE GLAUCOMA or ocular hypertension.",OPEN ANGLE GLAUCOMA,TRAVOPROST
720315748,5/12/2015 04:59:10,1634593246,5/12/2015 04:57:51,false,neodev,1.0,31910622,USA,CA,Los Angeles,108.185.211.151,[TREATS],[TREATS],in patients with,I didn´t select none.,137,40,-1,155,50,TWrex-cause,803872-FS1,"Ratliff M, Fellman RL, Sullivan EK et alTRAVOPROST a new prostaglandin analogue, is superior to timolol in lowering IOP in patients with OPEN ANGLE GLAUCOMA or ocular hypertension.",OPEN ANGLE GLAUCOMA,TRAVOPROST
720315749,5/11/2015 22:23:16,1634404068,5/11/2015 22:22:57,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[SYMPTOM],[SYMPTOM],OBESITY,N/A,39,0,-1,45,8,TWrex-cause,803599-FS1,ORLISTAT in the long term treatment of OBESITY in primary care settings.,OBESITY,ORLISTAT
720315749,5/11/2015 22:24:40,1634404650,5/11/2015 22:24:27,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],long term treatment,n/a,39,0,-1,45,8,TWrex-cause,803599-FS1,ORLISTAT in the long term treatment of OBESITY in primary care settings.,OBESITY,ORLISTAT
720315749,5/11/2015 22:30:32,1634406912,5/11/2015 22:30:10,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],ORLISTAT treatment of OBESITY,n/a,39,0,-1,45,8,TWrex-cause,803599-FS1,ORLISTAT in the long term treatment of OBESITY in primary care settings.,OBESITY,ORLISTAT
720315749,5/11/2015 22:39:47,1634411443,5/11/2015 22:39:25,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],long term treatment of,n/a,39,0,-1,45,8,TWrex-cause,803599-FS1,ORLISTAT in the long term treatment of OBESITY in primary care settings.,OBESITY,ORLISTAT
720315749,5/11/2015 22:40:26,1634411661,5/11/2015 22:39:59,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],ORLISTAT treatment of OBESITY,N/A,39,0,-1,45,8,TWrex-cause,803599-FS1,ORLISTAT in the long term treatment of OBESITY in primary care settings.,OBESITY,ORLISTAT
720315749,5/11/2015 22:44:24,1634413423,5/11/2015 22:44:05,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],ORLISTAT long term treatment of OBESITY,n/a,39,0,-1,45,8,TWrex-cause,803599-FS1,ORLISTAT in the long term treatment of OBESITY in primary care settings.,OBESITY,ORLISTAT
720315749,5/11/2015 22:53:34,1634417460,5/11/2015 22:52:23,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],ORLISTAT in long term treatment of OBESITY,n/a,39,0,-1,45,8,TWrex-cause,803599-FS1,ORLISTAT in the long term treatment of OBESITY in primary care settings.,OBESITY,ORLISTAT
720315749,5/11/2015 23:01:32,1634420061,5/11/2015 23:01:12,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,75.147.181.53,[TREATS],[TREATS],in the long term treatment of,N/A,39,0,-1,45,8,TWrex-cause,803599-FS1,ORLISTAT in the long term treatment of OBESITY in primary care settings.,OBESITY,ORLISTAT
720315749,5/11/2015 23:03:01,1634420545,5/11/2015 23:01:49,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[IS_A],[IS_A],ORLISTAT in the long term treatment of OBESITY in primary care settings.,N/A,39,0,-1,45,8,TWrex-cause,803599-FS1,ORLISTAT in the long term treatment of OBESITY in primary care settings.,OBESITY,ORLISTAT
720315749,5/11/2015 23:06:57,1634421983,5/11/2015 23:06:43,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,39,0,-1,45,8,TWrex-cause,803599-FS1,ORLISTAT in the long term treatment of OBESITY in primary care settings.,OBESITY,ORLISTAT
720315749,5/11/2015 23:07:00,1634422012,5/11/2015 23:06:03,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[OTHER],[OTHER],treatment,n/a,39,0,-1,45,8,TWrex-cause,803599-FS1,ORLISTAT in the long term treatment of OBESITY in primary care settings.,OBESITY,ORLISTAT
720315749,5/11/2015 23:08:16,1634422558,5/11/2015 23:07:18,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],treatment,the drug treats the condition,39,0,-1,45,8,TWrex-cause,803599-FS1,ORLISTAT in the long term treatment of OBESITY in primary care settings.,OBESITY,ORLISTAT
720315749,5/11/2015 23:08:34,1634422665,5/11/2015 23:08:05,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],in the long term treatment of,n/a,39,0,-1,45,8,TWrex-cause,803599-FS1,ORLISTAT in the long term treatment of OBESITY in primary care settings.,OBESITY,ORLISTAT
720315749,5/11/2015 23:10:02,1634423842,5/11/2015 23:07:40,false,clixsense,1.0,6330007,AUS,06,Hobart,101.178.23.54,[TREATS],[TREATS],long term treatment,n/a,39,0,-1,45,8,TWrex-cause,803599-FS1,ORLISTAT in the long term treatment of OBESITY in primary care settings.,OBESITY,ORLISTAT
720315749,5/11/2015 23:13:29,1634426158,5/11/2015 23:12:00,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,39,0,-1,45,8,TWrex-cause,803599-FS1,ORLISTAT in the long term treatment of OBESITY in primary care settings.,OBESITY,ORLISTAT
720315750,5/11/2015 22:23:33,1634404147,5/11/2015 22:23:18,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[PREVENTS],[PREVENTS],HERPES LABIALIS,N/A,86,107,-1,100,128,TWrex-cause,803877-FS1,"Spruance SL, Crumpacker CS, Schnipper LE et al. Early, patient initiated treatment of HERPES LABIALIS with TOPICAL 10% ACYCLOVIR",HERPES LABIALIS,TOPICAL 10% ACYCLOVIR
720315750,5/11/2015 22:24:56,1634404731,5/11/2015 22:24:41,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treatment,n/a,86,107,-1,100,128,TWrex-cause,803877-FS1,"Spruance SL, Crumpacker CS, Schnipper LE et al. Early, patient initiated treatment of HERPES LABIALIS with TOPICAL 10% ACYCLOVIR",HERPES LABIALIS,TOPICAL 10% ACYCLOVIR
720315750,5/11/2015 22:30:54,1634407095,5/11/2015 22:30:36,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],treatment of HERPES LABIALIS with TOPICAL 10% ACYCLOVIR,n/a,86,107,-1,100,128,TWrex-cause,803877-FS1,"Spruance SL, Crumpacker CS, Schnipper LE et al. Early, patient initiated treatment of HERPES LABIALIS with TOPICAL 10% ACYCLOVIR",HERPES LABIALIS,TOPICAL 10% ACYCLOVIR
720315750,5/11/2015 22:40:27,1634411675,5/11/2015 22:39:48,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[TREATS],[TREATS],treatment,n/a,86,107,-1,100,128,TWrex-cause,803877-FS1,"Spruance SL, Crumpacker CS, Schnipper LE et al. Early, patient initiated treatment of HERPES LABIALIS with TOPICAL 10% ACYCLOVIR",HERPES LABIALIS,TOPICAL 10% ACYCLOVIR
720315750,5/11/2015 22:41:07,1634411979,5/11/2015 22:40:27,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[TREATS],[TREATS],initiated treatment of HERPES LABIALIS with TOPICAL 10% ACYCLOVIR,N/A,86,107,-1,100,128,TWrex-cause,803877-FS1,"Spruance SL, Crumpacker CS, Schnipper LE et al. Early, patient initiated treatment of HERPES LABIALIS with TOPICAL 10% ACYCLOVIR",HERPES LABIALIS,TOPICAL 10% ACYCLOVIR
720315750,5/11/2015 22:45:59,1634414135,5/11/2015 22:44:25,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[TREATS],[TREATS],treatment of HERPES LABIALIS with TOPICAL 10% ACYCLOVIR,n/a,86,107,-1,100,128,TWrex-cause,803877-FS1,"Spruance SL, Crumpacker CS, Schnipper LE et al. Early, patient initiated treatment of HERPES LABIALIS with TOPICAL 10% ACYCLOVIR",HERPES LABIALIS,TOPICAL 10% ACYCLOVIR
720315750,5/11/2015 22:53:59,1634417598,5/11/2015 22:53:35,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],treatment of HERPES LABIALIS with TOPICAL 10% ACYCLOVIR,n/a,86,107,-1,100,128,TWrex-cause,803877-FS1,"Spruance SL, Crumpacker CS, Schnipper LE et al. Early, patient initiated treatment of HERPES LABIALIS with TOPICAL 10% ACYCLOVIR",HERPES LABIALIS,TOPICAL 10% ACYCLOVIR
720315750,5/11/2015 23:01:52,1634420148,5/11/2015 23:01:34,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,75.147.181.53,[TREATS],[TREATS],treatment of,N/A,86,107,-1,100,128,TWrex-cause,803877-FS1,"Spruance SL, Crumpacker CS, Schnipper LE et al. Early, patient initiated treatment of HERPES LABIALIS with TOPICAL 10% ACYCLOVIR",HERPES LABIALIS,TOPICAL 10% ACYCLOVIR
720315750,5/11/2015 23:04:21,1634420964,5/11/2015 23:03:02,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [IS_A],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]",HERPES LABIALIS with TOPICAL 10% ACYCLOVIR,N/A,86,107,-1,100,128,TWrex-cause,803877-FS1,"Spruance SL, Crumpacker CS, Schnipper LE et al. Early, patient initiated treatment of HERPES LABIALIS with TOPICAL 10% ACYCLOVIR",HERPES LABIALIS,TOPICAL 10% ACYCLOVIR
720315750,5/11/2015 23:07:10,1634422054,5/11/2015 23:06:58,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,86,107,-1,100,128,TWrex-cause,803877-FS1,"Spruance SL, Crumpacker CS, Schnipper LE et al. Early, patient initiated treatment of HERPES LABIALIS with TOPICAL 10% ACYCLOVIR",HERPES LABIALIS,TOPICAL 10% ACYCLOVIR
720315750,5/11/2015 23:07:40,1634422309,5/11/2015 23:07:02,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[OTHER],[OTHER],treatment,n/a,86,107,-1,100,128,TWrex-cause,803877-FS1,"Spruance SL, Crumpacker CS, Schnipper LE et al. Early, patient initiated treatment of HERPES LABIALIS with TOPICAL 10% ACYCLOVIR",HERPES LABIALIS,TOPICAL 10% ACYCLOVIR
720315750,5/11/2015 23:08:42,1634422748,5/11/2015 23:08:16,false,clixsense,1.0,30313955,GBR,K5,Poole,2.30.145.202,[TREATS],[TREATS],treatment,the condition is treated by the drug,86,107,-1,100,128,TWrex-cause,803877-FS1,"Spruance SL, Crumpacker CS, Schnipper LE et al. Early, patient initiated treatment of HERPES LABIALIS with TOPICAL 10% ACYCLOVIR",HERPES LABIALIS,TOPICAL 10% ACYCLOVIR
720315750,5/11/2015 23:08:59,1634422954,5/11/2015 23:08:35,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],treatment with,n/a,86,107,-1,100,128,TWrex-cause,803877-FS1,"Spruance SL, Crumpacker CS, Schnipper LE et al. Early, patient initiated treatment of HERPES LABIALIS with TOPICAL 10% ACYCLOVIR",HERPES LABIALIS,TOPICAL 10% ACYCLOVIR
720315750,5/11/2015 23:10:05,1634423853,5/11/2015 23:08:45,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,86,107,-1,100,128,TWrex-cause,803877-FS1,"Spruance SL, Crumpacker CS, Schnipper LE et al. Early, patient initiated treatment of HERPES LABIALIS with TOPICAL 10% ACYCLOVIR",HERPES LABIALIS,TOPICAL 10% ACYCLOVIR
720315750,5/11/2015 23:10:59,1634424660,5/11/2015 23:09:47,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,86,107,-1,100,128,TWrex-cause,803877-FS1,"Spruance SL, Crumpacker CS, Schnipper LE et al. Early, patient initiated treatment of HERPES LABIALIS with TOPICAL 10% ACYCLOVIR",HERPES LABIALIS,TOPICAL 10% ACYCLOVIR
720315751,5/12/2015 01:46:44,1634496311,5/12/2015 01:46:25,false,instagc,1.0,30326470,USA,CA,San Diego,170.213.2.111,[TREATS],[TREATS],treatment,N/A,99,41,-1,113,54,TWrex-cause,800523-FS1,"Nix DE, Cumbo TJ, Kuritzky P et al. Oral CIPROFLOXACIN in the treatment of serious soft tissue and BONE INFECTIONS: efficacy, safety, and pharmacokinetics.",BONE INFECTIONS,CIPROFLOXACIN
720315751,5/12/2015 03:29:46,1634550003,5/12/2015 03:29:06,false,bitcoinget,1.0,31256687,USA,NY,Brooklyn,24.146.181.193,[TREATS],[TREATS],treatment,n/a,99,41,-1,113,54,TWrex-cause,800523-FS1,"Nix DE, Cumbo TJ, Kuritzky P et al. Oral CIPROFLOXACIN in the treatment of serious soft tissue and BONE INFECTIONS: efficacy, safety, and pharmacokinetics.",BONE INFECTIONS,CIPROFLOXACIN
720315751,5/12/2015 03:48:31,1634558871,5/12/2015 03:47:58,false,neodev,1.0,32087449,USA,TX,Dallas,64.31.33.227,[TREATS],[TREATS],CIPROFLOXACIN BONE INFECTIONS:,N/A,99,41,-1,113,54,TWrex-cause,800523-FS1,"Nix DE, Cumbo TJ, Kuritzky P et al. Oral CIPROFLOXACIN in the treatment of serious soft tissue and BONE INFECTIONS: efficacy, safety, and pharmacokinetics.",BONE INFECTIONS,CIPROFLOXACIN
720315751,5/12/2015 04:22:30,1634575498,5/12/2015 04:22:15,false,bitcoinget,1.0,31947120,USA,CA,Arcadia,104.33.83.169,[TREATS],[TREATS],treatment of,N/A,99,41,-1,113,54,TWrex-cause,800523-FS1,"Nix DE, Cumbo TJ, Kuritzky P et al. Oral CIPROFLOXACIN in the treatment of serious soft tissue and BONE INFECTIONS: efficacy, safety, and pharmacokinetics.",BONE INFECTIONS,CIPROFLOXACIN
720315751,5/12/2015 05:01:51,1634594769,5/12/2015 05:01:26,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],treatment,none,99,41,-1,113,54,TWrex-cause,800523-FS1,"Nix DE, Cumbo TJ, Kuritzky P et al. Oral CIPROFLOXACIN in the treatment of serious soft tissue and BONE INFECTIONS: efficacy, safety, and pharmacokinetics.",BONE INFECTIONS,CIPROFLOXACIN
720315751,5/12/2015 05:11:44,1634600514,5/12/2015 05:11:26,false,neodev,1.0,31910622,USA,CA,San Francisco,108.169.6.201,[TREATS],[TREATS],in the treatment,I didn´t select none.,99,41,-1,113,54,TWrex-cause,800523-FS1,"Nix DE, Cumbo TJ, Kuritzky P et al. Oral CIPROFLOXACIN in the treatment of serious soft tissue and BONE INFECTIONS: efficacy, safety, and pharmacokinetics.",BONE INFECTIONS,CIPROFLOXACIN
720315751,5/12/2015 06:13:02,1634636739,5/12/2015 06:12:43,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],treatment,N/A,99,41,-1,113,54,TWrex-cause,800523-FS1,"Nix DE, Cumbo TJ, Kuritzky P et al. Oral CIPROFLOXACIN in the treatment of serious soft tissue and BONE INFECTIONS: efficacy, safety, and pharmacokinetics.",BONE INFECTIONS,CIPROFLOXACIN
720315751,5/12/2015 06:25:09,1634642400,5/12/2015 06:24:52,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[TREATS],[TREATS],treatment,N/A,99,41,-1,113,54,TWrex-cause,800523-FS1,"Nix DE, Cumbo TJ, Kuritzky P et al. Oral CIPROFLOXACIN in the treatment of serious soft tissue and BONE INFECTIONS: efficacy, safety, and pharmacokinetics.",BONE INFECTIONS,CIPROFLOXACIN
720315751,5/12/2015 06:41:58,1634649991,5/12/2015 06:41:29,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[TREATS],[TREATS],treatment,NA,99,41,-1,113,54,TWrex-cause,800523-FS1,"Nix DE, Cumbo TJ, Kuritzky P et al. Oral CIPROFLOXACIN in the treatment of serious soft tissue and BONE INFECTIONS: efficacy, safety, and pharmacokinetics.",BONE INFECTIONS,CIPROFLOXACIN
720315751,5/12/2015 06:42:50,1634650330,5/12/2015 06:42:18,false,prodege,1.0,18793920,USA,CA,Salinas,73.162.0.87,[TREATS],[TREATS],CIPROFLOXACIN treatment of serious BONE INFECTIONS:,n/a,99,41,-1,113,54,TWrex-cause,800523-FS1,"Nix DE, Cumbo TJ, Kuritzky P et al. Oral CIPROFLOXACIN in the treatment of serious soft tissue and BONE INFECTIONS: efficacy, safety, and pharmacokinetics.",BONE INFECTIONS,CIPROFLOXACIN
720315751,5/12/2015 06:43:22,1634650511,5/12/2015 06:42:47,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],treatment,n/a,99,41,-1,113,54,TWrex-cause,800523-FS1,"Nix DE, Cumbo TJ, Kuritzky P et al. Oral CIPROFLOXACIN in the treatment of serious soft tissue and BONE INFECTIONS: efficacy, safety, and pharmacokinetics.",BONE INFECTIONS,CIPROFLOXACIN
720315751,5/12/2015 06:46:17,1634651917,5/12/2015 06:45:50,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[TREATS],[TREATS],in the treatment of,N/A,99,41,-1,113,54,TWrex-cause,800523-FS1,"Nix DE, Cumbo TJ, Kuritzky P et al. Oral CIPROFLOXACIN in the treatment of serious soft tissue and BONE INFECTIONS: efficacy, safety, and pharmacokinetics.",BONE INFECTIONS,CIPROFLOXACIN
720315751,5/12/2015 07:01:42,1634658583,5/12/2015 07:01:20,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[TREATS],[TREATS],treatment of,N/a,99,41,-1,113,54,TWrex-cause,800523-FS1,"Nix DE, Cumbo TJ, Kuritzky P et al. Oral CIPROFLOXACIN in the treatment of serious soft tissue and BONE INFECTIONS: efficacy, safety, and pharmacokinetics.",BONE INFECTIONS,CIPROFLOXACIN
720315751,5/12/2015 07:51:59,1634689319,5/12/2015 07:51:43,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],in the treatment of,N/A,99,41,-1,113,54,TWrex-cause,800523-FS1,"Nix DE, Cumbo TJ, Kuritzky P et al. Oral CIPROFLOXACIN in the treatment of serious soft tissue and BONE INFECTIONS: efficacy, safety, and pharmacokinetics.",BONE INFECTIONS,CIPROFLOXACIN
720315751,5/12/2015 08:04:50,1634695650,5/12/2015 08:04:11,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[TREATS],[TREATS],treatment,Treatment o,99,41,-1,113,54,TWrex-cause,800523-FS1,"Nix DE, Cumbo TJ, Kuritzky P et al. Oral CIPROFLOXACIN in the treatment of serious soft tissue and BONE INFECTIONS: efficacy, safety, and pharmacokinetics.",BONE INFECTIONS,CIPROFLOXACIN
720315752,5/11/2015 22:15:52,1634400474,5/11/2015 22:15:33,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],PAROTITIS pancreatitis MUMPS VIRUS causative,n/a,43,210,1,51,221,TWrex-cause,810325-FS1,"The association of aseptic meningitis with PAROTITIS pancreatitis (abdominal pain and increased serum amylase levels), or oophoritis (abdominal pain and ovarian tenderness on pelvic examination) is a clue that MUMPS VIRUS is the causative agent.",PAROTITIS,MUMPS VIRUS
720315752,5/11/2015 22:16:25,1634400746,5/11/2015 22:16:05,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],oophoritis,N/A,43,210,1,51,221,TWrex-cause,810325-FS1,"The association of aseptic meningitis with PAROTITIS pancreatitis (abdominal pain and increased serum amylase levels), or oophoritis (abdominal pain and ovarian tenderness on pelvic examination) is a clue that MUMPS VIRUS is the causative agent.",PAROTITIS,MUMPS VIRUS
720315752,5/11/2015 22:18:26,1634401664,5/11/2015 22:17:28,false,neodev,1.0,11460728,CAN,BC,Burnaby,70.79.16.165,[SYMPTOM],[SYMPTOM],PAROTITIS is a clue that MUMPS VIRUS,N/A,43,210,1,51,221,TWrex-cause,810325-FS1,"The association of aseptic meningitis with PAROTITIS pancreatitis (abdominal pain and increased serum amylase levels), or oophoritis (abdominal pain and ovarian tenderness on pelvic examination) is a clue that MUMPS VIRUS is the causative agent.",PAROTITIS,MUMPS VIRUS
720315752,5/11/2015 22:18:33,1634401715,5/11/2015 22:18:14,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],causative agent.,n/a,43,210,1,51,221,TWrex-cause,810325-FS1,"The association of aseptic meningitis with PAROTITIS pancreatitis (abdominal pain and increased serum amylase levels), or oophoritis (abdominal pain and ovarian tenderness on pelvic examination) is a clue that MUMPS VIRUS is the causative agent.",PAROTITIS,MUMPS VIRUS
720315752,5/11/2015 22:18:54,1634401869,5/11/2015 22:16:45,false,elite,1.0,31883685,GBR,H2,Accrington,80.47.186.28,[CAUSES],[CAUSES],is the causative agent.,n/a,43,210,1,51,221,TWrex-cause,810325-FS1,"The association of aseptic meningitis with PAROTITIS pancreatitis (abdominal pain and increased serum amylase levels), or oophoritis (abdominal pain and ovarian tenderness on pelvic examination) is a clue that MUMPS VIRUS is the causative agent.",PAROTITIS,MUMPS VIRUS
720315752,5/11/2015 22:30:57,1634407107,5/11/2015 22:30:06,false,points4rewards,1.0,20306700,USA,WA,Bothell,50.125.145.37,[CAUSES],[CAUSES],causative,n/a,43,210,1,51,221,TWrex-cause,810325-FS1,"The association of aseptic meningitis with PAROTITIS pancreatitis (abdominal pain and increased serum amylase levels), or oophoritis (abdominal pain and ovarian tenderness on pelvic examination) is a clue that MUMPS VIRUS is the causative agent.",PAROTITIS,MUMPS VIRUS
720315752,5/11/2015 22:32:19,1634407588,5/11/2015 22:31:54,false,neodev,1.0,24564999,GBR,H9,London,86.145.227.9,[CAUSES],[CAUSES],causative agent.,n/a,43,210,1,51,221,TWrex-cause,810325-FS1,"The association of aseptic meningitis with PAROTITIS pancreatitis (abdominal pain and increased serum amylase levels), or oophoritis (abdominal pain and ovarian tenderness on pelvic examination) is a clue that MUMPS VIRUS is the causative agent.",PAROTITIS,MUMPS VIRUS
720315752,5/11/2015 22:33:06,1634407919,5/11/2015 22:32:10,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],PAROTITIS is clue that MUMPS VIRUS is the causative agent.,n/a,43,210,1,51,221,TWrex-cause,810325-FS1,"The association of aseptic meningitis with PAROTITIS pancreatitis (abdominal pain and increased serum amylase levels), or oophoritis (abdominal pain and ovarian tenderness on pelvic examination) is a clue that MUMPS VIRUS is the causative agent.",PAROTITIS,MUMPS VIRUS
720315752,5/11/2015 22:37:30,1634410214,5/11/2015 22:35:51,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SYMPTOM] [CAUSES],"[CAUSES]
[SYMPTOM]","The association of aseptic meningitis with PAROTITIS pancreatitis (abdominal pain and increased serum amylase levels), or oophoritis (abdominal pain and ovarian tenderness on pelvic examination) is a clue that MUMPS VIRUS is the causative agent.",N/A,43,210,1,51,221,TWrex-cause,810325-FS1,"The association of aseptic meningitis with PAROTITIS pancreatitis (abdominal pain and increased serum amylase levels), or oophoritis (abdominal pain and ovarian tenderness on pelvic examination) is a clue that MUMPS VIRUS is the causative agent.",PAROTITIS,MUMPS VIRUS
720315752,5/11/2015 22:41:10,1634411988,5/11/2015 22:40:49,false,instagc,1.0,28519532,USA,IA,Neola,38.121.112.217,[CAUSES],[CAUSES],causative agent.,na,43,210,1,51,221,TWrex-cause,810325-FS1,"The association of aseptic meningitis with PAROTITIS pancreatitis (abdominal pain and increased serum amylase levels), or oophoritis (abdominal pain and ovarian tenderness on pelvic examination) is a clue that MUMPS VIRUS is the causative agent.",PAROTITIS,MUMPS VIRUS
720315752,5/11/2015 22:44:47,1634413608,5/11/2015 22:44:12,false,bitcoinget,1.0,21743413,USA,WA,Lynnwood,75.147.181.53,[CAUSES],[CAUSES],is the causative agent.,N/A,43,210,1,51,221,TWrex-cause,810325-FS1,"The association of aseptic meningitis with PAROTITIS pancreatitis (abdominal pain and increased serum amylase levels), or oophoritis (abdominal pain and ovarian tenderness on pelvic examination) is a clue that MUMPS VIRUS is the causative agent.",PAROTITIS,MUMPS VIRUS
720315752,5/11/2015 22:45:33,1634413980,5/11/2015 22:44:54,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.185.107,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",association aseptic meningitis with PAROTITIS pancreatitis is a clue that MUMPS VIRUS is causative agent.,n/a,43,210,1,51,221,TWrex-cause,810325-FS1,"The association of aseptic meningitis with PAROTITIS pancreatitis (abdominal pain and increased serum amylase levels), or oophoritis (abdominal pain and ovarian tenderness on pelvic examination) is a clue that MUMPS VIRUS is the causative agent.",PAROTITIS,MUMPS VIRUS
720315752,5/11/2015 22:46:00,1634414136,5/11/2015 22:45:01,false,clixsense,1.0,6330007,AUS,06,Hobart,101.178.23.54,[CAUSES],[CAUSES],causative agent.,n/a,43,210,1,51,221,TWrex-cause,810325-FS1,"The association of aseptic meningitis with PAROTITIS pancreatitis (abdominal pain and increased serum amylase levels), or oophoritis (abdominal pain and ovarian tenderness on pelvic examination) is a clue that MUMPS VIRUS is the causative agent.",PAROTITIS,MUMPS VIRUS
720315752,5/11/2015 22:48:13,1634415345,5/11/2015 22:46:54,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],causative agent.,N/A,43,210,1,51,221,TWrex-cause,810325-FS1,"The association of aseptic meningitis with PAROTITIS pancreatitis (abdominal pain and increased serum amylase levels), or oophoritis (abdominal pain and ovarian tenderness on pelvic examination) is a clue that MUMPS VIRUS is the causative agent.",PAROTITIS,MUMPS VIRUS
720315752,5/11/2015 22:51:32,1634416818,5/11/2015 22:49:59,false,elite,1.0,30957357,CAN,BC,Kelowna,24.71.41.51,[MANIFESTATION],[MANIFESTATION],clue,I did not select none,43,210,1,51,221,TWrex-cause,810325-FS1,"The association of aseptic meningitis with PAROTITIS pancreatitis (abdominal pain and increased serum amylase levels), or oophoritis (abdominal pain and ovarian tenderness on pelvic examination) is a clue that MUMPS VIRUS is the causative agent.",PAROTITIS,MUMPS VIRUS
720315753,5/12/2015 05:07:31,1634597999,5/12/2015 05:06:58,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],Treatment,none,162,97,-1,169,111,TWrex-cause,803516-FS1,"440  >     Treatment of Symptomatic Cystitis, Pyelonephritis, or Fungus Balls  IV:  Conventional AMPHOTERICIN B: 0.3 0.6 mg/kg daily for 1 7 days for symptomatic CYSTITIS",CYSTITIS,AMPHOTERICIN B
720315753,5/12/2015 05:13:38,1634601679,5/12/2015 05:13:18,false,neodev,1.0,31910622,USA,CA,San Francisco,108.169.6.201,[TREATS],[TREATS],Treatment of,I didn´t select none.,162,97,-1,169,111,TWrex-cause,803516-FS1,"440  >     Treatment of Symptomatic Cystitis, Pyelonephritis, or Fungus Balls  IV:  Conventional AMPHOTERICIN B: 0.3 0.6 mg/kg daily for 1 7 days for symptomatic CYSTITIS",CYSTITIS,AMPHOTERICIN B
720315753,5/12/2015 06:17:58,1634639127,5/12/2015 06:17:27,false,clixsense,1.0,30681826,GBR,I3,Rochester,86.163.150.232,[TREATS],[TREATS],Treatment,N/A,162,97,-1,169,111,TWrex-cause,803516-FS1,"440  >     Treatment of Symptomatic Cystitis, Pyelonephritis, or Fungus Balls  IV:  Conventional AMPHOTERICIN B: 0.3 0.6 mg/kg daily for 1 7 days for symptomatic CYSTITIS",CYSTITIS,AMPHOTERICIN B
720315753,5/12/2015 06:27:38,1634643629,5/12/2015 06:27:18,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.56,[TREATS],[TREATS],Treatment,N/A,162,97,-1,169,111,TWrex-cause,803516-FS1,"440  >     Treatment of Symptomatic Cystitis, Pyelonephritis, or Fungus Balls  IV:  Conventional AMPHOTERICIN B: 0.3 0.6 mg/kg daily for 1 7 days for symptomatic CYSTITIS",CYSTITIS,AMPHOTERICIN B
720315753,5/12/2015 06:45:37,1634651620,5/12/2015 06:44:52,false,prodege,1.0,16878855,CAN,BC,Fort Saint John,216.232.163.142,[TREATS],[TREATS],Treatment,NA,162,97,-1,169,111,TWrex-cause,803516-FS1,"440  >     Treatment of Symptomatic Cystitis, Pyelonephritis, or Fungus Balls  IV:  Conventional AMPHOTERICIN B: 0.3 0.6 mg/kg daily for 1 7 days for symptomatic CYSTITIS",CYSTITIS,AMPHOTERICIN B
720315753,5/12/2015 06:47:55,1634652452,5/12/2015 06:47:34,false,elite,1.0,31856422,GBR,C9,Workington,92.18.169.149,[TREATS],[TREATS],Conventional daily for,N/A,162,97,-1,169,111,TWrex-cause,803516-FS1,"440  >     Treatment of Symptomatic Cystitis, Pyelonephritis, or Fungus Balls  IV:  Conventional AMPHOTERICIN B: 0.3 0.6 mg/kg daily for 1 7 days for symptomatic CYSTITIS",CYSTITIS,AMPHOTERICIN B
720315753,5/12/2015 06:54:06,1634655261,5/12/2015 06:53:02,false,neodev,1.0,31706957,NLD,07,Amsterdam,145.100.72.165,[TREATS],[TREATS],Treatment,n/a,162,97,-1,169,111,TWrex-cause,803516-FS1,"440  >     Treatment of Symptomatic Cystitis, Pyelonephritis, or Fungus Balls  IV:  Conventional AMPHOTERICIN B: 0.3 0.6 mg/kg daily for 1 7 days for symptomatic CYSTITIS",CYSTITIS,AMPHOTERICIN B
720315753,5/12/2015 07:04:48,1634659785,5/12/2015 07:04:23,false,instagc,1.0,24252915,GBR,K6,Portsmouth,89.240.160.95,[TREATS],[TREATS],Treatment,N/a,162,97,-1,169,111,TWrex-cause,803516-FS1,"440  >     Treatment of Symptomatic Cystitis, Pyelonephritis, or Fungus Balls  IV:  Conventional AMPHOTERICIN B: 0.3 0.6 mg/kg daily for 1 7 days for symptomatic CYSTITIS",CYSTITIS,AMPHOTERICIN B
720315753,5/12/2015 07:55:11,1634690867,5/12/2015 07:54:51,false,elite,1.0,32732290,GBR,A7,Birmingham,86.147.79.250,[TREATS],[TREATS],Treatment of,N/A,162,97,-1,169,111,TWrex-cause,803516-FS1,"440  >     Treatment of Symptomatic Cystitis, Pyelonephritis, or Fungus Balls  IV:  Conventional AMPHOTERICIN B: 0.3 0.6 mg/kg daily for 1 7 days for symptomatic CYSTITIS",CYSTITIS,AMPHOTERICIN B
720315753,5/12/2015 08:09:34,1634698119,5/12/2015 08:08:56,false,prodege,1.0,16101132,GBR,F9,Hayes,2.223.214.149,[TREATS],[TREATS],Treatment,Treated with,162,97,-1,169,111,TWrex-cause,803516-FS1,"440  >     Treatment of Symptomatic Cystitis, Pyelonephritis, or Fungus Balls  IV:  Conventional AMPHOTERICIN B: 0.3 0.6 mg/kg daily for 1 7 days for symptomatic CYSTITIS",CYSTITIS,AMPHOTERICIN B
720315753,5/12/2015 08:49:57,1634719770,5/12/2015 08:49:29,false,prodege,1.0,14528761,GBR,V2,Glasgow,2.222.244.231,[TREATS],[TREATS],Treatment,N/A,162,97,-1,169,111,TWrex-cause,803516-FS1,"440  >     Treatment of Symptomatic Cystitis, Pyelonephritis, or Fungus Balls  IV:  Conventional AMPHOTERICIN B: 0.3 0.6 mg/kg daily for 1 7 days for symptomatic CYSTITIS",CYSTITIS,AMPHOTERICIN B
720315753,5/12/2015 08:55:18,1634722532,5/12/2015 08:54:41,false,inboxpounds,1.0,29059658,GBR,H9,London,79.77.3.89,[TREATS],[TREATS],for symptomatic,N/A,162,97,-1,169,111,TWrex-cause,803516-FS1,"440  >     Treatment of Symptomatic Cystitis, Pyelonephritis, or Fungus Balls  IV:  Conventional AMPHOTERICIN B: 0.3 0.6 mg/kg daily for 1 7 days for symptomatic CYSTITIS",CYSTITIS,AMPHOTERICIN B
720315753,5/12/2015 09:33:19,1634744222,5/12/2015 09:32:30,false,neodev,1.0,30627835,GBR,H9,London,5.81.27.94,[TREATS],[TREATS],Treatment,N/A,162,97,-1,169,111,TWrex-cause,803516-FS1,"440  >     Treatment of Symptomatic Cystitis, Pyelonephritis, or Fungus Balls  IV:  Conventional AMPHOTERICIN B: 0.3 0.6 mg/kg daily for 1 7 days for symptomatic CYSTITIS",CYSTITIS,AMPHOTERICIN B
720315753,5/12/2015 10:35:06,1634794058,5/12/2015 10:33:56,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],"Treatment of Cystitis, AMPHOTERICIN B:",N/A,162,97,-1,169,111,TWrex-cause,803516-FS1,"440  >     Treatment of Symptomatic Cystitis, Pyelonephritis, or Fungus Balls  IV:  Conventional AMPHOTERICIN B: 0.3 0.6 mg/kg daily for 1 7 days for symptomatic CYSTITIS",CYSTITIS,AMPHOTERICIN B
720315753,5/12/2015 10:56:30,1634816577,5/12/2015 10:55:51,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH] [TREATS],"[TREATS]
[ASSOCIATED_WITH]",Treatment daily symptomatic,N/A,162,97,-1,169,111,TWrex-cause,803516-FS1,"440  >     Treatment of Symptomatic Cystitis, Pyelonephritis, or Fungus Balls  IV:  Conventional AMPHOTERICIN B: 0.3 0.6 mg/kg daily for 1 7 days for symptomatic CYSTITIS",CYSTITIS,AMPHOTERICIN B
